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Abstract 
Background: 
Early detection strategies for oral cancer aim to decrease the mortality 
rates and improve outcomes of the disease through early diagnosis and 
treatment. Guidance and regulatory bodies have an expectation that 
general dental practitioners will be able to promptly detect and refer 
patients with suspected oral cancerous lesions. However, the opportunities 
for early detection of oral cancer in primary dental care settings 
(particularly considering the low overall volume of the disease, the 
potentially increasing incidence rates, and the possibility of certain 
communities exhibiting particularly high rates) have not yet been 
investigated. This thesis examines the feasibility of early detection of oral 
cancer in primary dental care services, and undertakes risk-stratification to 
identify “high-risk” communities that can be utilised to target future early 
detection efforts. It further explores potential or missed opportunities for 
early detection in dental and other healthcare settings (both primary and 
secondary care), and assesses the feasibility of exploring routes to 
diagnosis. 
Aim: 
The aim of this thesis was to investigate opportunities for the early 
detection of oral cancer in Scotland by measuring the current burden of 
the disease, examining the feasibility of early detection in a dental setting, 
and exploring the potential role of alternative health care settings in early 
detection efforts.  
Methods 
Descriptive epidemiological and data linkage cohort studies utilising 
national routine administrative health datasets were undertaken. The 
descriptive epidemiological analysis included all cases of head and neck 
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cancer diagnosed between 1975 and 2012 and registered on the Scottish 
cancer Registry and annual midterm population estimates. These data 
were used to examine the incidence trends between 1975 and 2012 and the 
projected burden up to 2025 by individual subsites (oral cavity cancer, 
oropharyngeal cancer, and laryngeal cancer), age, sex, health board 
region, and socioeconomic status.  
The cohort study included all patients diagnosed with oral cancer between 
2010 and 2012 and registered on the Scottish Cancer Registry. The 
individual patient data were linked to NHS dental service activity in the 
two years prior to diagnosis, and this linked cohort dataset and published 
NHS Scotland dental workforce and registration and participation statistics 
were used to examine dental attendance rates and the feasibility of early 
detection of oral cancer in the primary dental care setting.  
The individual patient data from the cohort were also linked to the 
hospital outpatient, hospital inpatient/day case, primary dental care, and 
general practitioner prescription databases. These four healthcare services 
were selected based on data availability. The linked data were used to 
examine all healthcare service contacts made by the cohort in the two 
years prior to referral. Additionally, a preliminary exploration of the 
referral period (defined as the one-month period prior to diagnosis) was 
also undertaken. 
Results and conclusions 
The findings of this thesis showed that the incidence rates of head and 
neck cancer had increased in Scotland between 1975 and 2012, and this 
appeared to be largely driven by a dramatic rise in the rates of 
oropharyngeal cancer in recent decades. This burden was predicted to 
continue to rise up to 2025, with the rates of oropharyngeal cancer 
bypassing the rates of oral cavity cancer, which were expected to exhibit 
only a modest increase. Males, individuals above 60 years of age, and those 
from the most deprived areas of Scotland consistently exhibited the 
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highest rates of cancer, irrespective of subsite. Moreover, an almost dose-
like effect was seen to exist, with the rates of cancer increasing with the 
level of deprivation. Therefore, contrary to previous reports that 
oropharyngeal cancer exhibited an inverse socioeconomic profile, Scotland 
country-level data showed that those from the most deprived areas 
consistently bore the greatest incidence burden of head and neck cancer.  
Despite these increasing trends, the overall burden of oral cancer in 
Scotland was relatively low, and just over half of the cohort examined in 
this thesis had not contacted a general dental practitioner in the two years 
prior to diagnosis, thus automatically limiting opportunities for early 
detection. Dentists were estimated to potentially encounter one patient 
with oral cancer every 10 years, one patient with oral cavity cancer every 
17 years, and one patient with oropharyngeal cancer every 25 years. 
Therefore, strategies for early detection must consider the rarity of oral 
cancer incidence and the poor dental attendance patterns of patients, and 
the expectations of dentists in these efforts must be tempered. These 
results also highlight the importance of improving access and uptake of 
dental services among those at the highest risk of developing oral cancer 
(i.e. those from the most deprived communities).  
When examining the linked cohort data and undertaking a look-back 
analysis of their healthcare service contact history, just under half (45%) of 
the patients diagnosed with oral cancer were seen to have actually visited 
a primary care dental service clinic in the two years prior to the start of 
the referral period. However, the majority of the patients with oral cancer 
had contacted one of the four healthcare services examined (hospital 
outpatient, hospital inpatient/day-case, primary dental care, and general 
practitioner prescription) at least once over the same period, suggesting 
that there were potential or missed opportunities for the early detection 
of oral cancer in primary dental care and alternative healthcare settings. 
The proportions of patients contacting the four services increased closer to 
the start of the referral period, as did the mean number of contacts made 
with each service. Although not all of these instances would have 
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necessarily been associated with missed opportunities for early detection, 
it was highly likely that there were potential or missed opportunities 
amongst at least some of the patients with oral cancer.  
The two most common services contacted most recently before the start of 
the referral period were general practitioner prescription and hospital 
outpatient, and there was a possibility that these services were the sources 
of referral. The hospital specialties contacted most frequently during the 
one-month referral period were ENT, oral surgery, oral and maxillofacial 
surgery, and general surgery, suggesting that these contacts were likely to 
have been associated with the signs and symptoms of oral cancer. While no 
significant opportunities for the early detection of oral cancer in hospital 
or secondary care settings were identified, these findings demonstrated 
considerable potential in other primary care settings, particularly general 
medical practices and community pharmacies.  
In conclusion, this thesis identified several areas, particularly with regard 
to the subgroups of the population at the highest risk of developing cancer 
and alternative healthcare services, that early detection efforts can and 
should target. Future strategies should also aim to minimise delays in the 
diagnostic process and increase regular attendance rates by providing 
additional motivation and support to those who did not attend primary 
dental care clinics on a regular basis. 
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1 Introduction 
“It is hard to look at the tumour and not come away with the feeling that 
one has encountered a powerful monster in its infancy” (Mukherjee, 2010). 
As Siddhartha Mukherjee, an Indian-born American physicist and oncologist 
very eloquently described in his Pulitzer prize winning book, The Emperor 
of all Maladies, cancer is a killer disease that has become one of the 
leading causes of mortality in the world, and this trend is only going to 
continue to grow (Mukherjee, 2010). In an interview with the New York 
Times, Mukherjee said that he found himself “thinking of cancer as this 
character that has lived for 4,000 years” and wondering “what was its 
birth, what is its mind, its personality, its psyche?” (McGrath, 2010). This 
line of thought ultimately led to the birth of a biography of the disease 
that weaved together his experiences as an oncologist and the history of 
cancer treatment and research (Mukherjee, 2010). The “power” of cancer 
was more lyrically described previously by the American poet, Jason 
Shinder, when he, rather nonchalantly, said to his friend “cancer is a 
tremendous opportunity to have your face pressed right up against the 
glass of your mortality” upon receiving a diagnosis of non-Hodgkin’s 
lymphoma and leukaemia, diseases which ultimately claimed his life 
(Thernstrom, 2008). Mukherjee (2010) later commented on these words, 
saying that “what patients see through the glass is not a world outside 
cancer, but a world taken over by it—cancer reflected endlessly around 
them like a hall of mirrors”, highlighting the sheer power and 
overwhelming nature of the disease. Cancer not only has major impacts on 
the individuals affected by it and their families, but also on communities 
and countries. 
The World Health Organisation defined cancer as a “large group of diseases 
that are characterised by abnormal growth of cells beyond the limits of 
their usual boundaries, often accompanied by invasion into adjoining parts 
of the body and spread to other organs” (WHO, 2017a). The International 
Agency for Research on Cancer, in the 2014 World Cancer Report, 
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identified the global burden of cancer as one of the leading causes of 
mortality and morbidity, with over 14 million new patients and eight 
million cancer-related deaths occurring in 2012 alone (IARC, 2014). 
Approximately 60% of these new cancers and 70% of all cancer-related 
deaths occurred in Africa, Asia, and Central and South America. Vast global 
inequalities in the distribution of cancer between high and low-income 
countries were also observed, particularly by subsite, and such data were 
described by the WHO IARC as “key to an understanding of causation, and 
hence the development of preventive measures” (IARC, 2014). The total 
global annual economic cost of cancer was estimated to be approximately 
$US 1.16 trillion, thus posing a substantial threat to economies, families, 
and individuals (WHO, 2017a). The 70th World Health Assembly (2017) 
recently adopted a draft resolution, “Cancer prevention and control in the 
context of an integrated approach”, that included 18 sponsors, 40 member 
states, and 11 non-governmental organisations (NGO) (WHO, 2016). The 
broad consensus of this resolution was that cancer was a growing public 
health concern and required prioritisation and funding. Moreover, it 
clarified that this more concerted approach to the prevention and 
management of cancer was necessary if governments aimed to achieve the 
Sustainable Development Goals by 2030, particularly the target to decrease 
premature mortality from non-communicable diseases (NCDs), such as 
cancer, by one third, and the target which endeavoured to achieve 
universal health coverage to improve cancer care and outcomes (WHO, 
2017a).  
In 2012, head and neck cancers (comprising oral, pharyngeal and laryngeal 
cancers) were the seventh most common cancer in terms of incidence and 
ninth most common in terms of mortality globally (Ferlay et al., 2015). The 
majority (more than 60%) of these cancers are diagnosed at a late stage 
when the prognosis is considerably poorer and the treatment options are 
more expensive (CRUK, 2017b; Howlader et al., 2017). This thesis focuses 
on early detection efforts for oral cancer, and considers its relationship 
with the burden of the disease. This first chapter sets out the background 
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and context to the thesis and includes a literature review highlighting the 
various gaps and debates.  
Section 1.1– provides a broad background to the thesis, focusing mainly on 
the debates, both in the literature and clinically, in relation to the 
definitions of oral and head and neck cancer. 
Section 1.2 – reviews the descriptive epidemiological literature on oral 
cancer globally, and particularly in the United Kingdom. 
Section 1.3 – discusses the various concepts of early detection of oral 
cancer and the factors contributing to them, reviews the role of dental and 
alternative healthcare services in early detection efforts, and considers 
some of the evidence on missed opportunities for the early detection of 
cancer. 
Section 1.4 – provides a brief summary of the various debates in the 
literature and lists some of the gaps identified. 
Section 1.5 – sets out the hypotheses generated and the aims and 
objectives of this thesis.  
1.1 Cancer classification and definitions 
1.1.1 Early classification of diseases 
Nosology or the science of classification of diseases, if Albert Einstein’s 
definition of science as “an attempt to make the chaotic diversity of our 
sense experience correspond to a logically uniform system of thought” is to 
be adopted, has been a subject of research for a long time (McKusick, 
1969). The development of disease classification arose from a need to 
produce “comparable cause-of-death statistics”, and it allowed 
standardisation of groupings and the display of information collected 
during death registration (Moriyama et al., 2011). This work could be 
considered as the precursor of the discipline of descriptive epidemiology.  
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Moriyama et al. (2011) produced a detailed history of the classification of 
diseases. In summary, the first evidence of attempts to classify diseases 
(Jean Fernel’s Universa Medicini published in 1554 and Thomas Sydenham’s 
Opera Omnia published in 1685) were largely founded on humoral theories 
of disease and were of little use in terms of understanding the disease 
process. This approach underwent a radical change in the 18th century 
when various scientists such as Erasmus Darwin and F. Boissier de la Croix 
de Sauvages developed an interest in diseases. The latter published 
Nosologia Methodica, a treatise containing ten classes that were mainly 
symptoms subdivided into 300 orders and further genera. By the middle of 
this century, the ability of diseases to affect certain organs was 
recognised, and this led to the development of a morphological 
classification. Alibert’s Nosologie Naturelle, published in 1817, 
represented the last use of the “botanical” systems of disease 
classification, and was replaced by John Mason Good’s A Physiological 
System of Nosology, also published in 1817, which was included in future 
medical books and was used as a basis for disease nomenclature (Moriyama 
et al., 2011). 
William Farr, after examining all the existing nosologies, concluded that 
Sauvage’s work was the first of its kind to make any innovative 
contributions to the field. In 1839, he went on to publish the First Annual 
Report of the Registrar General of Births, Deaths, and Marriages in 
England (Felling, 1978; Eyler, 1979), where he divided the causes of death 
into three main categories: first were diseases that occurred on an 
epidemic or endemic basis or “communicable diseases”; second were 
diseases that appeared sporadically, which he further subdivided 
anatomically; and the third group was for death by violence. Although Farr 
campaigned the use of his system of classification extensively, it failed to 
gain popularity and was critiqued on various matters such as his decision to 
classify diseases anatomically and his notion of communicable diseases 
(Moriyama et al., 2011). Interestingly, William Farr, the nineteenth century 
British epidemiologist regarded as one of the founders of medical 
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statistics, also lends his name to the Farr Institute, a multicentre 
collaboration in the United Kingdom that provides infrastructure for big 
data and data linkage analysis (Farr Institute, 2017). 
The Great Exhibition held in 1851 in the Crystal Palace in London (UK), 
which brought together statisticians from all over the world, ultimately 
triggered the first International Statistical Congress in 1853 where “Causes 
of Death” was identified as one of the measures suitable for international 
statistical comparison (Moriyama et al., 2011). Jacques Bertillon, Chief of 
Statistics for the City of Paris, chaired a committee that was commissioned 
to prepare a classification of the causes of death, which was to be 
presented at the next meeting of the International Statistical Institute (ISI) 
held in Chicago (USA) in 1893. This list defined diseases by their nature of 
transmission or frequency of occurrence and included the following 14 
main headings: general diseases, diseases of the nervous system and sense 
organs, diseases of the circulatory system, diseases of the respiratory 
system, diseases of the digestive system, diseases of the genitourinary 
system, puerperal diseases, diseases of the skin and annexes, diseases of 
the locomotor organs, malformations, diseases of early infancy, diseases of 
old age, the effects of external causes, and ill-defined diseases. This 
classification received general acceptance and marked the birth of the 
International List of Causes of Death. By the next ISI meeting in 1899, this 
list had already been widely accepted in many countries in North America, 
South America, and Europe. In 1898, the American Public Health 
Association passed a resolution that this list would be revised every ten 
years, and this responsibility would be attributed to “an international 
committee for which strict regulations were set out” (Moriyama et al., 
2011). This was maintained up until the 6th revision when, following World 
War II and the demise of the League of Nations, this responsibility was 
handed over to the World Health Organisation who have been accountable 
for the revisions ever since (Moriyama et al., 2011).  
27 
 
 
1.1.2 International Classification of Diseases and Related 
Health Problems- 10th revision 
The International Classification of Diseases, now in its 10th revision, is a 
standardised diagnostic tool that defines the universe of diseases in a 
comprehensive manner, and its main purpose is to “allow systematic 
recording, analysis, interpretation, and comparison of mortality and 
morbidity data” across different countries and areas (WHO, 2004). It is also 
used for all epidemiological and health management purposes, including 
monitoring of the incidence and prevalence of various diseases and their 
relation to the characteristics of the affected individual, managing health 
care resources, ensuring that safety and quality guidelines are adhered to, 
scrutinising reimbursements, and monitoring outcomes. The International 
Classification of Diseases for Oncology (ICD-O) is an extension of the 
second (neoplasm) chapter of the International Classification of Diseases, 
and was first published by the WHO (2017c). It is mainly intended for use 
by cancer registries, and has a coding system that records tumour 
topography and morphology.  
The design of the ICD permits easy storage, retrieval, and analysis of 
health data to allow evidence based decision-making. It also permits easy 
exchange and comparison of data between various regions and hospital 
settings, as well as within the same region or hospital over different 
periods of time, and the principle users include nurses, health workers, 
physicians, health information managers, policy-makers, national health 
program managers, researchers, and epidemiologists (WHO, 2017c). 
However, this classification has also been described as having limited use 
when little or no information is available about the patient (Kurbasic et 
al., 2008). It is also considered unsuitable for indexing distinct clinical 
entities, and has some constraints in case of studies examining the 
financial aspects of diseases (WHO, 2004). Moreover, the definitive ICD 
coding of a disease can only be determined after several patient visits, and 
it is extremely rare for this to become apparent at the very first patient-
health care worker interaction (Kurbasic et al., 2008). This is particularly 
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true for cancer where there is a need to triangulate clinical and 
pathological information before confirming the diagnosis.  
Furthermore, although this system of classification of diseases is 
particularly good for the identification of individual precise anatomical 
sites (e.g. floor of the mouth), several debates begin to emerge when 
these sites are grouped into collective areas (e.g. oral cavity). This will be 
discussed in further detail later in this chapter. 
1.1.3 Definitions of head and neck cancer 
Head and neck cancer is defined by the World Health Organisation 
International Agency for Research on Cancer (WHO IARC) to broadly include 
all cancerous lesions of the lip, tongue, palate, floor of the mouth, gums, 
salivary glands, tonsils, oropharynx, nasopharynx, hypopharynx, and larynx 
(Barnes, 2005). However, various sources of literature often differ in their 
definitions of head and neck cancer, oral cavity cancer, and oropharyngeal 
cancer, particularly with regard to the subsites that are included within 
each of these groupings. The GLOBOCAN project, coordinated by IARC, 
provides a global perspective of the incidence, mortality, and survival of 
all cancers. This project addressed the “components” of head and neck 
cancer as individual subsites to show that incidence and mortality rates 
differed considerably based on the anatomical locations included, and 
made the data available via an interactive website (IARC, 2017a). 
However, they combined the lip (including external lip) and oral cavity as 
one subsite, and did not permit separation and examination of the rates of 
oropharyngeal cancer and oral cavity cancer individually. 
The National Cancer Institute (NCI), a subdivision of the US National 
Institute of Health, defined head and neck cancer as “cancer that arises in 
the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary 
glands, throat, or larynx [voice box])” (NCI, 2014). However, the fact 
sheets generated by the Surveillance, Epidemiology and End Results (SEER) 
program of the NCI used a different definition of head and neck cancer 
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wherein the oesophagus, eye and orbit, larynx, oral cavity and pharynx 
(with reporting for the sub-site of tongue), and thyroid were also included 
(Radosevich, 2013). Moreover, their main reports combined oropharynx and 
hypopharynx as one subsite, and the “Oral cavity and Pharynx” section of 
the SEER Cancer Statistics Review 1975-2014 focused on a combination of 
the anatomical locations and addressed the individual subsites only very 
briefly (Howlader et al., 2017). 
Another important and accessible source of cancer statistics in the United 
Kingdom is Cancer Research UK (CRUK), a cancer charity that promotes and 
funds research campaigns for better cancer prevention and management. 
They defined head and neck cancer as including approximately thirty 
different organs and tissues including the “eye, nasal and paranasal sinus 
(cancers in the nasal cavity and in the sinuses around the nose), 
nasopharynx (the area that connects the back of the nose to the back of 
the mouth), mouth and oropharynx (cancers of the tongue, the gums, 
cheeks, lip and floor and roof of the mouth), larynx or laryngeal cancer 
(cancer of the voice box), and oesophagus (cancer of the food pipe or 
gullet)” (CRUK, 2017a). In contrast, the National Head and Neck Cancer 
Audit, 2014, conducted in England and Wales, defined head and neck 
cancer as “neoplasms arising principally from the mouth (oral cavity), 
voice box (larynx), throat / upper gullet (pharynx), salivary glands, nose 
and sinuses, and primary bone tumours of the jaw”, and did not appear to 
include tumours involving the oesophagus (NHS, 2014). Similarly, the 
Scottish Cancer Registry defined head and neck cancer as including 
malignant neoplasms of the lip, oral cavity, pharynx, nasal cavity, middle 
ear, accessory sinuses, and the larynx (ICD-10 codes C00-C14 and C30-C32), 
and also did not include tumours of the oesophagus (ISD Scotland, 2017a).  
1.1.4 Definitions of oral cancer 
A review of the literature on the definitions of oral cancer revealed a lack 
of consensus in the terminology used, with common variations including 
cancer of the mouth and pharynx, cancer of the oral cavity, intraoral 
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cancer, oral cavity cancer, oral malignant tumours etc (Tapia and 
Goldberg, 2011). This not only complicated search strategies but also 
hindered the identification of all relevant and appropriate studies. 
Although no systematic review was undertaken here, a thorough literature 
search identified a short list of the various terms in use (Table 1-1).  
This was further complicated by a lack of consensus in the method of 
definition employed, with two main schools of thought becoming apparent. 
The first was an anatomical method of definition which took the 
boundaries of the various subsites into consideration, while the second was 
an aetiological method of definition largely focused on risk factors 
(particularly the relatively newly recognised risk factor, the human 
papilloma virus) (D’Souza, 2007).
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Table 1-1: Different terminologies used for “oral cancer” [adapted from (Tapia and 
Goldberg, 2011)] 
 
 
 
 
 
Cancer of the tongue and oral cavity and pharynx (Møller, 1989) 
 
Cancer of the oral cavity/oropharynx (Merletti et al., 1989) 
 
Tongue and mouth cancer (Franceschi et al., 1990) 
 
Malignant oral tumours (Östman et al., 1995) 
 
Mouth cancer (Moore et al., 2000a) 
 
Oral cavity and pharynx cancer (Canto and Devesa, 2002) 
 
Cancer of the oral cavity (Carvalho et al., 2004) 
 
Oral and pharyngeal cancer (Tarvainen et al., 2004) 
 
Intraoral cancer (Chandran et al., 2005) 
 
Oral cavity and oropharyngeal cancers (Gillison, 2007) 
 
Oral cavity and pharynx-throat cancer (Rodu and Cole, 2007) 
 
Cancer of mouth and pharynx (Tarvainen et al., 2008) 
 
Oral and oropharyngeal cancer (Warnakulasuriya, 2009a) 
 
Cancer of oral cavity and pharynx (Goldstein et al., 2010) 
 
Oral cancer (Zini et al., 2010) 
 
Oral cavity cancer (de Camargo Cancela et al., 2010) 
 
Oral malignant tumours (Rojas Alcayaga et al., 2010) 
 
 
32 
 
 
1.1.4.1  Anatomical definitions of oral cancer 
Unlike other parts of the body, the boundaries of the oral cavity, that is, 
where the “mouth” ends and the “throat” begins, cannot always be clearly 
demarcated, resulting in variations in the way in which “oral cancer” is 
defined in published literature, as reviewed by Tapia and Goldberg (2011). 
Gray’s Anatomy defined the mouth or oral cavity as extending from the 
internal mucosal surface of the lips to the palatoglossal fold antero-
posteriorly, and from the floor of the mouth and tongue to the hard palate 
infero-superiorly (Bannister et al., 1999). The buccal mucosa lined the 
cheek from the commissure of the lips to the palatoglossal fold, and the 
gingiva outlined the teeth. All of these soft tissues were lined by squamous 
epithelium, and different areas of the mouth exhibited different levels of 
keratinisation (Bannister et al., 1999). The oropharynx was the region lying 
behind the oral cavity, anatomically defined superiorly by the posterior 
section of the soft palate and inferiorly by the superior border of the 
epiglottis. Anterio-posteriorly, Gray’s stated that it extended from the 
posterior third of the tongue and the isthmus of Fauces to the 
oropharyngeal wall. The palatopharyngeal arches and tonsils were found 
laterally (Bannister et al., 1999).  
Although these are the broadly accepted boundaries, other anatomical 
texts seemed to vary in their descriptions of the boundaries (Cunningham, 
1818; Bannister et al., 1999; Rosse and Gaddum-Rosse, 1997), particularly 
with regard to the interface between the oral cavity and oropharynx. De 
Camargo Cancela et al. (2010) defined oral cancer as including only the 
areas within the vermillion border of the lip and the junction between the 
soft and hard palates, while others included the oropharynx 
(Warnakulasuriya, 2009a), nasopharynx and hypopharynx (Rodu and Cole, 
2007). 
Smith et al. (2010) stated that currently there existed an “uncontrolled 
explosion of different ways of describing information”, and this not only 
complicated epidemiological research but also made it difficult to identify 
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relevant literature with ease (Tapia and Goldberg, 2011). Grouping various 
anatomical sites under one definition had certain advantages such as 
reducing the risk of issues with classification and increasing the number of 
eligible cases in wider diagnostic categories, as concluded by Moore et al. 
(2000b). Moreover, according to Boyle et al. (1990), it also eliminated the 
need for accurate estimation of the primary site of the tumour, as 
classifying neoplasms into sub-groups of oral cancer often reduced the 
need for clinicians to assign a precise location to tumours that extended 
over multiple anatomical sites. However, this type of grouping also had 
some documented disadvantages including loss of information and masking 
or misrepresentation of the true rates of cancer, particularly when the 
anatomical subsites differed with regard to aetiology and pathogenesis 
and, in case of large populations, exhibited high incidence rates of any one 
of the subsites (Smith, 1989; Junor et al., 2010). 
1.1.4.2  Aetiological definition of oral cancer 
Evidence from case-control and descriptive epidemiological studies have 
suggested that oral cavity and oropharyngeal cancers may differ in terms 
of their risk factors (Chaturvedi et al., 2008). The most important 
advancements in understanding these risk factors were made under the 
auspices of the International Head and Neck Cancer Consortium (INHANCE). 
This collaboration pooled together individual participant data from 35 
large case-control studies, and now contains a total of 25,500 patients with 
head and neck cancer and 37,100 controls (INHANCE, 2004). Winn et al. 
(2015) summarised the results of the INHANCE analyses and reported that 
the key risk factors of oral cavity cancer were tobacco and alcohol 
consumption, with increased risk of developing cancer being observed upon 
smoking even a few cigarettes a day and considerable benefits being 
associated with quitting tobacco consumption. Other risk factors identified 
by them included socioeconomic factors such as low education and income, 
lean body weight, family history of head and neck cancer, and short 
height. Dietary factors such as increased intake of fruits and vegetables 
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and foods high in antioxidants, on the other hand, were reported to have a 
protective effect and reduce the risk of developing cancer.  
However, in relation to differences in aetiological factors by subsite, 
D’Souza et al. (2007), in their case-control study examining 100 patients 
diagnosed with oropharyngeal cancer and 200 controls, first reported an 
association between the human papillomavirus (HPV) infection and 
oropharyngeal cancer. This was corroborated by several other studies that 
reported an association between HPV infections and the individual subsites 
typically included under oropharyngeal cancer (El-Mofty and Lu, 2003; 
Herrero et al., 2003; Gillison, 2004; Dahlstrand and Dalianis, 2005; Furniss 
et al., 2007). In contrast, HPV infections did not appear to affect the oral 
cavity and other subsites in the head and neck region to the same degree, 
although the evidence on this was relatively unclear (Hübbers and Akgül, 
2015). 
This critical difference in the aetiology of oral cavity cancer and 
oropharyngeal cancer has resulted in many epidemiological studies opting 
to examine incidence trends by HPV-associated groups instead of the more 
traditional subsites (oral cavity and oropharynx) (Chaturvedi et al., 2008; 
Chaturvedi et al., 2011; Chaturvedi, 2012). This has also given rise to 
another method of definition wherein subsites exhibiting an association 
with HPV (such as the base of the tongue and tonsil) are included under 
oropharyngeal cancer (Gillison, 2000; Dahlstrand and Dalianis, 2005), and 
the remaining are classified under oral cavity cancer. In order to better 
understand these differences, the main global cancer epidemiology and 
surveillance agencies as well as a few known local groups were selected 
and their definitions of oral cavity and oropharyngeal cancers were 
assessed. Tables 1-2 and 1-3 show the variations in the subsites included 
under the definitions of “oral cavity cancer” and “oropharyngeal cancer” 
between some of these databases. The major differences appeared to lie 
in the grouping of the lingual tonsil, soft palate, uvula, and the base of the 
tongue, with some databases opting to include them under oral cavity 
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cancer (possibly anatomical method of definition) and others including 
them under oropharyngeal cancer (HPV-associated method of definition).  
Table 1-2: Inconsistencies in subsites included under “oral cavity cancer” in various 
descriptive databases 
 
 
 
X indicates inclusion in “oral cavity cancer” for this database;  
INHANCE: International Head and Neck Cancer Epidemiology Consortium;  
SEER: Surveillance, Epidemiology and End Results Program;  
ACS: American Cancer Society Cancer Facts and Figures Report;  
Gillison group: Maura Gillison research group+ recent publications (Chaturvedi et al. 2008, 
2011, 2013); 
CI5: Cancer incidence in Five Continents;  
NCIN: National Cancer Intelligence Network.  
 
Oral Cavity Cancer 
Subsite INHANCE SEER ACS 
IARC 
GLOBOCAN C15 
Gillison  
group NCIN 
Scottish 
Cancer 
Registry 
External lip  X X X     
Lip X X X X     
Base of 
tongue, NOS  X X X X   X 
Dorsal 
surface of 
tongue, NOS X X X X X X X X 
Lingual 
tonsil  X  X X  X X 
Overlapping 
lesion of 
tongue, or 
tongue NOS  X X X X X X X 
Upper gum X X X X X X X X 
Soft palate, 
Uvula  X X X X X  X 
Overlapping 
lesion of 
palate or 
palate NOS  X X X X X  X 
Cheek 
mucosa X X X X X X X X 
Overlapping 
lesion of 
other and 
unspecified X X X X X X X X 
Mouth, NOS X X X X X X X X 
Salivary 
parotid 
gland  X X X     
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Table 1-3: Inconsistencies in subsites included under “oropharyngeal cancer” in 
various descriptive databases 
 
 
Oropharyngeal Cancer 
Subsite INHANCE SEER 
Chaturvedi 
2008, 
2011, 2013 C15 NCIN 
Scottish 
Cancer 
Registry 
Base of 
tongue X  X  X X 
Lingual 
tonsil X  X   X 
Soft palate, 
NOS X     X 
Uvula X     X 
Tonsil X X X  X X 
Anterior 
surface of 
epiglottis  X X X X X 
Lateral wall 
of 
oropharynx X X X X X X 
Pharynx, 
NOS   X    
Waldeyer’s 
ring   X    
Overlapping 
lesion of 
lip, oral 
cavity and 
pharynx       
 
X indicates that this subsite is included in “oropharyngeal cancer” for this database or 
study. INHANCE: International Head and Neck Cancer Epidemiology Consortium;  
SEER: Surveillance, Epidemiology and End Results Program;  
ACS: American Cancer Society Cancer Facts and Figures Report;  
CI5: Cancer incidence in Five Continents;  
Gillison group: Maura Gillison’s research group+ recent publications (Chaturvedi et al. 
2008, 2011, 2013); 
NCIN: National Cancer Intelligence Network.  
The American Cancer Society and GLOBOCAN 2012 do include an oropharyngeal cancer 
group. 
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The Scottish Cancer Registry further complicated matters on their website 
by providing routine cancer statistics on “Cancers of the Lip, Oral Cavity 
and Pharynx” (defined as including ICD-10 codes C00-C14), “Cancers of the 
Mouth” (defined as including ICD-10 codes C03-C06), “Cancers of the Oral 
Cavity” (defined as including ICD-10 codes C01-C06) and “Cancer of the 
Oropharynx” (defined as including ICD-10 codes C01, C02.4, C05.1, C05.2, 
C09, C10) separately (Scottish Cancer Registry, 2017). 
There also remained a certain level of confusion surrounding the 
histological types that were included in the various definitions. Although it 
was clear that neoplasms involving the epithelium were always regarded as 
oral cancer, the inclusion of tissues surrounding the mucosa such as 
salivary, muscle, lymphoid, and nerve tissue within this definition was still 
controversial (Tapia and Goldberg, 2011). However, most authorities 
limited their definition of oral cavity and oropharyngeal cancer to 
squamous cell carcinomas as approximately 90% of all malignant lesions 
involving these subsites were of this type (Barnes, 2005). 
1.1.5 Clinicians’ perspectives on oral cancer definitions 
The World Health Organisation International Agency for Research on 
Cancer, in their report titled Pathology & Genetics: Head and Neck 
Tumours, summarised the signs and symptoms of oral cavity and 
oropharyngeal cancer and reported that small carcinomas of the oral cavity 
often remained asymptomatic, highlighting the need for a “high index of 
clinical suspicion”, particularly in “high-risk” patients (Barnes, 2005). 
Symptoms of locally advanced oral cancer included mucosal growth and 
ulceration, pain (including facial pain, sore throat, neck pain, tongue pain, 
pain when chewing, mouth pain, gingival pain, pain when swallowing, 
burning mouth, dental pain, pain in the palate, and ear-ache), 
paraesthesia, malodour from the mouth, trismus, bleeding, dysphagia and 
problems using prostheses, mobility of teeth, difficulty in speech, weight 
loss, and problems in breathing (Haya‐Fernández et al., 2004; Barnes, 
2005; Cuffari et al., 2006). Extremely advanced stages of cancer were 
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usually associated with ulcero-proliferative growths and necrosis that 
extended to the surrounding tissues, while patients in the terminal stages 
of oral cancer usually exhibited cervical lymphadenopathy, bleeding, skin 
fistulas, cachexia, and anaemia (Barnes, 2005; Bagan et al., 2010).  
Head and neck cancers are typically managed in tertiary settings by a 
single multidisciplinary team, and guidelines on the management of these 
cancers usually tend to cluster the individual sites into wider groupings. 
Malignant neoplasms themselves do not obey strict anatomical boundaries 
and can often bridge both the oral cavity and oropharyngeal subsites. In 
primary care, most guidelines for the detection of such lesions consider the 
two subsites (oral cavity and oropharynx) together as “oral cancer” as their 
signs and symptoms overlap considerably and dentists and other primary 
care practitioners potentially have a role in the primary and secondary 
prevention of cancers affecting both subsites (Kreimer, 2014; NICE, 2015a; 
NHS Scotland, 2016b). The National Institute for Health and Care 
Excellence’s (NICE) guideline on “Suspected cancer: recognition and 
referral” recommended a “suspected oral cancer referral” in case of 
unexplained ulcerations in the oral cavity for more than three weeks or a 
persistent lump in the neck, and an “urgent oral cancer referral” in case of 
a lump on the lip or in the oral cavity, a red or red and white patch in the 
oral cavity, or erythroleukoplakia (NICE, 2015b). Similarly, the Scottish 
Cancer Referral Guidelines provided a list of signs and symptoms for the 
recognition of all head and neck cancers combined (Table 1-4) (NHS 
Scotland, 2016b).  
Therefore, although it is important to focus on individual subsites from an 
aetiological and epidemiological perspective, as discussed previously, 
combining the two and examining them together as oral cancer continues 
to be more appropriate from a clinical perspective. 
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Table 1-4: Scottish Cancer Referral Guidelines for urgent suspicion of cancer referral: 
Head and Neck Cancer (NHS Scotland, 2016b) 
 
 
Persistent unexplained head and neck lumps for >3 weeks. 
Ulceration or unexplained swelling of the oral mucosa persisting for 
>3 weeks. 
All red or mixed red and white patches of the oral mucosa persisting 
for >3 weeks. 
Persistent hoarseness lasting for >3 weeks (request a chest X-ray at 
the same time). 
Dysphagia or odynophagia (pain on swallowing) lasting for >3 weeks. 
Persistent pain in the throat lasting for >3 weeks. 
 
1.1.6 Oral cancer definitions – conclusions from the literature  
The head and neck region encompasses numerous subsites, and cancers 
affecting these sites vary considerably in aetiology. Therefore, the manner 
in which subsite groupings are defined may have considerable impact on 
the outcomes of epidemiological research. The literature review (search 
strategy shown in Appendix 11) uncovered a general lack of consensus in 
the definition of “oral cancer”, which included variations in the 
terminology used, thus complicating search strategies and hindering the 
identification of appropriate studies, as well as the individual subsites (i.e. 
ICD codes) included within each grouping. Appraisal of the evidence 
revealed two main schools of thought with regard to the ICD codes 
included within each subsite grouping. The first was an anatomically driven 
method of definition, wherein subsites included within the “oral cavity 
cancer” and “oropharyngeal cancer” groupings were selected based on 
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their anatomical location and boundaries, while the second was an 
aetiological method of definition that grouped subsites based on their 
association with human papilloma virus infections.  
Therefore, based on this evidence, the current thesis decided to opt for a 
“compromise” (anatomical and HPV-associated) method of defining 
subsites for the descriptive epidemiological analyses examining the burden 
and trends of oral cavity and oropharyngeal cancer presented later in 
Chapters 2 and 3. The individual ICD-10 codes included within each subsite 
grouping have been discussed in detail in the later chapters and have also 
been shown in Appendix 1. Briefly, oropharyngeal cancer was defined as 
including the base of the tongue (C01), lingual tonsil (C2.4), tonsil (C09), 
oropharynx (C10), and the pharynx (C14); while oral cavity cancer 
included the inner lip (C00.3-C00.9), other and unspecified parts of the 
tongue (C02), gum (C03), floor of the mouth (C04), palate (C05), and other 
and unspecified parts of the mouth (C06). 
However, evidence also showed that, from a clinician’s perspective (both 
primary and secondary care), a more generalised definition of “oral 
cancer” that combined the two subsites (oral cavity cancer and 
oropharyngeal cancer) together was more fitting. This was mainly based on 
the fact that tumours rarely followed specific anatomical boundaries and 
the signs and symptoms of cancers affecting the various subsites in the 
head and neck region overlapped considerably. As a result, most guidelines 
for the detection of oral cancer considered the two subsites (oral cavity 
and oropharynx) together. 
Therefore, a more generalised definition of oral cancer [including the base 
of the tongue (C01), lingual tonsil (C2.4), tonsil (C09), oropharynx (C10), 
pharynx (C14), inner lip (C00.3-C00.9), other and unspecified parts of the 
tongue (C02), gum (C03), floor of the mouth (C04), palate (C05), and other 
and unspecified parts of the mouth (C06)] that combined oral cavity cancer 
and oropharyngeal cancer (defined as mentioned previously) was also 
considered in this thesis, particularly for the analyses presented in Chapter 
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3 and 4, as this was thought to be more relevant for interpretation of the 
results from a clinical perspective.  
1.2 Describing and assessing the incidence burden of 
head and neck cancer and subsites 
It has been estimated that approximately 38 million deaths in the world, 
representing two-thirds of the total 56 million deaths annually, are caused 
by non-communicable diseases (NCD), particularly cardiovascular disease, 
chronic respiratory disorder, diabetes, and cancer (Bray and 
Soerjomataram, 2015). Between 1990 and 2010, a global transition of sorts 
was observed, with deaths from communicable diseases decreasing by 17% 
and those from NCDs increasing by 30% (Bray and Soerjomataram, 2015). 
The majority (almost 80%) of these NCD-related deaths occurred in low- 
and middle-income countries, and a large proportion of those occurring in 
high-income countries were attributed to cancer (Bray and Soerjomataram, 
2015).  
A literature search for the incidence trends of oral cancer showed that the 
evidence varied considerably in terms of the subsites considered, with the 
majority of the studies focusing on head and neck cancer as a whole and 
laying smaller emphasis on certain subsites. Additionally, the literature 
also differed in terms of the combinations of individual subsites 
considered. Therefore, in order to examine the evidence on the burden 
and trends of oral cancer (and subsites), it is important to first assess the 
literature of head and neck cancer as oral cancer data are often included 
within these studies. Moreover, the burden and trends of head and neck 
cancer also provide an interesting context. Therefore, this section of the 
thesis first reviews the evidence on the global incidence burden of head 
and neck cancer, and then discusses variations in trends by individual 
subsites, gender, age, and socioeconomic status. It then brings the focus 
closer to home by reviewing the evidence on the incidence burden of oral 
cancer in the United Kingdom, discusses variations in the trends by 
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different sociodemographic determinants, and identifies some of the gaps 
in the literature. 
1.2.1 Global incidence burden of head and neck cancer over 
time 
The World Health Organisation International Agency for Research on 
Cancer reported that approximately 529,000 new cases and 292,000 deaths 
from oral cavity and pharyngeal cancers occurred globally in 2012 (IARC, 
2014). Although the individual subsites (lip, oral cavity, nasopharynx and 
pharynx) did not rank high, combined they represented the seventh most 
common cancer in terms of incidence in the world (IARC, 2014). 
Schottenfeld (2006) pooled together data from the Cancer Incidence in 
Five Continents (Volumes III to VIII) database and examined the trends of 
oral cavity and pharyngeal cancer by geographic area and gender for the 
period between 1968-1972 and 1993-1997. They reported that between 
1993 and 1997, the highest age-adjusted annual incidence rates of oral 
cavity and pharyngeal cancer were observed in males from the Somme and 
Bas-Rhin regions of France (more than 40 per 100,000 individuals) and 
females from South Karachi (Pakistan) and Bangalore (India) (more than 
ten per 100,000 individuals). Moreover, the age-adjusted incidence rates 
for males had exhibited an overall decline of 30% in some countries such as 
India, Puerto Rico, Columbia, Singapore, and Israel. In contrast, rates had 
increased by almost 100% in Japan, Denmark, Spain, Poland, and Germany. 
Similarly, for females, rates had decreased by 30% among Jews in Israel, 
Singaporean Indians, and Puerto Ricans, but had almost doubled in 
Germany, Denmark, Canada, and Switzerland. Strong birth cohort effects 
on trends were also observed in many countries, with incidence rates first 
beginning to increase among cohorts born in the early decades of the 20th 
century and then continuing to rise in the subsequent cohorts. The rising 
incidence rates between 1968-1989 in Slovakia were largely attributable to 
greater per capita consumption of tobacco and alcohol, while the trends 
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observed in countries such as Scotland, Denmark, Wales, and England 
reflected changes in the consumption of alcohol more than tobacco. 
The GLOBOCAN project, operated by the International Agency for Research 
on Cancer, has been providing estimates of the global cancer burden since 
1975 (IARC, 2017a). Parkin et al. (2005), in their summary of these 
estimates for 2002, reported that there were 274,000 cases of oral cavity 
cancer globally, and two-thirds of these occurred in males. The highest 
rates for men were observed in Western and Southern Europe, South Asia, 
Australia, New Zealand, and South Africa, while those for women were 
observed in South Asia. These rates largely reflected the high prevalence 
of key risk factors such as smoking and the consumption of smokeless 
tobacco (betel quid) in Europe and Asia, respectively.  
Warnakulasuriya (2009a) reviewed the global epidemiology of oral and 
oropharyngeal cancer in various high-risk regions of the world and reported 
that, in 2004, the highest incidence rates were observed in countries in 
South and South-East Asia (including Pakistan, India, Taiwan, and Sri 
Lanka), some parts of Western and Eastern Europe (including France, 
Hungary, Slovenia, and Slovakia), parts of Latin America and the Caribbean 
(including Puerto Rico, Brazil, and Uruguay), and some Pacific regions 
(including Melanesia and Papua New Guinea). Within the European Union, 
the highest incidence rates were observed in France and Hungary; Spain, 
Portugal, Switzerland, and Germany exhibited intermediate rates; and the 
lowest rates were seen in Greece, Finland, Sweden, and Cyprus. Moreover, 
although incidence rates were higher in western Europe, mortality rates 
were seen to be higher in the Eastern regions. Over the same period, the 
highest incidence rates in South America and the Caribbean were observed 
in Uruguay, Southern Brazil, and Argentina. In Asia, the highest incidence 
rates were observed in India, with over 100,000 cases being registered per 
year.  
Jemal et al. (2011) summarised the GLOBOCAN 2008 estimates and 
reported that the highest incidence rates were still observed in South-
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Central Asia and Central and Eastern Europe, while the lowest rates were 
seen in Africa, Eastern Asia, and Central America. Mortality rates 
decreased in Europe and Asia but increased in some Eastern European 
countries such as Hungary and Slovakia. This was largely attributed to the 
“tobacco epidemic”, particularly among women. Additionally, several 
studies also reported an increasing incidence of HPV-associated oral 
cancers, particularly in the United States and some countries in Europe 
(Robinson and Macfarlane; Shiboski et al., 2005; Conway et al., 2006 
Chaturvedi et al., 2011). 
The GLOBOCAN estimates for 2012 showed that the highest incidence rates 
of oral cancer were still observed in Melanesia, Central and Eastern 
Europe, and South-Central Asia, while the lowest rates occurred in Eastern 
Asia and Western Africa (Torre et al., 2015). Incidence rates were seen to 
decrease among males and increase among females in Southern and 
Western Europe; decrease in both males and females in Australia, North 
America, and Asia; and increase in countries in Eastern and Northern 
Europe (Torre et al., 2015). More recently, Shield et al. (2017) extracted 
data on all patients that were diagnosed with lip, oral cavity, and 
pharyngeal cancer in 2012 in 184 countries from the GLOBOCAN database, 
as well as more detailed information from 68 countries using the Cancer 
Incidence in Five Continents database. They used these to explore the 
incidence trends for 2012 by country, age, and sex, and reported that 
there were 529,500 new cases of lip, oral cavity and pharyngeal cancer 
globally, of which 70% (n=375,000) were males and 29% (n=154,400) were 
females. Moreover, this was predicted to rise by almost 62% to 856,000 
cases by 2035.  
The global trends of head and neck cancer incidence over time have 
exhibited a close correlation with the changing patterns of alcohol and 
tobacco consumption. For example, the increasing rates of oral cavity 
cancer in countries such as Pakistan and China reflected a rise in the 
consumption of tobacco, alcohol, and areca nut, while steady decreases 
over the past two decades in the United States represented declining 
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alcohol and tobacco consumption (Sankaranarayanan et al., 2015). 
Similarly, increases in the incidence of cancers of the base of the tongue 
could be attributed to an increase in the prevalence of human papilloma 
virus infections (Sankaranarayanan et al., 2015). 
Therefore, the evidence suggests that the global burden of head and neck 
cancer varies considerably by global regions and countries, as well as by 
subsite, age, sex, and socioeconomic status, reflecting differences in 
aetiology, diagnostic procedures, prognosis, and treatment. The literature 
on the disparities in the burden of oral cancer by various sociodemographic 
characteristics has been reviewed in the following sections. 
1.2.1.1  Global burden of head and neck cancer: by subsite 
Evidence shows that the rates of oral cavity cancer have decreased in 
various parts of the world, while the rates of oropharyngeal cancer have 
increased (Blot et al., 1993; Franceschi et al., 2000; Chaturvedi et al., 
2008; Auluck et al., 2010; Marur et al., 2010; Mork et al., 2010; Ramqvist 
and Dalianis, 2010; Chaturvedi, 2012; Gillison et al., 2012a). Chaturvedi et 
al. (2013) hypothesised that this divergent trend in the incidence of oral 
cavity and oropharyngeal cancer could be attributed to a fall in tobacco 
consumption accompanied by an increase in the prevalence of HPV 
infections. They tested this theory using data from the Cancer Incidence in 
Five Continents (Volumes VI to IX) database for the period between 1983-
2002, and reported significant increases in the incidence of oropharyngeal 
cancer in several economically developed countries like Japan, Australia, 
Denmark, and the Netherlands. However, no such increases were observed 
in economically developing countries such as Columbia, Costa Rica, India, 
Thailand, and the Philippines. A comparison of the incidence trends of oral 
cavity cancer and oropharyngeal cancer using age-period-cohort modelling 
revealed three main patterns, as follows: a) countries that exhibited 
statistically significant divergent incidence trends characterised by 
increases in the rates of oropharyngeal cancer and decreases in the rates 
of oral cavity cancer (USA, Canada, Japan, Slovakia); b) countries that 
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exhibited an increase in the incidence rates of both subsites, but with 
oropharyngeal cancer demonstrating a greater increase than oral cavity 
cancer (Denmark and the UK); and c) countries that exhibited similar 
trends for both subsites (Brazil and the Netherlands).  
These results were corroborated by Simard et al. (2014) who collected data 
on all patients with head and neck cancer diagnosed between 1983-1987 
and 1998-2002 in 83 registries representing 35 countries from the Cancer 
Incidence in Five Continents (C15) database. They examined the incidence 
trends by country, sex, and sub-site, and reported that the rates of oral 
cavity cancer had increased in both men and women in Japan, the United 
Kingdom, Slovak Republic, Denmark, Czech Republic, Finland and Estonia; 
remained stable in several South American countries; and decreased in 
Canada, Philippines, Thailand, the United States, India, and China. The 
rates of oropharyngeal cancer, on the other hand, had increased in both 
men and women in the United Kingdom, Belarus, Denmark, Norway, 
Finland, Czech Republic, and Sweden, and decreased in India and China. 
The incidence trends of oropharyngeal cancer were seen to differ by sex in 
other global regions, with only men exhibiting an increase in rates in 
Canada, Japan, India, and Germany.  
Shield et al. (2017) reported that oral cavity cancer exhibited the highest 
number of new patients (202,000) in 2012, and the global age-standardised 
rate (ASR) was 2.7 per 100,000 individuals. The proportionate incidence of 
oral cavity cancer was the lowest in North Africa and West Asia (29 %) and 
the highest in South-Central Asia (49%), which also exhibited the highest 
number of incident cases. Country-level examination revealed that Papua 
New Guinea exhibited the highest ASR (10.6), followed by the Maldives, Sri 
Lanka, and Pakistan. The number of incident cases of oropharyngeal cancer 
in 2012 was considerably lower at 100,500, and the age-standardised rates 
were 1.4 per 100,000 individuals. The contribution of oropharyngeal cancer 
to all lip, oral cavity, and pharyngeal cancers varied from 34% in North 
America to as low as 8% in North Africa and Western Asia, and the highest 
number of incident cases were observed in South-central Asia. Country-
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level examination showed the highest ASR (5.0 per 100,000 individuals) in 
Hungary, followed closely by Slovakia, Germany, and France.  
Therefore, the evidence showed that the rates of oropharyngeal cancer 
had increased in economically developed countries, and it was suggested 
that this could be attributed to the emergence of a “human papilloma 
virus epidemic” in the western world, North America, Oceania, and Europe 
in particular (Chaturvedi et al., 2013; Hashibe and Sturgis, 2013). Forman 
et al. (2012) suggested that this peak in the prevalence of HPV infections, 
particularly among women, was the result of a “westernisation” effect (a 
tendency to have multiple sexual partners at a young age) that was absent 
or rare among more “conservative societies”. In contrast, the high rates of 
oral cavity cancer in the Indian subcontinent (India and Sri Lanka in 
particular), South Asia (particularly the southern parts of China and 
Thailand), and parts of the United Kingdom and Europe with large Asian 
populations reflected the greater rates of consumption of tobacco and 
betel quid among these populations (Llewellyn et al., 2001; 
Warnakulasuriya, 2009a). An interesting point to bear in mind when 
considering these findings is that although cancers have been historically 
considered to be non-communicable diseases, the body of evidence 
demonstrating the role of human papilloma viruses in the aetiology of 
cervical and oropharyngeal cancers has been mounting steadily (Gillison, 
2004; D’Souza, 2007). Therefore, given that HPV can be transmitted 
through various pathways including open-mouth kissing and oral sexual 
practices, it may be reasonable to consider HPV-related oropharyngeal 
cancers as communicable diseases instead.  
1.2.1.2  Global burden of head and neck cancer: by gender 
Various studies have also reported considerable differences in the 
incidence trends of head and neck cancer by gender. Chaturvedi et al. 
(2013) reported that men exhibited a significant increase in the rates of 
oropharyngeal cancer in several economically developed countries 
(including the USA, Australia, Canada, Japan, Slovakia, Denmark, 
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Netherlands, and the United Kingdom), despite a non-significant increase 
or a decrease in the rates of oral cavity cancer. In contrast, all countries 
that exhibited increases in the rates of oropharyngeal cancer among 
women also demonstrated a rise in the rates of oral cavity cancer. Simard 
et al. (2014) stated that the largest increase in the rates of oral cavity 
cancer between 1983-1987 and 1998-2002 was observed among males in 
Finland and women in Spain. Moreover, rates of oral cavity cancer were 
generally twice as high among males compared to females in most 
countries, except for Belarus and Slovak Republic where the difference was 
almost 10-fold. The incidence rates of oropharyngeal cancer, on the other 
hand, increased among males only in India, Japan, Canada, and Germany. 
Moreover, the burden of oropharyngeal cancer among males was 
approximately 2-5 times that observed in females in most countries, 
except for Belarus and Slovak Republic where the difference was almost 
20-fold.  
More recently, Shield et al. (2017) reported that 71% of all new cases of 
lip, oral cavity, and pharyngeal cancer globally occurred in males, while 
only 29% occurred in females in 2012. Moreover, the global ASR of oral 
cavity cancer was 3.7 per 100,000 individuals in males and 1.8 per 100,000 
individuals in females, while the corresponding numbers for oropharyngeal 
cancer were 2.3 and 0.5 per 100,000 individuals, respectively. 
Warnakulasuriya (2009a), in his review of the global trends of oral cavity 
and oropharyngeal cancer, suggested that the differences in trends by 
gender could partly be explained by the higher prevalence of risk-habits 
such as smoking and alcohol consumption among men compared to women.  
1.2.1.3  Global burden of head and neck cancer: by age  
Cancers of the head and neck primarily affect older individuals due to 
years of exposure to conventional risk factors such as smoking and alcohol 
consumption. Schottenfeld (2006) reported that the incidence rates of oral 
cavity and pharyngeal cancer were approximately 3.1 per 100,000 
individuals among patients aged 35-39 years, and this increased to 41.1 and 
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46.4 per 100,000 individuals among the 65-69 and 80-84 year age-groups, 
respectively. Similar results were reported by Chaturvedi et al. (2013) in 
their age-period-cohort analysis of data from the Cancer Incidence in Five 
Continents database where they observed increasing rates of 
oropharyngeal cancer among individuals aged greater than 60 years in 
economically developed countries. These results were further corroborated 
by several other studies that also reported that the risk of developing oral 
cancer (defined as C02-C06) increased with age (Warnakulasuriya, 2009a; 
Shield et al., 2017).  
However, more recent evidence suggested a changing trend, with the rates 
of oral cancer increasing among younger individuals. Van Monsjou et al. 
(2013) reported that approximately 4-6% of patients with oral cancer were 
less than 40 years of age and often failed to exhibit any of the 
conventional risk factors. This increase in the incidence rates of head and 
neck cancer, and carcinomas involving the tongue in particular, among 
young people (defined as those less than 30 years of age) was first 
observed in the USA in the mid-1970’s (Shemen et al., 1984; Depue, 1986). 
This pattern was less pronounced amongst women due to the low 
frequency of cases. Later on, Schantz and Yu (2002) collected data on 
patients that were diagnosed with head and neck cancer between 1985-
1997 from the SEER database (n=63,409, of which 3339 were less than 40 
years of age) and categorised them into three age groups (less than 40 
years, 40-64 years, and more than 65 years). Their results showed that the 
rates of oral cancer had decreased in all of the groups except the “less 
than 40 years” age group over the study period. Instead, this group had 
undergone an increase of almost 62% in the incidence rates when 
compared to the period between 1973-1984, and this was particularly true 
for tongue cancer. The authors suggested that this was a result of birth 
cohort effects, with the rates beginning to increase among individuals born 
in the period between 1938-1942 and peaking in cohorts belonging to the 
period between 1943 and 1947. These results were corroborated by 
Llewellyn et al. (2001) in their review of risk factors for oral cancer among 
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young people where they compared the incidence rates of cancer among 
birth cohorts from the 1960’s and 1970’s to those from later decades and 
reported a doubling and sometimes even trebling of rates among young 
people in some countries.  
More recently, Gayar et al. (2014) used the SEER database to extract 
information on all patients with oropharyngeal cancer that were less than 
45 years of age and had been diagnosed between 1973 and 2009 (n=1603). 
The authors reported an overall increase in the incidence rates of 
oropharyngeal cancer (from 0.23 to 0.37 per 100,000 population) among 
patients aged less than 45 years, with the rise being particularly 
pronounced (from 0.79 to 1.39 per 100,000 individuals) among patients 
aged 35 to 44 years.  
1.2.1.4  Global burden of head and neck cancer: by socioeconomic 
status 
A socioeconomic inequality in the distribution of head and neck cancer is 
apparent at the global level, with developing countries consistently 
exhibiting higher incidence and mortality rates compared to developed 
countries (Warnakulasuriya, 2009a). In 2012, 65% of all incident cases and 
74% of all deaths caused by oral cancer were seen to occur in less 
developed regions of the world (IARC, 2014). However, these patterns 
were slightly different when the trends by individual subsites were 
examined. Chaturvedi et al. (2013) reported that increases in the rates of 
oropharyngeal cancer between 1983-2002 almost exclusively occurred in 
economically developed countries, possibly reflecting differences in the 
prevalence of HPV infections in comparison to economically developing 
countries.  
Upon examining incidence trends by the Human Development Index (HDI), 
which is a composite measure of life expectancy, education, and per 
capita income estimated by the United Nations Development Program 
(UNDP, 2015), Shield et al. (2017) reported that the burden of oral cavity 
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cancer was higher in countries with low HDIs while that of oropharyngeal 
cancer was higher in countries with high HDIs. However, this was 
contradicted to a certain extent by Fidler et al. (2017) who also reviewed 
the global burden of cancer (all sites) by HDI. They used the fixed cut-off 
values prescribed by the United Nations and categorised the countries 
based on their HDI scores into low, medium, high, and very high, where the 
low and very high categories included the most and least deprived 
countries, respectively. Their results showed a positive association 
between the age-standardised incidence rates of oral cancer and the level 
of human development. Moreover, they also reported that approximately 
41% of the global cancer incidence burden in 2012 occurred in very high 
HDI countries, while only 6% occurred in the low HDI countries. This 
pattern flipped when mortality rates were examined, with low HDI 
countries exhibiting poorer survival due to limited access to healthcare. 
However, it is essential to note here that the authors excluded India and 
China from this analysis, and both countries currently bear a greater 
proportion of the global burden of oral cancer. Therefore, this may have 
skewed the results considerably. 
The association between socioeconomic status and the risk of developing 
oral cancer has been well documented, with the lower social strata in a 
population consistently exhibiting higher incidence rates, higher mortality 
rates, and poorer survival rates (Faggiano et al., 1997; Kogevinas and 
Porta, 1997; Conway et al., 2008; Warnakulasuriya, 2009b). A meta-
analysis of forty-one studies with a total sample of 15,344 cases and 33,852 
controls reported that low income (OR 2.41), low occupational status (OR 
1.84), and low educational attainment (OR 1.85) were associated with a 
higher risk of developing oral cancer (Conway et al., 2008). Additionally, 
the effects of low monthly household income on the risk of oral cancer 
were also more pronounced in low income countries compared to high 
income countries (Conway et al., 2008). However, Dahlstrom et al. (2015), 
in their study examining 356 patients that were diagnosed with 
oropharyngeal cancer at the University of Texas MD Anderson Cancer 
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Centre, reported that the patients with HPV-positive oropharyngeal cancer 
that were included in their study exhibited high levels of education, 
income, and overall socioeconomic status. Further examination revealed 
that this was particularly true for patients with HPV-positive oropharyngeal 
cancer who were also non-smokers. 
1.2.2 Incidence burden of head and neck cancer in the 
United Kingdom: by subsite, age, gender, and 
socioeconomic status  
Cancer Research UK reported that 11,400 new cases of head and neck 
cancer (31 cases per day) were diagnosed in the United Kingdom between 
2012 and 2014, accounting for approximately 3% of all new cancer cases 
(CRUK, 2017d). Moreover, the incidence rates of head and neck cancer had 
increased by 30% since the early 1990s, with a 23% rise in age-standardised 
rates observed in the most recent decade (2003-2005 to 2012-2014) (CRUK, 
2017a). Warnakulasuriya (2009a), in his review of the trends of oral cancer 
in various high-risk countries, stated that the incidence rates in the United 
Kingdom had increased by approximately 3% each year since 1989, and this 
could be largely attributed to an increase in the consumption of alcohol 
post-World War II (Hindle et al., 2000).  
Louie et al. (2015) used population-based cancer registry data from 
England to examine the trends of head and neck cancer between 1995 and 
2011 and calculate projected rates up to 2025. Their results showed that 
the incidence rates of head and neck cancer had increased by 59% over the 
sixteen-year study period, and this appeared to be largely driven by a rapid 
rise in the rates of oropharyngeal cancer (average annual percentage 
change = +7.3% in males and +6.5% in females). Smaller increases were 
observed in the rates of oral cavity cancer. Examination of the projected 
rates showed that the incidence burden of head and neck cancer was 
expected to continue to rise (overall increase of 35% in males and 49% in 
females) up to 2025, with the largest predicted increase occurring in the 
rates of oropharyngeal cancer. Oral cavity cancer, on the other hand, was 
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predicted to stabilise in men and continue to increase in women. With 
regard to age, the incidence rates of oropharyngeal cancer had increased 
in all age-groups, particularly the 50-59 and 60-69 year groups, over the 
study period, and the median age of oropharyngeal cancer incidence was 
less than 60 years (Louie et al., 2015). 
The most recent detailed analysis of incidence trends of oral cancer in 
Scotland only examined rates between 1990 and 1999, and reported a 
general increase in both males and females over the 10-year study period 
(Conway et al., 2006). Moreover, Scotland also exhibited the highest 
incidence rates and the greatest lifetime risk of developing oral cancer in 
the United Kingdom. However, this study was limited by the fact that it 
examined the combined rates of oral cavity cancer and oropharyngeal 
cancer, reflecting the thinking at the time that these sites had a common 
aetiology.  
With regard to the patient profile, Macfarlane et al. (1987) first used age-
specific cancer incidence data in Scotland in 1987 to report an increase in 
the risk of tongue cancer among young males. A later study conducted in 
1992 analysed incidence and mortality data for the period of 1911 to 1989 
and reported a higher risk of oral cancer among Scottish young adults, with 
the incidence rates increasing by three-fold in the 35-64 year age-group 
between 1960-1964 and 1985-1989 (MacFarlane et al., 1992). Moreover, a 
strong cohort effect was also reported, with the rates increasing in every 
birth-cohort succeeding 1910, and the authors suggested that this could be 
attributed to an increase in the consumption of alcohol and tobacco 
(MacFarlane et al., 1992).  
Conway et al. (2007) used data from the Scottish Cancer Registry for the 
period between 1976 and 2002 to examine the incidence trends of oral 
cancer by deprivation, and reported a socioeconomic inequality in the 
distribution of oral cancer, with the most deprived areas consistently 
exhibiting the highest rates. Their results also showed that this inequality 
first appeared in the late 1970’s, and subsequently widened in the 1980’s 
54 
 
 
up to the late 1990’s. This was particularly true for males from the most 
deprived areas of Scotland who exhibited a dramatic increase in the 
incidence rates (+196%) over the study period. Conversely, women 
exhibited a slightly different pattern, with increases in the incidence rates 
being observed at all levels of deprivation, although the greatest increase 
still occurred in the most deprived areas (Conway et al., 2007). In another 
small population-based case-control study including 103 patients with head 
and neck cancer and 91 controls in Scotland, Conway et al. (2010) 
examined the association between the risk of developing head and neck 
cancer and the components of socioeconomic class including area-based 
measures of socioeconomic status, occupational social class, employment, 
and education. They reported that individuals residing in the most 
deprived areas of Scotland exhibited a higher risk of developing cancer 
relative to those living in the least deprived areas (OR 4.66, 95% CI 1.79-
12.18). Unemployment (OR 2.27, 95% CI 1.21-4.26) and manual 
occupational classes were also associated with a higher risk of developing 
cancer, while higher levels of education appeared to exhibit a protective 
effect (OR = 0.17, 95% CI 0.05–0.58). However, the authors also stated that 
smoking appeared to dominate the risk profile, and the statistical 
significance for all measures of social class were lost upon adjusting for it. 
Nevertheless, their results did show strong links between certain 
components of social class and the risk of developing head and neck cancer 
(Conway et al., 2010).  
1.2.3 Oral cancer burden – conclusions from the literature 
“All cancers are alike, but they are alike in a unique way.” 
These words, another quote from Siddharth Mukherjee’s The Emperor of 
all Maladies (Mukherjee, 2010), fittingly justify the need to elucidate the 
risk profile of various cancers. This section of the thesis described the 
incidence trends of head and neck cancer both globally and in the United 
Kingdom, and explored variations in these trends by several 
sociodemographic determinants. A review of the literature showed that the 
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rates of oral cancer were rising globally, and were predicted to continue to 
do so (Shield et al., 2017). Oropharyngeal cancer incidence was on the rise 
almost exclusively in economically developed countries, reflecting an 
increase in the prevalence of HPV infections. In contrast, economically 
developing countries exhibited a greater incidence burden of oral cavity 
cancer, and this was attributable to the continuing tobacco epidemic that 
had already started and declined earlier in the developed countries. 
Similar trends were also observed in England, with the increasing incidence 
of oral cancer being largely driven by a rapid rise in the rates of 
oropharyngeal cancer.  
With regard to the patient profile, males were seen to be at a higher risk 
of developing oral cancer, although there was evidence of increasing 
incidence rates of oral cavity cancer among women in developing 
countries, possibly reflecting a surge in tobacco consumption. A direct 
relationship existed between incidence rates and the level of deprivation, 
and this was also apparent at the global level, with economically 
developing countries consistently bearing the greatest burden of cancer. 
Lastly, although oral cancer was primarily a disease that affected older 
individuals, there was some evidence of the incidence rates increasing 
among the younger population. A similar patient profile was also observed 
in England, with males from lower socioeconomic strata being at the 
highest risk of developing cancer.  
The most recent exploration of incidence trends of oral cancer in Scotland 
only provided estimates up to 1999, and there were no studies that 
investigated variations in trends by individual subsites. Moreover, there 
was also no recent evidence on the patient profile of oral cancer in 
Scotland, particularly with regard to their socioeconomic status.  
1.3  Early detection of oral cancer  
The World Health Organisation’s Cancer Control: Knowledge into Action, 
WHO Guide for Effective Programs, was a six-part series that provided 
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practical advice for policy-makers and programme managers on ways to 
plan and implement cancer control programs effectively (WHO, 2006). This 
report recommended three key steps to planning an effective cancer 
control program, as follows: 
Step 1 answered the question “where are we now?”, in terms of the 
current state of the cancer problem and cancer control measures in effect. 
It was proposed that this could be achieved by conducting a “situation 
analysis” which would include assessment of a) the burden of cancer 
amenable to early detection, and b) the existing early detection plan and 
current activities and population coverage of services.  
Step 2 addressed the question “where do we want to be?”, the goal of 
which was to formulate and adopt policies and practices. The WHO 
recommended a number of steps to answer this, including a) identification 
of the target population for early detection of cancer, b) identification of 
gaps in the existing early detection services, c) establishing objectives for 
early diagnosis and screening, d) assessing the feasibility of early detection 
interventions, e) addressing ethical aspects, f) setting priorities for early 
detection, and g) choosing between early diagnosis and screening.  
Step 3 focused on the question “how do we get there?”, and this step 
aimed to identify the actions that were necessary for the implementation 
of policy. This included a) bridging any gaps in the existing system, b) 
working as a team, c) procuring the necessary resources, d) implementing 
the activities that are necessary for early diagnosis and screening, and e) 
monitoring and evaluation.  
The Early Detection module of the Cancer Control: Knowledge into Action, 
WHO Guide for Effective Programs series defined an early detection 
program as “the organised and systematic implementation of early 
diagnosis or screening (or both), diagnosis, treatment and follow-up”, and 
discussed the two principle strategies for timely recognition of cancer, 
namely, “early diagnosis” and “screening” (WHO, 2013).  
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Early diagnosis was helpfully defined by the World Health Organisation as 
an “awareness (by the public or health professionals) of early signs and 
symptoms of cancer in order to facilitate diagnosis before the disease 
becomes advanced” (WHO, 2017b). The World Health Organisation Guide 
to Cancer Early Diagnosis, a part of the Cancer Control: Knowledge into 
Action, WHO Guide for Effective Programs: Early Detection Module, 
referred to the concept as a form of “down-staging” and emphasised that 
its main objective was the detection of cancer at the earliest stage 
possible in order to improve survival and the quality of life (WHO, 2017b).  
Screening, on the other hand, was considered as “the systematic 
application of a screening test in a presumably asymptomatic population, 
with an aim to identify individuals with an abnormality suggestive of a 
specific cancer” (WHO, 2013). The Cancer Control: Knowledge into Action, 
WHO Guide for Effective Programs clarified that the main objective of 
screening was the identification of unrecognised (“pre-clinical”) cancer or 
“pre-cancerous lesions” in an apparently health population.  
Therefore, the key difference between the two objectives essentially lay in 
the clinical stage progression of the disease, as shown in Figure 1-1. In the 
context of oral cancer, screening aimed to identify oral potentially 
malignant disorders (OPMD) (Brocklehurst et al., 2013) (discussed later in 
section 1.3.1.1), while early diagnosis aimed to recognise the signs and 
symptoms of oral cancer (discussed previously in section 1.1.6) in a timely 
fashion so as to achieve diagnosis at an earlier stage.  
This section of the thesis first examines the literature on the two 
strategies included within early detection efforts (i.e. screening and early 
diagnosis) in the context of oral cancer, and discusses the potential role of 
dental practices in such efforts. It then goes on to consider some of the 
evidence on missed opportunities for early detection of cancer, including 
the factors contributing to their existence and the ways to measure them, 
and then identifies some of the gaps in the literature.  
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Figure 1-1: Distinguishing screening from early diagnosis based on symptom onset 
(image adapted from WHO Guide to Cancer Early Diagnosis) 
 
 
1.3.1 Early detection of oral cancer via screening 
1.3.1.1 Potentially malignant disorders 
As mentioned previously, the main aim of screening is the “identification 
of pre-clinical or pre-cancerous lesions in an apparently healthy target 
population” using tests, examinations, imaging, and other such procedures 
that can be applied rapidly and can be easily accessed by the target 
population (WHO, 2013). In 1978, a working group of the World Health 
Organisation (WHO) first suggested that precancerous conditions of the oral 
cavity should be classified into two main groups: precancerous lesions and 
precancerous conditions. A precancerous lesion was defined as 
“morphologically altered tissue in which oral cancer is more likely to occur 
than in its apparently normal counterpart”, while a precancerous condition 
was defined as a “state associated with a significantly increased risk of 
cancer” (WHO, 1973; Kramer et al., 1978). In 2005, another WHO workshop 
focusing on oral lesions with a predisposition for malignant transformation 
substituted the terms “precancerous” or “premalignant” with “potentially 
malignant”, and the distinction between precancerous lesions and 
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conditions was abandoned and replaced with “oral potentially malignant 
disorders” (OPMD) (Warnakulasuriya et al., 2007), and this has been widely 
recognised since (Brocklehurst et al., 2013; Walsh et al., 2013; Speight et 
al., 2017). 
Some of these OPMDs often exhibit molecular, genomic or chromosomal 
alterations that are usually observed in invasive cancers. Warnakulasuriya 
et al. (2007), in their report of the consensus views of the WHO 
Collaborating Centre for Oral Cancer and Precancer Working Group in the 
United Kingdom, summarised the most common OPMDs and their 
definitions. These included leukoplakia, erythroplakia, oral submucous 
fibrosis, actinic keratosis, lichen planus, discoid lupus erythematosus, 
candidiasis, palatal lesions in reverse smokers, and hereditary disorders 
with increased risk such as dyskeratosis congenita and epidermolysis 
bullosa. More recently, Sarode et al. (2011) proposed a new method of 
classifying OPMDs based on their pathogenesis, wherein lesions were 
categorised as follows: a) Group I: morphologically altered tissue in which 
an external factor is responsible for the aetiology and malignant 
transformation; b) Group II: morphologically altered tissue in which chronic 
inflammation is responsible for malignant transformation (chronic 
inflammation mediated carcinogenesis); c) Group III: inherited disorders 
that do not necessarily alter the clinical appearance of local tissue but are 
associated with a greater than normal risk of PMD or malignant 
transformation; and d) Group IV: no clinically evident lesion but oral cavity 
is susceptible to oral squamous cell carcinoma (OSCC). The authors further 
divided these categories into subgroups and suggested that this method of 
classification also had a therapeutic basis to some extent. 
The majority of OPMDs present as red or white patches and most commonly 
occur in the buccal mucosa, gingiva, tongue, and the floor of the mouth 
(Mortazavi et al., 2014). The affected area may exhibit decreased 
elasticity, appearing tough on palpation, and is usually painless. However, 
although these lesions have a statistically increased chance of becoming 
malignant (Napier and Speight, 2008), occasionally they may remain stable 
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or regress. Thus, there is a certain level of uncertainty associated with the 
natural progression of these conditions, making prediction of the fate of 
each lesion close to impossible. Biopsies are recommended for accurate 
diagnosis and confirmation of malignant transformation (Amagasa et al., 
2006). 
1.3.1.2  Screening for oral cancer 
Screening tests are not meant to be diagnostic and instead they aim to 
identify tissue changes that suggest an increased likelihood of developing 
disease (Wilson and Jungner, 1968). The most commonly used screening 
test for oral cancer is the conventional oral examination (COE), and various 
studies have confirmed its simplicity, accuracy and acceptability 
(Warnakulasuriya et al., 1984; Mehta et al., 1986; Warnakulasuriya and 
Nanayakkara, 1991; Mathew et al., 1996; Mathew et al., 1997; 
Sankaranarayanan, 1997). Walsh et al. (2013), in their systematic review 
comparing conventional oral examination, vital rinsing, light-based 
detection, biomarkers, and self-examination of the mouth, found that the 
accuracy of the conventional oral examination was dependant on the 
prevalence of the disease. However, it consistently exhibited a high level 
of specificity (greater than 0.80). Downer et al. (1995) reported similar 
results in their meta-analysis where they observed specificity values of 
0.85 to 0.97 for conventional oral examination. Another added advantage 
of visual examination was that it could be easily performed by non-medical 
or non-dental health professionals. These studies suggested that the 
conventional clinical oral examination had “satisfactory performance as a 
screening test” as it had sensitivity and specificity similar to that of the 
breast and cervical cancer screening programs (Speight et al., 2017). 
However, currently there is insufficient evidence of the effects of visual 
screening for oral cancer on the mortality rates. Kujan et al. (2006) and, 
more recently, Brocklehurst et al. (2013) attempted to undertake 
Cochrane reviews examining the effectiveness of current oral cancer 
screening methods in reducing mortality. However, both studies were able 
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to identify only one randomised controlled trial that met the inclusion 
criteria. This was a community-based, cluster-randomised controlled trial 
conducted in North Trivandrum, Kerala, India between 1996 and 2004 that 
investigated the effects of visual screening for oral cancer on the mortality 
rates in a high-risk population (Sankaranarayanan et al., 2005). The study 
selected a total of thirteen clusters, of which seven were randomly 
selected to receive three rounds of oral visual screening at three year 
intervals and the remaining six clusters received standard care. Four 
rounds of screening were executed over a fifteen-year period and the five-
year survival was found to be significantly higher in the intervention group 
compared to the control group. A statistically significant difference in the 
proportion of patients with stage I or II cancer (definitions of the stages of 
cancer have been discussed later in section 1.3.2.1) was also observed 
between the two groups. Moreover, Sankaranarayanan et al. (2005) also 
reported that although no significant difference in mortality was observed 
between the two groups, tobacco and alcohol users in the intervention 
group exhibited a 34% decrease in mortality rates compared to the control 
group and this was statistically significant. Lastly, among those who had 
completed all four rounds of screening (20% of the eligible population), a 
79% and 81% decrease in mortality was observed in the intervention arm 
and the high-risk group, respectively. This is the only randomised 
controlled study that has examined the effectiveness of oral cancer 
screening thus far and, given the high-risk nature of the population 
selected, provides considerable evidence of the benefits of screening. In 
Cuba, a national oral cancer control program was established in 1984 
wherein dentists were required to carry out visual oral examination in all 
patients above the age of 15 years. Evaluation of this program showed an 
increase in the proportion of stage I cases detected between 1983 and 
1989 (24% and 49%, respectively) and a decrease in the proportion of stage 
II and III cases over the same period (Garrote et al., 1995). This suggested 
that visual oral screening was beneficial for the early detection of cancer. 
However, this program was limited by the fact that its overall coverage 
was relatively poor, it lacked a systematic method of recruiting patients 
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which may have led to an under-representation of high-risk populations, 
and the compliance with referral was poor.  
Currently, oral cancer screening at the population level is not 
recommended due to the limited evidence on its efficacy in reducing 
mortality. The Cochrane review conducted by Brocklehurst et al. (2013) 
concluded that screening via conventional oral examination was effective 
in reducing mortality among “high-risk” individuals and communities, 
suggesting that opportunistic screening for oral cancer targeting these 
communities was a feasible option for early detection. This was further 
supported by Speight et al. (2006) who used simulation modelling 
techniques to examine the cost-effectiveness of screening for oral cancer 
in various primary care facilities. Using decision-analytic modelling, they 
compared the incremental-cost-effectiveness-ratios (ICERs) of various oral 
cancer screening strategies including no screening, invitational screening: 
general medical practice, invitational screening: general dental practice, 
opportunistic screening: general medical practice, opportunistic screening: 
general dental practice, opportunistic “high-risk” screening: general 
medical practice, opportunistic “high-risk” screening: general dental 
practice, and invitational screening: specialist, and their main outcome 
measures were quality-adjusted-life-years (QALY) and mean lifetime cost 
of each strategy. The authors concluded that “high-risk” screening, 
particularly in general dental practices, was cost-effective. Screening by 
general practitioners was found to be only marginally more expensive, 
despite lack of training and lower sensitivity and specificity, and this could 
potentially be a result of the greater population coverage by GPs. Similar 
results were reported by another study conducted in the Netherlands that 
examined the cost-effectiveness of screening for oral lichen planus (a form 
of OPMD) in a population of 100,000 over a period of one year (Van der 
Meij et al., 2002). The authors considered two screening strategies, as 
follows: a) screening by an oral specialist such as an oral and maxillofacial 
surgeon, and b) screening by a dentist. Using a simple decision tree 
framework, they estimated that the cost of no screening would be 
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approximately $3,000,000. The extra cost for screening by an oral 
specialist was $1,265,229 and that of screening by a dentist was 
approximately $400,000-425,000. The health gain from screening by a 
specialist was 592 quality-adjusted life-years (approximately 23.68 lives 
saved) and that of screening by a dentist was between 775 and 800 QALYs. 
However, from the perspective of the NHS, this study had several 
limitations. Firstly, it did not compare a wide range of screening strategies 
such as GP screening, invitational screening, or opportunistic screening. 
Secondly, some of the estimations included in the model were not derived 
in a systematic manner. Thirdly, the generalisability of the results to 
hospitals in the United Kingdom was unclear and, lastly, the timing of 
various events was not reported (Van der Meij et al., 2002). 
Although screening should ideally be delivered at the population level, the 
success of such a program is dependent on a number of factors including 
availability of adequate resources, prevalence of the disease, and 
compliance of the population with recommended screening measures 
(WHO, 2017d). Wilson et al. (1968), upon being commissioned by the WHO, 
developed a report where they defined certain criteria to guide selection 
of diseases or conditions that were amenable to screening at the 
population level, including its capacity to be detected at an early stage 
and the availability of suitable tests and treatment measures. However, if 
a disease failed to meet these criteria and population screening was not 
recommended, alternative early detection efforts could be employed 
including invitational (population-based) screening, workplace screening 
programs, opportunistic screening, and targeted “high-risk” screening 
(Speight et al., 2006).  
The United Kingdom’s National Screening Committee (UK NSC) proposed 20 
criteria that must be fulfilled in order for a screening program to be 
funded and accepted at the national level and, based on these, suggested 
that population screening for oral cancer was not recommended (UK NSC, 
2003). Speight et al. (2017) recently used these criteria to review the 
current global status of oral cancer screening for the Global Oral Cancer 
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Forum meeting held in New York in March 2016. They concluded that 
although it was feasible to screen for oral cancer, based on the fact that it 
was frequently preceded by a potentially malignant lesion, there was 
considerable ambiguity with regard to certain key factors. As mentioned 
earlier, the natural course of OPMDs is still relatively unclear and not all of 
them may progress to malignancy; however, the criteria used to define a 
positive screening test result do not account for this. Based on this, the 
authors concluded that there was a need for the development of better 
screening tests and an increased understanding of the natural course of 
OPMDs before oral cancer screening at the population level could be 
recommended.  
Therefore, overall the evidence currently appears to suggest that, from an 
efficacy and cost-effectiveness perspective, opportunistic screening for 
oral cancer targeting high-risk individuals is the most feasible option 
(Brocklehurst et al., 2013; Walsh et al., 2013). 
1.3.2 Early detection of oral cancer through timely diagnosis 
1.3.2.1 Cancer staging 
Knowledge regarding the extent of disease was reported to be key to the 
selection of appropriate treatment by various surgical groups and 
treatment guidelines. Cancer staging, or identification of the anatomic 
extent, topography, and histology of a neoplasm, allows easy exchange of 
information regarding the extent of the disease between clinicians, 
selection of appropriate treatment, stratification of patients included in 
clinical studies, determination of prognosis, and assessment of the impacts 
of early detection efforts (Greene and Sobin, 2008). It is usually completed 
at the time of diagnosis and may be of two types: clinical (based on 
physical examination, biopsy, and imaging) or pathological (based on what 
is discovered surgically). The most commonly used method of staging is the 
TNM (tumour, node, metastasis) system, developed and maintained by the 
American Joint Committee on Cancer (AJCC) and the Union for 
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International Cancer Control (UICC) (Denoix, 1944). This system 
incorporates all available information about a particular case, including 
those obtained by radiologic and endoscopic evaluation (National Cancer 
Institute, 2017). Here, the T category describes the size of the primary 
tumour in centimetres (Tx: cannot be measured; T0: no evidence of 
primary tumour; T1-T3: escalating size of primary tumour; T4: involvement 
of adjacent structures; Tis: carcinoma in situ); N describes the extent of 
lymph node involvement (Nx: lymph nodes cannot be evaluated; N0: no 
lymph node involvement; N1-N3: size, location and number of lymph nodes 
involved; Nx: lymph nodes cannot be evaluated), and M describes the 
absence or presence of distant metastasis (Mx: cannot be evaluated; M0: 
no distant metastasis; M1: distant metastasis). The tumour stage 
specifications vary with the subsite involved. While the staging for extent 
of lymph node involvement remains the same throughout, T and M may 
vary, and together they help determine the overall stage (I, II III, IV) of a 
particular lesion. Stage 1 is the earliest stage of cancer when the tumour is 
less than two centimetres in size and has not spread to the neighbouring 
tissues, lymph nodes, and organs, while Stage II includes neoplasms that 
are greater than two centimetres but less than four centimetres in size and 
have not spread to the neighbouring lymph nodes and organs (CRUK, 2017c; 
IARC, 2017b). Stage III include a) cancers that are greater than four 
centimetres but have not spread to the lymph nodes or other parts of the 
body, or b) cancers that are of any size but have spread to one lymph node 
(no bigger than three centimetres) on the same side of the neck. Stage IV 
is the advanced stage of cancer and is further divided into categories a, b, 
and c based on the extent of metastasis and the size of the lesion (CRUK, 
2017c; IARC, 2017b). 
Over the years, changes to the TNM staging system have been based on 
improvements in the understanding of the natural history and extent of the 
disease. The head and neck region comprises of a variety of anatomical 
sites, and neoplasms involving these differ considerably in terms of 
aetiology, presentation, and pathology, making development of an 
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accurate staging system complicated. Several studies previously reported 
inadequacies in the seventh revision of the TNM staging system for head 
and neck cancer, particularly with regard to the identification of HPV-
positive disease (Dahlstrom et al., 2013; Huang et al., 2015). This led to 
the inclusion of a new stage classification for HPV-positive oropharyngeal 
cancer in the most recent eighth revision of the TNM staging system for 
head and neck cancer, reflecting development of a better understanding of 
the aetiology, character, and prognosis of the disease. Moreover, it also 
includes clinical and pathological N-definitions and T-N groupings 
separately. Huang and O’Sullivan (2017), in their overview of this eighth 
revision of the TNM classification, stated that these changes were 
necessary as clinical trials now address HPV-positive and HPV-negative 
oropharyngeal cancer separately and practice guidelines would probably 
reflect this in the future. Moreover, these changes were also relevant for 
conversations with patients and their families, cancer surveillance 
measures, and clinical care.  
Stage of cancer at the time of diagnosis has been shown to be one of the 
most crucial prognostic markers of head and neck cancer (Janot et al., 
1996; Iro and Waldfahrer, 1998; Chu and DeVita, 2005), with advanced 
stage of disease being associated with high mortality (82% 5-year survival 
rates for localised disease. 51% for regional disease, and 28% for distant 
metastasis) (Ragin et al., 2007; Goy et al., 2009). Rusthoven et al. 
reported that the survival rates of patients with late stage (III-IV) 
carcinoma was significantly lower than that of those with early stage (I-II) 
cancer (p=0.04) (Rusthoven et al., 2010). Moreover, the five-year survival 
rates decreased drastically as the stage of cancer progressed (from 90% at 
stage I to 60% at Stage III and 4% at Stage IVc) (Iro and Waldfahrer, 1998; 
Carvalho et al., 2005). Oral squamous cell carcinomas with very small 
surface size (less than two centimetres) exhibited higher survival rates 
compared to those with greater surface size (Moore et al., 1986). 
Treatment options have also been reported to become increasingly 
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complex and expensive as the stage of cancer at the time of diagnosis 
progresses (Shah and Lydiatt, 1995; Lingen et al., 2008). 
However, the evidence suggested that over 60% of patients with head and 
neck cancer are still detected at a late stage (Stage III or Stage IV) when 
the prognosis was considerably poorer and treatment options were more 
complex and expensive (Dolan et al., 1998; Holmes et al., 2003; Brandizzi 
et al., 2005; Lingen et al., 2008). Although the silent nature of the lesion 
may be partly responsible for this, recent hypotheses suggested that delays 
in diagnosis may also have a role to play, based on the reasonable 
assumption that the stage of cancer at the time of diagnosis is a function 
of the time it had to develop before detection (Mackillop et al., 1996). 
1.3.2.2  Early diagnosis of oral cancer  
As discussed previously, the main goal of early diagnosis of oral cancer is 
detection of the disease at the earliest stage possible when the prognosis 
significantly better. The WHO Guide to Cancer Early Diagnosis 
recommended three key steps to achieving this, as follows: (a) awareness 
of cancer symptoms and accessing care (patient interval), (b) clinical 
evaluation, diagnosis, and staging (diagnosis interval), and (c) access to 
treatment (treatment interval) (WHO, 2017b). All of these steps should 
ideally be achieved within 90 days, although the exact targets may vary 
with the type of cancer and the healthcare system (WHO, 2017b). 
Currently, the Cancer Waiting Time Target of the Scottish Government is a 
maximum of 62 days from the receipt of referral to the first treatment and 
31 days from a decision to treat to actual treatment (ISD Scotland, 2017b). 
In 2017, 85% of patients that were diagnosed with head and neck cancer in 
Scotland had met the 62-day target from the receipt of referral to the first 
treatment (ISD Scotland, 2017b). However, there are several barriers in the 
form of various types of diagnostic delays that may hinder efforts to 
achieve these steps and, subsequently, the early diagnosis of cancer.  
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1.3.2.3 Barriers to early diagnosis: diagnostic delay 
The main barrier to the achievement of early diagnosis was diagnostic 
delay, defined as the total period of time elapsed between first noticing a 
symptom and diagnosis of the cancer, and it has been reported to have 
considerable influence on survival (Onizawa et al., 2003; McLeod et al., 
2005). It is typically divided into three types, namely, patient, 
professional, and system delay, and various factors may play a role in the 
occurrence of these delays (Güneri and Epstein, 2014). 
Patient delay: this refers to the time elapsed between the first detection 
of symptom by the patient and the first time he or she consults a 
healthcare provider. It is specifically a barrier to the first step (awareness 
of cancer symptoms and accessing care) out of the three that were 
recommended by the WHO (discussed previously in 1.3.2.2). A systematic 
review examining factors affecting patient delay was able to identify only 
eight relevant studies, highlighting the dearth of research and conflicting 
nature of evidence available in this field (Scott et al., 2006). The authors 
reported that although there was considerable evidence of patients with 
oral cancer delaying seeking professional help after noticing symptoms, 
few of them were able to provide conclusive explanations for doing so. 
However, similar studies in other cancer sites have suggested that 
psychosocial factors such as fear, embarrassment, the assumption that 
symptoms were caused by common ailments, and existence of other social 
priorities may play a role in such delays (de Nooijer et al., 2001). This was 
further supported more recently by Güneri and Epstein (2014) in their 
review where they reported that factors such as fear, denial, worry, and 
perceptions of social responsibilities affected the duration of delay. A 
case-series analysis of 306 patients with head and neck cancer in the 
Netherlands reported that patients were more likely to visit a healthcare 
provider sooner after self-discovery of symptoms if they had prior 
knowledge and a higher level of awareness of cancer (Tromp et al., 2005), 
and this reinforced the theory put forth by a considerably older study that 
suggested that the most common determinant of delay was cancer 
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knowledge (Antonovsky and Hartman, 1974). However, Hackett et al. 
suggested that often this delay was a conscious and deliberate act on the 
part of the patient, rather than a lack of knowledge and worry, and was 
fuelled by underlying psychosocial factors such as fear and perceptions of 
social accountability. Moreover, worry, though a complex variable, was 
seen to be inversely proportional to the duration of delay, with those 
worrying about a particular symptom often exhibiting reduced delay 
(Hackett et al., 1973). Kumar et al. in their questionnaire study of 79 
patients observed an association between patient delay and regular visits 
to the doctor, socioeconomic status, patient beliefs such as “ill-fated to 
have cancer” and “family tension due to long treatment”, availability of 
transport and being escorted by someone. However, the definitions of 
these variables were unclear and the size and directions of these 
associations were not explained adequately, limiting the interpretability of 
the results (Kumar et al., 2001).  
Professional delay: although this usually always starts from the time a 
patient consults a healthcare provider, the definition of the endpoint has 
been shown to vary (e.g. referral to specialist, time to biopsy, time to 
treatment) (Stefanuto et al., 2014). It specifically acts as a barrier to 
achievement of the second step (clinical evaluation, diagnosis, and 
staging) out of the three that were recommended by the WHO (discussed 
previously in 1.3.2.2). Gómez et al. (2010), in their review of factors 
responsible for diagnostic delay in oral cancer, reported that there was 
considerable, albeit ambiguous, evidence on a relationship between the 
academic degrees of clinicians, particularly with regard to general medical 
practitioners and dentists, and the rapidity of diagnosis. They found that 
some studies attributed the fact that general medical practitioners were 
likely to refer patients with oral cancer quicker than dentists to a high 
index of suspicion, while others put it down to high prevalence of oral 
lesions and low incidence of oral cancer and suggested that dental 
clinicians were more likely to offer treatment for such lesions instead of 
referring the patient, often resulting in delayed diagnosis of cancer. The 
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authors also reported finding evidence of knowledge gaps regarding the 
risk factors, preventive measures, and changes associated with oral 
cancer, particularly in the early stages, among dentists (Gómez et al., 
2010). This was further corroborated by Güneri and Epstein (2014) who 
reported that dental and medical practitioners may fail to recognise 
malignant lesions of the oral cavity due to the relatively low incidence of 
these cancers in the general population and their non-specific appearance 
and potentially insidious nature. They suggested that, in such cases, 
patients should be referred immediately to minimise delay and the urgency 
of the referral was the clinician’s responsibility. The authors also reported 
that although dental practitioners were more likely to come upon patients 
with oral squamous cell carcinomas, only a small proportion of patients 
showed a tendency to visit dentists upon self-discovery of symptoms, 
reflecting the tendency of assuming that “dentists were for teeth and 
gums”, and this often resulted in further delays in diagnosis (Güneri and 
Epstein, 2014).  
Other factors that may have an influence on professional delay include 
vague or unspecific clinical signs (Bruun, 1976), lack of experience or 
unfamiliarity with the disease (Guggenheimer et al., 1989), low index of 
suspicion (Holland, 1975), deficient clinical examination (Robbins et al., 
1950), and presence of co-morbidities (Allison et al., 1998). Conway et al. 
(2002), in their paper discussing the role of primary healthcare teams in 
the prevention and detection of oral cancer, stressed upon the necessity of 
creating awareness amongst dental practitioners regarding local referral 
arrangements in order to avoid any delays. Moreover, they also encouraged 
telephonic conversations with various oral and maxillofacial surgeons, ENT 
surgeons, or oral medicine consultants, thus avoiding further delays by 
allowing the practitioner to ensure that the consultant in question dealt 
with that specific type of case. The authors also suggested that, in case of 
a diagnosis of cancer, the patient should be referred to the appropriate 
services by means of a telephonic conversation as well as a letter marked 
urgent. 
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System delay: this refers to any delays caused by “system” factors such as 
limited accessibility to healthcare, availability of specific treatments, and 
high associated costs. This too typically acts as a barrier to achievement of 
the second step out of the three that were recommended by the WHO 
(discussed previously in 1.3.2.2). Güneri and Epstein (2014) reported that 
scheduling or system delays were mainly caused by barriers in the health 
care system, availability of resources, and healthcare economics. 
Additionally, access to health care facilities and availability of the 
appropriate treatments may also have a role to play. 
Seoane et al. (2012), in their meta-analysis of data from ten studies and 
nine countries, examined the association between various time intervals 
considered in studies focusing on diagnostic delay and a range of outcome 
measures such as survival and the TNM stage of head and neck cancer. 
Their pooled ORs using TNM stage as the outcome of interest showed a 
substantial increase in the risk of late stage cancer with diagnostic delay, 
and this increase in risk was greater for professional delay than for patient 
delay. Moreover, diagnostic delay was also moderately associated with 
increased mortality of head and neck cancer, and this relationship was 
particularly strong for referral delay (Seoane et al., 2012).  
1.3.3 The role of dental practices and alternative healthcare 
settings in the early detection of oral cancer  
General dental practitioners, through regular patient contact, are placed 
in an ideal position to increase awareness of the known risk factors of oral 
cancer, deliver preventive advice, examine the oral soft tissues of patients 
for OPMDs, and prevent recurrence or spread of the cancer (Conway et al., 
2002). They also play a crucial role in the management of oral cancer 
through patient counselling and early referral which, in turn, facilitates 
early diagnosis and prompt treatment (Conway et al., 2002). 
Conway et al. (2002), in their paper discussing the role of primary 
healthcare teams in the prevention and detection of oral cancer, suggested 
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that provision of a thorough extra- and intra-oral examination during 
regular dental check-ups could help in the early detection of potentially 
malignant or malignant lesions. Briefly, they suggested that the extra-oral 
examination included a thorough inspection of the skin of the outer lip and 
the lymph node groups in the neck for any abnormalities such as 
lymphadenopathy, which usually presents as a hard, asymmetrical swelling 
or mass that is often tender on touch. The authors stated that this could 
be achieved by standing behind the patient and palpating the neck starting 
from the submental group of lymph nodes under the chin, posteriorly onto 
the submandibular group, followed by the jugulodigastric group, and finally 
down along the deep cervical chain of lymph nodes. They recommended 
that this should then be followed by an examination of the oral mucosa for 
any evidence of ulcerations, lumps, indurated or fixated areas, poor wound 
healing, or evidence of potentially malignant conditions such as oral sub-
mucous fibrosis, leukoplakia, or erythroplakia. The “high-risk” areas 
included the floor of the mouth, which could be examined by asking the 
patient to touch his palate with the tip of his tongue, and the posterior 
and lateral aspects of the tongue, which could be examined by pulling on 
the tongue using gauze, thus permitting complete visualisation of both 
right and left borders. Other dangerous areas included the retromolar 
areas and the hard and soft palate, which could be examined using the 
dental mirror. The dorsal surface of the tongue could be inspected by 
asking the patient to stick out his tongue and checking for any 
abnormalities. 
However, although visual examination of the oral cavity is part of a regular 
dental visit, timely detection and referral of oral cancer in the dental 
setting is also largely dependent on patients consulting dentists frequently 
enough to achieve this. Research from around the world suggests that the 
proportion of patients with oral cancer that had contacted a general dental 
practitioner on a regular basis was considerably low, thus automatically 
limiting the opportunities for early detection in the dental setting. Tromp 
et al. (2005), in their case-series analysis consisting of 306 patients that 
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were diagnosed with head and neck cancer between 2000 and 2002 in a 
tertiary referral centre in the Netherlands, reported that only 12% of the 
sample had contacted a dentist first upon detecting symptoms, and 82% 
had been in contact with their general practitioner instead. Similar results 
were reported by another clinical cohort study in Western Australia that 
examined the dental attendance patterns of all patients that were 
diagnosed with oral cavity and oropharyngeal cancer between January 2005 
and December 2009 in one teaching hospital, and found that the majority 
of the patients did not have regular contact with a dentist (mean duration 
since last dental visit: 5.6 years) (Frydrych and Slack-Smith, 2011). With 
regard to patient access to opportunities for early detection of oral cancer, 
Netuveli et al. (2006) used data from the Health Survey for England (2001) 
(n=13,784) and the British Household Panel Survey (n=5547) to examine the 
association between dental attendance patterns and various known risk 
factors of oral cancer. Their results showed that the likelihood of attending 
a dental practice regularly decreased as the number of factors favouring 
carcinogenesis (i.e. patients who exhibited high risk scores for all five of 
the examined factors — age, sex, alcohol consumption, smoking, and low 
intake of fruits and vegetables) and, subsequently, the risk of developing 
oral cancer increased. This was particularly striking in case of smoking. 
Moreover, the low probability of regular dental attendance in this “high-
risk” group appeared to remain stable over time (over 1-, 3-, 5-, and 10-
year periods). The authors termed this as the “inverse screening law” and 
suggested that opportunistic screening in dental practices would not be an 
efficient early detection strategy in the United Kingdom as only those who 
were at the lowest risk of developing cancer would be screened (Netuveli 
et al., 2006). These results were further corroborated by another study 
that also used data from the British Household Panel Survey to examine the 
association between dental attendance patterns and the known risk factors 
of oral cancer including socioeconomic status (Yusof et al., 2006). Their 
results showed that “high-risk” individuals (defined as males, above 40 
years of age, with low socioeconomic status and education, manual 
occupational social class, and smokers) usually exhibited poorer dental 
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attendance patterns. These studies highlighted the role of alternative 
settings, particularly general practitioners and other specialist practices, 
in the early detection of oral cancer.  
The notion of involving other primary healthcare services in early detection 
efforts was first proposed in 1990 when Prout et al. (1990) examined 130 
patients that were diagnosed with head and neck cancer between 
September 1, 1985 and March 31, 1988 in Boston, and reported that 94% of 
them had visited a healthcare provider at least once in the 24 months prior 
to diagnosis. The services contacted were typically those that the subjects 
considered as their “regular source of care”, and the authors stated that 
these findings emphasised the need to integrate these services in 
strategies for the early detection of head and neck cancer. More recently, 
Reid et al. (2004) created a study dataset consisting of 11,312 patients 
diagnosed with head and neck cancer (defined as including the lip, oral 
cavity, pharynx, and larynx) between 1991 and 1999 in the United States 
by linking data from the Surveillance, Epidemiology and End Results (SEER) 
Program with files from the Centre for Medicare and Medicaid Services 
Program, and reported that 93% of the patients with localised stage 
disease and 88% of the patients with advanced stage disease had contacted 
a general practitioner at least once in the year before diagnosis. The 
authors stated that these contacts formed the “basis of opportunistic 
screening” for head and neck cancer. A systematic review of 12 studies 
examining patient acceptance of oral cancer screening in non-dental 
settings reported that undiagnosed cases appeared to prefer seeking help 
from a general practitioner in case of noticing symptoms, and also 
favoured general medical practice settings over dental clinics for oral 
cancer screening (Paudyal et al., 2014). Ligier et al. (2016) examined the 
medical consultation patterns of 342 patients that were diagnosed with 
head and neck cancer (defined as including the anatomic subsites oral 
cavity, oropharynx, hypopharynx, and larynx) in 2010 in a high-incidence 
region in France. The patients (n=342) were identified from four French 
cancer registries, and their medical data were matched with data on the 
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uptake of healthcare, provided by the French National Health Insurance 
General Regime. The authors reported that only 21% of the patients had 
visited a dentist in the two to twelve months prior to diagnosis, and this 
proportion decreased as the level of deprivation increased. However, the 
vast majority (86%) of the patients had consulted a general medical 
practitioner over the same period, and a dose-response association was 
observed between the number of GP consultations and a localised stage of 
cancer at the time of diagnosis, suggesting that “medical monitoring” had 
an influence on stage. Although the authors mentioned that their results 
were generalisable to countries with similar health care set-ups, their 
sample size was relatively small and this may have affected the accuracy 
and precision of the results.  
More locally and recently in the United Kingdom, Crossman et al. (2016) 
randomly selected 200 out of the 478 patients with oral and oropharyngeal 
cancer included in the 2010 Cancer Patient Experience Survey (which 
consisted of 67,713 adults treated for cancer between January and March 
2010 at one of the 158 National Health Service hospitals in England), and 
sent them a postal questionnaire that collected information on the health 
services they had contacted before receiving a diagnosis of cancer and the 
symptoms that had prompted them to do so. They found that only 32% of 
the patients had been referred to secondary care by a dentist, while 56% 
had been referred by a general practitioner instead. The authors concluded 
that GPs played a crucial role in the early detection of oral cancer, and 
listed common signs and symptoms that could be used for assessment and 
decision-making.  
In England, the National Cancer Intelligence Network linked data from the 
Administrative Hospital Episode Statistics database with Cancer Waiting 
Times data, cancer screening programme data, and cancer registration 
data to examine the “Routes to Diagnosis” for patients that were 
diagnosed with cancer (all sites) between 2006 and 2013 (Elliss-Brookes et 
al., 2012). They found that 21% of all oral cavity cancer and 26% of all 
oropharyngeal cancer diagnoses in England occurred following GP referrals 
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in 2013. Moreover, diagnoses via the “Two-weeks Wait (TWW)” route, 
defined as including “all urgent GP referrals with a suspicion of cancer”, 
and the “Other Outpatient” route, defined as “an elective route starting 
with an outpatient appointment”, had increased between 2006 and 2013. 
The authors clarified that there was also the possibility that some of the 
referrals via the latter route (“Other Outpatient”) were originally initiated 
by general practitioners (Elliss-Brookes et al., 2012; NCIN, 2017).  
1.3.4 Missed opportunities for the early detection of oral 
cancer  
Society’s expectations of a prompt diagnosis of cancer, although context-
specific, often conflicts with the challenges associated with its actual 
achievement, and this is becoming increasingly apparent to healthcare 
professionals and researchers. This has resulted in a sudden escalation of 
research focusing on the ways to identify errors in the diagnostic process 
and strategies to minimise associated diagnostic delays. 
Diagnostic errors, known to cause harm to patients, are usually a result of 
both system and cognitive contributory factors. Recently, Singh et al. 
rebranded these errors as “missed opportunities” in the diagnostic process, 
and began to explore ways to define as well as measure them (Singh, 
2014). The main idea behind this rebranding was to shift the focus and, 
subsequently, resources from attribution of blame to learning from these 
situations. Lyratzopoulos et al. (2015) defined missed opportunities as 
“instances where post-hoc judgement indicates that alternative decisions 
or actions could have led to a more timely diagnosis, that is, something 
different could have been done or considered under the given 
circumstances to reach a more prompt diagnosis”. Recognition of these 
missed opportunities could inform policy decisions and facilitate the 
identification of areas where health services could be improved. This 
would consequently contribute to the “situation analysis of existing cancer 
services” (including assessment of the current population coverage of 
services, the cost of strategies currently in place, barriers to provision of 
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care including delays, and the quality of care provided) recommended by 
the World Health Organisation in the Guide to Cancer Early Diagnosis 
(WHO, 2017b). 
1.3.4.1  Factors contributing to missed opportunities  
Most missed opportunities are usually the result of a complex interplay of 
various patient, provider, and system factors, some of which have been 
discussed previously in section 1.3.2.3, and understanding this web is 
crucial for the development of strategies to minimise diagnostic errors and 
delays in diagnosis (Singh et al., 2013). This calls for a multidisciplinary 
approach that takes psychology, human factors, and informatics into 
account. As elaborated by Lyratzopoulos et al. (2015), the “model of 
pathways to treatment” proposed by Scott et al. (2013) divides the entire 
patient process into four intervals (symptom appraisal, help-seeking, 
diagnosis, and pre-treatment), and the diagnostic interval is relevant for 
missed opportunities. This diagnostic process can be further divided into 
three main phases. The first is the initial diagnostic assessment phase, 
which represents the first clinical encounter between the patient and a 
health care practitioner and typically includes recording of medical 
history, clinical examination and diagnosis reasoning. The second phase is 
diagnostic test performance and interpretation, and this generally includes 
execution and interpretation of diagnostic tests such as blood tests, 
endoscopies, imaging, and associated decisions. The final phase is 
diagnostic follow-up and coordination, which includes all decisions and 
tasks that are completed based on the results of the diagnostic tests 
performed in the previous phase. 
Lyratzopoulos et al. (2015), in their review of the evidence on missed 
opportunities for the timely diagnosis of cancer, reported that they could 
occur in any one of these three diagnostic stages, and that there were a 
vast range of factors that contributed to their occurrence. For example, 
factors contributing to missed opportunities in the initial diagnostic 
assessment phase included inadequate history taking and examination; 
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rigid consultation norms; cognitive factors that hinder optimal clinical 
assessment and reasoning such as anchoring bias (focusing on a single piece 
of information), availability bias, “commitment to a steer”, presence of 
co-morbidities among older individuals, unfamiliarity with cancer 
presentations, and “epidemiological bias” that make prompt suspicion of 
cancer even more difficult, particularly in cases of rare cancers and in low-
risk groups; language barriers; access and system time constraints; and 
referral norms (Lyratzopoulos et al., 2015). The factors contributing to 
missed opportunities in the diagnostic test performance and interpretation 
phase included “no-show” events and lack of system resilience in coping 
with them; diagnostic testing process complexity; and inadequacies in the 
investigation strategy, while those contributing to the diagnostic follow-up 
and coordination phase were patient factors such as patients not feeling 
empowered enough to or simply not knowing how to seek out their test 
results; over-reliance on “patient call-back”; and lack of follow-up or 
appreciation of abnormal test-results. 
1.3.4.2  Evidence of missed opportunities in the diagnosis of 
cancer - retrospective clinical reviews 
A large proportion of the evidence on the occurrence of missed 
opportunities in the diagnostic process is based on retrospective reviews of 
cohorts of patients with cancer. For example, Singh et al. (2010) 
retrospectively reviewed all of the electronic health records of patients 
that were newly diagnosed with primary lung cancer at two geographically 
dispersed Veterans Affairs (VA) medical centres. They identified two main 
types of missed opportunities, and these were Type 1, which included 
episodes of care where a failure to recognise predefined “clinical clues” 
was observed, and Type 2, where there was a failure to complete a 
diagnostic procedure, consultation or requested follow-up in response to a 
predefined clue within a 30-day period. The authors undertook a detailed 
review of all progress reports, consultation, laboratory, and radiology 
reports, and all additional data relevant to the diagnostic process, and 
found that 38% of the 633 new cases of lung cancer showed evidence of 
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missed opportunities for early diagnosis. The median period between 
observation of the first symptom and pathologic diagnosis was 132 days in 
patients with at least one event of missed diagnosis. In contrast, this 
period was equal to only 19 days in patients with no evidence of missed 
opportunities. Type 1 missed opportunities were observed in approximately 
25% of the patients (median delay period of 168 days), while Type 2 missed 
opportunities were observed in 21% of the patients (median delay period of 
141.5 days) (Singh et al., 2010). Mitchell et al. (2013) analysed data from 
the Significant Event Audit (SEA) in the North of England to better 
understand the pathway to diagnosis of lung cancer. The SEA is a quality 
improvement technique that is widely used in primary care practice in the 
United Kingdom, and it can be applied to any aspect of healthcare in order 
to obtain a structured understanding of the circumstances surrounding a 
particular event of interest (Pringle et al., 1995). The authors identified a 
total of nine out of 132 cases where opportunities for early diagnosis were 
missed, and reported the circumstances surrounding these events with an 
aim to provide a learning opportunity (Mitchell et al., 2013). In another 
study examining missed opportunities for cervical cancer screening among 
642 women diagnosed with cervical cancer at the Kaiser Permanente 
Medical Care program in Northern California, 60% of the women were 
reported to have not undergone a PAP smear in the 36 months prior to 
diagnosis, of which 75% had had contact with primary care services within 
the same period (Kinney et al., 1998). 
These studies showed that retrospectively reviewing cohorts of patients 
with cancer was an efficient way to detect missed opportunities as it 
permitted identification of the location of the error and examination of 
the reasons for its occurrence (e.g. presence of comorbidities, inadequate 
understanding of test results etc). Moreover, it also made quantification of 
the associated delay possible, thus exposing crucial areas where efforts to 
improve diagnostic quality may be focused.  
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1.3.4.3  Evidence of missed opportunities in the diagnosis of 
cancer - epidemiological evidence 
In addition to retrospective case reviews, there is also a considerable 
amount of epidemiological evidence on the existence of missed 
opportunities for early diagnosis of cancer. The review conducted by 
Lyratzopoulos et al. (2015) found that several studies had used “surrogate 
markers” for missed opportunities, including multiple general practitioner 
consultations before referral (Lyratzopoulos et al., 2012; Lyratzopoulos et 
al., 2013), emergency attendances (Elliss-Brookes et al., 2012; Mitchell et 
al., 2013), and abnormal or “red flag” findings (such as a lump in the neck, 
hoarseness, dysphagia, ulceration, or weight loss in the case of oral 
cancer) (Murphy et al., 2014; Douglas et al., 2017). 
In another study, Lyratzopoulos et al. (2012) used data from the 2010 
National Cancer Patient Experience Survey conducted in England to explore 
variations in the number of pre-referral general practitioner consultations 
among 41,299 patients with 24 different types of cancers. They 
hypothesised that the number of such visits was an indicator of patient 
experience, and attempted to identify factors that acted as independent 
predictors of three or more pre-referral consultations. Ahmed et al. (2014) 
stated that patient experience could be “conceptualised both as patients’ 
experiences of care and as feedback received from patients about those 
experiences”, and the National Health Service in England specified eight 
domains (physical comfort, respect, emotional support, information and 
communication, and access to care) that were crucial for a “good” patient 
experience (NHS, 2012). Lyratzopoulos et al. (2012) observed large 
variations in the proportions of patients who had visited a general 
practitioner (GP) three times or more before referral, and these variations 
appeared to be associated with the type of cancer diagnosed (lowest for 
breast cancer and malignant melanoma; highest for multiple myeloma and 
pancreatic cancer). Women, younger patients, and those belonging to 
ethnic minority groups were more likely to visit a general practitioner 
more than three times pre-referral, although the variations were less 
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prominent when examined by socioeconomic characteristics, providing a 
certain level of reassurance that a comprehensive coverage system like the 
National Health Service in the United Kingdom was capable of providing 
equitable care. The authors concluded that the patients that were 
diagnosed with more well-known cancers were less likely to have had a 
large number of pre-referral consultations. Similar results were reported 
by the National Audit of Cancer Diagnosis in Primary Care conducted in 
England in 2009/2010 where almost 38% out of 229 patients that were 
diagnosed with oropharyngeal cancer had consulted their general 
practitioner two or more times for cancer-related issues before being 
referred to a specialist for assessment (Rubin et al., 2011).  
Research from Denmark suggested that the frequency of diagnostic tests 
and hospital visits of patients subsequently diagnosed with cancer was 
considerably higher than those with no cancer in the months preceding 
diagnosis (Christensen et al., 2012; Ahrensberg et al., 2013; Hansen et al., 
2015). Christensen et al. (2012), in their national registry based case-
control study, compared the monthly general practitioner consultation 
frequencies of all patients with cancer (diagnosed between 2001 and 2006 
and identified from the Danish Cancer Registry) in the year before 
diagnosis to that of 1,272,100 gender-matched controls from the general 
population. They found that the patients with cancer exhibited a modest 
increase in GP consultations five to six months before diagnosis, and that 
this number peaked one month before diagnosis. Moreover, the number of 
hospital visits and diagnostic examinations began to rise approximately 
three to four months before diagnosis, and this escalated steeply two 
months before diagnosis. Overall, patients with cancer were seen to utilise 
health services significantly more than the reference population 
throughout the study period (one year before diagnosis) (Christensen et 
al., 2012).  
Similarly, Hansen et al. (2015) reported that patients with colorectal 
cancer had higher odds of consulting a general practitioner more than five 
times in the year preceding diagnosis compared to patients without cancer. 
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They also observed a significant increase in the number of GP consultations 
nine months before diagnosis, and this finally peaked one month before 
diagnosis (Hansen et al., 2015). However, in contrast to Lyratzopoulos et 
al. (2012), these studies did not account for a referral period and 
considered diagnosis as the end-point. As a result, it was unclear at what 
point these contacts shifted from being missed opportunities for early 
detection via screening to becoming missed opportunities for early 
diagnosis, caused by delays in the diagnostic process itself. Nevertheless, 
they do highlight the significance of unusual patterns of health service 
contacts in the identification of opportunities for early detection.  
Although these kinds of epidemiological data do not provide any 
information regarding the nature of these consultations and not all of 
these instances would have been necessarily associated with missed 
opportunities for the early detection of cancer, it did provide a strong 
indication that there were potentially missed opportunities amongst at 
least some of the patients with cancer (Rubin et al., 2011; Lyratzopoulos 
et al., 2015). 
1.4 Summary of debates and gaps in the literature 
This section of the thesis summarises some of the key debates and 
conclusions from the literature, discusses some of the gaps identified in 
the evidence, and then provides a rationale for this thesis. 
The first issue encountered upon commencement of a literature search for 
epidemiological evidence on the incidence trends of head and neck cancer 
(and subsites) was a lack of consensus and considerable debate surrounding 
the way in which these sites were defined. This included an absence of 
unanimity in the terminology used as well as the specific ICD codes 
included within each subsite grouping. Upon reviewing the literature, two 
main schools of thought with regard to the specific definitions of the 
individual subsites (i.e. ICD codes included within each grouping) were 
identified. The first was an anatomical method of definition based on the 
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physical boundaries of the individual subsites, and the second was an 
aetiological (risk factors) driven method of definition where the subsites 
were defined based on their association with HPV infections. Based on this 
evidence, the current thesis developed and proposed a “compromise” 
approach which utilised a mixed (anatomical and HPV-associated) method 
of defining subsites for the descriptive epidemiological analyses presented 
later in Chapters 2 and 3. The individual ICD codes included in each group 
have been shown in Appendix 1. Briefly, oropharyngeal cancer was 
defined as including the base of the tongue (C01), lingual tonsil (C2.4), 
tonsil (C09), oropharynx (C10), and the pharynx (C14); while oral cavity 
cancer included the inner lip (C00.3-C00.9), other and unspecified parts of 
the tongue (C02), gum (C03), floor of the mouth (C04), palate (C05), and 
other and unspecified parts of the mouth (C06). However, the evidence 
also showed that tumours rarely followed the specific anatomical 
boundaries of the oral cavity and oropharynx, and the signs and symptoms 
of both cancers overlapped considerably. Moreover, most clinical 
guidelines for the detection of oral cancer appeared to combine and 
address both subsites together. Given that dentists and other healthcare 
practitioners have a role in the primary and secondary prevention of 
cancers affecting both subsites (oral cavity and oropharynx), a more 
generalised definition of “oral cancer” that combined the two subsites 
appeared to be more appropriate from a clinical perspective. Therefore, 
this was the approach adopted in the analyses presented in Chapters 3 and 
4.  
Global epidemiological evidence showed that the incidence burden of head 
and neck cancer was rising, and these trends varied considerably by subsite 
and various sociodemographic characteristics (Shield et al., 2017). The 
incidence rates of oropharyngeal cancer were rising almost exclusively in 
higher income countries, reflecting an increase in the prevalence of HPV 
infections, while the burden of oral cavity cancer was increasing in lower 
income countries, and this could be attributed to the continuing tobacco 
epidemic that had already started to decline earlier in the high-income 
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countries. In the United Kingdom, the incidence rates of head and neck 
cancer had increased between 1995 and 2011, and this appeared to be 
largely driven by a rapid rise in the rates of oropharyngeal cancer (Louie et 
al., 2015). Moreover, examination of projected rates revealed that this 
upward trend was expected to persist up to 2025. The most recent 
examination of the incidence burden of oral cancer (defined as C00-C06, 
C09-C10) in Scotland only focused on trends up to 1999, and also examined 
both oral cavity cancer and oropharyngeal cancer together as one subsite 
(Conway et al., 2006).  
With regard to the patient profile, males were seen to consistently exhibit 
higher incidence rates of oral cancer compared to females irrespective of 
subsite, although there was some evidence of an increasing burden of oral 
cavity cancer among women in lower income countries, possibly reflecting 
a sudden surge in tobacco consumption among this group. Socioeconomic 
inequality in the distribution of oral cancer was observed, with the rates of 
cancer increasing as the level of deprivation increased. This gap by 
deprivation was also apparent at the global level, with economically 
developing countries consistently bearing the greater burden of cancer 
compared to the economically developed countries (Warnakulasuriya, 
2009a; Shield et al., 2017). However, when considering the individual 
subsites, data from the United States appeared to suggest a substantially 
different patient profile for oropharyngeal cancer, with patients being 
predominantly male, exhibiting higher socioeconomic status, and being 
considerably younger (Dahlstrom et al., 2015). There have been no 
population studies to date that have examined the within-country burden 
of oropharyngeal cancer relative to socioeconomic status. The literature 
review also showed that the majority of patients with head and neck 
cancer were primarily older individuals, although there was some evidence 
of incidence rates increasing among the younger population (defined as 
being less than 30 years), particularly for tongue cancer (Depue, 1986). A 
similar patient profile was also observed in the United Kingdom, with 
males, individuals aged less than 70 years, and those with lower 
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socioeconomic status being at the highest risk of developing oral cancer 
(Conway et al., 2007; Conway et al., 2008; Louie et al., 2015).  
Seoane et al. (2015), in their systematic review and meta-analysis, showed 
that early stage of cancer at the time of diagnosis improved prognosis 
considerably and decreased the cost of treatment. General dental 
practitioners appear to have a potentially pivotal role in the early 
detection of oral cancer through regular patient contact. However, this is 
largely dependent on the general dental practice attendance patterns of 
patients with oral cancer. Evidence suggested that the “inverse screening 
law”, which stated that those at the highest risk of developing oral cancer 
were also least likely to consult a general dental practitioner on a regular 
basis, was applicable in the United Kingdom (Netuveli et al., 2006; Yusof et 
al. 2006). In England, examination of the routes to diagnosis of cancer 
showed that a majority of oral cancer referrals appeared to be coming 
from sources that were out-with the dental setting (Elliss-Brookes et al., 
2012). These studies appeared to suggest a potential role of alternative 
healthcare services in the early detection of oral cancer.  
The World Health Organisation, in their Cancer Control: Knowledge into 
Action, WHO Guide for Effective Programs report, clarified that the two 
main strategies for early detection of oral cancer were screening and early 
diagnosis (WHO, 2006). Currently, there is insufficient evidence in favour 
of oral cancer screening at the population level, and various cost-
effectiveness analyses have shown that targeted opportunistic screening of 
“high-risk” individuals appeared to be more feasible (Speight et al., 2006). 
With regard to early diagnosis of cancer, the WHO referred to it as a form 
of “down-staging”, and recommended three key steps to achieving this, 
including a) awareness of cancer signs and symptoms and accessing care 
(patient interval), b) clinical evaluation, diagnosis and staging (diagnosis 
interval), and c) access to treatment (treatment interval), all of which 
should be accomplished within 90 days (WHO, 2013).  
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Missed opportunities for the early diagnosis of cancer may occur at any 
stage of the diagnostic process, and these are usually indicative of delays 
that occurred at the patient, professional, and system levels 
(Lyratzopoulos et al. 2015). A wide range of influences may play a role in 
the occurrence of these delays, including psychological factors, low index 
of suspicion due to a low prevalence of the disease, lack of experience or 
unfamiliarity with the disease, presence of co-morbidities, poor access to 
healthcare services, and limited resources. Such missed opportunities can 
be examined and measured by means of retrospective clinical reviews as 
well as a variety of “surrogate markers” such as unusual patterns of pre-
referral consultations with healthcare services and emergency 
presentations. There is a considerable amount of research that shows 
existence of such missed opportunities for early detection of cancer, and 
the majority of these are in relation to cervical and breast cancer. 
However, there are limited studies investigating missed opportunities for 
early detection of oral cancer.  
The studies reviewed in this chapter led to the identification of several 
gaps in the literature. Although it is well-known that early stage at the 
time of diagnosis of oral cancer is associated with significantly better 
prognosis, a large proportion of the patients continue to be diagnosed at a 
later stage. General dental practitioners appear to have a pivotal role in 
the early detection of oral cancer, but the feasibility of this is largely 
dependent on the dental attendance patterns of patients and the volume 
of the disease. Therefore, the first gap identified in the literature was that 
there were no studies that provided recent as well as projected estimates 
of the incidence burden of head and neck cancer in Scotland by individual 
subsites and various sociodemographic characteristics. Moreover, there was 
also no information on the socioeconomic profile of the distribution of oral 
cavity cancer and oropharyngeal cancer at the population level, with 
studies from the US suggesting that oropharyngeal cancer had a different, 
more affluent patient profile (Dahlstrom et al., 2015). Secondly, although 
the evidence suggested that those at the highest risk of developing oral 
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cancer were also least likely to contact general dental practitioners on a 
regular basis, all of these studies were undertaken over a decade ago and 
none of them considered a population approach. There was limited 
information on the dental attendance patterns of patients with oral cancer 
in Scotland, and no evidence on the distribution of the incidence burden in 
relation to the location and socioeconomic profile of the area in which the 
general dental practices were located. Examination of this could assist in 
the identification of areas with particularly high incidence of oral cancer, 
which future early detection efforts could then target. Thirdly, although 
there was a considerable amount of evidence that confirmed the existence 
of missed opportunities for early detection of cancer, the majority of it 
was in relation to cervical and breast cancer. There were no studies that 
investigated missed opportunities for the early detection of oral cancer. 
Fourthly, the healthcare service contacts made by patients with oral 
cancer in Scotland prior to diagnosis had not been explored, and these 
contacts could be considered as potential missed opportunities for early 
diagnosis. Lastly, the potential role of alternative healthcare services in 
the early detection of oral cancer was unknown, and there was also no 
evidence on the routes to diagnosis of oral cancer among patients in 
Scotland.  
Overall, although the literature suggested that the importance of oral 
cancer as a public health problem had been recognised, the size of this 
problem and its relationship with early detection efforts was still 
somewhat overlooked. Moreover, while a lot of the emphasis on oral 
cancer screening efforts had been focused in the dental setting, the 
potential role of other healthcare settings in early detection remained 
relatively under-explored.  
1.5 Aims, objectives and hypotheses 
The overarching aim of this thesis was to investigate opportunities for the 
early detection of oral cancer in Scotland. The objectives and hypotheses 
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have been numbered according to the chapter and order in which they 
appear in this thesis.  
 
Chapter 2 Aim: To examine the incidence burden and sociodemographic 
profile of patients with head and neck cancer in Scotland. 
Chapter 2 Hypotheses 
Chapter 2 hypothesis (a): The trends of head and neck cancer are 
increasing and are projected to continue to do so.  
Chapter 2 hypothesis (b): This increase in incidence rates of head and 
neck cancer will largely be driven by an increase in the rates of 
oropharyngeal cancer. 
Chapter 2 hypothesis (c): The patient profile of oropharyngeal cancer will 
differ from other subsites, particularly in relation to socioeconomic status. 
Chapter 2 hypothesis (d): In relation to the socioeconomic distribution of 
head and neck cancer, there will be a clear stratification of “high-risk” 
areas in the more deprived communities that could be utilised to target 
early detection initiatives. 
Chapter 2 Objectives  
Chapter 2 objective (a): To create a cohort of patients with head and 
neck cancer (and subsites) using data from the Scottish cancer Registry. 
Chapter 2 objective (b): To describe and analyse the incidence burden 
and trends of oral cavity, oropharyngeal and laryngeal cancer in Scotland 
between 1975 and 2012 by key sociodemographic determinants including 
age, sex, area-based socioeconomic deprivation, geographic region and 
year of diagnosis. 
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Chapter 2 objective (c): To compute future projected incidence rates up 
to 2025 for all head and neck, oral cavity, oropharyngeal, and laryngeal 
cancer by key sociodemographic determinants including age, sex, area-
based socioeconomic deprivation, geographic region and year of diagnosis. 
Chapter 2 objective (d): To produce a sociodemographic risk profile of all 
patients with head and neck, oral cavity, oropharyngeal and laryngeal 
cancer for stratification. 
Chapter 3 Aim: To investigate whether early detection of oral cancer in 
dental settings is a realistic expectation, given the current burden and 
sociodemographic risk profile of the disease and the location and 
distribution of general dental practices in Scotland.  
Chapter 3 Hypotheses 
Chapter 3 hypothesis (a): The number of patients with oral cancer (oral 
cavity cancer and oropharyngeal cancer) a general dental practitioner in 
Scotland can expect to see will be low. 
Chapter 3 hypothesis (b): Dentists working in more deprived areas will 
expect to see a greater number of patients with oral cancer (oral cavity 
cancer and oropharyngeal cancer) compared to dentists working in 
relatively less deprived areas. 
Chapter 3 Objectives 
Chapter 3 objective (a): To collate data from the Scottish Cancer Registry 
and routine administrative NHS Scotland data on dental practice 
distribution, dental workforce, and population dental registration and 
participation (attendance) rates. 
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Chapter 3 objective (b): To estimate the number of patients with oral 
cancer (oral cavity and oropharyngeal cancer) an NHS primary care dentist 
may expect to see per year and over time. 
Chapter 3 objective (c): To examine how the estimates of the number of 
patients with oral cancer (oral cavity and oropharyngeal cancer) may vary 
with the location and distribution of dental practices in relation to the 
socioeconomic deprivation of the area. 
Chapter 3 objective (d): To link Scottish Cancer Registry data with routine 
NHS dental service payment claims data to calculate dental attendance 
rates of patients with oral cancer (oral cavity and oropharyngeal cancer) in 
the two years preceding diagnosis.  
Chapter 4 Aim: To identify potentially missed opportunities for the 
early detection of oral cancer in dental and alternative healthcare 
settings. 
Chapter 4 Hypotheses 
Chapter 4 hypothesis (a): There are a number of potentially missed 
opportunities for the early detection of oral cancer in dental and other 
healthcare services. 
Chapter 4 hypothesis (b): These potentially missed opportunities increase 
in frequency in the months directly prior to the start of the referral period.  
Chapter 4 Objectives 
Chapter 4 objective (a): To create a longitudinal population cohort by 
linking the available routine administrative health service data including 
hospital outpatient, hospital inpatient/day-case, primary dental care, and 
GP prescriptions with the Scottish Cancer Registry oral cancer data. 
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Chapter 4 objective (b): To calculate the proportion of patients with oral 
cancer who had contacted all/any of the healthcare services (hospital 
outpatient, hospital inpatient/day-case, primary dental care, and GP 
prescriptions) in the two years prior to diagnosis, and examine the mean 
number of contacts made over the same period. 
Chapter 4 objective (c): To calculate the proportion of patients with oral 
cancer who had contacted each of the services (hospital outpatient, 
hospital inpatient/day-case, primary dental care, and GP prescriptions) 
individually over the two years prior to the start of the referral period, 
examine the mean number of contacts made with each service, and assess 
any variations by year and six-month periods prior to the start of the 
referral period in order to identify any alternative opportunities for early 
detection efforts. 
Chapter 4 objective (d): To undertake a focused examination of primary 
dental care service contacts of patients with oral cancer by analysing the 
frequency and reasons for consultation by year and six-month periods in 
order to identify any “potentially missed” opportunities for early detection 
in the dental setting. 
Chapter 4 objective (e): To examine the nature of contacts made by 
patients with oral cancer during the one month period directly preceding 
diagnosis, defined here as the “referral period”, in order to assess the 
feasibility of using this data to examine the routes to diagnosis of oral 
cancer. 
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2 Incidence trends of head and neck cancer in 
Scotland (1975-2012), projected rates up to 
2025, and determinants of trends. 
2.1 Introduction 
According to the World Health Organisation International Agency for 
Research on Cancer (WHO IARC), head and neck cancers including all 
neoplasms of the lip, oral cavity, and pharynx were the seventh most 
common in terms of incidence globally in 2012 (approximately 529,000 new 
cases annually) (IARC, 2014). The literature review in Chapter 1 of this 
thesis showed that the increasing incidence burden of head and neck 
cancer globally appeared to be largely driven by a rapid rise in the rates of 
oropharyngeal cancer, and this was particularly true in developed 
countries like Canada, United States, Japan, Switzerland, Australia, 
England and parts of Eastern Europe (Chaturvedi et al., 2011; Forte et al., 
2012; Chaturvedi et al., 2013; Hong et al., 2014). Rates of oral cavity 
cancer were also rising among men and women in some European 
countries, stabilising in certain Asian countries, and decreasing in Canada 
and USA (Chaturvedi et al., 2013; Simard et al., 2014). With regard to the 
risk profile of head and neck cancer, males consistently exhibited higher 
incidence rates, irrespective of subsite (Shield et al., 2017), and a 
socioeconomic inequality existed in the distribution of cancer, with higher 
levels of deprivation being associated with a greater risk of developing 
cancer (Conway et al., 2008). Specifically, low levels of education (OR 
1.85, 95% CI: 1.60 - 2.15), low income (OR 2.41, 95% CI: 1.59 - 3.65) and 
low occupational status (OR 1.84, 95% CI: 1.47 - 2.31) were significantly 
associated with an increase in risk of developing oral cancer. This chapter 
of the thesis first summarises some of the evidence on the trends and risk 
profile of head and neck cancer in the United Kingdom and identifies some 
of the gaps in the literature. It then lists the specific aims and objectives 
of this study, describes the data and methodology used, discusses the 
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findings and offers possible explanations for them and, finally, deliberates 
the strengths and limitations of the study.  
Louie et al. (2015) used population-based cancer registry data in England 
to examine the incidence burden of head and neck cancer between 1995 
and 2011 and reported an upward trend (59% increase in incidence rates). 
These rates were expected to continue to rise by 35% in males and 49% in 
females up to 2025. Moreover, this increase appeared to be largely driven 
by a rapid rise in the rates of oropharyngeal cancer (average annual 
percentage change = +7.3% in males and +6.5% in females), while smaller 
increases were observed in the rates of oral cavity cancer. The incidence 
rates of oropharyngeal cancer increased in all age-groups, particularly the 
50-59 and 60-69 year groups, over the study period, and the median age of 
incidence was less than 60 years (Louie et al., 2015). These results were 
corroborated by Tataru et al. (2017) who used data from the former 
Thames Cancer Registry to examine trends of head and neck cancer in 
London between 1985 and 2010 by age, sex, site, deprivation, and 
ethnicity. Their results showed that the age-standardised incidence rates 
of head and neck cancer had increased by 40% in males and 87% in females 
over the study period, and this upward trend was statistically significant 
for oral cavity, oropharyngeal, and thyroid cancer. Moreover, 
approximately six out of ten patients with head and neck cancer were from 
the most deprived areas of London, and the greatest proportion of 
diagnosed patients were white males above 65 years of age. 
The most recent detailed analysis of incidence trends of oral cancer in 
Scotland only examined rates between 1990 and 1999, and reported a 
general increase in European age-standardised incidence rates of 28% in 
males and 33% in females over the 10-year study period (Conway et al., 
2006). Moreover, Scotland also exhibited the highest incidence rates and 
the greatest lifetime risk of developing oral cancer in the United Kingdom. 
However, this study was limited by the fact that it examined rates of oral 
cavity cancer and oropharyngeal cancer combined, reflecting the thinking 
at the time that these sites had a common aetiology.  
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With regard to patient profile, several studies reported an increased risk of 
head and neck cancer among young males in Scotland (Macfarlane et al., 
1987; MacFarlane et al., 1992). Moreover, a strong cohort effect was also 
reported, with the rates increasing in every birth-cohort succeeding 1910, 
and the authors suggested that this could be attributed to a surge in the 
consumption of alcohol and tobacco (MacFarlane et al., 1992). In Scotland, 
Conway et al. (2007) used cancer registry data to examine trends of oral 
cancer between 1976 and 2002 by deprivation, and reported a 
socioeconomic gap in incidence rates that first appeared in the late 1970’s 
and subsequently widened in the 1980’s up to the late 1990’s. This was 
particularly true for males from the most deprived areas of Scotland who 
exhibited an increase of 196% in incidence rates over the study period. 
Women, on the other hand, exhibited a slightly different pattern with 
increases in incidence rates being observed in all levels of deprivation, 
although the greatest increase still occurred in the most deprived areas 
(Conway et al., 2007). Upon examining the association between risk of 
developing head and neck cancer and the components of socioeconomic 
class (area-based measures of socioeconomic status, occupational social 
class, employment, and education) using data from 103 patients with head 
and neck cancer and 91 controls in Scotland, Conway et al. (2010) found 
that individuals residing in the most deprived areas exhibited a higher risk 
of developing cancer relative to those living in the least deprived areas (OR 
4.66, 95% CI 1.79-12.18). Unemployment (OR 2.27, 95% CI 1.21-4.26) and 
manual occupational classes were also associated with a higher risk of 
developing cancer, while higher levels of education exhibited a protective 
effect (OR = 0.17, 95% CI 0.05–0.58). However, the authors clarified that 
smoking appeared to dominate the risk profile and the statistical 
significance for all measures of social class were lost upon adjusting for it. 
Nevertheless, their results did show strong links between certain 
components of social class and the risk of developing head and neck cancer 
(Conway et al., 2010).  
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Therefore, evidence from around the globe as well as within the United 
Kingdom reports a rapid increase in the rates of oropharyngeal cancer and 
a stabilisation in the incidence of oral cavity cancer over time, highlighting 
the differences in the aetiology of the two. Moreover, younger males from 
lower socioeconomic strata appear to be at the highest risk of developing 
cancer, irrespective of subsite. However, currently, there are no recent 
estimates of the trends of oral cancer in Scotland by subsite and various 
determinants such as age, sex, and socioeconomic status, and research in 
this area will help inform strategies for prevention and early detection. 
2.2 Aim, hypotheses and objectives  
Therefore, the aim of this study was to examine the incidence burden and 
sociodemographic profile of patients with head and neck cancer in 
Scotland.  
The individual hypotheses were: 
Chapter 2 hypothesis (a): The trends of head and neck cancer are 
increasing and are projected to continue to do so.  
Chapter 2 hypothesis (b): This increase in incidence rates of head and 
neck cancer will largely be driven by an increase in the rates of 
oropharyngeal cancer. 
Chapter 2 hypothesis (c): The patient profile of oropharyngeal cancer will 
differ from other subsites, particularly in relation to socioeconomic status. 
Chapter 2 hypothesis (d): In relation to the socioeconomic distribution of 
head and neck cancer, there will be a clear stratification of “high-risk” 
areas in the more deprived communities that could be utilised to target 
early detection initiatives. 
The individual objectives were:  
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Chapter 2 objective (a): To create a cohort of patients with head and 
neck cancer (and subsites) using data from the Scottish Cancer Registry. 
Chapter 2 objective (b): To describe and analyse the incidence burden 
and trends of oral cavity, oropharyngeal and laryngeal cancer in Scotland 
between 1975 and 2012 by key sociodemographic determinants including 
age, sex, area-based socioeconomic deprivation, geographic region and 
year of diagnosis. 
Chapter 2 objective (c): To compute future projected incidence rates up 
to 2025 for all head and neck, oral cavity, oropharyngeal, and laryngeal 
cancer by key sociodemographic determinants including age, sex, area-
based socioeconomic deprivation, geographic region and year of diagnosis. 
Chapter 2 objective (d): To produce a sociodemographic risk profile of all 
patients with head and neck, oral cavity, oropharyngeal and laryngeal 
cancer for stratification. 
2.3 Patients and methods 
2.3.1 Ethical considerations 
An initial data access request was submitted to the Scottish Cancer 
Registry, part of the Information and Statistics Division (ISD) of the NHS 
National Services Scotland (NHS NSS). As the data was non-patient 
identifiable, no application to the Public Benefit and Privacy Panel was 
necessary and access was approved by the Caldicott Guardian for NHS NSS. 
A Confidential Data Release Form was signed by the author and Professor 
David Conway (Appendix 6). The West of Scotland Research Ethics 
Committee identified this project as “Surveillance” and formally confirmed 
that NHS ethical approval would not be required (Appendix 3). 
Additionally, ethical approval was also obtained from the Research Ethics 
Committee of the Institute of Medicine, Veterinary, and Life Sciences, 
University of Glasgow (Appendix 4). 
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2.3.2 Data  
Data on all patients with head and neck cancer (ICD-10 codes shown in 
Appendix 1) diagnosed in Scotland between 1975 and 2012 were included in 
this study. The information requested included cancer subsite (determined 
using ICD-10 codes), sex of the patient, health board region of the 
patient’s residence, year of diagnosis, age of the patient at the time of 
diagnosis, and deprivation quintile of the patient’s residence. 
The three-digit ICD-10 codes were grouped into subsites, as follows: 
oropharyngeal cancer which included base of the tongue (C01), lingual 
tonsil (C2.4), tonsil (C09), oropharynx (C10), and pharynx (C14); oral 
cavity cancer which included inner lip (C00.3-C00.9), other and 
unspecified parts of the tongue (C02), gum (C03), floor of the mouth (C04), 
palate (C05), and other and unspecified parts of the mouth (C06); and 
laryngeal cancer(C32). Additionally, an all head and neck cancer grouping 
which included all of the above-mentioned subsites along with 
hypopharynx, salivary glands, and outer lip was also created. The final 
sample included only the head and neck cancer, oral cavity cancer, 
oropharyngeal cancer, and laryngeal cancer groupings, and all ICD codes 
not included in these groupings were deleted. 
Age was grouped into five-year categories and, based on NHS health board 
boundaries, the geographic regions were grouped into North (Grampian, 
Highland, Islands), East (Borders, Fife, Forth Valley, Lothian, Tayside), and 
West (Ayrshire and Arran, Dumfries & Galloway, Greater Glasgow & Clyde, 
Lanarkshire). Socioeconomic status was measured by the area-based 
Carstairs Deprivation index grouped into deciles (Carstairs v1991) (ISD 
Scotland, 2017c). This index is measured at the postcode sector level and 
takes four variables into account, namely: male unemployment, 
households with no car, overcrowded households, and the percentage of 
people in social classes IV and V. It is calculated using census data and is 
available for the years 1971, 1981, 1991, and 2001.  
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Annual mid-year population estimates by age, sex, deprivation indices and 
geographic regions were also collated for the period between 1975 and 
2012 (National Records Scotland, 2017).  
An additional sub-group analysis was performed on patients that were 
diagnosed between 2001 and 2012 in order to utilise the more recently 
developed small area-based socioeconomic index, the Scottish Index of 
Multiple Deprivation (SIMD 2009) (Donnelly, 2009). This is calculated taking 
seven domains of deprivation into consideration, namely: income, 
employment, education, housing, health, crime and geographical access. It 
is measured at the data-zone level, thus resulting in coverage of smaller 
populations than the Carstairs index.  
2.3.3 Statistical analysis 
Initial data management included deleting records that were duplicates or 
had missing data and creating new variables including subsites, age groups, 
and health board regions. Thereafter, incidence rates per 100,000 
population (1975-2012) and projected rates up to 2025 were calculated for 
all subsites by age, sex, deprivation (measured by Carstairs 1991), health 
board region, and year of diagnosis. Direct standardisation was undertaken 
using the European Standard population to account for changes in the age 
composition of the population and allow easier comparison between areas 
(Waterhouse, 1976). Adjusted Poisson regression rate-ratios were used to 
compare the subsites by age, sex, deprivation, health board region, and 
year of diagnosis. 
A sub-group analysis was also performed on patients that were diagnosed 
between 2001 and 2012. All examined variables remained the same, except 
for deprivation which was measured by deciles of the Scottish Index of 
Multiple Deprivation (SIMD) 2009. All statistical analyses were performed 
using SAS V9.3 on Windows 7 Enterprise. 
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2.4  Results  
2.4.1 Final sample 
Our study comprised of 28,217 individuals diagnosed with head and neck 
cancer between 1975 and 2012, of which 19,755 (70%) were males and 
8462 (30%) were females. The mean age was 63.8 years (standard 
deviation: ± 12.3 years). The age-standardised incidence rates of cancer 
per 100,000 individuals and the fully adjusted Poisson regression rate-
ratios by sociodemographic characteristics have been shown in Tables 2-1 
and 2-2, respectively.  
The sub-group analysis using SIMD as an indicator of socioeconomic status 
consisted of 11,416 patients that were diagnosed with head and neck 
cancer between 2001 and 2012. Of these, 8009 (70%) were males and 3407 
(30%) were females. The age-standardised incidence rates of cancer per 
100,000 individuals and the fully adjusted Poisson regression rate-ratios by 
sociodemographic characteristics for this sub-group have been presented in 
Tables 2-3 and 2-4, respectively. 
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Table 2-1: EASR per 100,000 person-years by age, sex, geographic region, 
deprivation (Carstairs 1991), and year of diagnosis (1975-2012). 
 
  HNC OPC OCC Larynx 
 N Rate N Rate N Rate N Rate 
Age 
0-25 135 0.28 7 0.01 35 0.07 5 0.01 
26-30 87 0.94 2 0.02 29 0.31 5 0.05 
31-35 145 1.54 9 0.10 44 0.47 16 0.17 
36-40 294 3.46 36 0.42 79 0.93 67 0.79 
41-45 537 6.39 80 0.96 177 2.11 150 1.79 
46-50 1185 15.13 179 2.32 408 5.27 402 5.19 
51-55 1817 22.80 261 3.38 603 7.79 674 8.67 
56-60 2484 32.17 349 4.72 756 10.19 1001 13.41 
61-65 2648 38.64 348 5.37 803 12.29 1091 16.62 
66-70 2736 41.80 328 5.26 866 13.84 1119 17.75 
71-75 2334 45.52 260 5.27 747 15.11 935 18.79 
76-80 1656 44.71 175 4.81 609 16.66 572 15.65 
81-85+ 1015 30.61 109 3.30 421 12.75 293 8.88 
Sex 
Male 19755 20.67 3352 3.60 5851 6.28 7744 8.29 
Female 8462 8.41 1272 1.27 3467 3.46 2009 2.01 
Region 
North 9768 13.55 1547 2.18 3201 4.50 3375 4.74 
East 4431 14.56 786 2.59 1467 4.84 1286 4.24 
West 14018 14.95 2291 2.50 4650 5.06 5092 5.53 
Carstairs 
1 4254 21.53 682 3.51 1354 6.95 1644 8.42 
2 3499 17.40 534 2.77 1122 5.80 1337 6.89 
3 3059 15.44 490 2.53 983 5.07 1107 5.69 
4 3050 15.56 545 2.83 948 4.92 1090 5.65 
5 2676 13.63 431 2.23 893 4.61 901 4.64 
6 2717 14.00 426 2.22 939 4.90 927 4.83 
7 2483 12.68 426 2.20 855 4.41 766 3.95 
8 2453 12.62 402 2.09 848 4.41 785 4.08 
9 2154 11.06 364 1.88 736 3.81 656 3.39 
10 1872 9.63 324 1.68 640 3.31 540 2.79 
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EASR: European age standardised rates, HNC: Head & neck cancer; OPC: Oropharyngeal 
cancer; OCC: Oral cavity cancer; N: Number of events
Year  
1975 502 12.57 69 1.75 140 3.73 180 4.50 
1976 439 10.95 55 1.42 135 3.52 153 3.75 
1977 521 12.66 63 1.60 155 3.95 173 4.25 
1978 485 11.70 60 1.51 130 3.32 187 4.55 
1979 513 12.57 55 1.40 148 3.79 176 4.29 
1980 531 12.99 55 1.42 152 3.81 190 4.65 
1981 594 14.30 49 1.20 184 4.63 220 5.32 
1982 585 13.94 54 1.32 215 5.28 203 4.95 
1983 634 14.92 77 1.90 188 4.62 249 6.04 
1984 589 14.03 51 1.22 200 4.88 231 5.60 
1985 643 15.03 74 1.78 215 5.22 4.87 5.89 
1986 621 14.65 61 1.46 187 4.50 246 5.90 
1987 608 14.17 62 1.46 226 5.44 214 5.08 
1988 651 15.00 73 1.73 224 5.32 242 5.73 
1989 674 15.29 88 2.08 219 5.18 252 5.94 
1990 718 16.30 86 2.03 242 5.70 278 6.59 
1991 720 16.37 97 2.29 244 5.74 274 6.47 
1992 710 16.03 92 2.14 236 5.55 302 7.06 
1993 719 16.22 91 2.13 234 5.43 288 6.73 
1994 739 16.43 91 2.09 259 5.98 282 6.49 
1995 750 16.61 104 2.40 267 6.19 253 5.79 
1996 864 18.72 124 2.83 271 5.49 340 7.77 
1997 768 16.76 138 3.11 245 5.55 255 5.81 
1998 826 17.94 103 2.33 296 6.64 279 6.37 
1999 865 18.61 138 3.09 298 6.71 313 7.09 
2000 804 17.11 133 2.96 267 5.93 305 6.85 
2001 880 19.81 152 3.35 289 6.51 314 7.13 
2002 858 19.12 150 3.28 304 6.80 286 6.41 
2003 893 19.65 162 3.51 324 7.08 289 6.46 
2004 906 19.80 182 3.95 306 6.68 304 6.71 
2005 883 18.98 182 3.79 315 6.79 276 6.06 
2006 931 19.86 191 3.98 304 6.50 310 6.69 
2007 961 20.20 202 4.17 341 7.17 291 6.17 
2008 910 18.79 203 4.13 324 6.70 276 5.77 
2009 1029 20.97 266 5.25 339 6.97 281 5.83 
2010 1025 20.71 241 4.73 344 7.00 306 6.29 
2011 1016 20.32 253 4.93 328 6.56 288 5.86 
2012 1124 22.04 320 6.17 357 7.04 270 5.35 
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Table 2-2: Adjusted Poisson regression rate-ratios for subsites by age, sex, geographic region, deprivation (Carstairs 1991), and year of 
diagnosis (1975-2012) 
 
 
 HNC OPC OCC Larynx 
RR 95% CI p RR 95% CI  p RR 95% CI p RR 95% CI p 
Age 
0-25 0.02 0.02-0.02 <.001 0.01 0.00-0.01 <.001 0.02 0.01-0.02 <.001 0.00 0.00-0.00 <.001 
26-30 0.07 0.05-0.08 <.001 0.02 0.01-0.03 <.001 0.07 0.05-0.09 <.001 0.02 0.01-0.03 <.001 
31-35 0.10 0.09-0.12 <.001 0.04 0.03-0.07 <.001 0.10 0.08-0.13 <.001 0.04 0.02-0.06 <.001 
36-40 0.24 0.21-0.26 <.001 0.17 0.13-0.22 <.001 0.20 0.17-0.24 <.001 0.17 0.13-0.21 <.001 
41-45 0.46 0.43-0.50 <.001 0.45 0.38-0.53 <.001 0.45 0.39-0.51 <.001 0.37 0.32-0.44 <.001 
46-50 (ref.) -   -   -   -   
51-55 1.62 1.53-1.71 <.001 1.62 1.44-1.83 <.001 1.58 1.43-1.75 <.001 1.82 1.64-2.02 <.001 
56-60 2.38 2.25-2.51 <.001 2.21 1.97-2.49 <.001 2.31 2.10-2.54 <.001 3.02 2.74-3.33 <.001 
61-65 2.79 2.65-2.95 <.001 2.34 2.08-2.63 <.001 2.73 2.49-2.99 <.001 3.73 3.39-4.10 <.001 
66-70 3.06 2.90-3.23 <.001 2.19 1.93-2.47 <.001 3.04 2.77-3.34 <.001 4.29 3.90-4.72 <.001 
71-75 3.39 3.21-3.58 <.001 2.03 1.78-2.32 <.001 3.30 3.00-3.64 <.001 4.74 4.30-5.23 <.001 
76-80 3.44 3.24-3.65 <.001 1.97 1.71-2.28 <.001 3.54 3.20-3.91 <.001 4.32 3.89-4.80 <.001 
81-85+ 2.36 2.20-2.52 <.001 1.08 0.90-1.29 0.398 2.66 2.39-2.97 <.001 2.56 2.26-2.90 <.001 
Sex 
Sex 
Male 2.72 2.66-2.79 <.001 3.10 2.90-3.30 <.001 2.11 2.02-2.20 <.001 4.77 4.54-5.01 <.001 
Female (ref.) -   -   -   -   
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 HNC OPC OCC Larynx 
 RR 95% CI p RR 95% CI p RR 95% CI p RR 95% CI p 
Region 
North 
(ref.) 
-   -   -   -   
East 0.85 0.82-0.88 <.001 0.81 0.74-0.88 <.001 0.88 0.83-0.94 <.001 1.01 0.95-1.08 0.738 
West 0.81 0.78-0.84 <.001 0.85 0.78-0.92 <.001 0.89 0.84-0.95 <.001 0.98 0.92-1.05 0.527 
Carstairs 1991 
1 2.59 2.45-2.74 <.001 2.49 2.18-2.86 <.001 2.40 2.18-2.65 <.001 3.34 3.02-3.69 <.001 
2 1.83 1.72-1.93 <.001 1.83 1.59-2.11 <.001 1.86 1.69-2.06 <.001 2.50 2.26-2.77 <.001 
3 1.66 1.57-1.76 <.001 1.67 1.45-1.92 <.001 1.62 1.47-1.79 <.001 2.07 1.87-2.30 <.001 
4 1.66 1.57-1.76 <.001 1.85 1.61-2.12 <.001 1.56 1.41-1.73 <.001 2.06 1.86-2.28 <.001 
5 1.47 1.38-1.56 <.001 1.44 1.25-1.66 <.001 1.47 1.32-1.62 <.001 1.71 1.54-1.91 <.001 
6 1.42 1.34-1.51 <.001 1.35 1.17-1.56 <.001 1.47 1.33-1.63 <.001 1.70 1.53-1.89 <.001 
7 1.30 1.22-1.38 <.001 1.32 1.15-1.53 <.001 1.33 1.20-1.47 <.001 1.39 1.24-1.55 <.001 
8 1.26 1.19-1.34 <.001 1.24 1.07-1.43 0.004 1.30 1.17-1.44 <.001 1.40 1.26-1.56 <.001 
9 1.12 1.05-1.19 <.001 1.13 0.97-1.31 0.107 1.14 1.02-1.26 0.019 1.19 1.06-1.33 0.003 
10 (ref.) 
 
-   -   -   -   
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 HNC OPC OCC Larynx 
 RR 95% CI p RR           95% CI        p 
95% CI 
p 
RR 95% CI p RR 95% CI          p 
p 
Year 
1975 (ref.) -   -   -   -   
1976 0.88 0.77-1.00 0.049 0.79 0.56-1.13 0.204 0.96 0.76-1/22 0.732 0.84 0.68-1.04 0.118 
1977 1.02 0.91-1.16 0.698 0.90 0.64-1.27 0.566 1.10 0.87-1.38 0.426 0.95 0.77-1.17 0.645 
1978 0.94 0.83-1.07 0.355 0.86 0.61-1.22 0.403 0.92 0.72-1.16 0.475 1.00 0.82-1.23 0.972 
1979 1.01 0.89-1.14 0.872 0.79 0.55-1.12 0.191 1.04 0.83-1.31 0.736 0.96 0.78-1.18 0.699 
1980 1.04 0.92-1.18 0.507 0.79 0.55-1.12 0.183 1.06 0.84-1.34 0.606 1.04 0.84-1.27 0.736 
1981 1.15 1.02-1.29 0.024 0.70 0.48-1.00 0.055 1.28 1.03-1.60 0.027 1.19 0.97-1.44 0.091 
1982 1.11 0.99-1.25 0.080 0.77 0.54-1.09 0.144 1.49 1.20-1.84 <.001 1.09 0.89-1.33 0.427 
1983 1.18 1.05-1.33 0.006 1.09 0.79-1.51 0.607 1.30 1.04-1.61 0.020 1.31 1.08-1.58 0.006 
1984 1.13 1.00-1.27 0.052 0.72 0.50-1.03 0.073 1.37 1.10-1.69 0.005 1.24 1.02-1.50 0.035 
1985 1.19 1.06-1.34 0.003 1.04 0.75-1.44 0.825 1.45 1.18-1.80 <.001 1.29 1.06-1.56 0.010 
1986 1.17 1.04-1.32 0.007 0.85 0.60-1.20 0.363 1.27 1.02-1.58 0.034 1.29 1.06-1.56 0.010 
1987 1.14 1.01-1.28 0.034 0.86 0.61-1.21 0.386 1.52 1.23-1.88 <.001 1.11 0.91-1.36 0.293 
1988 1.20 1.07-1.35 0.002 1.01 0.73-1.40 0.950 1.50 1.21-1.85 <.001 1.25 1.03-1.52 0.024 
1989 1.22 1.08-1.37 <.001 1.21 0.88-1.66 0.233 1.45 1.17-1.79 <.001 1.29 1.07-1.56 0.009 
1990 1.28 1.14-1.44 <.001 1.18 0.86-1.62 0.306 1.60 1.30-1.96 <.001 1.42 1.18-1.71 <.001 
1991 1.29 1.15-1.44 <.001 1.33 0.97-1.81 0.072 1.61 1.30-1.98 <.001 1.40 1.16-1.69 <.001 
1992 1.26 1.12-1.41 <.001 1.25 0.92-1.71 0.160 1.55 1.25-1.91 <.001 1.51 1.25-1.81 <.001 
1993 1.26 1.13-1.42 <.001 1.23 0.90-1.68 0.198 1.52 1.23-1.88 <.001 1.44 1.19-1.73 <.001 
1994 1.29 1.16-1.45 <.001 1.22 0.89-1.67 0.212 1.67 1.36-2.05 <.001 1.39 1.15-1.67 <.001 
1995 1.29 1.16-1.45 <.001 1.38 1.02-1.88 0.036 1.72 1.40-2.10 <.001 1.23 1.01-1.48 0.037 
1996 1.46 1.30-1.63 <.001 1.63 1.22-2.19 0.001 1.71 1.40-2.10 <.001 1.65 1.37-1.97 <.001 
1997 1.32 1.18-1.48 <.001 1.80 1.35-2.41 <.001 1.55 1.26-1.90 <.001 1.25 1.03-1.50 0.026 
1998 1.39 1.25-1.56 <.001 1.34 0.99-1.82 0.057 1.85 1.51-2.26 <.001 1.35 1.11-1.62 0.002 
1999 1.44 1.29-1.60 <.001 1.77 1.33-2.37 <.001 1.86 1.52-2.27 <.001 1.51 1.25-1.80 <.001 
2000 1.32 1.18-1.48 <.001 1.70 1.27-2.27 <.001 1.65 1.34-2.02 <.001 1.44 1.19-1.72 <.001 
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 HNC OPC OCC Larynx 
 RR 95% CI p RR           95% CI        p 
95% CI 
p 
RR 95% CI p RR 95% CI          p 
p 
Year 
             
2001 1.43 1.28-1.60 <.001 1.93 1.45-2.56 <.001 1.70 1.39-2.09 <.001 1.47 1.23-1.77 <.001 
2002 1.37 1.23-1.53 <.001 1.85 1.39-2.46 <.001 1.79 1.46-2.19 <.001 1.31 1.09-1.58 0.005 
2003 1.42 1.27-1.58 <.001 1.99 1.50-2.64 <.001 1.88 1.54-2.29 <.001 1.34 1.12-1.62 0.002 
2004 1.42 1.27-1.58 <.001 2.22 1.68-2.93 <.001 1.77 1.44-2.16 <.001 1.35 1.12-1.63 0.001 
2005 1.36 1.22-1.51 <.001 2.19 1.66-2.89 <.001 1.83 1.50-2.24 <.001 1.22 1.01-1.47 0.040 
2006 1.39 1.25-1.55 <.001 2.27 1.72-2.99 <.001 1.70 1.39-2.07 <.001 1.37 1.14-1.65 <.001 
2007 1.42 1.28-1.58 <.001 2.38 1.81-3.13 <.001 1.88 1.54-2.29 <.001 1.26 1.04-1.52 0.016 
2008 1.32 1.18-1.47 <.001 2.31 1.76-3.04 <.001 1.75 1.43-2.14 <.001 1.19 0.98-1.43 0.076 
2009 1.46 1.31-1.63 <.001 3.02 2.32-3.94 <.001 1.81 1.48-2.20 <.001 1.20 0.99-1.45 0.057 
2010 1.46 1.32-1.63 <.001 2.72 2.08-3.56 <.001 1.82 1.49-2.22 <.001 1.28 1.07-1.54 0.008 
2011 1.44 1.29-1.60 <.001 2.81 2.15-3.66 <.001 1.75 1.43-2.13 <.001 1.18 0.98-1.43 0.077 
2012 1.53 1.37-1.70 <.001 3.45 2.66-4.48 <.001 1.86 1.53-2.26 <.001 1.12 0.92-1.35 0.257 
RR: Rate-ratio; p: p value; HNC: Head & neck cancer; OPC: Oropharyngeal cancer; OCC: Oral cavity cancer. 
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Table 2-3: EASR per 100,000 person-years by age, sex, geographic region, deprivation 
(SIMD 2009), and year of diagnosis (2001-2012) 
 
 
 HNC OPC OCC Larynx 
 N Rate N Rate N Rate N Rate 
Age 
0-25 70 0.36 5 0.03 24 0.13 1 0.01 
26-30 45 1.17 5 0.13 19 0.49 5 0.13 
31-35 68 1.66 10 0.24 29 0.71 7 0.17 
36-40 172 3.75 39 0.85 60 1.31 32 0.70 
41-45 379 7.96 119 2.50 131 2.75 71 1.49 
46-50 
(ref.) 
698 15.57 243 5.42 235 5.24 150 3.35 
51-55 1294 31.10 406 9.76 396 9.52 326 7.83 
56-60 1756 45.52 463 12.00 571 14.80 526 13.63 
61-65 1933 55.99 444 12.86 635 18.39 611 17.70 
66-70 1674 57.47 312 10.71 559 19.19 616 21.15 
71-75 1438 57.92 213 8.58 478 19.25 538 21.67 
76-80 1019 52.60 161 8.31 355 18.32 367 18.94 
81-85+ 598 46.20 61 4.71 249 19.24 173 13.37 
Sex 
SEX 
Male 8009 26.76 1866 6.23 2330 7.78 2761 9.22 
Female 3407 10.62 638 1.99 1545 4.82 730 2.28 
Region 
REGION 
North 1790 16.07 461 4.14 601 5.40 472 4.24 
East 4033 17.15 836 3.56 1394 5.93 1231 5.24 
West 5593 20.44 1207 4.41 1880 6.87 1788 6.54 
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EASR: European age standardised rates, HNC: Head & neck cancer; OPC: Oropharyngeal 
cancer; OCC: Oral cavity cancer; N: Number of events.
 HNC OPC OCC Larynx 
 N Rate N Rate N Rate N Rate 
SIMD 
1 1897 29.90 392 6.18 606 9.55 673 10.61 
2 1596 25.51 352 5.63 500 7.99 543 8.68 
3 1460 23.32 299 4.77 494 7.89 472 7.54 
4 1230 19.66 243 3.88 411 6.57 407 6.50 
5 1113 17.91 237 3.81 395 6.36 317 5.10 
6 1035 16.76 239 3.87 363 5.88 295 4.78 
7 904 14.64 227 3.68 318 5.15 244 3.95 
8 853 13.97 215 3.52 302 4.95 214 3.50 
9 705 11.55 169 2.77 245 4.01 182 2.98 
10 623 10.19 131 2.14 241 3.94 144 2.35 
Year 
YEAR 
2001 880 19.81 152 3.35 289 6.51 314 7.13 
2002 858 19.12 150 3.28 304 6.80 286 6.41 
2003 893 19.65 162 3.51 324 7.08 289 6.46 
2004 906 19.80 182 3.95 306 6.68 304 6.71 
2005 883 18.98 182 3.79 315 6.79 276 6.06 
2006 931 19.86 191 3.98 304 6.50 310 6.69 
2007 961 20.20 202 4.17 341 7.17 291 6.17 
2008 910 18.79 203 4.13 324 6.70 276 5.77 
2009 1029 20.97 266 5.25 339 6.97 281 5.83 
2010 1025 20.71 241 4.73 344 7.00 306 6.29 
2011 1016 20.32 253 4.93 328 6.56 288 5.86 
2012 1124 22.04 320 6.17 357 7.04 270 5.35 
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Table 2-4: Subgroup analysis- Adjusted Poisson regression rate-ratios for subsites by age, sex, geographic region, deprivation (SIMD 
2009), and year of diagnosis (2001-2012) 
  HNC   OPC  OCC Larynx 
 RR 95% CI p RR 95% CI p RR 95% CI p RR 95% CI p 
Age 
0-25 0.02 0.02-0.03 <0.001 0 0.00-0.01 <0.001 0.02 0.01-0.03 <0.001 0 0.00-0.01 <0.001 
26-30 0.07 0.05-0.10 <0.001 0.02 0.01-0.06 <0.001 0.09 0.06-0.14 <0.001 0.04 0.01-0.09 <0.001 
31-35 0.10 0.08-0.13 <0.001 0.05 0.02-0.08 <0.001 0.13 0.09-0.19 <0.001 0.05 0.02-0.10 <0.001 
36-40 0.24 0.20-0.28 <0.001 0.16 0.11-0.22 <0.001 0.25 0.19-0.33 <0.001 0.20 0.14-0.30 <0.001 
41-45 0.51 0.45-0.58 <0.001 0.47 0.37-0.58 <0.001 0.52 0.42-0.65 <0.001 0.44 0.33-0.59 <0.001 
46-50 (ref) 
erg((ref.) 
-   -   -      
51-55 2.00 1.83-2.20 <0.001 1.81 1.55-2.12 <0.001 1.82 1.55-2.14 <0.001 2.34 1.93-2.84 <0.001 
56-60 2.94 2.69-3.21 <0.001 2.23 1.91-2.61 <0.001 2.83 2.43-3.30 <0.001 4.08 3.40-4.89 <0.001 
61-65 3.6 3.30-3.92 <0.001 2.37 2.03-2.77 <0.001 3.51 3.02-4.07 <0.001 5.31 4.44-6.34 <0.001 
66-70 3.71 3.40-4.06 <0.001 2.01 1.70-2.38 <0.001 3.65 3.14-4.25 <0.001 6.35 5.31-7.59 <0.001 
71-75 3.81 3.48-4.18 <0.001 1.65 1.37-1.98 <0.001 3.70 3.17-4.33 <0.001 6.69 5.58-8.01 <0.001 
76-80 3.59 3.26-3.96 <0.001 1.66 1.36-2.03 <0.001 3.60 3.06-4.25 <0.001 6.17 5.10-7.46 <0.001 
81-85+ 3.35 3.00-3.73 <0.001 1.00 0.76-1.33 0.977 3.92 3.28-4.68 <0.001 4.73 3.80-5.89 <0.001 
Sex 
Male 2.81 2.70-2.92 <0.001 3.31 3.02-3.62 <0.001 1.82  1.71-1.94 <0.001 4.60 4.24-5.00 <0.001 
Female(ref) 
(ref.) 
-            
Region 
North (ref) -   -   -   -   
East 1.06 1.00-1.12 0.05 0.86 0.77-0.97 0.012 1.10 1.00-1.21 0.057 1.20 1.08-1.33 <0.001 
West 1.07 1.02-1.14 0.011 0.93 0.83-1.04 0.185 1.11 1.01-1.22 0.028 1.21 1.09-1.34 <0.001 
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SIMD: Scottish index of multiple deprivation; RR: Rate-ratio; p: p value; HNC: Head & neck cancer; OPC: Oropharyngeal cancer; OCC: Oral cavity 
cance 
  
 HNC OPC OCC Larynx 
 RR 95% CI p RR 95% 
CI 
p RR 95% CI p RR 95% CI p 
SIMD 
1 3.3 3.01-3.62 <0.001 3.33 2.72-4.07 <0.001 2.69 2.31-3.13 <0.001 4.98 4.15-5.97 <0.001 
2 2.6 2.37-2.85 <0.001 2.83 2.31-3.46 <0.001 2.08 1.78-2.43 <0.001 3.75 3.11-4.51 <0.001 
3 2.31 2.10-2.54 <0.001 2.33 1.89-2.86 <0.001 2.00 1.71-2.33 <0.001 3.19 2.64-3.84 <0.001 
4 1.89 1.72-2.08 <0.001 1.82 1.47-2.25 <0.001 1.62 1.38-1.90 <0.001 2.67 2.21-3.23 <0.001 
5 1.73 1.57-1.91 <0.001 1.74 1.41-2.16 <0.001 1.58 1.35-1.86 <0.001 2.13 1.75-2.60 <0.001 
6 1.58 1.43-1.75 <0.001 1.72 1.39-2.13 <0.001 1.44 1.22-1.69 <0.001 1.96 1.60-2.39 <0.001 
7 1.36 1.23-1.51 <0.001 1.61 1.30-2.00 <0.001 1.25 1.05-1.47  0.01 1.60 1.30-1.96 <0.001 
8 1.35 1.22-1.49 <0.001 1.60 1.29-1.99 <0.001 1.24 1.04-1.46  0.014 1.47 1.19-1.81 <0.001 
9 1.12 1.00-1.25  0.042 1.25 1.00-1.57  0.053 1.01 0.84-1.21  0.923 1.26 1.01-1.56 0.041 
10 (ref.) 
 
-   -   -   -   
Year 
2001 (ref.) -     -     -     -     
2002 0.97 0.88-1.07 0.52 0.98 0.78-1.23 0.864 1.05 0.89-1.23 0.586 0.91 0.77-1.07 0.235 
2003 1.00 0.91-1.10 0.977 1.05 0.84-1.31 0.667 1.11 0.94-1.30 0.216 0.91 0.78-1.07 0.252 
2004 1.01 0.92-1.10 0.906 1.17 0.94-1.45 0.163 1.03 0.88-1.21 0.689 0.95 0.81-1.11 0.516 
2005 0.97 0.88-1.06 0.516 1.15 0.93-1.43 0.198 1.05 0.90-1.23 0.53 0.85 0.73-1.00 0.054 
2006 1.01 0.92-1.11 0.798 1.20 0.97-1.48 0.101 1.01 0.86-1.18 0.944 0.95 0.81-1.11 0.516 
2007 1.03 0.91-1.13 0.478 1.25 1.01-1.54 0.039 1.12 0.95-1.31 0.169 0.88 0.75-1.04 0.126 
2008 0.97 0.88-1.06 0.464 1.24 1.00-1.53 0.046 1.05 0.89-1.23 0.571 0.83 0.70-0.97 0.021 
2009 1.08 0.99-1.18 0.101 1.60 1.31-1.95 <0.001 1.08 0.92-1.27 0.326 0.83 0.71-0.98 0.024 
2010 1.06 0.97-1.16 0.209 1.43 1.17-1.75 <0.001 1.08 0.93-1.27 0.317 0.89 0.76-1.04 0.155 
2011 1.04 0.95-1.13 0.442 1.48 1.21-1.81 <0.001 1.02 0.87-1.19 0.814 0.83 0.71-0.97 0.021 
2012 1.13 1.04-1.24 0.005 1.85 1.53-2.25 <0.001 1.10 0.94-1.28 0.242 0.77 0.65-0.90 0.001 
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2.4.2 Trends over time 
Overall, the incidence rates of head and neck cancer appeared to have 
increased significantly over the study period (1975-2012), with the rates 
in 2012 being approximately 1.53 (RR 1.53, 95% CI 1.37-1.70) times that 
in 1975. This increase was largely driven by a dramatic rise in the 
incidence rates of oropharyngeal cancer (RR 3.45, 95% CI 2.66-4.48), 
while rates of oral cavity cancer exhibited a significantly smaller 
increase over the same period (RR 1.86, 95% CI 1.53-2.26) (Figure 2-1). 
Laryngeal cancer exhibited a very small increase in incidence rates 
between 1975 and 2012, but this was not statistically significant (RR 
1.12, 95% CI 0.92-1.35).  
Figure 2-1: European age-standardised incidence rates between 1975-2012 by subsite 
 
HNC: Head and neck cancer; OCC: Oral cavity cancer; OPC: Oropharyngeal cancer 
The sub-group analysis showed that the rates of head and neck cancer 
increased rapidly in the most recent decade (2001-2012), with the rates 
in 2012 being 1.13 (RR 1.13, 95% CI 1.04-1.24) times the rates seen in 
2001. Once again, this appeared to be driven by a rapid increase in the 
incidence rates of oropharyngeal cancer, which almost doubled (RR 1.85, 
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95% CI 1.53-2.25) over this period. Rates of oral cavity cancer remained 
relatively stable between 2001 and 2012 (RR 1.10, 95% CI 0.94-1.28), and 
rates of laryngeal cancer decreased slightly (RR 0.77, 95% CI 0.65-0.90) 
over the same period (Figure 2-2). 
Incidence projections up to 2025 showed a sharp increase in the rates of 
head and neck cancer, and oropharyngeal cancer was expected to be 
largely responsible for this. Moreover, rates of oropharyngeal cancer 
were expected to bypass the rates of oral cavity cancer, which were 
expected to have only a relatively modest increase. Rates of laryngeal 
cancer were predicted to decrease up to 2025 (Figure 2-2). 
Figure 2-2: European age-standardised incidence rates per 100k persons between 2001-
2012 (bold lines) and projected rates (dotted lines) up to 2025 by subsite 
 
 
HNC: Head and neck cancer; OCC: Oral cavity cancer; OPC: Oropharyngeal cancer 
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2.4.3 Trends by age  
Head and neck cancer appeared to be a disease primarily affecting older 
individuals, with a greater number of the patients included in this study 
being above 45 years of age (Table 2-1). The incidence rates were seen 
to peak in the 71-75 year age group, and then begin to decline in the 80+ 
age group. This decrease in rates in the 80+ age group was likely a result 
of survival bias, that is, the incidence numbers represented only those 
individuals who had survived long enough to be diagnosed with cancer, 
and excluded those who had died from other unrelated causes before 
they could receive a diagnosis of cancer. 
The peak incidence of oropharyngeal cancer was observed in the 61-65 
year age-group, while that of oral cavity cancer and laryngeal cancer 
were seen in the 76-80 and 71-75 year age-groups, respectively (Figure 
2-3). The 41-45 year age-group was chosen as the reference category in 
the model as incidence numbers below this were very small. Regression 
analysis showed that rates of oropharyngeal cancer were more than 
double in the 61-65 age-group (RR 2.34, 95% CI 2.08-2.63) compared to 
the reference category (41-45 age-group), and this was statistically 
significant (Table 2-2). Relative to the reference group, the highest rate-
ratios for oral cavity cancer (RR 3.54, 95% CI 3.20-3.91) and laryngeal 
cancer (RR 4.74, 95% CI 4.30-5.23) were observed in the 76-80 and 71-75 
years age-groups, respectively (Table 2-2). 
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Figure 2-3: European age-standardised incidence rates by age-group 
 
 
HNC: Head and neck cancer; OCC: Oral cavity cancer; OPC: Oropharyngeal cancer 
2.4.4 Trends by sex 
Males were found to exhibit considerably higher incidence rates than 
females, and this was consistent for all subsites (Table 2-1, Figure 2-4). 
Regression analysis showed that the rates of head and neck cancer 
among males was 2.72 times the rates among females, and this was 
statistically significant. The corresponding rate-ratios for the other 
subsites were as follows: 3.10 (95% CI 2.90-3.30) for oropharyngeal 
cancer, 2.11 for oral cavity cancer (95% CI 2.02-2.20), and 4.77 laryngeal 
cancer (95% CI 4.54-5.01) (Table 2-2), and these were all statistically 
significant.  
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Figure 2-4: European age-standardised incidence rates (1975-2012) by sex 
 
 
HNC: Head and neck cancer; OCC: Oral cavity cancer; OPC: Oropharyngeal cancer 
2.4.5  Trends by geographic region 
No major differences in incidence burden were observed between the 
different geographic regions, irrespective of subsite, with rate-ratios of 
the North, East, and West health board regions being quite similar (Table 
2-1). 
2.4.6 Trends by socioeconomic status 
The most deprived areas of Scotland (Carstairs 1) consistently exhibited 
higher rates of cancer compared to the least deprived areas (Carstairs 
10), irrespective of subsite (Table 2-1). Moreover, a dose-like effect was 
seen to exist, with the rates of cancer increasing as level of deprivation 
increased (Figure 2-5). This socioeconomic inequality and dose-like 
effect persisted in the additional sub-group analysis of patients that 
were diagnosed between 2001 and 2012 using SIMD as an indicator of 
deprivation (Figure 2-6).  
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Figure 2-5: European age-standardised incidence rates (1975-2012) for each 
subsite by Carstairs 1991 (where 1= most deprived, 10=least deprived) 
 
  
HNC: Head and neck cancer; OCC: Oral cavity cancer; OPC: Oropharyngeal cancer 
 
Figure 2-6: European age-standardised incidence rates per 100k persons (2001-
2012) for each subsite by Scottish Index of Multiple Deprivation 2009 (where 1=most 
deprived, 10= least deprived) 
 
 
HNC: Head and neck cancer; OCC: Oral cavity cancer; OPC: Oropharyngeal cancer 
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Regression analysis of patients that were diagnosed between 1975 and 
2012 showed that the rates of head and neck cancer in the most 
deprived areas (Carstairs 1) was 2.59 (RR 2.59 95% CI 2.45-2.74) times 
that of the least deprived areas (Carstairs 10), and this was statistically 
significant (Table 2-2). The corresponding rate-ratios for the other 
subsites were as follows: RR 2.49, 95%CI 2.18-2.86 for oropharyngeal 
cancer; RR 2.40, 95%CI 2.18-2.65 for oral cavity cancer; and RR 3.34, 95% 
CI 3.02-3.69 for larynx (Table 2-2). 
The additional regression analysis of more recent patients that were 
diagnosed between 2001 and 2012 showed that the rates of head and 
neck cancer in the most deprived areas (SIMD 1) was 3.3 (RR 3.3 95% CI 
3.01-3.62) times the rates seen in the least deprived areas (SIMD 10), 
and this was statistically significant (Table 2-4). This inequality persisted 
upon examination of the other subsites; moreover, the socioeconomic 
gap appeared to have widened for oropharyngeal cancer (RR 3.33, 95% CI 
2.72-4.07) and laryngeal cancer (RR 4.98; 95% CI 4.15-5.97), but 
remained relatively unchanged for oral cavity cancer (RR 2.69; 95% CI 
2.31-3.13) between 2001 and 2012 (Table 2-4). 
2.5  Discussion 
2.5.1 Key points, comparison with other work, and 
potential explanations 
This study was the first national descriptive epidemiological study to 
examine trends of head and neck cancer in Scotland by subsite and 
socioeconomic status. The results showed that the incidence rates of 
oropharyngeal cancer were almost at par with the rates of oral cavity 
cancer and had overtaken those of laryngeal cancer by the year 2012. 
Moreover, this increasing trend was expected to persist, with the rates 
of oropharyngeal cancer bypassing oral cavity cancer by 2025. 
Conversely, rates of oral cavity cancer were predicted to remain 
relatively stable and rates of laryngeal cancer were expected to 
decrease up to 2025. Males consistently exhibited higher rates of cancer, 
irrespective of subsite, and the peak age of incidence of oropharyngeal 
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cancer was approximately 5-10 years lower than the other subsites. A 
socioeconomic inequality in incidence was observed across all subsites, 
with the most deprived areas consistently exhibiting the highest rates of 
cancer relative to the least deprived areas. Additionally, this 
socioeconomic inequality exhibited a dose-effect relationship, with the 
rates of cancer rising as levels of deprivation increased.  
Similar results were reported by Chaturvedi et al. (2013) who used data 
from the Cancer Incidence in Five Continents database to carry out an 
age-period-cohort analysis, and reported an increase in the incidence of 
oropharyngeal cancer accompanied by a relative stabilising of rates of 
oral cavity cancer globally. In England, a detailed cancer registry 
analysis showed that the incidence rates of head and neck cancer 
increased by 59% between 1995 and 2011, and this was largely driven by 
an increase in the rates of oropharyngeal cancer (average annual 
percentage change = +7.3% in males and +6.5% in females) (Louie et al., 
2015). This was in general agreement with the results of the current 
study which showed an increase of 32% in incidence rates of head and 
neck cancer in Scotland over the same time period (1995–2011), and this 
was also driven by a rapid rise in the rates of oropharyngeal cancer. 
Additionally, Louie et al. (2015) also reported that the rates of head and 
neck cancer were predicted to continue to escalate up to 2025, and 
oropharyngeal cancer was expected to be largely responsible for this 
increased burden. Meanwhile, oral cavity cancer was predicted to 
stabilise in men and continue to increase in women. The projection 
estimates in the current study showed a similar increase in the rates of 
head and neck cancer, driven largely by a rapid rise in the rates of 
oropharyngeal cancer, in Scotland. Moreover, the peak incidence of 
oropharyngeal cancer in Scotland was observed in the 61–65 age-group, 
and this was in agreement with the trends observed in England where 
rates of oropharyngeal cancer were higher in younger individuals (less 
than 60 years) (Louie et al., 2015). HPV type 16 has been shown to play 
an aetiological role in oropharyngeal cancer (Gillison, 2004; D’Souza, 
2007), and Hashibe and Sturgis (2013) proposed that the changing profile 
of head and neck cancer incidence could be explained by the controlling 
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of a “tobacco epidemic while a human papillomavirus epidemic 
emerges”. The plateauing in the rates of oral cavity cancer may be a 
result of the decreasing global rates of smoking observed in the recent 
past. This theory was further supported by the decreasing incidence 
rates of laryngeal cancer, whose key risk factors include smoking and 
alcohol consumption (CRUK, 2018), observed in the most recent decade 
as it indicated a reduction in the prevalence of these risk factors. The 
increase in the rates of oropharyngeal cancer possibly reflect the 
changes in sexual behaviours among recent birth cohorts, which in turn 
increases risk of exposure to oral HPV infection (Chaturvedi et al., 2013; 
Louie et al., 2015).  
The results of this study showed higher incidence rates amongst men 
compared to women, and this was in agreement with another 
retrospective analysis conducted by Chaturvedi et al. (2008) in the 
United States. A brief presentation on cancer incidence in Scotland 
showed that oropharyngeal cancer was potentially the fastest increasing 
cancer in the country, particularly amongst men (Junor et al., 2010). 
This difference in the rates between sexes could be explained to some 
extent by the greater prevalence of HPV among men compared to 
women (Chaturvedi et al., 2011; Gillison et al., 2012b; Hashibe and 
Sturgis, 2013).  
However, in contrast to a previous small clinical series (Dahlstrom et al., 
2015), the current study showed that the socioeconomic inequalities in 
incidence rates of cancer persisted irrespective of subsite in Scotland, 
with the most deprived areas of the country consistently exhibiting the 
highest rate-ratios relative to the least deprived areas. This difference 
may be explained partly by the fact that previous studies examining 
trends of head and neck cancer in Scotland combined oral cavity cancer 
and oropharyngeal cancer and examined them as one subsite (Conway et 
al., 2006), and this may have resulted in a masking of the differential 
rates. Therefore, this study examined the rates of head and neck cancer 
as a whole as well as by individual subsites (oral cavity cancer, 
oropharyngeal cancer, and larynx), thus permitting a more detailed 
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exploration of differences in the determinants of incidence trends. 
Another possible explanation for this inequality could be that higher 
socioeconomic position often reinforces healthy behaviours such as 
maintenance of oral hygiene and regular physical exercise (Liberatos et 
al., 1988; Ross and Wu, 1995), while education and higher-level 
occupations are often associated with better access to health services 
and reduced exposure to occupational risk factors of head and neck 
cancer (Riechelmann, 2002).  
2.5.2 Data quality 
This study utilised robust, routinely collected administrative data from 
the Scottish Cancer Registry (SMR06). The quality indicators for 
registration of head and neck cancer tumours at the Scottish Cancer 
Registry are high, with approximately 85% of patients being 
microscopically confirmed and less than 2% Death Certificate Only 
registrations (Parkin et al., 2005; UKIACR, 2017). Several studies have 
also provided evidence of the high (95.4%), and constantly improving, 
case-ascertainment (Brewster et al., 1994; Brewster et al., 1997; 
Brewster et al., 2002; ISD Scotland, 2016a), and the levels of 
completeness of data in 2016 were 96% for patient information and 
96.4% for tumour information (UKIACR, 2017). 
2.5.3 Strengths and limitations  
The main strength of this study lay in the quality of the data used 
(Section 2.5.2). Use of national level data resulted in a population-
representative cohort spanning several decades, which improved the 
strength and generalisability of the results. Finally, examination of 
individual subsites separately as well as together permitted a more 
detailed exploration of the differences in the determinants that were 
driving these trends.  
The limitations of this study were mainly those related to limited 
availability of data, and included lack of information on HPV status, 
behavioural factors (e.g. tobacco and alcohol consumption), and stage of 
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cancer at the time of diagnosis. This information could have provided a 
clearer picture of the risk profile of patients with head and neck cancer. 
Secondly, this study used geographic area-based measures of 
socioeconomic status. Such deprivation indices assign all individuals 
living within a certain area the same score, making interpretation of 
these measures complex. When used as a surrogate individual measure, 
it may be inferred that all individuals living in a certain socioeconomic 
area have the same individual socioeconomic status, and this has been 
described as an “ecological fallacy” (Berkman and Macintyre, 1997; 
Macintyre and Ellaway, 2000). However, such ecological interpretation 
may be advantageous in terms of indicating the social and physical 
environment or circumstances, for example, adequate access to health 
care services. Ideally, a combination of individual and area-based 
socioeconomic measures would be combined in a multi-level analysis to 
take account of individual and area effects. Thirdly, although previous 
studies have reported high levels of reliability for cancer registration 
data, particularly with regard to demographic, diagnostic and treatment 
information (Brewster, 2002), there are no recent estimates of this 
currently available. Therefore, there is a possibility of misclassification 
in the data, particularly with regard to the ICD10 codes assigned to 
lesions in cases where practitioners were unable to identify the origin of 
the primary tumour. Lastly, although examination of the incidence 
trends by individual subsites provided greater clarity from an 
epidemiological perspective, further research could also include 
examination of the trends of oral cancer as a whole [defined as including 
the base of the tongue (C01), lingual tonsil (C2.4), tonsil (C09), 
oropharynx (C10), pharynx (C14), inner lip (C00.3-C00.9), other and 
unspecified parts of the tongue (C02), gum (C03), floor of the mouth 
(C04), palate (C05), and other and unspecified parts of the mouth (C06)] 
in Scotland over time by various sociodemographic determinants. 
2.6  Conclusion 
In conclusion, this study shows the changing trends in the burden and 
determinants of head and neck cancer. Oropharyngeal cancer is an 
emerging public health problem, with the rates dramatically increasing 
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in Scotland. Despite previous reports, the sociodemographic 
determinants of oropharyngeal cancer are not substantially different 
from other head and neck cancers, particularly in relation to gender and 
SES profile. 
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3  Is detecting oral cancer in general dental 
practices a realistic expectation? - A 
population-based study using population-
linked data in Scotland. 
3.1 Introduction 
Chapter 2 of this thesis examined the incidence rates of head and neck 
cancer by subsite in Scotland and reported an upward trend between 
1975 and 2012. This appeared to be largely driven by a rapid increase in 
the rates of oropharyngeal cancer, while those of oral cavity cancer 
exhibited a slower increase and then stabilised over the same period. 
Moreover, the rates of head and neck cancer were expected to continue 
to rise up to 2025, and males living in the most deprived areas of 
Scotland were at the highest risk of developing cancer, irrespective of 
subsite.  
In June 2012, the General Dental Council was presented with a case 
where a senior dental officer employed by NHS Ayrshire and Arran failed 
to “adequately examine or assess a malignant ulcer” in a patient treated 
between December 2009 and June 2010 (Evans, 2012). This patient 
subsequently died from the cancer. Another similar case was reported in 
December 2013 in Northern Ireland where a senior dentist failed to 
diagnose a potentially malignant lesion that had existed for 15 years in a 
patient, and subsequently faced 46 charges of misconduct at the 
disciplinary hearing conducted by the General Dental Council (BBC News, 
2013). The dentist, following a public hearing, was ultimately “struck 
off” the GDC register in September 2014. These incidents brought the 
topic of oral cancer screening and early detection into focus once again, 
and the GDC announced that “Oral Cancer: Improving Early Detection” 
would be included as a recommended subject for continuing professional 
development (CPD) (General Dental Council, 2017). This decision was 
based not only on the failure of dentists in detecting oral cancer in a 
timely manner, but also on the increasing incidence and potentially life-
threatening nature of this disease.  
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The World Health Organisation defined screening as “the systematic 
application of a screening test in a presumably asymptomatic 
population, with an aim to identify individuals with an abnormality 
suggestive of a specific cancer” (WHO, 2013). The United Kingdom 
National Screening Committee published a list of criteria that must be 
fulfilled in order for a mass screening program for a disease to be 
recommended, and Speight et al. (2017) recently used this list to assess 
the current global status of oral cancer screening. They concluded that 
although oral cancer screening was feasible, as it was frequently 
preceded by a potentially malignant lesion, there was insufficient 
evidence in support of the effectiveness of a population-wide screening 
program, and targeted screening of high-risk individuals (identified by 
smoking and alcohol behaviours) was recommended instead. Moreover, 
this was previously reported to be the most cost-effective option by 
Speight et al. (2006) who used simulation modelling techniques to 
examine the cost-effectiveness of screening for oral cancer in various 
primary care facilities.  
General dental practitioners are placed in an ideal position to examine 
the oral soft tissues of patients for cancerous or pre-cancerous lesions 
through regular patient contact, thus increasing the opportunities for 
early detection of oral cancer and the delivery of appropriate advice to 
increase awareness of known risk factors. In England, Saving Lives: Our 
Healthier Nation (UK Government, 1999) and Modernising NHS 
Dentistry - Implementing the NHS Plan (UK Government, 2000) 
recommended incorporation of the dental team in the delivery of 
preventive advice in order to increase the public health role of the team 
through a common risk factor approach (Grabauskas and Leparski, 1987; 
WHO, 2000). Moreover, the dental team can also play a crucial role in 
the management of oral cancer through patient counselling and early 
referral which, in turn, facilitates early diagnosis and prompt treatment 
(Conway et al., 2002).  
However, given the relatively low volume of the disease in Scotland (as 
reported in Chapter 2), the feasibility of early detection of oral cancer in 
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general dental practices remains unclear. In Britain, anecdotal evidence 
suggests that a dentist may expect to see “few, if any, cases of mouth 
cancer during their career” (McCarthy, 2016). Similar concerns were 
raised in relation to general medical practitioners in England identifying 
childhood cancer. Feltbower et al. (2004), in their Short Opinion 
published in the British Journal of Cancer in 2004, examined the 
distribution of childhood cancer cases by Primary Care Trusts in England 
and Wales, in an attempt to understand the likelihood of a single general 
practitioner referring a case of childhood cancer for treatment. They 
considered Yorkshire as a representative area of England and Wales, and 
used data from the Yorkshire Specialist Register of Cancer in Children 
and Young People, a population-based register recording cancer cases 
from various sources, and the 2001 local authority mid-year population 
estimates to calculate the incidence of childhood cancer per Primary 
Care Trust. Their results showed that a single general practitioner in 
Yorkshire would see one case of childhood cancer every twenty years. 
Currently there are very few studies that have attempted to use this 
methodology to estimate the distribution of oral cancer by general 
dental practices. A thorough literature search returned only one Letter 
to the Editor published in the British Dental Journal in April 2014 (Ogden 
et al., 2015). The authors reflected the attendance pattern of the 
general population (approximately 60% reported to visit the dentist 
regularly) to the total number of incident cases of mouth cancer per 
year to estimate that approximately 4060 out of 6767 cases must have 
visited the dentist. This represented approximately one case per ten 
dentists. They then included potentially malignant lesions such as 
leukoplakia and erythroplakia to their calculation, along with a 
population rate of 2.5%, and estimated that approximately 24 potentially 
malignant lesions occurred in a year or, in other words, two a month 
(Ogden et al., 2015). However, the authors failed to clarify the 
definition of oral cancer that was used and the time period considered, 
and also did not take registration rates into consideration. 
Timely detection and referral of oral cancer in the dental setting is also 
largely dependent on patients consulting dentists frequently enough to 
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achieve this. The literature review presented in Chapter 1 identified 
several studies from the Netherlands, Western Australia, and France that 
reported poor dental attendance patterns among patients with oral 
cancer (Tromp et al., 2005; Frydrych and Slack-Smith, 2011; Ligier et 
al., 2016). More locally, Netuveli et al. (2006) used data from the Health 
Survey for England (2001) (n=13,784) and the British Household Panel 
Survey (n=5547) to examine the association between dental attendance 
patterns and various known risk factors of oral cancer, and reported that 
the likelihood of attending a dental practice regularly decreased as the 
number of factors favouring carcinogenesis (age, sex, alcohol 
consumption, smoking, low intake of fruits/vegetables) and, 
subsequently, the risk of developing oral cancer increased. The authors 
termed this as the “inverse screening law” and suggested that 
opportunistic screening in dental practices would not be an efficient 
preventive strategy in the United Kingdom as only those who were at low 
risk of developing cancer would be screened. These results were further 
supported by Yusof et al. (2006) who also used data from the British 
Household Panel Survey to examine the association between dental 
attendance patterns and known risk factors of oral cancer, including 
socioeconomic status, and found that “high-risk” individuals (defined as 
males, above 40 years of age, low SES and education, manual 
occupational social class, smokers) exhibited poorer dental attendance 
patterns.  
Dental Workforce Reports in Scotland for 2012 showed that although 
there were socioeconomic inequalities in access to health care services 
such as medical practices, the distribution of dental practices did not 
follow this pattern (Audit Scotland, 2012), with the most deprived areas 
of Scotland also exhiibting a higher number of dental practices. 
Published dental registration rates for adults in the same year showed 
considerable population coverage of these services, with approximately 
78% and 73% of the adult population from the most and least deprived 
areas, respectively, being registered with a general dental practice (ISD 
Scotland, 2016b). However, in contrast to the registration rates, the 
published participation rates for adults exhibited a socioeconomic skew, 
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with only 74% of registered adults from the most deprived areas and 82% 
of registered adults from the least deprived areas having attended a 
dental practice in the previous two years. However, currently there are 
no studies that accurately estimate the distribution of patients with oral 
cancer by the location of primary care general dental practices (GDP) in 
Scotland, nor take into consideration how these trends may vary with 
area-based socioeconomic deprivation. Moreover, no studies have 
accurately investigated whether the patients that were diagnosed with 
oral cancer were registered or attended general dental practices prior to 
diagnosis and, given the changing incidence of oral cancer noted 
previously, there are no recent estimates of the likelihood of a general 
dental practitioner encountering a patient with the disease. Given the 
overall low number of patients with oral cancer in Scotland, the 
feasibility of carrying out screening at the primary care level is unknown, 
and quantification of the number of patients a practitioner may expect 
to encounter per year may help us develop a better understanding of 
whether a more stratified or targeted approach is necessary. Research in 
this area will also help us understand the distribution of the burden of 
oral cancer in Scotland and inform strategies for targeting training and 
future referral pathways. 
3.2  Aim, hypotheses and objectives  
Therefore, the aim of this study was to investigate whether early 
detection of oral cancer in dental settings is a realistic expectation, 
given the current burden and sociodemographic risk profile of the 
disease, and the location and distribution of general dental practices in 
Scotland.  
The hypotheses were:  
Chapter 3 hypothesis (a): The number of patients with oral cancer (oral 
cavity cancer and oropharyngeal cancer) a general dental practitioner in 
Scotland can expect to see will be low. 
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Chapter 3 hypothesis (b): Dentists working in more deprived areas will 
expect to see a greater number of patients with oral cancer (oral cavity 
cancer and oropharyngeal cancer) compared to dentists working in 
relatively less deprived areas. 
The individual objectives were: 
Chapter 3 objective (a): To collate data from the Scottish Cancer 
Registry and routine administrative NHS Scotland data on dental practice 
distribution, dental workforce, and population dental registration and 
participation (attendance) rates. 
Chapter 3 objective (b): To estimate the number of patients with oral 
cancer (oral cavity and oropharyngeal cancer) an NHS primary care 
dentist may expect to see per year and over time. 
Chapter 3 objective (c): To examine how the estimates of the number 
of patients with oral cancer (oral cavity and oropharyngeal cancer) may 
vary with the location and distribution of dental practices in relation to 
the socioeconomic deprivation of the area. 
Chapter 3 objective (d): To link Scottish Cancer Registry data with 
routine NHS dental service payment claims data to calculate dental 
attendance rates of patients with oral cancer (oral cavity and 
oropharyngeal cancer) in the two years preceding diagnosis.  
3.3 Patients and methods 
3.3.1 Ethical considerations  
As mentioned earlier in Section 2.3.1, an initial data access request was 
submitted to the Scottish Cancer Registry, which is part of the 
Information Services Division (ISD) of the NHS National Services Scotland 
(NHS NSS). As the data was non-patient-identifiable, no application to 
the Public Benefit and Privacy Panel (PBPP) was necessary and access 
was approved by the Caldicott Guardian for NHS NSS. A Confidential Data 
Release Form was signed by the author and Professor David Conway 
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(Appendix 6). The West of Scotland Research Ethics Committee 
(WOSRES) identified this project as ‘Surveillance’ and formally confirmed 
that NHS ethical approval would not be required (Appendix 3).  
An application for ethical approval was made to the University of 
Glasgow, College of Medicine, Veterinary and Life Sciences Ethics 
Committee, and was received on the 15th of December 2015 (Appendix 
5).  
As the data included in the additional linked dataset was generated by 
the NHS and patient-identifiable, access could only be arranged upon 
approval from the Public Benefit and Privacy Panel for Health and Social 
Care (PBPP). The electronic Data Research and Innovation Service 
(eDRIS) serves as a single point of contact to assist researchers in 
navigating the PBPP application process and organising data access in a 
secure environment, and their aim is to help conduct research in an 
easier, more efficient and convenient way. First contact with eDRIS 
involved submission of a research protocol that detailed the background, 
aims and objectives and the implications of the study to be undertaken. 
Thereafter, a research co-ordinator (Mark McCartney based at National 
Services Scotland) was assigned, who provided assistance with the PBPP 
application process including identification of appropriate datasets and 
relevant variables. The necessary Information Governance training was 
obtained by completion of an e-learning course (Research Data and 
Confidentiality e-learning course) conducted by the Medical Research 
Council on the 22nd of September 2015 (Appendix 7). The final PBPP 
application was submitted on the 21st of January 2016 for consideration 
at the panel meeting that was held on the 23rd of February 2016. 
Following several unforeseen delays, PBPP approval was finally received 
on the 21st of April 2016 (Appendix 9), and the application was then 
forwarded to the relevant teams for processing and uploading of data 
onto the NHS NSS eDRIS National Safe Haven (remote access). There was 
considerable unexpected delay in this step, and the linked datasets were 
finally uploaded in October 2016.  
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3.3.2 Data 
This study used data from the Scottish Cancer Registry (SMR06) and the 
Management Information and Dental Accounting System (MIDAS) 
datasets, details of which have been provided later in Chapter 4. Briefly, 
the Scottish Cancer Registry, started in 1958, collects and stores 
information on all Scottish residents diagnosed with malignancies (ISD 
Scotland, 2017d), while the MIDAS database, which is the computerised 
payment system for the General Dental Service in Scotland, processes 
and stores information on all individuals registered with an NHS dental 
practice in a dynamic fashion. 
This study included all patients that were diagnosed with oral cavity 
cancer and oropharyngeal cancer (as defined previously in Chapter 2) 
between 2010 and 2012 and registered with the Scottish Cancer Registry. 
Briefly, oral cavity cancer included ICD-10 codes C00.3-C00.9 and C02-
C06 while oropharyngeal cancer included codes C01, C2.4, C09, C10, and 
C14. Additionally, these two subsites were also combined and examined 
as oral cancer (OC; ICD10 codes C00.3-C00.9, C01-C06, C09-C10, C14). 
Socioeconomic status was measured by the recently developed small 
area-based socioeconomic index, the Scottish Index of Multiple 
Deprivation (SIMD 2009), which combines data from seven domains of 
deprivation including income, employment, education, housing, health, 
crime, and geographical access (Donnelly, 2009). It is measured initially 
at the data-zone level, thus allowing greater coverage of smaller 
populations, and grouped into fifths of the population (where 1 = most 
deprived areas, 5 = least deprived areas).  
Data on the number of primary care dentists per year per SIMD fifth were 
collected from NHS National Services Scotland (ISD Scotland, 2016c) and 
used to calculate the mean number of dentists per SIMD fifth over the 
study period (2010 to 2012). In this study, primary care dentists 
comprised of those working in the general dental services (GDS) 
including non-salaried and salaried dentists, but excluded Community 
Dental Services, now known as the Public Dental Services in Scotland. 
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Dental registration and participation (attendance) rates for all adults in 
Scotland as of 30th September 2012 were accessed from the Information 
Services Division website and NHS Scotland online publications (ISD 
Scotland, 2012; ISD Scotland, 2016b). 
Additionally, a dataset that anonymously linked individual patient 
records (all patients that were diagnosed with oral cancer, oral cavity 
cancer, and oropharyngeal cancer between 2010 and 2012) to their 
MIDAS records in the two years prior to diagnosis using the NHS Scotland 
unique ID number was also obtained. The MIDAS variables included were 
the patient’s gender, patient’s age at the time of contact, 
socioeconomic deprivation level (measured by SIMD v2009), start and 
stop dates of treatment, and treatment received. Here, the “start date 
of treatment” variable was used as an indicator of contact, and each 
unique date was considered as one contact irrespective of the number of 
claims made. This variable also included all contacts made as part of 
routine dental check-ups.  
3.3.3 Statistical Analysis 
Initial data management included checking for any missing variables and 
assessing the distribution of patients and practitioners. The expected 
number of patients per general dental practitioner, based on the 
assumption that all of them were seen by one, was calculated by 
dividing the number of patients that were diagnosed with oral cancer, 
oral cavity cancer, and oropharyngeal cancer per year by the number of 
dentists registered with the NHS in the same year.  
However, given that the whole population is not necessarily registered 
with an NHS general dental practitioner and only a proportion of those 
that are will consult a dentist regularly, there is a possibility that this 
simple calculation is an overestimation. Therefore, published 
registration and participation (attendance) rates for each SIMD fifth 
were then applied to obtain a more accurate estimate of the number of 
patients that a general dental practitioner would likely encounter per 
year (ISD Scotland, 2016b). Registration rates included all individuals in 
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the general population who were registered with an NHS GDP, while 
participation (attendance) rates represented the proportion of 
registered patients who had contacted a general dental practitioner for 
either examination or treatment (or both) in the last two years.  
The additional linked dataset was used to calculate the number and 
proportion of diagnosed patients by subsite and SIMD that had contacted 
a primary dental care service in the two years preceding diagnosis. 
These proportions were then applied to obtain a more realistic estimate 
of the number of patients a general dental practitioner would likely 
encounter per year. 
3.4  Results 
This study included 1988 patients that were diagnosed with oral cancer 
between 2010 and 2012, of which 1127 were oral cavity cancer and 861 
were oropharyngeal cancer. Among the patients with oral cavity cancer, 
57% were male (n=646) and 43% were female (n=481), while 74% (n=634) 
of patients with oropharyngeal cancer were male and 26% (n=227) were 
female. The patient demographics by subsite have been shown in Table 
3-1. 
Under the assumption that all patients were seen by a general dental 
practitioner, the overall estimated number of patients per GDP per year 
in Scotland was 0.22 for oral cancer (one patient every 4.5 years), 0.12 
for oral cavity cancer (one patient every 8.3 years), and 0.09 for 
oropharyngeal cancer (one patient every 11.1 years) (Table 3-2). Upon 
application of published dental registration and participation 
(attendance) rates, these estimates increased to 0.13 for oral cancer 
(one patient every 8 years), 0.07 for oral cavity cancer (one patient 
every 14 years), and 0.05 for oropharyngeal cancer (one patient every 20 
years). No major differences by deprivation fifths of the practice 
location was observed (Table 3-2). The estimated number of patients per 
GDP per year in the most deprived areas were 0.13 (one patient every 8 
years) for oral cancer, 0.07 (one patient every 14 years) for oral cavity 
cancer, and 0.05 (one patient ever 20 years) for oropharyngeal cancer, 
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while the corresponding numbers in the least deprived areas were 0.11 
(one patient every 9.10 years) for oral cancer, 0.06 (one patient every 
16.7 years) for oral cavity cancer, and 0.04 (one patient every 25 years) 
for oropharyngeal cancer. 
Table 3-1: Demographics of patients that were diagnosed with oral cancer, oral 
cavity cancer, and oropharyngeal cancer between 2010 and 2012 
 
 
 
OC: Oral cancer; OCC: Oral cavity cancer; OPC: Oropharyngeal cancer; SIMD: Scottish 
Index of Multiple Deprivation 2009; 
 
 
 
 OCC (n, %) OPC (n, %) OC (n, %) 
Sex 
Male 646 (57.3) 634 (73.6) 1280 (64.4) 
Female 481 (42.7) 227 (26.4) 708 (35.6) 
SIMD 
1 (Most deprived) 291 (25.8) 237 (27.5) 528 (26.6) 
2 244 (21.7) 183 (21.3) 427 (21.5) 
3 245 (21.7) 177 (20.6) 422 (21.2) 
4 194 (17.2) 153 (17.8) 347 (17.5) 
5 (Least deprived) 153 (13.6) 111 (12.9) 264 (13.3) 
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Table 3-2: Estimates of the expected and actual number of oral cancer cases (2010-2012) a GDP may encounter per year (taking published dental 
registration and participation, and actual attendance rates into consideration), and calculation of the number of years elapsed before one patient is 
seen. 
 
 
SIMD 
100% dental registration and participation 
(attendance) assumed 
Application of published registration and 
participation (attendance) rates 
Application of actual attendance rates 
Mean 
no. of 
patients 
over 
three 
years 
Mean 
no. of 
dentists 
over 
three 
years 
Estimation 
of number 
of patients 
per 
dentist 
Estimation 
of no. of 
years before 
one patient 
encountered 
 
Reg. 
rates 
(%) 
Part. 
rates 
(%) 
Estimation 
of no. of 
patients 
visiting 
dentist in 
last one 
year 
Estimation of 
number of 
patients per 
dentist 
Estimation of 
no. of years 
before one 
patients 
encountered 
Proportion of 
patients that 
contacted 
dentist in 
two years 
before 
diagnosis (%) 
** 
Estimation of 
number of 
patients per 
dentist 
 
Estimation of 
no. of years 
before one 
patients 
encountered 
 
 
OC 
All 
Scotland 
662.66 3025.33 0.22 4.55 73.7 78.7 384.35 0.13 7.69 46.4 0.10 10.00 
1 (Most 
deprived) 
176.00 771.33 0.23 4.35 77.8 73.6 100.79 0.13 7.69 45.2 0.10 10.00 
2 142.33 790 0.18 5.56 74.2 77.2 81.53 0.10 10.00 44.3 0.08 12.50 
3 140.66 631 0.22 4.55 71.5 79.2 79.65 0.12 8.33 47.4 0.12 8.33 
4 115.66 439 0.26 3.85 71.7 81.5 67.59 0.15 6.67 48.8 0.13 7.70 
5 (Least 
deprived) 
88.000 478.66 0.18 5.56 73.2 82.0 52.82 0.11 9.10 47.8 0.09 11.11 
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SIMD 
100% dental registration and participation 
(attendance) assumed 
Application of published registration and 
participation (attendance) rates 
Application of actual attendance rates 
Mean 
no. of 
patients 
over 
three 
years 
Mean 
no. of 
dentists 
over 
three 
years 
Estimation 
of number 
of patients 
per 
dentist 
Estimation 
of no. of 
years before 
one patient 
encountered 
 
Reg. 
rates 
(%) 
Part. 
rates 
(%) 
Estimation 
of no. of 
patients 
visiting 
dentist in 
last one 
year 
Estimation 
of number 
of patients 
per dentist 
Estimation 
of no. of 
years before 
one patients 
encountered 
Proportion 
of patients 
that 
contacted 
dentist in 
two years 
before 
diagnosis (%) 
** 
Estimation of 
number of 
patients per 
dentist 
 
Estimation of 
no. of years 
before one 
patients 
encountered 
OCC 
All 
Scotland 
375.66 3025.33 0.12 8.33 73.7 78.7 217.89 0.07 14.29 49.1 0.06 16.67 
1 (Most 
deprived) 
97.66 771.33 0.12 8.33 77.8 73.6 55.92 0.07 14.29 47.4 0.06 16.67 
2 81.33 790 0.10 10 74.2 77.2 46.58 0.05 20.00 47.8 0.05 20.00 
3 81.66 631 0.13 7.69 71.5 79.2 46.24 0.07 14.29 49.7 0.06 16.67 
4 65.00 439 0.15 6.67 71.7 81.5 37.98 0.08 12.5 55.1 0.08 12.50 
5 (Least 
deprived) 
51.00 477.66 0.11 9.09 73.2 82.0 30.61 0.06 16.67 42.6 0.05 20.00 
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100% dental registration and participation 
(attendance) assumed 
Application of published registration and 
participation (attendance) rates 
Application of actual attendance rates 
Mean 
no. of 
patients 
over 
three 
years 
Mean 
no. of 
dentists 
over 
three 
years 
Estimation 
of number 
of patients 
per 
dentist 
Estimation 
of no. of 
years before 
one patient 
encountered 
 
Reg. 
rates 
(%) 
Part. 
rates 
(%) 
Estimation 
of no. of 
patients 
visiting 
dentist in 
last one 
year 
Estimation of 
number of 
patients per 
dentist 
Estimation 
of no. of 
years before 
one patients 
encountered 
Proportion 
of patients 
that 
contacted 
dentist in 
two years 
before 
diagnosis (%) 
** 
Estimation of 
number of 
patients per 
dentist 
 
Estimation of 
no. of years 
before one 
patients 
encountered 
OPC 
 
All 
Scotland 
287 3025.33 0.09 11.11 
73.
7 
78.7 166.47 0.05 20.00 42.9 0.04 25.00 
1 (Most 
deprived) 
80.00 771.33 0.10 10 77.8 73.6 45.80 0.05 20.00 42.3 0.04 25.00 
2 62.33 790 0.07 14.29 74.2 77.2 35.70 0.04 25.00 39.7 0.03 33.33 
3 59.33 631 0.09 11.11 71.5 79.2 33.59 0.05 20.00 44.2 0.04 25.00 
4 51.00 439 0.12 8.33 71.7 81.5 29.80 0.06 16.67 40.9 0.05 20.00 
5 (Least 
deprived) 
37.00 477.66 0.07 14.29 73.2 82.0 22.20 0.04 25.00 53.7 0.04 25.00 
 
OC: Oral cancer; OCC: Oral cavity cancer; OPC: Oropharyngeal cancer; SIMD: Scottish Index of Multiple Deprivation 2009; Reg. rates: Registration rates; 
Part. rates: Participations rates.  
**Taken from Table 3-3 
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The additional linked dataset exhibited a small difference in the number of 
patients (1%), but this was considered to be too small to have significantly 
affected the results. Individual patient data linkage showed that 54% of 
patients with oral cancer, 51% of patients with oral cavity cancer, and 57% 
of patients with oropharyngeal cancer had no contact with an NHS primary 
care dentist in the two years preceding diagnosis (Table 3-3). Some 
inequities in dental contacts were observed, with 55% (n=356) of patients 
with oral cancer, 53% (n= 194) of patients with oral cavity cancer, and 58% 
(n= 162) of patients with oropharyngeal cancer from the most deprived 
areas of Scotland (SIMD 1) having no contact with an NHS primary care 
dentist in the two years preceding diagnosis. Conversely, 52% (n=74) of 
patients with oral cancer, 57% (n=43) of patients with oral cavity cancer, 
and 46% (n=31) of patients with oropharyngeal cancer from the least 
deprived areas of Scotland (SIMD 5) had no contact with a primary dental 
care service in the two years preceding diagnosis (Table 3-3). However, 
this difference in proportions was quite small and likely did not have any 
clinical significance.  
Upon application of these dental attendance proportions, the results 
showed that a general dental practitioner would encounter one patient 
with oral cancer every ten years, one patient with oral cavity cancer every 
17 years, and one patient with oropharyngeal cancer every 25 years (Table 
3-2).  
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Table 3-3:Number and percentages of patients with oral cancer, oral cavity cancer, 
and oropharyngeal cancer (2010-2012) who made contact with a general dental 
practitioner in the two years preceding diagnosis- all Scotland by SIMD 
 
 
Contact SIMD (n, %)  
1 
(Most 
deprived) 
2 3 4 5 
(Least 
deprived) 
Missing 
SIMD 
Total 
 
 
 
 
 
OC 
Yes 294 
45.23 
 
182 
44.39 
 
195 
47.45 
 
164 
48.81 
 
68 
47.89 
 
8 
 
911 
 
46.43 
No 356 
54.7 
 
228 
55.61 
 
216 
52.55 
 
172 
51.19 
 
74 
52.11 
 
5 
 
1051 
 
53.57 
Total 650 
 
410 
 
412 
 
335 
 
142 
 
13 1962 
 
 
 
 
 
OCC 
Yes 175 
47.43 
 
112 
47.86 
 
118 
49.79 
 
103 
55.08 
 
  32  
4 
544 
  42.67 49.10 
No 194 
52.57 
 
122 
52.14 
 
119 
50.21 
 
84 
44.92 
 
43 
57.33 
 
 
2 
564 
50.90 
Total 371 
 
234 
 
237 
 
187 
 
75 
 
6 1108 
 
 
 
 
 
OPC 
Yes 119 
42.35 
 
70 
39.77 
 
77 
44.25 
 
61 
40.94 
 
36 
53.73 
 
 
4 
367 
42.97 
No 162 
57.65 
 
106 
60.23 
 
97 
55.75 
 
88 
59.06 
 
31 
46.27 
 
 
3 
487 
57.03 
Total 282 
 
177 
 
175 
 
149 
 
67 
 
7 854 
 
 
 
OC: Oral cancer; OCC: Oral cavity cancer; OPC: Oropharyngeal cancer; SIMD: Scottish 
Index of Multiple Deprivation 2009. 
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3.5  Discussion 
3.5.1 Key points, comparison with other work, and potential 
explanations 
This was the first national descriptive epidemiological study that 
attempted to estimate the proportion of patients with oral cancer, oral 
cavity cancer, and oropharyngeal cancer that had attended a primary 
dental care service in Scotland in the two years preceding diagnosis, and to 
also accurately estimate the number of patients that a general dental 
practitioner may encounter over time. The results showed that the 
majority of patients that were included in this study had made no contact 
with a primary care general dental practice in the two years prior to 
diagnosis, thus automatically limiting opportunities for early detection. 
These results were in agreement with several other studies conducted in 
France, The Netherlands, and Western Australia (Tromp et al., 2005; 
Frydrych and Slack-Smith, 2011) that also reported poor dental attendance 
patterns in the majority of patients with head and neck cancer, oral 
cancer, and oropharyngeal cancer (reviewed previously in Chapter 1). Of 
these, the most recent study conducted in a high-incidence region in 
France reported that the majority (80%) of patients with head and neck 
cancer (n=342; defined as including the anatomic subsites oral cavity, 
oropharynx, hypopharynx, and larynx) included in their study had not 
consulted a dentist in the two to twelve months prior to diagnosis (Ligier et 
al., 2016). Additionally, previous studies in the United Kingdom used 
national survey data to report poor dental attendance rates among “high-
risk” groups (Netuveli et al., 2006; Yusof et al., 2006), and these were also 
in agreement with the results of the current study.  
Application of these attendance rates showed that a general dental 
practitioner would encounter one patient with oral cancer every ten years, 
one patient with oral cavity cancer every 17 years, and one patient with 
oropharyngeal cancer every 25 years. If published registration and 
participation (attendance) rates were applied instead, these numbers 
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decreased to one patient with oral cancer every 8 years, one patient with 
oral cavity cancer every 14 years, and one patient with oropharyngeal 
cancer every 20 years. These results suggest that with greater efforts to 
fully engage with all patients and increase regular attendance rates, the 
potential detection rate could markedly increase. No obvious patterns or 
relationships with deprivation of the practice location were observed, and 
this could partly be explained by the fact that although there are 
inequalities in access to NHS primary care services such as general medical 
practices in Scotland, the distribution of dental practices does not follow 
this pattern (Audit Scotland, 2012). Therefore, registration rates do not 
exhibit the typical inequalities skew, although participation (attendance) 
rates are lower in the more deprived communities (ISD Scotland, 2016b). 
As a result, this offsets the higher rates of oral cancer in deprived areas as 
they are distributed among the higher number of dentists in the same 
areas. Moreover, the linkage study showed no major socioeconomic 
patterns in dental attendance rates, with the proportions of individuals 
that made no contact with a GDP in the two years preceding diagnosis 
being quite similar for the most and least deprived areas of Scotland (55% 
and 52%, respectively). This lack of a social pattern in dental attendance 
rates could be explained by possible differences in the SIMD of the 
patient’s residence and that of the practice location they attended, and 
this was likely facilitated by the existence of a universal health care 
service such as the NHS. In other words, availability of access to free 
dental check-ups made it possible for a patient who lived in the most 
deprived area of Scotland (SIMD 1) to attend a dental practice located in a 
different SIMD.  
Several studies have employed similar methodologies to estimate the 
number of emergency events that a dentist would likely encounter per year 
(Fast et al., 1986; Chapman, 1997; Girdler and Smith, 1999); however, 
none have applied it to estimate the time elapsed before a dentist would 
encounter a patient with oral cancer. A simple calculation of the headline 
distribution of patients with oral cancer in relation to the number of 
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dentists in England, Northern Ireland and Wales suggested there would be 
one patient per ten dentists per year (Ogden et al., 2015). However, the 
authors did not provide any information on the definition of oral cancer 
that was used or the time period under consideration, and also did not 
take registration rates into consideration. 
The results of this study showed considerable differences in the number of 
patients with oral cavity cancer and oropharyngeal cancer that a general 
dental practitioner in Scotland could expect to see per year. The main 
implication of this for GDPs, particularly given the changing background of 
incidence trends for both subsites, is a need for vigilance and awareness, 
particularly with regard to signs and symptoms that may be indicative of 
the subsite involved. For example, although the national guidelines for 
referral combine the two subsites as oral cancer, certain signs and 
symptoms such as dysphagia or odynophagia lasting for more than 3 weeks, 
persistent lump in the throat, and persistent pain in the throat lasting for 
more than 3 weeks may be indicative of oropharyngeal cancer (NHS 
Scotland, 2016b). These results also emphasise the importance of including 
thorough extra- as well as intra-oral examinations in routine dental check-
ups, particularly among “high-risk” individuals.  
In this study, registration rates included all of the individuals in the 
general population who were registered with an NHS dentist, while 
participation (attendance) rates represented the proportion of registered 
patients who had contacted a general dental practitioner for either 
examination or treatment (or both) in the past two years (ISD Scotland, 
2016b). The latter does not include patients who only visited the dentist 
occasionally, for emergency treatments only, or attended a private 
dentist. These published rates were used to estimate the likelihood of a 
dentist encountering a patient with oral cancer. Furthermore, the linkage 
study revealed that a sizeable proportion of the patients that were 
included in this study had not contacted a dentist in the two years 
preceding diagnosis, and application of these actual attendance rates 
(which showed even lower contact among those from the most deprived 
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communities) further reduced the likelihood of encountering a patient with 
oral cancer.  
Another factor that ought to be taken into consideration when interpreting 
these results is that this study considered the deprivation status of the 
dental practices, and not that of the patients themselves, to calculate the 
number of patients per general dental practitioner. The linkage study, on 
the other hand, considered the SIMD fifth of the patient’s area of 
residence to better elucidate if deprivation had any effect on their 
likelihood of contacting a general dental practice. This, however, raises 
the possibility of ecological fallacy as a patient who lives in a particular 
SIMD fifth may not necessarily attend a dental practice within the same 
SIMD fifth, just as the registration profile of a practice may not necessarily 
reflect the SIMD fifth his/her practice is located in.  
3.5.2 Strengths and Limitations 
The main strengths of this study lie in the robust nature of the detailed, 
routinely collected administrative data used. The Scottish Cancer Registry 
data have been reported to exhibit high levels of accuracy, completeness, 
and reliability, particularly in relation to diagnostic and treatment details 
and demographics (Brewster et al., 1994; Brewster et al., 1997; Brewster 
et al., 2002). Registration and participation (attendance) rates are also 
highly accurate, as are data from the MIDAS database, which is the 
payment system for NHS dental practitioners in Scotland and is, therefore, 
dependant on practitioners submitting claims for payment.  
One data limitation of this study was that headcounts of dentists in a 
practice were used for all calculations, and the whole-time equivalents of 
each practitioner was unknown. It would be fair to assume that many of 
these practitioners were employed part-time, and this may have affected 
the estimates of likely time to see a patient. The second unknown 
limitation is in relation to the accuracy and completeness of the data 
linkage. Kendrick and Clarke (1993) reported that clerical monitoring of 
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pair-wise linking showed that the false negative rates (the proportion of 
pairs which the system fails to link) and the false positive rates (the 
proportion of pairs which are incorrectly linked) were both approximately 
three percent. Additionally, the completeness of the unique identification 
number on both the Scottish Cancer Registry and MIDAS databases have 
been reported to be very high (approximately 99%) (ADLS, 2017; ISD 
Scotland, 2017e). Therefore, records of patients with oral cancer that did 
not link to a dental record in MIDAS would be because they did not have a 
dental contact rather than because their identification numbers did not 
match or that data linkage was unsuccessful. Thirdly, this study only 
considered NHS primary care dentists, and did not include those belonging 
to the private sector. However, the Dental Workforce Report showed that 
only 17% of adults received private treatment only over a 12-month period 
in 2012 (NHS Education for Scotland, September 2012). Moreover, an 
analysis of a previous version of this report in 2008 showed that the private 
sector mainly attracted patients with higher incomes, relatively good oral 
health, and low future dental care needs (NHS Education for Scotland, 
2008). Based on this and the fact that the majority of the patients included 
in this study were from the most deprived areas of Scotland, it was 
assumed that non-inclusion of private dentists in this study would have had 
minimum impact on the results reported. The last limitation of this study 
was that it only considered a three-year period. The MIDAS data included 
in this study was requested as a part of a larger PBPP application linking 
several other datasets together, one of which (the Prescribing Information 
System) only had data available from 2009 (Chapter 4). As a result, a 
three-year time-period was selected so as to maintain consistency. 
Nevertheless, given the changing trends of oral cancer reported in Chapter 
2, the results of this study provide a recent estimate of the number of 
patients a general dental practitioner in Scotland may expect to encounter 
per year.  
Interpretation of the estimates of the time elapsed before a general dental 
practitioner would encounter a patient with oral cancer has to be 
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considered in the context of the current guidelines for early detection and 
referral of head and neck cancer which suggest that identification of 
mucosal abnormalities require urgent referral (NICE, 2015a; NHS Scotland, 
2016b). A recent systematic review and meta-analysis found that the 
conversion rate, that is, the proportion of patients with oral cancer who 
were referred within two weeks was approximately 10%, while the 
detection rate, that is, the proportion of patients with oral cancer who had 
been referred under the two-week rule was approximately 40% and 
increasing (Langton et al., 2016). This suggests that approximately 60% of 
patients with oral cancer are referred out-with the two-week referral 
pathway. Moreover, there appears to be an increasing number of patients 
with head and neck conditions, including oral potentially malignant 
disorders (OPMDs), that are being referred, but fewer patients are being 
diagnosed with head and neck cancer. 
Previous authors have noted that patients with oral cancer do not generally 
present at general dental (or indeed medical) practices (Gómez et al., 
2010). Therefore, the question of whether early detection of oral cancer is 
feasible has been raised, given the complex range of factors associated 
with referral pathways into care and definitive diagnosis and treatment. 
One major factor may be the fact that early oral cavity cancer and 
oropharyngeal cancer may be asymptomatic or cause subtle mucosal 
changes. Access to primary dental care or medical services may also be 
more difficult or limited among those at highest risk, that is, those from 
poorer socioeconomic circumstances or among older groups (Mercer and 
Watt, 2007). Other problems associated with early detection and referral 
delays include professional issues such as limited capability to undertake 
full clinical examination, training issues, or potential capacity issues 
(scheduling issues, payment etc.) (Güneri and Epstein, 2014). To this 
complex mix of factors, the researcher proposes that the underlying 
burden of disease is an additional factor that needs careful consideration.  
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3.6  Conclusion 
In conclusion, despite being a low volume cancer, these results show that 
the hitherto encountered anecdote that a dentist may come across only 
two patients with oral cancer in his/her lifetime is not quite true. The 
original question “is early detection of oral cancer a realistic expectation?” 
remains somewhat rhetorical. Although the findings confirm that the rarity 
of the condition compounded by the lower attendance among those who 
were diagnosed with oral cancer will likely impact on the dentist’s ability 
to detect oral cancer early, it is worth reiterating that national guidelines 
do not expect general dental practitioners to make a diagnosis of oral 
cancer, but rather to identify sustained abnormalities and refer in a timely 
manner (NICE, 2015a; NHS Scotland, 2016b).  
These findings indicate the importance of developing early detection 
strategies for primary dental care services that consider the changing 
patterns and rarity of the condition. Moreover, it is important to continue 
to work to develop and evaluate innovative strategies for dental services 
to reach out to those who do not attend regularly, to better network 
dental with other primary care services, and to explore the possibility of 
early detection strategies in alternative settings.  
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4 Missed opportunities for early detection of 
oral cancer: the role of primary health care 
dental and medical services. 
4.1 Introduction 
The literature review presented in Chapter 1 of this thesis discussed the 
potentially pivotal role of dentists in the early detection and prompt 
referral of oral cancer through regular patient contact and routine 
examination of the soft tissues of the mouth. However, this is also largely 
dependent on patients consulting dentists frequently enough to achieve 
this. Research from around the world suggests that the proportion of 
patients with head and neck cancer that had contacted a general dental 
practitioner regularly was considerably low, thus automatically limiting 
opportunities for early detection in the dental setting. A case-series 
analysis that was completed in a tertiary referral centre in the Netherlands 
reported that only 12% of their study sample (n=306 patients that were 
diagnosed with head and neck cancer between 2000 and 2002) had 
contacted a dentist first upon detecting symptoms, and 82% had consulted 
a general medical practitioner instead (Tromp et al., 2005). This was in 
agreement with another clinical cohort study that reported that the 
majority of patients that were diagnosed with oral cavity and 
oropharyngeal cancer between January 2005 and December 2009 in one 
teaching hospital in Western Australia did not have regular contact with a 
dentist (mean duration since last dental visit: 5.6 years) (Frydrych and 
Slack-Smith, 2011). More locally, two studies used data from the British 
Household Panel Survey to demonstrate that the “inverse screening law”, 
which suggests that those at the highest risk of developing cancer are also 
least likely to consult a primary dental care service regularly, was 
applicable for oral cancer in Britain (Netuveli et al., 2006; Yusof et al., 
2006). Chapter 3 of this thesis reported similar results for Scotland, with 
the majority of patients that were diagnosed with oral cavity and 
oropharyngeal cancer between 2010 and 2012 having made no contact with 
a general dental practitioner in the two years prior to diagnosis.  
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These studies highlighted the role of alternative settings, particularly 
general practitioners and other specialist practices, in the early detection 
of head and neck cancer. Prout et al. (1990) first examined 130 patients 
that were diagnosed with head and neck cancer between September 1st 
1985 and March 31st 1988 in Boston, and reported that 94% of them had 
visited a healthcare provider at least once in the 24 months prior to 
diagnosis. Moreover, the services contacted were typically those that the 
subjects considered as their “regular source of care”, emphasising the 
need to integrate these services in strategies for the early detection of 
cancer. The general consensus of literature from around the world, 
reviewed previously in Chapter 1, was that the majority of patients with 
head and neck cancer exhibited poor dental attendance patterns and 
preferred consulting general practitioners upon self-discovery of symptoms 
instead (Reid et al., 2004; Paudyal et al., 2014; Ligier et al., 2016). 
In the United Kingdom, Crossman et al. (2016) conducted a postal 
questionnaire study among 200 patients with oral and oropharyngeal 
cancer randomly selected from the 2010 Cancer Patient Experience Survey 
(which consisted of 67,713 adults treated for cancer between January and 
March 2010 at one of the 158 National Health Service hospitals in England), 
and collected information on all of the health service contacts made by the 
patients before diagnosis of cancer and the symptoms that had prompted 
them to do so. They reported that only 32% of the patients had been 
referred to secondary care by a dentist, while 56% had been referred by a 
general practitioner instead. The authors concluded that general 
practitioners played a crucial role in the early detection of oral cancer, 
and listed common signs and symptoms that could be used for assessment 
and decision-making. In England, the National Cancer Intelligence Network 
linked data from the Administrative Hospital Episode Statistics database 
with Cancer Waiting Times data, cancer screening programme data, and 
cancer registration data and examined the “Routes to Diagnosis” for 
patients that were diagnosed with cancer (all sites) between 2006 and 
2013 (Elliss-Brookes et al., 2012). Their results showed that 21% of all oral 
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cavity cancer and 26% of all oropharyngeal cancer diagnoses in England 
occurred following GP referrals in 2013. Moreover, diagnoses via the “Two-
weeks Wait (TWW)” route (defined as including “all urgent GP referrals 
with a suspicion of cancer”) and the “Other Outpatient” route (defined as 
“an elective route starting with an outpatient appointment”) had 
increased between 2006 and 2013, and there was a possibility that some of 
the referrals via the latter route (“Other Outpatient”) were originally 
initiated by general practitioners (Elliss-Brookes et al., 2012; NCIN, 2017).  
Thus, collectively, the evidence appears to suggest that opportunistic 
screening for oral cancer, if limited to dental practitioners only, may miss 
a large fraction of the population at highest risk, and early detection 
strategies should extend to include general practitioners and specialist 
services too. However, to date, this has not been tested in a country with 
very good population dental service coverage such as Scotland.  
Lyratzopoulos et al. (2015) defined missed opportunities as “instances 
where post-hoc judgement indicates that alternative decisions or actions 
could have led to a more timely diagnosis, that is, something different 
could have been done or considered under the given circumstances to 
reach a more prompt diagnosis”, and identification of these could inform 
policy decisions and facilitate identification of areas where health services 
can be improved. The literature review presented in Chapter 1 discussed 
some of the available evidence on the existence of missed opportunities 
and the use of “surrogate markers”, including multiple GP consultations 
before referral (Lyratzopoulos et al., 2012; Lyratzopoulos et al., 2013), 
emergency attendances (Elliss-Brookes et al., 2012; Mitchell et al., 2013), 
and abnormal findings (Murphy et al., 2014), to measure them.  
Multiple consultations usually indicate prolongation of the time from 
presentation to referral, often resulting in progression of the clinical stage 
and a worsening of the outcomes. Evidence shows that their strongest 
predictors are usually tumour site and prevalence (Lyratzopoulos et al., 
2014). A study utilising data from the 2010 National Cancer Patient 
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Experience Survey, which included 41,299 patients with 24 different types 
of cancer, reported large variations in the proportions of patients who had 
visited a general practitioner (GP) three times or more before referral, and 
that these variations appeared to be associated with the type of cancer 
diagnosed (lowest for breast cancer and malignant melanoma; highest for 
multiple myeloma and pancreatic cancer) (Lyratzopoulos et al., 2012). 
Women, younger patients, and those belonging to ethnic minority groups 
were more likely to consult a general practitioner more than three times 
pre-referral, although the variations were less prominent when examined 
by socioeconomic characteristics, thus providing a certain level of 
reassurance that a comprehensive coverage system like the National 
Health Service in the United Kingdom was capable of providing equitable 
care. The authors concluded that patients that were diagnosed with more 
well-known cancers were less likely to have had a large number of pre-
referral consultations. Similar results were reported by the National Audit 
of Cancer Diagnosis in Primary Care, conducted in England in 2009/2010, 
where almost 38% out of 229 patients that were diagnosed with 
oropharyngeal cancer had consulted their general practitioner two or more 
times for cancer-related issues before being referred to a specialist for 
assessment (Rubin et al., 2011).  
Several other studies also reported that the frequency of consultations and 
diagnostic tests increased in the months preceding diagnosis, and these 
have been reviewed previously in Chapter 1 (Christensen et al., 2012; 
Hansen et al., 2015). Christensen et al. (2012), in their national registry 
based case-control study that included all incident cases of cancer 
diagnosed between 2001 and 2006 and identified from the Danish Cancer 
Registry together with 1,272,100 gender-matched controls from the 
general population, reported that the patients with cancer exhibited a 
modest increase in general practitioner consultations five to six months 
before diagnosis and that this number peaked one month before diagnosis. 
The number of hospital visits and diagnostic examinations began to 
increase approximately three to four months before diagnosis and 
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escalated steeply two months before diagnosis. However, in contrast to 
Lyratzopoulos et al. (2012), these studies did not account for a referral 
period and considered diagnosis to be the end-point. As a result, it was 
unclear at what point in time these contacts shifted from being missed 
opportunities for early detection via screening to becoming missed 
opportunities for early diagnosis that were caused by delays in the 
diagnostic process itself. Nevertheless, they did highlight the significance 
of unusual patterns of health service contacts in the identification of 
opportunities for early detection. 
Although these kind of epidemiological data do not provide any information 
regarding the nature of these consultations and not all of these instances 
would have necessarily been associated with missed opportunities for early 
detection of cancer, it did provide a strong indication that there were 
potential missed opportunities amongst at least some of the patients with 
cancer (Rubin et al., 2011; Lyratzopoulos et al., 2015). Chapters 2 and 3 of 
this thesis showed that the incidence burden of oral cancer was relatively 
low in Scotland and the majority of the patients did not contact a primary 
dental care service on a regular basis. Therefore, dentists were likely to 
encounter a limited number of patients in their career, thus limiting 
opportunities for early detection of oral cancer. Nevertheless, there are 
several other services (e.g. general medical practices, hospital outpatient 
and inpatient/day-case services, and pharmacies) through which a cancer 
patient can enter the health care system, and all of these contacts can be 
considered as opportunities for early detection. However, currently there 
are no studies that examine the healthcare service contacts made by 
patients with oral cancer in Scotland in the two years prior to diagnosis.  
Scotland currently has “some of the best administrative and care data in 
the world” (Pavis and Morris, 2015), with the Information Services Division 
of National Services Scotland charged with the responsibility of ensuring 
the quality, completeness, and comparability of the data for over 40 years 
(ISD Scotland, 2017f). The Scottish national strategy and framework for 
data linkage, “Joined-up Data for Better Decisions: A strategy for 
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improving data access and analysis”, was developed with the aim of 
improving access to data and subsequent analysis through data linkage 
executed in a legal and ethical manner (The Scottish Government, 2012a). 
This framework defined data linkage as “the joining of two or more 
administrative or survey datasets to greatly increase their value for 
analysis”, mainly for research and statistical purposes that help understand 
groups or populations. Therefore, this study intends to utilise the wealth of 
routinely collected, administrative health data and data linkage capability 
in Scotland to link various national administrative databases and examine 
the healthcare service contacts that were made by patients with oral 
cancer in the years prior to diagnosis, with the aim of identifying 
potentially missed opportunities that can be harnessed in the future for 
early detection efforts.  
4.2 Aims, hypotheses and objectives  
The main aim of this study was to examine if there was any evidence of 
potentially missed opportunities for early detection of oral cancer (oral 
cavity and oropharyngeal cancer) in primary dental care settings, and to 
also explore the possibility of such opportunities in alternative health care 
settings in Scotland. 
The hypotheses were: 
Chapter 4 hypothesis (a): There are a number of potentially missed 
opportunities for the early detection of oral cancer in dental and other 
healthcare services. 
Chapter 4 hypothesis (b): These potentially missed opportunities increase 
in frequency in the months directly prior to the start of the referral period.  
The objectives were: 
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Chapter 4 objective (a): To create a longitudinal population cohort by 
linking the available routine administrative health service data including 
hospital outpatient, hospital inpatient/day-case, primary dental care, and 
GP prescriptions with the Scottish Cancer Registry oral cancer data. 
Chapter 4 objective (b): To calculate the proportion of patients with oral 
cancer who had contacted all/any of the healthcare services (hospital 
outpatient, hospital inpatient/day-case, primary dental care, and GP 
prescriptions) in the two years prior to diagnosis, and examine the mean 
number of contacts made over the same period. 
Chapter 4 objective (c): To calculate the proportion of patients with oral 
cancer who had contacted each of the services (hospital outpatient, 
hospital inpatient/day-case, primary dental care, and GP prescription) 
individually over the two years prior to the start of the referral period, 
examine the mean number of contacts made with each service, and assess 
any variations by year and six-month periods prior to the start of the 
referral period in order to identify any alternative opportunities for early 
detection efforts. 
Chapter 4 objective (d): To undertake a focused examination of primary 
dental care service contacts of patients with oral cancer by analysing the 
frequency and reasons for consultation by year and six-month periods in 
order to identify any “potentially missed” opportunities for early detection 
in the dental setting. 
Chapter 4 objective (e): To examine the nature of contacts made by 
patients with oral cancer during the one month period directly preceding 
diagnosis, defined here as the “referral period”, in order to assess the 
feasibility of using this data to examine the routes to diagnosis of oral 
cancer. 
152 
 
 
4.3  Patients and methods 
This section describes the ethical and information governance approval 
processes of the study, reviews the datasets used and the data requested 
from them, and clarifies the data linkage process undertaken. It then goes 
on to set out the data management process undertaken to create the final 
linked cohort used, and finally discusses the statistical analysis methods 
used to meet the specific research objectives.  
4.3.1 Ethical considerations and data access 
An application for ethical approval was made to the University of Glasgow, 
College of Medicine, Veterinary and Life Sciences Ethics Committee, and 
was approved on 15th December 2015 (Appendix 5).  
As the data to be used in this study were generated by the NHS and 
identifiable, access could only be arranged upon approval from the 
national information governance committee, the Public Benefit and Privacy 
Panel for Health and Social Care (PBPP). This application process has been 
discussed previously in Chapter 3. Briefly, a research protocol that detailed 
the background, aims and objectives, and the implications of the study to 
be undertaken was first submitted to the electronic Data Research and 
Innovation Service (eDRIS), which serves as a single point of contact to 
assist researchers in navigating the PBPP application process and organising 
data access in a secure environment (ISD Scotland, 2017g). Thereafter, a 
research co-ordinator was assigned, who assisted with the PBPP application 
process including identification of available datasets and relevant 
variables. The necessary Information Governance training was obtained by 
completion of an e-learning course (Research Data and Confidentiality e-
learning course) conducted by the Medical Research Council on 22nd 
September 2015 (Appendix 7). The final PBPP application was submitted on 
21st January 2016 for consideration at the panel meeting that was held on 
the 23rd of February 2016. Following several unforeseen time delays, PBPP 
approval was finally received on the 21st of April 2016 (Appendix 9), and 
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the application was then forwarded to the relevant teams for processing 
and uploading of data onto the NHS NSS eDRIS National Safe Haven (remote 
access). There were further unexpected delays from eDRIS at this stage, 
and the completed linked datasets were finally uploaded in October 2016.  
4.3.2 Datasets available and used 
The starting point of this study was an oral cancer (defined as C00.3-C00.9, 
C01-C06, C09-C10, C14) diagnosis that was recorded on the Scottish Cancer 
Registry, and this was used to “look back” into the health records 
available. Based on NHS Scotland Health Service data availability (ISD 
Scotland, 2017f), this study utilised the hospital inpatient/day-case 
(SMR01— Scottish Morbidity Record 01), hospital outpatient appointments 
(SMR00 — Scottish Morbidity Record 00), prescriptions (PIS), and primary 
dental care (MIDAS — Management Information and Dental Accounting 
System) datasets. Unfortunately, primary care general practitioner data 
were not available, and prescriptions issued by GPs were used as a proxy 
for GP contact instead.  
4.3.2.1  Scottish Cancer Registry 
The Scottish Cancer Registry (known as “SMR06”), which was started in 
1958, collects and stores information on all Scottish residents that have 
been diagnosed with malignancies (ISD Scotland, 2017d). The data include 
a patient’s personal, demographic, diagnostic (including site, histology, 
hospital of diagnosis, tumour behaviour), and geographical information 
(including socioeconomic status measured by SIMD and Carstairs, NHS area 
board, and electoral ward). Although tumour stage and grade for certain 
cancers (namely breast, cervical, and colorectal cancer) have been 
recorded from 1997 onwards, these data are still unavailable for head and 
neck cancer. Routine indicators, computer validation, and ad-hoc studies 
of accuracy and completion are used to monitor the quality of the registry 
data. In 2016, the level of completeness of data in SMR06 was 96% for 
patient information and 96.4% for tumour information (UKIACR, 2017). The 
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average head and neck cancer case ascertainment across NHS boards in 
Scotland was 95% (ISD Scotland, 2016a).  
For the purpose of this study, the data on all patients that were diagnosed 
with head and neck cancer between 2008 and 2012 were requested (ICD-10 
codes C00–C14 & C32; detailed codes requested shown in Appendix 1). The 
variables included were age at the time of diagnosis, sex, health board of 
residence, Scottish Index of Multiple Deprivation decile of residence at the 
time of diagnosis, date of diagnosis, and ICD-10 diagnosis codes. 
4.3.2.2  Management Information and Dental Accounting System (MIDAS) 
The Management Information and Dental Accounting System (MIDAS) 
database is the computerised payment system for the General Dental 
Service in Scotland. It processes and stores information on all individuals 
that are registered with an NHS dentist in a dynamic fashion, allowing 
figures to be added daily. Therefore, the number of patients registered 
changes with time, depending on when the data are extracted. There are 
approximately 500 treatment fee codes (Items of Service) included in the 
Statement of Dental Remuneration (SDR), which is the primary dental care 
contract for NHS Scotland (PSD, 2017). A course of treatment is one where 
at least one of these Items of Service have been claimed by the primary 
care dentist on a GP17 payment form and submitted to the Practitioner 
Services Division of NHS Scotland, who then verifies the claim and pays the 
list number that the fee-code was claimed under. This dataset contains 
personal identifiers and geographical information of the practitioner and 
patient, start and stop dates of treatment, information on treatments 
received, and financial information (PSD, 2017).  
Records of all of the dental contacts that were made by patients with head 
and neck cancer (as described in section 4.3.2.1) between 2003 and 2012 
were requested. The variables included were the patient’s sex, age at the 
time of contact, socioeconomic deprivation level (measured by SIMD 
v2009), start and stop dates of treatment, and treatment received. Here, 
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the “start date of treatment” variable was used as an indicator of contact, 
and each unique date was considered as one contact irrespective of the 
number of claims made on that date. 
4.3.2.3  Hospital inpatient/ day-case admissions (SMR01) 
This dataset (known as “SMR01”) collects episode-level data on day-case 
and hospital inpatient admissions and discharges from acute specialties 
across Scotland (ISD Scotland, 2017h). Each episode, defined as “an 
inpatient episode or a day-case episode”, is initiated by a referral 
(including re-referrals) or admission and is ended by a hospital discharge. 
This dataset contains patient identifiers as well as information on the 
location of the episode, the admission type, patient condition, and waiting 
times. Additionally, geographical information such as SIMD and health 
board are also included. The diagnosis and treatment fields are mandatory 
for this dataset and, therefore, are of good quality and have high levels of 
completeness, (88% and 94% accuracy for diagnosis and treatment, 
respectively) (ISD Scotland, 2017f). 
Records of all of the hospital inpatient/day-case contacts made by patients 
with head and neck cancer (as described in section 4.3.2.1) between 2003 
and 2012 were requested. The variables included were each patient’s sex, 
age at the time of contact, socioeconomic deprivation level (measured by 
SIMD v2009), date of admission, date of discharge, and specialty attended. 
Here, the “date of admission” variable was used as an indicator of contact, 
and each date was considered as one contact irrespective of the number of 
procedures undertaken on that date.  
4.3.2.4  Hospital outpatient appointments (SMR00) 
This dataset (known as “SMR00”) records episode-level data on patients 
who are attending hospital outpatient clinics in all specialties (ISD 
Scotland, 2017i). This includes new and recall appointments. It contains 
patient identifiers (e.g. name, age, and sex), information on the 
procedures performed, and geographical measures such as SIMD status and 
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health board. Data on the diagnosis and treatment procedures that were 
undertaken are limited in this dataset as it is not mandatory to complete 
these fields (ISD Scotland, 2017j). However, data in relation to patient 
contact and dates are mandatory due to national requirements to monitor 
waiting times (ISD Scotland, 2017b).  
Records of all hospital outpatient contacts made by the patients with head 
and neck cancer (as described in section 4.3.2.1) between 2003 and 2012 
were requested. The variables included were the patient’s sex, age at the 
time of contact, socioeconomic deprivation level (measured by SIMD 
v2009), date of attending clinic, specialty attended, and referral source. 
Here, the “date of attending clinic” variable was used as an indicator of 
contact, and each unique date was considered to be one contact 
irrespective of the number of procedures undertaken on that date.  
4.3.2.5  Prescribing Information System (PIS) 
The Prescribing Information System (labelled “PIS”) contains all primary 
care prescribing and dispensing information at the patient-level, electronic 
messaging data, as well as various financial items (NHS Scotland, 2017a). 
The information is supplied by the Practitioner Services Division (PSD) who 
are responsible for processing and pricing all of the prescriptions that are 
dispensed in Scotland. The vast majority of these prescriptions (70%) are 
written by general practitioners, and the remainder are written by other 
authorised personnel such as dentists and nurses (Audit Scotland, 2013). 
This dataset contains information on the patient, prescriber, and dispenser 
as well as data on the items that are prescribed, dispensed, and 
reimbursed. The PIS dataset only became nationally available in 2009, as 
the level of capture of patient identifiers before this was low (68% in 2003 
as opposed to 87% in 2009) (Alvarez-Madrazo et al., 2016). Although the 
individual-level data has a high level of completeness, it is influenced by 
the prescriber (e.g. patient identifier capture was 99% for general 
practitioners and only 2% for dentists in 2014) as well as the type of 
medicine prescribed (Alvarez-Madrazo et al., 2016). The low patient 
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identifier capture for dentists is mainly because they do not have access to 
the electronic prescribing system, and they only recently gained access to 
the CHI (Community Health Index) database. However, for the purposes of 
this study all dental contacts were captured via the MIDAS database.  
Records of all of the prescriptions that were issued to patients with head 
and neck cancer (as described in section 4.3.2.1) between 2009 and 2012 
were requested. The variables included were the patient’s sex, age at the 
time of contact, socioeconomic deprivation level (measured by SIMD 
v2009), date of issue of prescription, prescriber type, and item prescribed. 
Here, the “date of issue of prescription” variable was used as an indicator 
of contact, and each unique date was considered to be one contact 
irrespective of the number of claims that were made on that date. The 
prescription data were to be used to infer contact with a general 
practitioner (where it was not a repeat prescription) and a pharmacist. 
Although the original intention of this study was to request primary care 
general practitioner contact information, there was a delay of several 
years in establishing a GP database in Scotland. It has only finally 
commenced in 2017 and is known as the Scottish Primary Care Information 
Resource (SPIRE) (ISD Scotland, 2017k).  
4.3.3 Data linkage 
Data linkage was performed using probability matching techniques that 
were based upon the Howard Newcombe principles, and was performed by 
a third party (University of Edinburgh) on behalf of the electronic Data 
Research and Innovation (eDRIS, 2017a). After the initiation of the project 
and the securement of a data sharing agreement (Appendix 10), the Data 
Controllers (NHS National Services Scotland Information Services Division) 
prepared the data as per the specifications of the agreement and sent a 
file containing only personal identifying information to the indexing 
service, provided by National Records Scotland (NRS). Indexing ensures 
that all personal information such as names and addresses are kept 
separate from the rest of the process, thus maintaining anonymity. 
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Thereafter, NRS matched this file to a “linking population spine” that 
contained the name, gender, address, and date of birth of all individuals in 
Scotland who had contacted the NHS to generate a “source key”. This 
“source key” was sent back to the Data Controllers so that they could 
replace their own IDs and then pass the data on to National Services 
Scotland (NSS). NRS also generated a second “linking key” which was sent 
to NSS to allow them to join the SMR06, SMR00, SMR01, PIS, and MIDAS 
datasets. Upon receiving the anonymised dataset from the Data 
Controllers, NSS checked that the file included only the requested data and 
then used the keys to join the five relevant datasets (SMR06, SMR00, 
SMR01, PIS, and MIDAS) together. The linking ID was then replaced with a 
new project ID and the dataset was placed in a Safe Haven that could be 
accessed for analysis (only by MP and supervisor AM). This step ensured the 
quality of the data and also made sure that only agreed information was 
placed in the Safe Haven, thus providing additional security (eDRIS, 2017a; 
eDRIS, 2017b). 
The analysis of this linked dataset was completed within the safe haven, 
which is a stand-alone secure facility with strictly controlled access. The 
researchers could only use the software provided within the safe haven to 
analyse the data, and all of the outputs that were produced were then 
checked for any potential risk of disclosure of identifiable data before 
being moved out of the haven. No data could be moved out of the Safe 
Haven at any point (eDRIS, 2017a; eDRIS, 2017b). Figure 4-1 shows a 
flowchart of the steps of data linkage that were undertaken. 
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Figure 4-1: Data linkage process 
 
 
 
 
SMR06: Scottish Cancer Registry; SMR00: Hospital outpatient services; SMR01: hospital 
inpatient/ day-case service; MIDAS: Management Information and Dental Accounting 
System; PIS: Prescribing Information System; NRS: National Records Scotland. 
This allowed MP and AM to see all records belonging to an individual across all the 
datasets without seeing any of the personal identifiers.
The linkage agent then replaced all the dataset unique Person ID numbers with the 
master Person ID number on each of the content data files.
The linkage agent received 2 files- all the datasets and their unique person ID 
numbers plus a master control file containing a master person ID and all the 
dataset unique Person index ID numbers.
The Research Coordinator confirmed receiving the agreed upon data and sent it to 
the linkage agent (an automated computer program that carries out the linkage)
The Data Providers attached the received index ID number to the remaining 
contents of the dataset to be provided for linkage and sent it to the Research 
Coordinator.
The Data Providers then received a file with their own person or record ID number 
and a unique person index ID number specific to that dataset. This file was 
generated by the indexing team.
The indexing team (NRS) used complex algorithms to probability match the 
identifiers to the Population Spine.
Data providers (SMR06, SMR00, SMR01, PIS, & MIDAS teams) supplied personal 
identifiers and their own person or record ID numbers to the indexing team (NRS).
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4.3.4 Data management 
Scottish Cancer Registry (SMR06): the original linked dataset provided by 
eDRIS consisted of 5296 records of patients that were diagnosed with 
primary head and neck cancer (ICD-10 codes requested shown in Appendix 
1) between 2008 and 2012 (see flowchart of data management process that 
yielded the final sample in Figure 4-2). Briefly, after deleting six duplicate 
records, the remaining 5290 observations were divided into three groups of 
subsites, namely, oral cavity cancer, oropharyngeal cancer, and other. 
These subsites of interest were defined as follows: oral cavity cancer — 
inner lip (C00.3 — C00.9), other and unspecified parts of tongue (C02), gum 
(C03), floor of mouth (C04), palate (C05), and other and unspecified parts 
of mouth (C06); oropharyngeal cancer — base of tongue (C01), lingual 
tonsil (C2.4), tonsil (C09), oropharynx (C10), and pharynx (C14); and other 
— all remaining ICD-10 codes shown in Appendix 1. Thereafter, a total of 
84 records with discrepancies in the data were deleted, including 21 
records with the same subsite and incidence date and 25 records with 
different subsites and the same incidence date. Additionally, 33 records 
with the same subsite and different incidence date, and five records with 
different subsite and incidence date were found. The earlier incidence 
date was retained in both cases. For the purposes of this study, only 
patients that were diagnosed with oral cavity cancer (n=1108) and 
oropharyngeal cancer (n=854) between 2010 and 2012 (n=1962) were 
retained, yielding a final sub-cohort of 1962 patients (Figure 4-2). The 
original plan was to examine the individual subsites separately, in keeping 
with the rest of the thesis. However, upon commencement of analysis, the 
numbers for oral cavity cancer and oropharyngeal cancer individually were 
found to be too small to analyse separately, and a decision was made to 
combine and examine them as oral cancer instead. Nevertheless, it has 
been argued that dentists have a potential role in the early detection of 
both sites and, as stated previously, most of the guidelines for the 
detection of cancer consider the two subsites together as oral cancer as 
their signs and symptoms overlap considerably (lump in the neck, problem 
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swallowing, lumps or ulcers in the mouth, and hoarseness of voice) 
(Kreimer, 2014; NICE, 2015a; NHS Scotland, 2016b).  
Figure 4-2: Scottish Cancer Registry — Initial data management: 
 
 
Patients with head 
and neck cancer
diagnosed between 
2008-2012 
n=5296
6 duplicate records 
deleted
n=5290 
ICD-10 codes 
grouped into 
following subsites:
CIS/Neoplasm of 
uncertain 
behaviour, external 
lip, larynx, OCC, 
oropharyngeal 
cancer;
(158 missing-
kaposis sarcoma, 
lymphoma etc)
21 records with same 
subsite and incidence 
date deleted.
n=5269
25 records with same 
incidence date and 
different subsite deleted.
n=5244
33 record with same 
subsite and different 
incidence dates. Later 
incidence date 
deleted.
n=5211
Variables renamed, 
incidence dates 
grouped by calender 
years. 
1932 'other cancer' 
(external lip, larynx, 
hypopharynx, CIS, 
missing) cases deleted.
n=3279
1312 patients that were 
diagnosed before 2010 
deleted.
Sub-cohort containing 
oral cavity cancer and 
oropharyngeal cancer
diagnosed between 
calender years 2010 and 
2012 retained.
n=1967
5 IDs diagnosed 
with different 
subsite at a later 
date. Earlier 
incidence date and 
corresponding 
subsite retained.
n=1962
162 
 
 
Management Information and Dental Accounting System (MIDAS): This 
dataset contained records of all of the dental contacts that were made by 
patients with head and neck cancer (diagnosed 2008 — 2012) between 2003 
and 2012. The original linked dataset contained 44,994 observations. Upon 
examination, 3881 duplicate records (records with identical ID number and 
all other fields) were identified and deleted. The variables were renamed 
for convenience, and the “start date of treatment” variable was then used 
to create a new calendar year variable. This variable was then used to 
retain all contacts between 2007 and 2012. Thus, the preliminary sub-
cohort consisted of 29,821 records (Figure 4-3).  
Figure 4-3: Management Information and Dental Accounting System — Initial data 
management 
 
 
All dental contacts made by 
patients with head and neck 
cancer (in original SMR06 dataset) 
between 2003-2012 .
n= 44,994 observations
3881 duplicates deleted
n=41,113
Variables renamed, dates grouped 
by calender year. 
11,292 records before 2007 
deleted
Preliminary sub-cohort containing 
all dental contacts made by 
patients with head and neck 
cancer between 2007 and 2012 
created. 
n=29,821
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The approach to the analysis was adapted to the Scottish Dental Workforce 
Report, (NHS Education for Scotland, September 2012) and the treatment 
code items (n=500) were grouped into broad categories of appointment 
type, as follows — “Exam & Diagnosis”, “Emergency” and “Treatment”. 
Briefly, the “Exam and Diagnosis” group included all assessment and 
diagnostic codes including examination and radiographs, the “Emergency” 
group consisted of all treatment codes that indicated emergency 
intervention, and the “Treatment” group consisted of all procedures (e.g. 
conservative prosthetic, endodontic, and oral surgery) that could be 
performed by a dentist (treatment claim codes in each group are shown in 
Appendix 2). Finally, the number of contacts that were made by the 
patients over specific periods of time was used to create a new variable to 
determine the patient’s frequency of dental attendance. 
Prescribing Information System (PIS): This dataset contained information 
on all of the prescriptions that were issued to patients with head and neck 
cancer (diagnosed 2008 — 2012) between the period of 2009 to 2012. The 
time period that was examined for this dataset differed from the other 
datasets due to a limited availability of data (with the PIS dataset only 
becoming nationally available from 2009). The original linked dataset that 
was received contained 288,184 records. Of these, 3958 were duplicates 
(records with identical ID number and all other fields) and were deleted, 
leaving a total of 284,226 records. As stated before, data on general 
practitioner contacts were unavailable in Scotland, and the PIS system 
could be considered as a proxy for GP contacts. Therefore, after renaming 
the variables for convenience, only those prescriptions that were issued by 
general practitioners were retained, which resulted in a preliminary sub-
cohort of 281,389 records (Figure 4-4).  
For the purpose of this study, the “date of issue of prescription” variable 
was considered as an indicator of GP contact and, once again, each date 
was considered as one contact irrespective of the number of prescriptions 
issued. Unfortunately, the PIS database does not have a flag for repeat 
prescriptions, preventing us from identifying and excluding them from the 
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dataset. No detailed examination of the type of medications that were 
prescribed was undertaken as this would require expertise in 
bioinformatics to handle and analyse such large volumes of data, even for 
this small sample, and this was considered beyond the scope of this study. 
Thus, PIS data was unfortunately not a “conservative” estimate of general 
practitioner contact. 
Figure 4-4:Prescribing Information System — Initial data management 
 
 
All prescriptions issued to patients 
with head and neck cancer (in 
original SMR06 dataset) between 
2009-2012 .
n= 288,184 
3958 duplicates deleted
n=284,226
Variables renamed, dates grouped 
by calender year. 
2913 prescriptions issued by 
community pharmacies, dentists, 
hospitals, nurses and pharmacists 
deleted.
Preliminary sub-cohort containing 
all prescriptions issued by GPs to 
patients with head and neck cancer
between 2009-2012 created.
n=281,389
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Hospital outpatient attendance (SMR00): the original linked dataset that 
was received contained 43,681 records of outpatient contacts made by 
patients with head and neck cancer (diagnosed between 2008 — 2012) 
between 2003 and 2012. Of these, only 34 were duplicates (records with 
identical ID number and all other fields) and were deleted. Thereafter, the 
variables were renamed for convenience, and the “clinic attendance date” 
variable was used to create a new calendar year variable. For the purposes 
of this study, this new variable was then used to retain all records between 
2007 and 2012 only, which resulted in a preliminary sub-cohort of 33,922 
records (Figure 4-5). 
In this case, the “clinic attendance date” was used as an indicator of 
contact and, once again, each unique date was considered as one contact. 
This was considered to be a “conservative” estimate of contact.  
Figure 4-5: Hospital outpatient attendance — Initial data management 
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Hospital inpatient/ day-case (SMR01): the original linked dataset 
contained 15,409 records of SMR01 contacts made by patients with head 
and neck cancer (diagnosed between 2008 — 2012) between 2003 and 
2012. Of these, only four records were duplicates (records with identical ID 
number and all other fields) and were deleted. Thereafter, the variables 
were renamed for convenience, and the “admission date” variable was 
used to create a new calendar year variable. For the purposes of this 
study, this new variable was then used to retain all records between 2007 
and 2012 only, which resulted in a preliminary sub-cohort of 12,024 records 
(Figure 4-6). 
The “admission date” variable was used as an indicator of contact, and 
each unique date was considered as one contact. This was considered to be 
a “conservative” estimate of contact.  
Figure 4-6: Hospital inpatient/ day-case — Initial data management 
 
All hospital inpatient/day-case
contacts made by patients 
with head and neck cancer
(in original SMR06 dataset) 
between 2003-2012 .
n=15,409
4 duplicates deleted
n=15,405
Variables renamed, dates 
grouped by calender year. 
3381 records before 2007 
deleted
Preliminary sub-cohort 
containing all hospital 
inpatient/day-case contacts 
made by patients with head 
and neck cancer between 
2007 and 2012 created.
n=12,024
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4.3.5 Final linked cohort 
4.3.5.1  Creation of the final cohort 
The individual datasets received from eDRIS were all linked to one another 
by means of a unique identification number, the CHI (Community Health 
Index) number. The Community Health Index is a register of all patients 
who have used the Scottish National Health Service, and the identification 
number is usually assigned at the point of first contact with the NHS. In 
other words, each patient had a unique ID number that remained 
consistent across all datasets. Upon completion of initial data 
management, the preliminary sub-cohorts created from the individual 
datasets were combined using this number to create the final cohort to be 
used for analysis. The SMR06 dataset created was considered as the master 
ID file, and only records of patients that were included in this cohort were 
retained in the final dataset (Figure 4-7). The SIMD decile of the patient’s 
residence, recorded by the Scottish Cancer Registry, was considered to be 
the master SIMD and was used for all socioeconomic analyses. If a 
particular ID number did not appear in any one of the databases, it was 
assumed that the particular patient had made no contact with that service 
within the study period.  
Therefore, the final cohort consisted of all primary dental care, hospital 
outpatient, and hospital inpatient/ day-case records between 2007 — 2012 
and all GP prescription records between 2009 — 2012 for the 1962 patients 
that were diagnosed with oral cancer between 1st January 2010 and 31st 
December 2012.  
4.3.5.2  Definition of oral cancer used 
The original aim, as stated in Chapter 3, was to investigate oral cancer, 
oral cavity cancer, and oropharyngeal cancer separately. However, given 
the relatively small numbers observed upon linking the datasets, a decision 
was made that detailed examination by subsite would not be feasible and 
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was outside the scope of this thesis. Instead, emphasis was given to oral 
cancer (oral cavity and oropharyngeal cancer combined; ICD10 codes 
C00.3-C00.9, C01-C06, C09-C10, C14) as dentists have a role in the early 
detection of both subsites, and most guidelines for the detection of oral 
cancer consider the two subsites together as their signs and symptoms 
overlap considerably (hoarseness of voice, lump in the neck, problem 
swallowing, lumps or ulcers in the mouth) (Kreimer, 2014; NICE, 2015a; 
NHS Scotland). Therefore, from an early detection perspective, combining 
the two subsites and examining them as “oral cancer” appeared to be 
more appropriate.  
 
Figure 4-7: Creation of final cohort of patients with oral cancer (2010-2012) for 
analysis 
SMR06: Scottish Cancer Registry; SMR00: Hospital outpatient services; SMR01: hospital 
inpatient/ day-case service; MIDAS: Management Information and Dental Accounting 
System; PIS: Prescribing Information System; OC: Oral Cancer.  
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4.3.6 Statistical analysis methods 
After initial data management and linkage, descriptive analysis was 
undertaken. Frequency tables (numbers and percentages) showing patient 
demographics of the cohort were generated. 
Unfortunately, the referral date (and source) for patients with oral cancer 
was unknown from the routine administrative datasets available. However, 
the cancer waiting time targets of the Scottish Government are 62 days 
from the receipt of referral to first treatment and 31 days from decision-
to-treat to first treatment (ISD Scotland, 2017b). For the purpose of this 
analysis, the decision to treat was assumed to be the same as the date of 
diagnosis. Therefore, given that 31 days out of the 62-day target was after 
the decision to treat (date of diagnosis), the referral period was unlikely to 
be more than 30 days. Based on this, a 30-day referral period (defined as 
the period from the receipt of referral up to the decision to treat) was 
selected for this analysis (Figure 4-8), and all healthcare service contacts 
made by the patients during this period were assumed to be part of the 
referral process. This was considered the appropriate cut-off for Scottish 
data given the referral guidelines (NHS Scotland, 2016b).  
However, this would not be appropriate in case of patients who did not 
meet the national waiting time targets and, therefore, an additional 
sensitivity analysis that considered a two-month (60 days) referral period 
was also undertaken. This was similar to the approach adopted by Ligier et 
al. (2016), who adopted a more conservative and longer two-month 
referral period for their study.  
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Figure 4-8: Visual representation of Waiting Time targets and definition of the referral 
period 
 
 
Thereafter, frequency tables showing the proportion of patients who had 
contacted any of the four services examined (hospital outpatient, hospital 
inpatient/day-case, primary dental care, and GP prescription) in the two 
years prior to the start of the referral period (t–30) were generated. 
Additionally, the mean number of contacts made with each service over 
the entire pre-referral two-year period, individual years, and six-month 
periods were also calculated. A one-sample t-test was used to test the 
statistical significance of differences in the mean number of contacts 
between the different time periods, and also to provide a 95% confidence 
interval for the mean difference 
For the purpose of this analysis, Year–1 was defined as the most recent 
365-day period prior to the start of the referral period (t–30), while Year–2 
represented the 365-day period preceding that (Figure 4-9). 
In a similar way, Y1H1 was defined to be the most recent six months prior 
to the start of the referral period, Y1H2 represented the six-months 
preceding that, and so on until Y2H2 which represented the six-month 
period furthest away from the start of the referral period (Figure 4-9). 
Receipt of 
referral 
Decision to treat 
 
Target=62 days 
First 
treatment 
Target=31 days 
Referral period 
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Figure 4-9: Visual representation of cohort time periods leading up to oral cancer 
diagnosis. 
 
[t: date of diagnosis; Y1H1: Year—1 half 1; Y1H2: Year—1 half 2; Y2H1: Year—2 half 1; Y1H1: 
Year—2 half 2] 
Additionally, a detailed analysis of the nature of all dental contacts in the 
two years preceding the start of the referral period was undertaken. 
Frequency tables including number and percentage by reason for contact 
were generated. McNemar’s test was used to examine the statistical 
significance of within-person differences. This test was chosen as the 
dataset consisted of paired data. 
Contacts made within the one-month referral period were also analysed 
separately. Particularly, the mean number of contacts made within this 
period overall and by each service was calculated. As mentioned 
previously, a sensitivity analysis investigating the two-month period 
preceding diagnosis (“t–60 days”) was also undertaken to assess whether 
the referral period was a distinct period including high levels of hospital 
contacts. Additionally, the last service contacted before the start of the 
referral period was also examined. All data analyses were undertaken using 
SAS 9.4 on the National Safe Haven.  
4.4 Results 
At this stage, it is essential to draw attention back to the fact that the 
current study focuses on oral cancer and, unlike the previous chapters, 
does not consider the individual subsites (oral cavity cancer and 
oropharyngeal cancer). This decision was made based primarily on the 
numbers observed (oral cavity cancer=1108, oropharyngeal cancer=854) 
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upon commencement of analysis, and this has been discussed further in 
Section 4.3.4.  
4.4.1 Cohort description - patient demographics 
This study included 1962 patients that were diagnosed with oral cancer 
between 1st January 2010 and 31st December 2012 and registered with the 
Scottish Cancer Registry. Nearly two-thirds of these patients were males 
(n=1269, 65%), were above the age of 45 years (n=1846, 94%), and were 
from the most deprived areas of Scotland (SIMD 1: n=650, 33%) (Table 4-1). 
Of these 1962 patients, the vast majority (95%, n=1867) had contacted at 
least one of the four services (hospital inpatient/ day-case, hospital 
outpatient, GP prescription, and primary dental care) in the two years 
prior to the start of the referral period (t–30) (“Ever” group), while only a 
very small proportion (5%, n=95) had not contacted any of the four services 
over the same period (“Never” group) (Table 4-1). A comparison of the 
patient profile of the two groups showed no major differences, with the 
majority of the “Ever” and “Never” groups being male (64% and 73%, 
respectively), above 45 years of age (94% and 95%, respectively), and from 
the most deprived areas of Scotland (SIMD 1: 33% and 32%, respectively) 
(Table 4-1).  
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Table 4-1: Demographics of all patients with oral cancer diagnosed between 2010-
2012 by contact with any healthcare service in the two years prior to the start of the 
referral period. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All patients 
N (%) 
Ever 
N (%) 
Never 
N (%) 
Total 1962 (100.00) 1867 (95.16) 95 (4.84) 
Sex 
Males 1269 (64.68) 1200 (64.27) 69 (72.63) 
Females 693 (35.32) 667 (35.73) 26 (27.37) 
Age 
0 - 25 10 (0.51) 9 (0.48) 1 (1.05) 
26 - 35 21 (1.07) 17 (0.91) 4 (4.21) 
36 - 45 85 (4.33) 85 (4.55) 0 (0.00) 
46 - 55 407 (20.74) 374 (20.03) 33 (34.74) 
56 - 65 630 (32.11) 593 (31.76) 37 (38.95) 
66 - 75 489 (24.92) 473 (25.33) 16 (16.84) 
76 - 85 263 (13.40) 259 (13.87) 4 (4.21) 
>86 57 (2.91) 57 (3.05) 0 (0.00) 
SIMD 
1 (most deprived) 650 (33.13) 620 (33.21) 30 (31.58) 
2 410 (20.90) 396 (21.21) 14 (14.74) 
3 412 (21.00) 390 (20.89) 22 (23.16) 
4 335 (17.07) 318 (17.03) 17 (17.89) 
5 (least deprived) 142 (7.24) 130 (6.96) 12 (12.63) 
Frequency Missing = 13 (0.66%) 
Health board region 
East 701 (35.88) 669 (35.97) 32 (34.04) 
North 333 (17.04) 320 (17.20) 13 (13.83) 
West 920 (47.08) 871 (46.83) 49 (52.13) 
Frequency Missing = 8 (0.40%) 
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4.4.2 Patient contact with healthcare services 
This section examines the proportion of patients with oral cancer (n=1962) 
that had contacted all or any of the healthcare services (hospital 
outpatient appointments, hospital inpatient/day-case admissions, GP 
prescriptions, and primary dental care) in the two years prior to the start 
of the referral period, calculates the mean number of contacts made, and 
explores any variations over time. 
A greater proportion of patients contacted all or any of the four services in 
the most recent year prior to the start of the referral period (Year–1) 
compared to the year preceding that (Year–2) (93% vs 86%, respectively); 
however, this difference was quite small (Table 4-2). The mean number of 
contacts [16.9, standard deviation (S.D) 14.4] was higher in the most 
recent year prior to the start of the referral period (Year–1) compared to 
the year preceding that (Year–2) (10.9, S.D 11.7) (Table 4-2). The mean 
difference in the number of contacts was 6.0 [one-sample t-test 
p=<0.0001, 95% confidence interval (C.I) = 5.5-6.5] and this was 
statistically significant (Table 4-3). This increase was also clinically 
significant, with patients with oral cancer making 6 more contacts with all 
or any of the four healthcare services in the most recent year prior to the 
start of the referral period compared to the year preceding that.  
The proportion of patients that had contacted all or any of the four 
services at least once in six months increased from 74% (n=1459) in the six-
month period furthest away from the start of the referral period (Y2H2) to 
91% (n=1778) in the most recent six months prior to the start of the 
referral period (Y1H1) (Table 4-2). The mean difference in the number of 
contacts between the most recent six months prior to the start of the 
referral period (Y1H1) and the six months preceding that (Y1H2) was 1.0 
(one-sample t-test p=<0.0001, 95% C.I = 0.8–1.1) (Table 4-3). The mean 
difference in the number of contacts between the most recent six months 
prior to the start of the referral period (Y1H1) and the six-month period 
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furthest away from the start of the referral period (Y2H2) was 3.0 (one-
sample t-test p=<0.0001, 95% C.I = 2.7-3.2) (Table 4-3). 
Table 4-2: All or any healthcare service contacts over time for patients with oral 
cancer diagnosed between 2010-2012 (n=1962) 
 
 
Never 
contacted 
healthcare 
service  
n (%) 
Ever 
contacted 
healthcare 
services  
n (%) 
Minimum 
number 
of 
contacts 
Maximum 
number 
of 
contacts 
Mean 
number 
of 
contacts 
Standard 
deviation 
Year–2 
(least 
recent) 
274 (13.97) 
1688 
(86.03) 
0 90.00 10.90 11.78 
Year–1  
(most 
recent) 
143 (7.29) 
1819 
(92.71) 0 108.00 16.96 14.40 
 
Y2H2 (least 
recent) 503 (25.64) 
1459 
(74.36) 
0 
48.00 5.00 6.12 
Y2H1 
388 (19.78) 
1574 
(80.22) 
0 
45.00 5.89 6.38 
Y1H2 
270 (13.76) 
1692 
(86.24) 
0 41.00 7.00 6.64 
Y1H1 (most 
recent) 184 (9.38) 
1778 
(90.62) 
0 51.00 8.02 6.91 
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Table 4-3: One-sample t-test comparing time periods by mean number of service contacts 
 
One-sample t-test comparing time periods by service contacts 
 
 
 
 
Service 
contacted 
 
Year–1 vs. Year–2  
 
Y1H1 vs. Y1H2 
 
Y1H1 vs. Y2H1 
 
Y1H1 vs. Y2H2 
 
Mean 
difference 
in number 
of 
contacts 
 
 
 
 
95% 
CI 
 
 
 
 
P value 
 
 
Mean 
difference 
in number 
of 
contacts 
 
 
 
 
 
95% 
CI 
 
 
 
 
P-value 
 
 
Mean 
difference 
in number 
of 
contacts 
 
 
 
 
95% 
CI 
 
 
 
 
P value 
 
Mean 
difference 
in number 
of 
contacts 
 
 
 
95% 
CI 
 
 
 
 
P value 
All/Any 
service 
contacts 6.05 
5.59-
6.51 <0.0001 1.01 
0.83-
1.19 <0.0001 2.12 
1.89-
2.34 <0.0001 3.01 
2.75-
3.27 <0.0001 
Hospital 
inpatient/day-
case service 
contacts 0.27 
0.15-
0.39 <0.0001 0.01 
-
0.03-
0.05 0.6168 0.05 
0.01-
0.09 0.0177 0.04 
-
0.01-
0.09 0.0925 
Hospital 
outpatient 
service 
contacts 0.08 
0.01-
0.15 <0.0198 0.20 
0.12-
0.27 <0.0001 0.24 
0.16-
0.32 <0.0001 0.23 
0.14-
0.32 <0.0001 
GP 
prescription 
service 
contacts 3.68 
3.35-
4.01 <0.0001 0.74 
0.60-
0.88 <0.0001 1.76 
1.57-
1.94 <0.0001 2.67 
2.44-
2.89 <0.0001 
Primary 
dental care 
service 
contacts 2.02 
1.77-
2.27 <0.0001 0.07 
0.04-
0.10 <0.0001 0.08 
0.04-
0.11 <0.0001 0.08 
0.05-
0.11 <0.0001 
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4.4.3  Hospital inpatient/day-case (SMR01) 
A greater proportion of patients had contacted a hospital inpatient/day-
case service in the most recent year prior to the start of the referral 
period (Year–1) compared to the year preceding that (Year–2) (25% vs 23%, 
respectively); however, this difference was also quite small (Table 4-4). 
The mean number of hospital inpatient/day-case contacts was 0.5 (S.D 1.5) 
in the most recent year prior to the start of the referral period (Year–1) 
and 0.4 (S.D 1.2) in the year preceding that (Year–2) (Table 4-4). The mean 
difference in the number of contacts was 0.2 and, although this was 
statistically significant (one-sample t-test p = <0.0001, 95% C.I 0.1–0.3), it 
was unlikely to have any clinical significance as the difference in number 
of hospital inpatient/day-case contacts between the two years was less 
than one contact (Table 4-3).  
The proportion of patients that had contacted a hospital inpatient/day-
case service at least once in six months marginally increased from 14% 
(n=271) in the six-month period furthest away from the start of the referral 
period (Y2H2) to 17% (n=331) in the most recent six months prior to the 
start of the referral period (Y1H1) (Table 4-4). The mean number of 
hospital outpatient contacts was 0.9 (S.D 1.9) in the most recent six 
months prior to the start of the referral period (Y1H1), 0.7 (S.D 1.64) in 
the six months preceding that (Y1H2), 0.7 (S.D 1.61) in the six months 
preceding Y1H2, and 0.7 (S.D 1.68) in the six-month period furthest away 
from the start of the referral period (Y2H2) (Table 4-4). The mean 
difference in the number of contacts between the most recent six months 
prior to the start of the referral period (Y1H1) and the six-month period 
preceding that (Y1H2) was 0.01 (one-sample t-test p=0.6168, 95% C.I = –
0.03–0.05) (Table 4-3). The mean difference in the number of contacts 
between the most recent six months prior to the start of the referral 
period (Y1H1) and the six-month period furthest away from the start of the 
referral period (Y2H2) was 0.04 (one-sample t-test p=0.0925, 95% C.I = –
0.01–0.09) (Table 4-3). These differences were neither statistically nor 
clinically significant.   
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Table 4-4: Hospital inpatient/ day-case service (SMR01) contacts over time for patients 
with oral cancer diagnosed between 2010-2012 (n=1962) 
 
 
Never 
contacted 
hospital 
inpatient/ 
day-case 
service  
n (%) 
Ever 
contacted 
hospital 
inpatient/ 
day-case 
service  
n (%) 
Minimum 
number 
of 
contacts 
Maximum 
number 
of 
contacts 
Mean 
number 
of 
contacts 
Standard 
deviation 
Year–2 
(least 
recent) 
1505 
(76.71) 
457 (23.29) 0 19.00 0.49 1.29 
Year–1 
(most 
recent) 
1468 
(74.82) 
494 (25.18) 
0 30.00 0.57 1.56 
 
Y2H2 
(least 
recent) 
1691 
(86.19) 
271 (13.81) 
0 
28.00 0.74 1.68 
Y2H1 1700 
(86.65) 
262 (13.35) 0 
29.00 0.73 1.61 
Y1H2 1674 
(85.32) 
288 (14.68) 0 26.00 0.77 1.64 
Y1H1 
(most 
recent) 
1631 
(88.13) 
331 (16.87) 0 27.00 0.97 1.92 
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4.4.4 Hospital outpatient appointments (SMR00) 
A greater proportion of patients had contacted hospital outpatient services 
in the most recent year prior to the start of the referral period (Year–1) 
compared to the year preceding that (Year–2) (50% vs 44%, respectively) 
(Table 4-5). The mean number of hospital outpatient contacts was 1.74 
(S.D 3.13) in the most recent year prior to the start of the referral period 
(Year–1) and 1.46 (S.D 2.95) in the year preceding that (Year–2) (Table 4-
5). The mean difference in the number of contacts between the two years 
was 0.08 and this was neither statistically nor clinically significant (one-
sample t-test p <0.0198, 95% C.I = 0.01–0.15) (Table 4-3). 
The proportion of patients that had contacted a hospital outpatient service 
at least once in six months increased from 32% (n=634) in the six-month 
period furthest away from the start of the referral period (Y2H2) to 40% 
(n=781) in the six-month period closest to the start of the referral period 
(Y1H1) (Table 4-5). The mean number of hospital inpatient/day-case 
contacts in the most recent six months (Y1H1) was 0.2 (S.D 0.83) and this 
was very similar to the mean number of contacts in all of the other six-
month periods (Y1H2: mean=0.2, S.D = 0.9; Y2H1: mean=0.2, S.D = 0.8; 
Y2H2: mean=0.2, S.D = 0.8) (Table 4-5). The one-sample t-test showed that 
the mean difference in the number of contacts between the most recent 
six months prior to the start of the referral period (Y1H1) and the six 
months preceding that (Y1H2) was 0.2 (p <0.0001, 95% C.I 0.1–0.2); 
between the six-month period closest to the start of the referral period 
(Y1H1) and Y2H1 was 0.2 (p <0.0001, 95% C.I 0.1–0.3); and between the 
most recent six months prior to the start of the referral period (Y1H1) and 
the six-month period furthest from start of the referral period (Y2H2) was 
also 0.2 (p <0.0001, 95% C.I 0.1–0.3) (Table 4-3). Once again, despite 
statistical significance, the differences in the number of contacts between 
two six-month periods were consistently less than one contact, suggesting 
limited clinical significance.  
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Table 4-5: Hospital outpatient service (SMR00) contacts over time for patients with 
oral cancer diagnosed between 2010-2012 (N=1962) 
 
 
Never 
contacted 
hospital 
outpatient 
service  
n (%) 
Ever 
contacted 
hospital 
outpatient 
service  
n (%) 
Minimum 
number 
of 
contacts 
Maximum 
number 
of 
contacts 
Mean 
number 
of 
contacts 
Standard 
deviation 
Year–2 
(least 
recent) 
1103 
(56.22) 
859 
(43.78) 
0 57.00 1.46 2.95 
Year–1 
(most 
recent) 
973 
(49.59) 
989 
(50.41) 
0 53.00 1.74 3.13 
 
Y2H2 
(least 
recent) 
1328 
(67.69) 
634 
(32.31) 
0 19.00 0.25 0.85 
Y2H1 1325 
(67.53) 
637 
(32.47) 
0 
11.00 0.24 0.81 
Y1H2 1293 
(65.90) 
669 
(34.10) 
0 17.00 0.28 0.96 
Y1H1 
(most 
recent) 
1181 
(60.19) 
781 
(39.81) 
0 13.00 0.29 0.83 
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4.4.5 Prescribing Information System (PIS) 
The proportion of patients that had been issued a prescription by a general 
practitioner had increased in the most recent year prior to the start of the 
referral period compared to the year preceding that (Year–1: 89%, Year–2: 
73%). The mean number of GP prescriptions issued was 12 (S.D 10.9) in the 
most recent year prior to the start of the referral period (Year–1) and 8.3 
(S.D 10.0) in the year preceding that (Year–2) (Table 4-6). The mean 
difference in the number of contacts between the two years was 3.6 and 
this was statistically significant (one-sample t-test p<0.0001, 95% C.I = 3.3–
4.0) (Table 4-3). This increase was also clinically significant, with 3.6 more 
prescriptions being issued by general practitioners in the most recent year 
prior to the start of the referral period.  
The proportion of patients that had been issued a prescription by a general 
practitioner had increased drastically from 57% (n=1113) in the six-month 
period furthest away from the start of the referral period (Y2H2) to 85% 
(n=1663) in the six-month period closest to the start of the referral period 
(Y1H1) (Table 4-5). The mean number of GP prescriptions issued was 6.4 
(S.D 5.8) in the six-month period closest to the start of the referral period 
(Y1H1), 5.7 (S.D 5.5) in the six months preceding that (Y1H2), 4.6 (S.D 
5.44) in the six months preceding Y1H2 (Y2H1), and 3.7 (S.D 5.22) in the 
six-month period furthest away from the start of the referral period (Y2H2) 
(Table 4-6). The mean difference in the number of contacts between the 
six-month period closest to the start of the referral period (Y1H1) and the 
six months preceding that (Y1H2) was 0.7 (p <0.0001, 95% C.I 0.6–0.8); 
between the six-month period closest to the start of the referral period 
(Y1H1) and Y2H1 was 1.7 (p <0.0001, 95% C.I 1.5–1.9), and between the 
six-month period closest to the start of the referral period (Y1H1) and the 
six-month period furthest away from the start of the referral period (Y2H2) 
was 2.6 (p <0.0001, 95% C.I 2.4–2.8) (Table 4-3).  
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Table 4-6: GP prescription service (PIS) contacts over time for patients with oral 
cancer diagnosed between 2010-2012 (n=1962) 
 
 
Never 
contacted 
GP 
prescription 
service  
n (%) 
Ever 
contacted 
GP 
prescription 
service  
n (%) 
Minimum 
number 
of 
contacts 
Maximum 
number 
of 
contacts 
Mean 
number 
of 
contacts 
Standard 
deviation 
Year–2 
(least 
recent) 
539 (27.47) 
1423 
(72.53) 
0 72.00 8.36 10.06 
Year–1 
(most 
recent) 
224 (11.42) 
1738 
(88.58) 
0 73.00 12.04 10.97 
 
Y2H2 
(least 
recent) 
894 (43.27) 
1113 
(56.73) 
0 36.00 3.72 5.22 
Y2H1 
609 (31.04) 
1353 
(68.96) 
0 
41.00 4.64 5.44 
Y1H2 
381 (19.42) 
1581 
(80.58) 
0 37.00 5.65 5.57 
Y1H1 
(most 
recent) 
299 (15.24) 
1663 
(84.76) 
0 42.00 6.39 5.86 
183 
 
 
4.4.6 Dental service contacts 
This section presents the results of a focused examination of all primary 
dental care service contacts made by the patients with oral cancer in the 
two years prior to the start of the referral period, with the aim of 
identifying any potentially missed opportunities for opportunistic screening 
in the primary dental care setting. 
4.4.6.1  Patient demographics by primary dental care service contact 
status 
Just over half of the patients with oral cancer had made no contact with a 
primary dental care service in the two years prior to the start of the 
referral period (“Never- dental” group: n= 1086, 55%; “Ever-dental” group: 
n=876, 45%) (Table 4-7), thus automatically limiting opportunities for early 
detection. It is vital to bear in mind that these numbers represent patients 
who had or had not made contact with a primary dental care service in the 
two years preceding the start of the one-month referral period (t–30) and, 
therefore, represent a more refined analysis compared to that presented in 
Chapter 3 which considered the two-year period directly preceding the 
date of diagnosis. Therefore, while 911 (46%) patients with oral cancer had 
contacted a primary dental care service in the two years prior to diagnosis 
(t) (shown in Chapter 3 Table 3-3), a slightly smaller number of 876 
patients with oral cancer had consulted a general dental practitioner in the 
two years prior to the start of the one-month referral period (t-30 days) 
(Table 4-7).  
A comparison of the patient profile of the two groups showed no major 
differences, with a majority of the patients with oral cancer in the “Ever-
dental” and “Never-dental” groups being male (65% for both), above 45 
years of age (92% and 96%, respectively), and from the most deprived areas 
of Scotland (SIMD 1: 31% and 35%, respectively) (Table 4-7). In contrast, 
only 36% of the “Ever-dental” group were females, 8% were below 45 years 
of age, and 8% were from the least deprived areas of Scotland (SIMD 5). 
Similarly, only 35% of the “Never-dental” group were females, 4% were 
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below 45 years of age, and 7% were from the least deprived areas of 
Scotland (SIMD 5) (Table 4-7). 
Table 4-7: Patient demographics by dental service contact in the two years prior to 
the start of the referral period. 
 
 
Total 
n (%) 
Ever-dental  
n (%) 
Never-dental  
n (%) 
Total 1962 (100.00) 876 (44.65) 1086 (55.35) 
Sex 
Males 1269 (64.68) 565 (64.50) 704 (64.83) 
Females 693 (35.32) 311 (35.50) 382 (35.17) 
Age 
0 - 25 10 (0.51) 7 (0.80) 3 (0.28) 
26 - 35 21 (1.07) 11 (1.26) 10 (0.92) 
36 - 45 85 (4.33) 56 (6.39) 29 (2.67) 
46 - 55 407 (20.74) 200 (22.83) 207 (19.06) 
56 - 65 630 (32.11) 299 (34.13) 331 (30.48) 
66 - 75 489 (24.92) 191 (21.80) 298 (27.44) 
76 - 85 263 (13.40) 91 (10.39) 172 (15.84) 
>86 57 (2.91) 21 (2.40) 36 (3.31) 
SIMD 
1 (most deprived) 650 (33.13) 273 (31.16) 377 (34.71) 
2 410 (20.90) 179 (20.43) 231 (21.27) 
3 412 (21.00) 189 (21.58) 223 (20.53) 
4 335 (17.07) 157 (17.92) 178 (16.39) 
5 (least deprived) 142 (7.24) 70 (7.99) 72 (6.63) 
Frequency Missing = 13 (0.66%) 
Region of Residence 
East 701 (35.88) 349 (38.89) 352 (32.62) 
North 333 (17.04) 113 (12.91) 220 (20.39) 
West 920 (47.08) 413 (47.20) 507 (46.99) 
Frequency Missing = 8 (0.41%) 
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4.4.6.2  Frequency of primary dental care service contacts 
The proportion of patients that had contacted a dental service did not 
differ between the most recent year prior to the start of the referral 
period and the year preceding that (Year–1: 32%, Year–2: 32%). However, 
the mean number of contacts made in the most recent year prior to the 
start of the referral period was considerably higher than that observed in 
the year preceding it (Year–1: mean 2.6, S.D 5.9; Year–2: mean 0.5, S.D 
1.0) (Table 4-8). The mean difference in the number of contacts between 
the two years was 2.0 contacts and this was statistically significant (one-
sample t-test p<0.0001, 95% C.I 1.7–2.2) (Table 4-3). Moreover, this was 
also clinically significant, with two more primary dental care service 
contacts being observed in the year prior to the start of the referral period 
compared to the year furthest away from the start of the referral period.  
The proportion of patients that had contacted a primary dental care 
service at least once in six months increased from 23% (n=447) in the six-
month period furthest away from the start of the referral period (Y2H2) to 
29% (n=566) in the six-month period closest to the start of the referral 
period (Y1H1) (Table 4-8). The mean number of dental service contacts 
was 0.3 (S.D 0.57) in the most recent six-month period prior to the start of 
the referral period (Y1H1), and this was slightly higher than all of the other 
six-month periods examined (Y1H2: mean=0.3, S.D = 0.5; Y2H1: mean=0.2, 
S.D = 0.6; Y2H2: mean=0.2, S.D = 0.6) (Table 4-8). The mean difference in 
number of contacts between the most recent six-month period prior to the 
start of the referral period (Y1H1) and the six months preceding that 
(Y1H2) was 0.07 (one-sample t-test p< 0.0001, 95% C.I = 0.04–0.1); 
between the most recent six-month period prior to the start of the referral 
period (Y1H1) and Y2H1 was 0.08 (one-sample t-test p <0.0001, 95% C.I = 
0.04–0.1); and between the most recent six-month period prior to the start 
of the referral period (Y1H1) and the six-month period furthest away from 
the start of the referral period (Y2H2) was 0.08 (one-sample t-test p 
<0.0001, 95% = C.I 0.05 — 0.1) (Table 4-3). While these differences were 
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statistically significant, they were unlikely to have any clinical significance 
as the differences were less than one contact every six months 
Table 4-8: Dental service (MIDAS) contacts over time for patients with oral cancer 
diagnosed between 2010-2012 (n=1962) 
 
 
Never n 
(%) 
Ever n 
(%) 
Minimum 
number 
of 
contacts 
Maximum 
number 
of 
contacts 
Mean 
number 
of 
contacts 
Standard 
deviation 
Year–2 
(least 
recent) 
1338 
(68.20) 
624 
(31.80) 
0 9.00 0.58 1.04 
Year–1 
(most 
recent) 
1344 
(68.50) 
618 
(31.50) 
0 49.00 2.61 5.98 
 
Y2H2 
(least 
recent) 
1515 
(77.22) 
447 
(22.78) 
0 6.00 0.29 0.60 
Y2H1 
1510 
(76.96) 
452 
(23.04) 
0 6.00 0.29 0.61 
Y1H2 
1483 
(75.59) 
479 
(24.41) 
0 4.00 0.30 0.59 
Y1H1 
(most 
recent) 
1396 
(71.15) 
566 
(28.85) 
0 5.00 0.37 0.67 
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4.4.6.3  Nature of primary dental care service contacts 
This section carries out a detailed exploration of the reasons for primary 
dental care service contact by focusing on the “Ever-dental” contact group 
(n=876), that is, patients who had contacted a primary dental care service 
in the two years prior to the start of the referral period.  
Upon analysing the reasons for contact, the majority (n=713, 81%) of the 
“Ever-dental” contact group were seen to have undergone at least one 
“Exam and/or Diagnosis” category procedure during their visit in the two 
years prior to the start of the referral period. However, only 12% (n=105) 
of the patients had attended for a “Treatment” procedure only, and a 
smaller proportion of 7% (n=58) had attended for “Emergency” purposes 
only (Table 4-9).  
For a more detailed examination by individual year, the patients were 
classified into the following groups: a) “1-2 contacts” — those who had one 
to two contacts with a general dental practitioner per year, and b) “>2 
contacts” — those who had more than two contacts with a general dental 
practitioner per year. One to two appointments per year (one every six 
months) were considered to be “routine” (regular), as per the current SDR-
primary dental care contract regulation (NHS Scotland, 2017b). Of the 876 
(45%) patients with oral cancer who had consulted a primary dental care 
service in the two years preceding the start of the referral period (Table 4-
9), 252 (29%) had made zero contact in Year–2 and 258 (29%) had made 
zero contact in Year–1 (Table 4-9). The proportion of patients that had 
made routine contact (one to two contacts) decreased drastically from 57% 
in the year furthest from the start of the referral period (Year–2) to 18% in 
the most recent year prior to the start of the referral period (Year–1) 
(Table 4-9). Therefore, just over half of the patients (n=456, 52%) had 
made non-routine frequency of contact (more than two contacts) in the 
most recent year prior to the start of the referral period (Year–1), and this 
was considerably larger than the proportion seen in the year preceding 
that (Year–2) (n=121, 14%) (Table 4-9).  
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With regard to the reasons for contact, 41% (n=363) of the patients 
exhibited higher than the usual routine frequency of contacts (more than 
two contacts) for “Exam and Diagnosis” purposes in the most recent year 
prior to the start of the referral period (Year–1) compared to only 8% 
(n=70) in the year preceding that (Year–2). In other words, the proportion 
of patients that had more than just a routine number of contacts, 
particularly for exam and diagnosis purposes, had risen in the most recent 
year prior to the start of the referral period. A similar pattern was 
observed with regard to the other categories, that is, the proportion of 
patients that had more than a routine number of contacts with a dental 
service for “Treatment” or “Emergency” purposes only was greater in the 
most recent year prior to the start of the referral period (Year–1) 
compared to the year preceding that (Year–2) (Table 4-9). These 
differences were seen to be statistically significant (McNemar’s test 
p<0.0001). Therefore, the results suggest that a) a greater proportion of 
patients with oral cancer (52.05%) that were included in the “Ever-dental” 
group had increased their frequency of attending a dental service (i.e. 
more than the routine one to two contacts per year) in the year prior to 
the start of the referral period, and b) the patients appeared to have 
mainly undergone some form of examination and/or diagnostic procedures 
during these contacts.  
The number of dental service contacts made by the patients was then 
examined by six-month periods in a similar way, with Y1H1 representing 
the most recent six months prior to the start of the referral period, Y1H2 
being the six months preceding that, and so on until Y2H2 which was the 
six-month period furthest away from the start of the referral period 
(Figure 4-9). Here, one contact per six months (i.e. two contacts per year) 
was considered to be “routine”. The patients with oral cancer were 
classified into the following groups: a) “1 contact” — for those who had 
one contact with a dental service over a six-month period, and b) “>1 
contact” — for those who had more than one contact with a dental service 
over a six-month period. 
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Table 4-9: Frequency of dental service contact of “Ever-dental” group (n=876) by 
reason for contact. 
 
 
 
 
Time 
period 
 
 
 
No of contacts 
Reason for contact 
Exam & 
Diagnosis 
N (%) 
Emergency  
N (%) 
Treatment 
N (%) 
Total 
N (%) 
Two-year period prior to the start 
of referral 713 (81.39) 58 (6.62) 105 (11.99) 876 (100) 
Examination by individual year 
 
 
Year–2  
0 Contacts — — — 252 (28.77) 
1–2 Contacts 437 (49.89) 23 (2.63) 43 (4.91) 503 (57.42) 
>2 Contacts 70 (7.99) 8 (0.91) 43 (4.91) 121 (13.81) 
 
 
Year–1  
0 Contacts — — — 258 (29.45) 
1–2 Contacts 133 (15.18) 19 (2.17) 10 (1.14) 162 (18.49) 
>2 Contacts 363 (41.44) 24 (2.74) 69 (7.88) 456 (52.05) 
Examination by six-month periods 
 0 Contacts — — — 429 (48.97) 
Y2H2 1 Contact 306 (34.93) 11 (1.26) 31 (3.54) 348 (39.73) 
 >1 Contact 48 (5.48) 12 (1.37) 39 (4.45) 99 (11.30) 
 
Y2H1 
0 Contacts — — — 424 (48.40) 
1 Contact 312 (35.62) 13 (1.48) 30 (3.42) 355 (40.53) 
>1 Contact 57 (6.51) 6 (0.68) 34 (3.88) 97 (11.07) 
 0 Contacts — — — 397 (45.32) 
Y1H2 1 Contact 327 (37.33) 17 (1.94) 43 (4.91) 387 (45.32) 
 >1 Contact 63 (7.19) 7 (0.80) 22 (2.51) 92 (10.50) 
 
Y1H1 
0 Contacts — — — 310 (35.39) 
1 Contact 378 (43.15) 24 (2.74) 49 (5.59) 451 (51.48) 
>1 Contact 76 (8.68) 13 (1.48) 26 (2.97) 115 (13.13) 
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Of the 876 patients with oral cancer who had contacted a primary dental 
care service in the two years before the start of the referral period, only 
35% (n= 310) had made zero contacts in the most recent six-month period 
prior to the start of the referral period (Y1H1). This was considerably lower 
than the number of patients who had made zero contact in all of the 
remaining six-month periods examined (Y1H2: n=397, 45%; Y2H1: n= 424 
48%; Y2H2: n= 429, 49%) (Table 4-9). A somewhat downward trend 
appeared to exist, with the number of patients with no contact with a 
dental service decreasing from the six-month period furthest away from 
the start of the referral period (Y2H2) to the six-month period closest to 
the start of the referral period (Y1H1).  
The number of patients that had contacted a primary dental care service 
once over a six-month period appeared to exhibit a somewhat upward 
trend closer to the start of the referral period (Table 4-9). More 
specifically, only 40% (n=348) of patients had contacted the dental service 
once in Y2H2 (the six-month period furthest away from the start of the 
referral period), and this proportion had increased to just over half (51%, 
n=451) in the most recent six-months prior to the start of the referral 
period (Y1H1). This is important as even one contact could be considered 
as an opportunity for early detection of oral cancer.  
When examining for non-routine patterns of contact (i.e. more than one 
contact per six-month period), 13% (n=115) of the patients had made more 
than one contact with a dental service in the most recent six-month period 
(Y1H1) prior to the start of the referral period. This proportion was 
slightly, but not significantly, greater than that seen in the remaining six-
month periods examined, with the corresponding proportions being 11% 
(n=92) in the six-month period preceding the most recent one (Y1H2), 11% 
(n=97) in the more recent six-month period of the year furthest away from 
the start of the referral period (Y2H1), and 11% (n=99) in the six-month 
period furthest away from the start of the referral period (Table 4-9). 
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Lastly, when examining the reasons for contact with a dental service, 9% 
(n= 76) of the patients were seen to have had more than one contact for 
some form of examination or diagnostic procedure in the most recent six-
months (Y1H1) prior to the start of the referral period. This proportion was 
slightly greater than that seen in the remaining six-month periods 
examined, with the corresponding proportions being 7% (n=63) in the six-
month period preceding the most recent one (Y1H2), 7% (n=57) in the more 
recent six-month period of the year furthest away from the start of the 
referral period (Y2H1), and 5% (n=48) in the six months furthest away from 
the start of the referral period (Table 4-9). The number of patients who 
had one or more contact with a general dental practitioner for some form 
of examination and diagnosis procedure, albeit still low, appeared to 
increase closer to the start of the referral period (Table 4-9). The 
difference between the two halves of the most recent year prior to the 
start of the referral period was statistically significant (McNemar’s test 
comparing Y1H1 AND Y1H2: p-value <0.005). Moreover, the proportions of 
patients who had attended a primary dental care service for “Emergency” 
and “Treatment” purposes only in the most recent six months prior to the 
start of the referral period were 1% (n=13) and 3% (n=26), respectively. 
Although these numbers were much smaller, these contacts could 
potentially be additional opportunities for the early detection of cancer.  
Therefore, the results show that a) the number and proportion of patients 
contacting a primary dental care service at least once increased closer to 
the start of the referral period; b) the number and proportion of patients 
with non-routine contacts (more than one contact per six-month period) 
increased closer to the start of the referral period; and c) a larger 
proportion of the cohort underwent some form of examination and/or 
diagnostic procedure in the most recent six months prior to the start of the 
referral period (Y1H1) compared to the earlier six-month periods 
examined. 
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4.4.7 Route to diagnosis 
4.4.7.1  Service contacted last before the start of the referral period 
The last service contacted by patients with oral cancer before the start of 
the referral period was examined as a potential proxy for referral. The two 
most common services that were contacted were GP prescription (n=48% 
n=932) and hospital outpatient (22%, n=437), with only 16% (n=314) of the 
“referrals” appearing to have come from dental services (Table 4-10). 
While this was a very superficial exploration and there was no actual 
referral data available, the results seem to indicate that the route to 
diagnosis was largely from services other than dental. This chimes with the 
earlier findings that a large proportion of patients with oral cancer were 
not attending primary dental care services routinely.  
Table 4-10 Last service contacted before the start of the referral period 
 
Last service contacted Frequency Percent 
Hospital inpatient/day-case  279 14.22 
Hospital outpatient  437 22.27 
GP prescription 932 47.50 
Primary dental care 314 16.00 
 
4.4.7.2  Contacts made during the one-month referral period 
The referral period was defined as the 30-day period prior to diagnosis, 
and it was assumed that all contacts made during this period were part of 
the referral process. The vast majority of the patients (98%, n=1925) had 
made contact with at least one of the four services examined within the 
referral month, and the mean number of contacts was 3.5 (S.D 2.4) (Table 
4-11).  
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Of the 1925 patients with oral cancer who had contacted a service within 
the referral period, the majority had contacted hospital outpatient (86%, 
n=1685) and GP prescription (74%, n=1449) services (Table 4-11). In 
contrast, considerably smaller proportions had contacted primary dental 
care and hospital inpatient/day-case services (primary dental care: 13%, 
n=251; hospital inpatient/day-case: 33%, n= 644) (Table 4-11). The mean 
number of contacts was 0.3 (S.D 0.6) for hospital inpatient/day-case 
services, 1.1 (S.D 0.8) for hospital outpatient, 1.5 (S.D 1.4) for GP 
prescription, and 0.4 (S.D 1.6) for primary dental care services. 
Table 4-11: Ever/never and mean number of contacts with hospital outpatient, 
hospital inpatient/ day-case, primary dental care and GP prescription services during 
referral period 
 
 
Service 
Contact 
 
n (%) 
Minimum 
no. of 
contacts 
Maximum 
no. of 
contacts 
Mean 
no. of 
contacts 
Standard 
deviation 
All/Any service Ever 1925 (98.11)  
0 
 
17 
 
3.56 
 
2.42 
Never 37 (1.89) 
Hospital 
inpatient/ day-
case  
Ever 644 (32.82)  
0 
 
8 
 
0.38 
 
0.62 Never 1318 (67.18) 
Hospital 
outpatient  
Ever 1685 (85.88)  
0 
 
7 
 
1.19 
 
0.81 
Never 277 (14.12) 
GP 
prescription  
Ever 1449 (73.85)  
0 
 
9 
 
1.54 
 
1.46 
Never 513 (26.15) 
Primary dental 
care  
Ever 
Never 
251 (12.79) 
1711 (87.21) 
 
0 
 
15 
 
0.46 
 
1.61 
 
Further examination of the hospital inpatient/day-case and hospital 
outpatient specialties contacted during the referral period showed that the 
vast majority of the patients with oral cancer that were included in this 
study were visiting the ENT (hospital outpatient: 36%, hospital 
inpatient/day-case: 55%), Oral and Maxillofacial Surgery (hospital 
outpatient: 23%, hospital inpatient/day-case: 21%), and hospital outpatient 
General Surgery departments (33%) (Table 4-12).   
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Table 4-12: Hospital outpatient and hospital inpatient/day-case specialties contacted 
during referral period (30 days) 
 
Hospital outpatient 
specialty contacted N (%) 
Hospital inpatient/day-case 
specialty contacted 
 
N (%) 
Ear, nose & throat 609 (36.14) Ear, nose & throat 356 (55.28) 
General surgery 564 (33.47) Oral & maxillofacial surgery 136 (21.12) 
Oral surgery ** 395 (23.44) General medicine 53 (8.23) 
Oral medicine 27 (1.60) Oral surgery 44 (6.83) 
Clinical oncology 16 (0.95) General surgery 7 (1.09) 
Plastic surgery 12 (0.71) Plastic surgery 7 (1.09) 
Gastroenterology 8 (0.47) Clinical oncology 5 (0.78) 
Dermatology 7 (0.42) Geriatric medicine 5 (0.78) 
Haematology 7 (0.42) Cardiology 4 (0.62) 
Trauma & orthopaedics 6 (0.36) Ophthalmology 4 (0.62) 
Ophthalmology 5 (0.30) Respiratory medicine 3 (0.47) 
Urology 4 (0.24) Trauma & orthopaedics 3 (0.47) 
Endocrinology 3 (0.18) Gastroenterology 2 (0.31) 
General medicine 3 (0.18) GP without obstetrics 2 (0.31) 
General psychiatry 2 (0.12) Haematology 2 (0.31) 
Geriatric medicine 2 (0.12) Palliative medicine 2 (0.31) 
Gynaecology 2 (0.12) Acute medicine 1 (0.16) 
Medical oncology 2 (0.12) Anaesthetics 1 (0.16) 
Renal medicine 2 (0.12) Dermatology 1 (0.16) 
Restorative dentistry 2 (0.12) Infectious diseases 1 (0.16) 
Cardiology 1 (0.06) Paediatrics 1 (0.16) 
Clinical radiology 1 (0.06) Rehabilitation medicine 1 (0.16) 
Neurology 1 (0.06) Rheumatology 1 (0.16) 
Palliative medicine 1 (0.06) Urology 1 (0.16) 
Psychiatry of old age 1 (0.06) Vascular surgery 1 (0.16) 
Respiratory medicine 1 (0.06)   
Rheumatology 1 (0.06)   
** This includes Oral and Maxillofacial Surgery as, at the time of this study being 
conducted, outpatient Oral and Maxillofacial Surgery clinics were being mis-coded as 
"dental oral surgery" clinics (Wales, 2018). 
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4.4.7.3  Contacts made during the two-month referral period (sensitivity 
analysis) 
A preliminary sensitivity analysis was also undertaken where the referral 
period was increased to 60 days (“t–60 days”), and all hospital outpatient 
and hospital inpatient/day-case contacts made during this period were 
examined. The services contacted most frequently during the 60-day 
referral period were the same as those contacted during a 30-day referral 
period (ENT, oral and maxillofacial surgery, and general surgery).  
It was hypothesised that if the number and proportion of patients who had 
contacted these services over a 60-day referral period increased drastically 
from that observed in the 30-day referral period analysis, the additional 
patients would likely have made these contacts in the 30 days preceding 
the start of the 30-day referral period (t–30). However, the results showed 
that the number and proportion of patients with oral cancer contacting 
these services over a 60-day referral period did not differ drastically from 
the number that contacted these services over a 30-day referral period.  
To explain this further, the difference between the number of patients 
who contacted a hospital outpatient ENT service over a 60-day referral 
period and a 30-day referral period was only 22 (60–day referral period: n= 
631, 36%; 30–day referral period: n=609, 36%). Therefore, only 22 patients 
had contacted a hospital outpatient ENT in the 30 days preceding the start 
of the 30-day referral period, while 609 had contacted the same over the 
30-day referral period (“t-30 days”). Similar results were observed for the 
other services, with the additional number of patients that made contact 
in the 30 days preceding the start of the 30-day referral period being 0 for 
hospital inpatient/day-case ENT, three for hospital outpatient oral surgery, 
two for hospital inpatient/day-case oral surgery and so on.This suggests 
that a referral period of 30-days was a reasonable assumption as the 
results of the sensitivity analysis would have exhibited a greater increase 
in the number and proportion of patients contacting these services if 
patients had indeed been referred earlier (Table 4-13).  
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Table 4-13:  Sensitivity analysis - Hospital outpatient and hospital inpatient/day-case 
specialties contacted during referral period (60 days) ( 
 
** 
This includes Oral and Maxillofacial Surgery as, at the time of this study being conducted, 
outpatient Oral and Maxillofacial Surgery clinics were being mis-coded as "dental oral 
surgery" clinics (Wales, 2018). 
Hospital outpatient 
specialty contacted N (%) 
Hospital inpatient/day-case 
specialty contacted 
 
N (%) 
Ear, Nose & Throat 631 (36.31) Ear, Nose & Throat 356 (52.28) 
General surgery 576 (33.14) Oral & maxillofacial surgery 136 (19.97) 
Oral surgery ** 398 (22.90) General medicine 66 (9.69) 
Oral medicine 27 (1.55) Oral surgery 46 (6.75) 
Clinical Oncology 19 (1.09) General surgery 13 (1.91) 
Plastic surgery 12 (0.69) Geriatric medicine 7 (1.03) 
Dermatology 9 (0.52) Plastic surgery 7 (1.03) 
Haematology 9 (0.52) Cardiology 6 (0.88) 
Gastroenterology 8 (0.46) Gastroenterology 6 (0.88) 
Trauma & Orthopaedics 7 (0.40) Clinical oncology 5 (0.73) 
General medicine 5 (0.29) Ophthalmology 5 (0.73) 
Ophthalmology 5 (0.29) Respiratory medicine 4 (0.59) 
Endocrinology 4 (0.23) Trauma & orthopaedics 4 (0.59) 
Gynaecology 4 (0.23) GP without obstetrics 3 (0.44) 
Urology 4 (0.23) Acute medicine 2 (0.29) 
Cardiology 2 (0.12) Haematology 2 (0.29) 
General psychiatry 2 (0.12) Palliative medicine 2 (0.29) 
Geriatric medicine 2 (0.12) Urology 2 (0.29) 
Medical oncology 2 (0.12) Vascular surgery 2 (0.29) 
Renal medicine 2 (0.12) Anaesthetics 1 (0.15) 
Restorative dentistry 2 (0.12) Dermatology 1 (0.15) 
Clinical radiology 1 (0.06) Gynaecology 1 (0.15) 
Infectious diseases 1 (0.06) Infectious diseases 1 (0.15) 
Neurology 1 (0.06) Paediatrics 1 (0.15) 
Palliative medicine 1 (0.06) Rehabilitation medicine 1 (0.15) 
Psychiatry of old age 1 (0.06) Rheumatology 1 (0.15) 
Respiratory medicine 1 (0.06)   
Rheumatology 1 (0.06)   
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Table 4-14: Summary table- All service contacts over time of patients with oral cancer diagnosed between 2010-2012 (n=1962) 
Service 
contacted No. of contacts 
Contact by year 
 
Contact by six-month periods 
Contact during 
referral period 
Year— 2 Year—1  Y2H2 Y2H1 Y1H2 Y1H1 t-30 days 
 
 
All/Any 
Service 
contacts 
Never n (%) 
Ever n (%) 
Min. no of contacts 
Max. no. of contacts 
Mean no. of contacts 
STD 
274 (13.97) 
1688 (86.03) 
0 
90.00 
10.90 
11.78 
143 (7.29) 
1819 (92.71) 
0 
108.00 
16.96 
14.40 
 503 (25.64) 
1459 (74.36) 
0 
48.00 
5.00 
6.12 
388 (19.78) 
1574 (80.22) 
0 
45.00 
5.89 
6.38 
270 (13.76) 
1692 (86.24) 
0 
41.00 
7.00 
6.64 
184 (9.38) 
1778 (90.62) 
0 
51.00 
8.02 
6.91 
37 (1.89) 
1925 (98.11) 
0 
17.00 
3.56 
2.42 
 
 
Hospital 
inpatient/ 
day-case 
service 
contacts 
Never n (%) 
Ever n (%) 
Min. 
Max. 
Mean  
STD 
1505 (76.71) 
457 (23.29) 
0 
19.00 
0.49 
1.29 
1468 (74.82) 
494 (25.18) 
0 
30.00 
0.57 
1.56 
1691 (86.19) 
271 (13.81) 
0 
28.00 
0.74 
1.68 
1700 (86.65) 
262 (13.35) 
0 
29.00 
0.73 
1.61 
1674 (85.32) 
288 (14.68) 
0 
26.00 
0.77 
1.64 
1631 (88.13) 
331 (16.87) 
0 
27.00 
0.97 
1.92 
1325 (67.53) 
637 (32.47) 
0 
8.00 
0.38 
0.62 
 
Hospital 
outpatient 
service 
contacts 
Never n (%) 
Ever n (%) 
Min. 
Max. 
Mean  
STD 
1103 (56.22) 
859 (43.78) 
0 
57.00 
1.46 
2.95 
973 (49.59) 
989 (50.41) 
0 
53.00 
1.74 
3.13 
1328 (67.69) 
634 (32.31) 
0 
19.00 
0.25 
0.85 
1325 (67.53) 
637 (32.47) 
0 
11.00 
0.24 
0.81 
1293 (65.90) 
669 (34.10) 
0 
17.00 
0.28 
0.96 
1181 (60.19) 
781 (39.81) 
0 
13.00 
0.29 
0.83 
277 (14.12) 
1685 (85.88) 
0 
7.00 
1.19 
0.81 
 
 
GP 
prescription 
service 
contacts 
Never n (%) 
Ever n (%) 
Min. 
Max. 
Mean  
STD 
539 (27.47) 
1423 (72.53) 
0 
72.00 
8.36 
10.06 
224 (11.42) 
1738 (88.58) 
0 
73.00 
12.04 
10.97 
849 (43.27) 
1113 (56.73) 
0 
36.00 
3.72 
5.22 
609 (31.04) 
1353 (68.96) 
0  
41.00 
4.64 
5.44 
381 (19.42) 
1581 (80.58) 
0 
37.00 
5.65 
5.57 
299 (15.24) 
1663 (84.76) 
0 
42.00 
6.39 
5.86 
527 (26.86) 
1435 (73.14) 
0 
9.00 
1.54 
1.46 
 
 
Primary 
dental care 
service 
contacts 
Never N (%) 
Ever N (%) 
Min. no of contacts 
Max. no. of contacts 
Mean no. of contacts 
STD 
1338 (68.20) 
624 (31.80) 
0 
9.00 
0.58 
1.04 
1344 (68.50) 
618 (31.50) 
0 
49.00 
2.61 
5.98 
 1515 (77.22) 
447 (22.78) 
0 
6.00 
0.29 
0.60 
1510 (76.96) 
452 (23.04) 
0 
6.00 
0.29 
0.61 
1483 (75.59) 
479 (24.41) 
0 
4.00 
0.30 
0.59 
1396 (71.15) 
566 (28.85) 
0 
5.00 
0.37 
0.67 
1711 (87.21) 
251 (12.79) 
0 
15.00 
0.46 
1.61 
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4.5 Discussion 
4.5.1 Key points, comparison with other work, and potential 
explanations 
This study attempted to identify potentially missed opportunities for early 
detection of oral cancer by examining how patients made contact with 
healthcare services in the two years preceding referral using routine 
administrative linked data. It also included an exploratory analysis of the routes 
to diagnosis of oral cancer during the one-month referral period. This section 
summarises some of the key findings of this study, compares it to existing 
evidence, and draws together previous literature to discuss possible explanations 
for the results observed. 
The findings of this study showed that nearly all of the patients (95%) had 
contacted at least one of the four services (hospital inpatient/day-case, hospital 
outpatient, primary dental care, GP prescription) in the two years prior to the 
start of the referral period. These results were corroborated by Ligier et al. 
(2016) who reported that 88% of the patients with head and neck cancer (n=342) 
from a high-incidence region in France included in their study had contacted a 
health professional (GP, dentist, ENT specialist, non-ENT specialist) at least once 
in the two to 12-month period preceding diagnosis. However, under half (45%) of 
the patients with oral cancer that were included in the current study had 
contacted a primary dental care service in the two years preceding the start of 
the referral period. These results were in agreement with several other studies 
conducted in France, The Netherlands, and Western Australia that also reported 
poor dental attendance patterns in the majority of patients with head and neck 
cancer, oral cancer, and oropharyngeal cancer (Tromp et al., 2005; Frydrych and 
Slack-Smith, 2011). Ligier et al. (2016) also reported similar results, with 
approximately 80% of patients with head and neck cancer (n=342; defined as 
including the anatomic subsites oral cavity, oropharynx, hypopharynx, and 
larynx) that were included in their study showing no evidence of having 
consulted a dentist in the two to twelve months prior to diagnosis. Examination 
of the profile of patients with no primary dental care service contact in the two 
years prior to the start of the referral period showed that the majority of them 
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were males, aged above 45 years, and from the most deprived areas of Scotland, 
and this was in keeping with the “inverse screening law”, proposed by Netuveli 
et al. (2006), which stated that “high-risk” individuals were less likely to attend 
healthcare practices frequently enough to benefit from early detection efforts.  
These results suggest that there are potential opportunities for early detection 
of oral cancer, but they do not all lie within primary dental care services. This 
study looked at novel contacts for early detection of oral cancer in 
hospital/secondary care settings (both hospital inpatient/day-case and hospital 
outpatient), but found limited evidence of it. However, it did identify 
considerable potential in other primary care settings, particularly the GP and 
pharmacy, with 89% of patients with oral cancer that were included in this study 
being issued a GP prescription in the most recent year prior to the start of the 
referral period. Although a large proportion of these were likely to be repeat 
prescriptions, almost all of them would have been dispensed at the pharmacy. 
Therefore, pharmacists may have a role to play in the early detection of oral 
cancer as they are in an ideal position to provide smoking and alcohol cessation 
advice; increase awareness regarding the signs, symptoms, and risk factors of 
oral cancer; and refer patients exhibiting the warning signs of oral cancer (e.g. 
persistent mouth lesions that have not healed with medication) to a dentist in a 
timely fashion (Weinberg, 2006). However, there is also a possibility that some 
of these dispensing contacts did not involve actual face-to-face contact between 
the pharmacist and the patient (e.g where the prescriptions were delivered to 
the patient’s home), and this would eliminate any opportunities for early 
detection in GP or pharmacy settings altogether. Future studies exploring 
dispensing contacts in further detail should take this into consideration when 
interpreting results.  
The proportion of patients contacting each of the four services increased over 
the two -year period prior to the start of the referral period, irrespective of the 
service. The mean number of contacts with each of these services also exhibited 
an upward trend, although the differences between the individual years had 
more clinical significance than those between the six-month periods. The 
frequency of primary dental care service contacts (mean difference in number of 
contacts between Year-1 and Year-2: 2 contacts) and GP prescription contacts 
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(mean difference in number of contacts between Year-1 and Year-2: 3.6 
contacts) appeared to have significantly increased in the most recent year prior 
to the start of the referral period compared to the previous year. When 
examined by six-month periods, the differences in the number of hospital 
outpatient, hospital inpatient/day-case, and primary dental care service 
contacts, although statistically significant, were consistently less than one and 
therefore unlikely to have any clinical significance. The only noteworthy 
difference was in the number of GP prescriptions issued in the most recent six 
months before the start of the referral period, compared to the six-month 
period furthest away from the start of the referral period (mean difference in 
number of GP prescriptions issued: 2.6). Therefore, not only were more patients 
contacting these services closer to the start of the referral period, their 
frequency of contact, particularly with the primary dental care and GP 
prescription services, had also increased.  
This study considered two contacts with dental services per year to be “routine” 
in accordance with The Statement of Dental Remuneration, which is the primary 
dental care contract that permits a dentist to make only one examination claim 
every six months (NHS Scotland, 2017b). Of those who had contacted a primary 
dental care service (n=876), 52% (n=456) had made an unusual number of 
contacts (exceeding “routine”, that is, two contacts per year) in the most recent 
year prior to the start of the referral period, and 41% (n=363) of these contacts 
were for examination and diagnostic purposes. When considering the most 
recent six-month period prior to the start of the referral period, 51% (n=451) had 
made at least one contact with a primary dental care service, of which 43% 
(n=378) were for examination and diagnosis purposes. Moreover, 13% (n=115) had 
made more than one contact, of which 9% (n=76) were associated with 
examination and diagnostic procedures. Finally, the proportion of patients 
making an unusual number of contacts, particularly for examination and 
diagnosis purposes, exhibited an upward trend throughout the examination 
period. Therefore, not only were the patients with oral cancer that were 
included in this study contacting primary dental care services more frequently 
closer to the start of the referral period, they were also undergoing examination 
and diagnostic procedures at these visits.  
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Lyratzopoulos et al. (2015) previously reported that unusual pre-referral health 
service contacts could be indicative of missed opportunities for early diagnosis of 
cancer in at least some of the cases. Several other studies (Christensen et al., 
2012; Lyratzopoulos et al., 2012; Ahrensberg et al., 2013; Hansen et al., 2015) 
have also previously used unusual pre-referral consultation patterns as a 
“surrogate marker” for missed opportunities for early diagnosis and as an 
indicator of patient experience. Based on this, and given that oral cancer is 
frequently preceded by potentially malignant disorders (van der Waal, 2009), 
the increasing frequency of pre-referral contacts with health services that was 
observed in this study could represent missed opportunities for early detection, 
appointments with potential oral cancer concerns, or potential further 
opportunities for earlier detection and referral. 
Lastly, a superficial exploration of contacts made just before and during the 
one-month referral period was also undertaken as a proxy for the routes to 
diagnosis of patients with oral cancer. The two most common services that were 
contacted last before the start of the referral period were GP prescription and 
hospital outpatient. Although not definitive, there was a possibility that these 
consultations were the sources of referral, suggesting that the majority of 
patients with oral cancer that were included in this study were referred by GPs 
or were emergency presentations, and only 16% of them had been referred by a 
dentist. This was in keeping with the study conducted by Elliss-Brookes et al. 
(2012) where they examined the “Routes to Diagnosis” of cancer in England and 
reported that the most common ones were “Emergency” and “GP referrals”. 
Another study conducted in Ireland reported that 19% of oral cancer referrals 
came from hospital sources and only one in six patients were referred by a 
dentist (O’Sullivan, 2001). Although the numbers observed in the current study 
were slightly higher (approximately 36% from hospital sources and 16% from 
dentists), the overall implication that the majority of the referrals were coming 
from hospitals and the contribution of dentists was minimal in comparison 
remained the same.  
The vast majority (98%) of the patients that were included in the current study 
had contacted at least one of the four services during the one-month referral 
period, and the most commonly contacted services were hospital outpatient and 
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GP prescription. In comparison, very few patients had consulted primary dental 
care or hospital inpatient/day-case admission services during the same period. 
Moreover, the hospital outpatient and hospital inpatient/ day-case specialties 
that were contacted most frequently within this one-month referral period were 
ENT, general surgery, and oral and maxillofacial surgery, suggesting that, as 
suspected, these contacts were likely to be already associated with the 
symptoms and signs of oral cancer. There was also a possibility of the hospital 
outpatient service being the referral destination for a large proportion of the 
patients included in this study. These results were in agreement with those of 
Ligier et al. (2016) who also reported that ENTs were the most common 
specialists consulted by patients with head and neck cancer post-referral. 
4.5.2 Strengths and limitations 
The main strength of this study lay in the use of big, high-quality, robust, 
routinely collected national data that allowed examination of a population 
representative cohort spanning several years. These data were readily available. 
The Scottish Cancer Registry has high levels of completeness of data (96% for 
patient information and 96% for tumour information in 2016) (UKIACR, 2017). 
Additionally, 85% of the patients registered on SMR06 are confirmed 
microscopically and only 2% are Death Certificate Only registrations (Parkin et 
al., 2005; UKIACR, 2017). There was also considerable evidence on the high, and 
continually developing, levels of case-ascertainment (Brewster et al., 1994; 
Brewster et al., 1997; Brewster et al., 2002). The hospital inpatient/day-case 
database has an accuracy rate of 88% and 94% for main condition and main 
operation/procedure, respectively. With regard to the prescription database, 
95% of the records on PIS at the end of 2014 included unique identifiers that 
allowed it to be easily linked to other datasets. Rigorous quality checks are 
executed on the raw data before they are submitted to the prescription 
database and made publicly available, and it was reported to have high-levels of 
completeness with regard to individual-level data, although this was found to be 
influenced by the type of health care practitioner (Alvarez-Madrazo et al., 
2016). 
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The presence of unique identifiers in the various databases permitted data 
linkage which, in turn, allowed examination of the medical consultation histories 
of patients over a period of several years. The quality of data linkage in Scotland 
is quite high, and Kendrick and Clarke (1993) reported that clerical monitoring 
of pair-wise linking showed that the false negative rates (the proportion of pairs 
which the system fails to link) and the false positive rates (the proportion of 
pairs which are incorrectly linked) were both approximately three percent. The 
use of data linkage lowered the risk of selection bias, allowed access to detailed 
longitudinal trajectories that permitted testing of various novel hypotheses, and 
was cost-effective. The advantages and disadvantages of data linkage have been 
discussed in detail in Chapter 5. 
The limitations of this study are mainly related to the individual databases and 
the restrictions imposed by the unavailability of data. The first main limitation 
was the lack of availability of general practitioner data in Scotland. This study 
used prescriptions issued by GPs as a proxy for GP contact. However, there is a 
possibility that at least some of these would have been repeat prescriptions 
which would not require face-to-face contact with a general practitioner. Harris 
and Dajda (1996) first examined the scale of repeat prescribing using data from 
115 practices identified from the IMS MediPlus database over a period of one 
year. They reported that repeat prescriptions accounted for 75% of all 
prescriptions issued, and approximately 48% of all patients that were included in 
their study (n= 750,390) had been issued a repeat prescription. Moreover, the 
percentage of repeat prescriptions were seen to increase with age. More 
recently, in their cross-sectional study examining repeat prescriptions issued by 
29 general practices in one Primary Care Trust in England, Petty et al. (2014) 
reported that approximately 77% of all prescriptions issued in 2011 were repeat 
prescriptions, with the mean number of repeat items per individual being 1.87. 
Moreover, approximately 43% of the population in the United Kingdom had 
received at least one repeat prescription in the year of study. The authors stated 
that their results were largely “typical of the UK” as their study included both 
small and large practices that covered a wide socioeconomic and cultural range 
of population. Although the proportion of repeat prescriptions issued in Scotland 
is currently not measured, personal communication with the principle 
pharmacist at the Information Services Division Scotland, revealed that the 
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generally accepted assumption was that approximately 80% of all prescriptions 
issued in Scotland were repeat prescriptions (McTaggart, 2018). Therefore, this 
must be taken into consideration when interpreting the results of this thesis as it 
may have led to an overestimation of contacts with general practitioners.  
The Prescribing Information System (PIS) database has several limitations of its 
own. In 2009, the PIS database achieved 87% completeness with regard to 
patient identifiers. However, this number fell to only 68% in 2008 and continued 
to decrease up to less than 1% in 2003 (Alvarez-Madrazo et al., 2016). It was 
therefore recommended that longitudinal studies requiring individual-level 
prescription data, such as the current one, should only go as far back as 2009 
(Alvarez-Madrazo et al., 2016). This meant that information on “GP contacts” 
was only available for a period of one year before diagnosis for patients that 
were diagnosed in 2010. This may have biased the results slightly as the duration 
examined did not remain the same for all of the patients that were included in 
the study. Another limitation was that this database does not record the 
diagnosis or indication for prescription, and this information would have allowed 
us to ascertain whether or not the contacts were cancer-related. No detailed 
examination of the medications prescribed to the patients was undertaken as 
this would require expertise in bioinformatics, even for such a small cohort, and 
was therefore considered to be beyond the scope of this thesis. Further analysis 
in this area would have provided a clearer picture of the health care contacts 
that were cancer-related. Lastly, the PIS database also does not flag repeat 
prescriptions, making it impossible to decipher if the prescriptions issued by 
general practitioners were one-off or a part of a course of treatment. Although 
examination of the items and dates prescribed would have allowed identification 
of repeat prescriptions, this was considered to be beyond the scope of this 
thesis.  
As mentioned earlier, small numbers prevented examination of pre-referral 
health service contacts of patients with oral cancer by individual subsites (oral 
cavity cancer and oropharyngeal cancer). This limited the researcher from 
teasing out any differences in opportunities for early detection by subsite, which 
would have been useful from an epidemiological and primary prevention 
perspective. However, dentists have a role in the early detection of both sites, 
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and most guidelines for detection of cancer consider the two subsites together 
as oral cancer as their signs and symptoms overlap considerably (hoarseness of 
voice, lump in the neck, problem swallowing, lumps or ulcers in the mouth) 
(Kreimer, 2014; NICE, 2015a; NHS Scotland). Therefore, from an early detection 
perspective, combining the two subsites and examining them as “oral cancer” 
appeared to be more appropriate.  
The Management Information and Dental Accounting System only provides 
information on treatments undertaken, with no record of the diagnosis or 
indication for the same. Once again, this information would have allowed us to 
determine whether the contacts with primary dental care services were cancer-
related. Another limitation of the MIDAS database was that it only provided 
access to records of patients registered with a General Dental Practitioner 
(registration rate less than 80% in 2012), and patients attending private dental 
practices were excluded. This may have resulted in an underestimation of the 
number of contacts with a primary dental care service.  
Furthermore, this study used the “start date of treatment” variable as an 
indicator of contact with a dental service. This was a conservative measure of 
“contact” because while many of the “end date of treatment” were on the same 
date as the “start date of treatment” (n=1380, 70%), a good number (n=582, 
30%) of treatment courses would have been spread over several weeks and even 
months. Similarly, the “admission date” variable was used as an indicator of 
contact with hospital inpatient/ day-case services, and contacts over the period 
between “admission date” and “discharge date” were not considered. This may 
have resulted in an underestimation of the number of contacts made with health 
care services.  
Additionally, there was no information on the stage of cancer at the time of 
diagnosis, and this would have helped develop a better understanding of the 
impact of missed opportunities for early detection/diagnosis. Moreover, referral 
data was also not available and this information would have permitted 
elucidation of the “routes to diagnosis”. There was also limited information on 
the nature of the contacts with health care services, particularly hospital and GP 
contacts. Although the patient may have been present at the service, there was 
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a possibility that the reason for contact was unrelated to the diagnosis of cancer 
and, therefore, examination of the oral cavity was unnecessary. This may have 
resulted in an overestimation of the opportunities for early detection.  
Lastly, Bohensky et al. (2010) undertook a structured narrative review of factors 
that affected the quality of data linkage as these may introduce systemic bias in 
the outcomes reported. They found that several elements including age, sex, 
race, setting, health and socioeconomic status were associated with a risk of 
incomplete data linkage, although the evidence on the association between 
some of these factors and the probability of incomplete linkage occurring was 
inconsistent. The authors categorised the various reasons for incomplete linkage 
occurring into three broad groups, namely: governance issues such as the need 
for consent, method of linkage employed, and accuracy and completeness of the 
original datasets used for linkage. Additionally, factors such as a lack of a 
standardised definition for data or inconsistencies in coding practices may 
further complicate matters. These factors may introduce a certain level of bias 
in the results of the study and, therefore, must be kept in mind when 
interpreting outcomes. The authors developed a framework to aid researchers in 
reporting data linkage studies, and this tool was used as a guide during the 
formulation of this thesis. The main goals of this framework were to attain a 
certain level of consistency in the reporting of data linkage studies, create an 
awareness of the limitations of such studies among clinicians and policy-makers, 
and assist them in interpreting the outcomes while bearing the potential for bias 
in mind.  
4.6 Conclusion  
In conclusion, although dentists are in an ideal position to detect oral cancer 
early, the reality is that the majority of the patients simply do not consult 
dentists frequently enough to permit this. Therefore, there is a need to focus on 
motivating individuals, particularly those from the most socioeconomically 
deprived areas, to attend dental practices more frequently. Moreover, the 
results of this study suggested that there were opportunities for early detection 
of oral cancer in alternative healthcare services such as GPs and pharmacies, 
and early detection strategies should target these settings in the future. 
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5  Discussion 
5.1  Introduction 
This final chapter of the thesis summarises the principle findings of the three 
studies that were undertaken (Chapter 2-4), highlights the contributions to 
the literature by comparing the results to existing work, and discusses the 
results in the context of the thesis hypotheses. It then draws on existing 
literature, some of which has been reviewed previously in Chapter 1, to 
discuss possible explanations for the findings; recognises some of the 
methodological strengths and limitations of the study; discusses some of the 
further work that can be undertaken; and finally makes recommendations that 
are based on the results observed. 
5.2 Summary of results, contributions to the literature, 
and fulfilment of study hypotheses 
The overarching aim of this thesis was to identify opportunities for early 
detection of oral cancer in Scotland by: a) examining the incidence burden 
and sociodemographic profile of patients with head and neck cancer in 
Scotland by individual subsite; b) investigating whether early detection of oral 
cancer in dental settings was a realistic expectation, given the current burden 
and sociodemographic risk profile of the disease and the location and 
distribution of general dental practices; and c) identifying any potentially 
missed opportunities for early detection of oral cancer in dental and 
alternative healthcare settings. This section first summarises the principle 
findings of the thesis, highlights the contributions to the literature, and finally 
discusses the results in the context of the individual study hypotheses.  
5.2.1 Summary of the results and contributions to the literature 
5.2.1.1 Summary of the results  
Chapter 2 of this thesis, a different version of which was published in Oral 
Oncology in 2016 (Purkayastha et al., 2016), was the first national descriptive 
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epidemiological study to use routine administrative data to examine the 
incidence trends of head and neck cancer in Scotland between 1975 and 2012 
by individual subsites and various sociodemographic determinants. Although 
the original plan for this study was to examine the trends for the United 
Kingdom as a whole, the results for England were examined and published by 
colleagues in London and Birmingham (Louie et al., 2015) while the current 
study was still in the process of discussing and sequencing the UK-wide Cancer 
Registry data from the National Cancer Intelligence Network. Moreover, 
analysis by area-based socioeconomic deprivation across the UK also proved to 
be difficult due to the lack of availability of a uniform measure of deprivation 
(i.e. the Scottish Index of Multiple Deprivation and the English and Welsh 
Indices of Multiple Deprivation were not standardised). Therefore, a decision 
was made to focus on the trends of head and neck cancer over time by various 
subsites and sociodemographic characteristics in Scotland exclusively. The 
literature review presented in Chapter 1 first resolved some of the issues 
around the definitions of oral cavity cancer and oropharyngeal cancer and 
clarified distinct groupings of ICD-10 codes for this study as this was essential 
for understanding the burden of head and neck cancer by subsite. Analysis of 
incidence trends over time showed that the rates of head and neck cancer had 
risen between 1975 and 2012, and that this appeared to be largely driven by a 
dramatic increase in the rates of oropharyngeal cancer. Moreover, this burden 
of incidence was expected to continue to rise up to 2025, with the rates of 
oropharyngeal cancer surpassing the rates of oral cavity cancer, which was 
expected to exhibit only a modest increase. Males, patients above 60 years of 
age, and those from the most deprived areas of Scotland consistently 
exhibited the highest incidence rates of cancer, irrespective of subsite. 
Moreover, a dose-effect relationship between the incidence burden and 
deprivation was seen to exist, with the risk of developing cancer increasing as 
the level of deprivation increased. These results were in agreement with 
Louie et al. (2015) who also reported a rise in the incidence rates of head and 
neck cancer (1995-2011) that appeared to be driven by a dramatic increase in 
the burden of oropharyngeal cancer in England.  
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Chapter 3 was the first study to examine the feasibility of early detection of 
oral cancer, oral cavity cancer, and oropharyngeal cancer in dental settings, 
given the relatively low volume of the disease in Scotland. It examined the 
distribution of the incidence burden that was reported in Chapter 2 in relation 
to the location and socioeconomic status of general dental practices, and 
accurately estimated the proportion of patients that had contacted a primary 
care dentist in the two years preceding diagnosis. A different version of this 
chapter was submitted to the British Dental Journal for publication. The 
principle finding of this study was that just over half (approximately 54%) of 
the patients with oral cancer that were included in this study had made no 
contact with a dentist in the two years prior to diagnosis, thus automatically 
limiting opportunities for early detection in a dental setting. Application of 
published registration and participation (attendance) rates at NHS dental 
practices showed that a dentist would encounter one case of oral cancer 
every 8 years. However, application of the actual attendance rates that were 
calculated using data linkage showed that this number was more likely to be 
approximately one case of oral cancer every ten years. No socioeconomic 
inequality was observed in the number of patients with oral cancer a dentist 
could expect to see per year due to the relatively equal distribution of NHS 
dental practices in Scotland (Audit Scotland, 2012). 
Chapter 4 of this thesis explored potentially missed opportunities for early 
detection of oral cancer in primary dental care and other healthcare services, 
and undertook an initial exploratory analysis of the possible routes to 
diagnosis. The results showed that just under half of the patients had 
contacted a primary dental care service in the two years prior to the start of 
the referral period, but nearly all (95%) of them had contacted at least one of 
the four services examined (hospital outpatient, hospital inpatient/day-case, 
primary dental care, and GP prescription) over the same period. These results 
suggested that there were several potential opportunities for the early 
detection of oral cancer, but they were not necessarily within primary dental 
care services. Moreover, the proportions of patients contacting the four 
services increased closer to the start of the referral period, as did the mean 
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number of contacts made with each service. This implies that there was an 
existence of delays in the diagnostic process as any contact with the four 
services over the study period could be considered as a potentially missed 
opportunity for early detection of oral cancer. The two services that were 
most commonly contacted before the start of the referral period were GP 
prescription and hospital outpatient services. Although it was not that 
definitive, there was a possibility that these consultations were the sources of 
referral, suggesting that most of the patients with oral cancer that were 
included in this study were referred by GPs or via alternative routes as 
emergency presentations. Almost all of the patients (98%) had contacted at 
least one of the four services during the one-month referral period, and the 
most commonly contacted services were GP prescription and hospital 
outpatient. In comparison, very few patients had consulted primary dental 
care or hospital inpatient/day-case services during the same period. The 
hospital outpatient specialties most commonly contacted were ENT, oral 
surgery, oral and maxillofacial surgery, and general surgery, confirming that 
these consultations within the one-month referral period were indeed cancer-
related. 
5.2.1.2  Contributions to the literature 
As discussed previously in Chapter 1, the World Health Organisation’s Cancer 
Control: Knowledge into Action, WHO Guide for Effective Programs was a six-
part series that provided practical advice for policy-makers and programme 
managers on ways to plan and implement cancer control programs effectively 
(WHO, 2017b). This report suggested three key steps to developing a 
successful cancer control program, and made recommendations with regard to 
actions that would help accomplish them. These have been discussed in detail 
previously in Chapter 1, and this section will only consider the specific action 
recommendations that are relevant to this thesis. 
The first recommended step of planning an effective cancer control program 
was answering the question “where are we now?” by conducting a “situation 
analysis”. This included assessment of a) the burden of cancer amenable to 
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early detection, and b) the existing early detection plan and current 
population coverage of services. The findings presented in Chapters 2 and 3 
contributed to a “situation analysis” of early detection of oral cancer in 
Scotland by a) exploring the incidence rates of head and neck cancer over 
time by subsite, thus identifying the burden of cancer amenable to early 
detection, and b) examining the distribution of this burden in relation to the 
location of general dental practices, hence clarifying the population coverage 
of current dental services in Scotland. 
The second recommended step of building an effective cancer control 
program was answering the question “where do we want to be?”. The WHO 
suggested several actions that would help answer this question, and the ones 
that were most relevant to this thesis were a) identification of the target 
population for early detection of cancer, b) assessment of feasibility of early 
detection interventions, c) identification of gaps in early detection services, 
and d) choosing between early diagnosis and screening approaches.  
The descriptive epidemiological study presented in Chapter 2 assessed the risk 
profile of oral cancer in Scotland and found that males, patients above 60 
years of age, and those from the most deprived areas consistently exhibited 
the highest incidence burden and, therefore, also represented the target 
“high-risk” population for early detection efforts. Moreover, the estimation of 
the proportion of patients with oral cancer that had contacted a general 
dental practice in the two years prior to the start of the referral period 
(Chapter 3) showed that there was a section of the population that simply did 
not contact GDPs on a regular basis and, therefore, required further targeted 
efforts that provided additional support and motivation. Chapter 3 of this 
thesis examined the feasibility of early detection of oral cancer in primary 
dental care services by exploring the distribution of the incidence burden in 
relation to the location and socioeconomic status of general dental practices 
in Scotland, and also calculating the number of patients with oral cancer that 
a dentist could expect to see per year. Finally, Chapter 4 contributed to the 
identification of gaps in early detection services by showing that patients with 
oral cancer exhibited increasing frequency of consultations with healthcare 
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services prior to referral, indicating poor patient experience and avoidable 
delays in the diagnostic process (Lyratzopoulos et al., 2012). Moreover, the 
findings of this study also contributed to Step 2 (d) to a certain extent by 
examining potentially missed opportunities for early detection of oral cancer 
over a period of two years prior to referral. Consideration of this extended 
period of time meant that these opportunities could be suitable for either 
screening or early diagnosis based on when they occurred. In other words, 
contacts further away from referral could be considered as potential 
opportunities for opportunistic screening, while those closer to referral could 
be considered as missed opportunities for early diagnosis as patients would 
probably have started exhibiting the signs and symptoms of oral cancer by 
then.  
Therefore, the findings of this thesis showed that although the rates of oral 
cancer are rising in Scotland, early detection in primary dental care services 
may not be entirely feasible given the relatively low overall incidence burden 
in Scotland and the large proportion of patients that do not contact a general 
dental practitioner on a regular basis. However, there do seem to be 
opportunities for early detection of oral cancer in alternative healthcare 
settings, with nearly all of the patients having contacted one of the four 
services examined (hospital outpatient, hospital inpatient/ day-case, primary 
dental care, and GP prescription) in the two years prior to the start of the 
referral period and the majority of the referrals appearing to have come from 
hospital outpatient or GP prescription services. Lastly, the increasing 
frequency of contacts with these services nearer to the start of the referral 
period suggest that there were avoidable delays in the diagnostic process, and 
minimising these could contribute towards the improvement of early 
detection of oral cancer.  
5.2.2 Thesis hypotheses 
This section discusses the results of this thesis in the context of the individual 
study hypotheses. The overarching aim of this thesis was to investigate 
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opportunities for early detection of oral cancer in Scotland. The hypotheses 
for the individual studies have been listed below.  
Chapter 2 hypothesis (a): The trends of head and neck cancer are increasing 
and are projected to continue to do so.  
Chapter 2 hypothesis (b): This increase in incidence rates of head and neck 
cancer will largely be driven by an increase in the rates of oropharyngeal 
cancer. 
Chapter 2 hypothesis (c): The patient profile of oropharyngeal cancer will 
differ from other subsites, particularly in relation to socioeconomic status. 
Chapter 2 hypothesis (d): In relation to the socioeconomic distribution of 
head and neck cancer, there will be a clear stratification of “high-risk” areas 
in the more deprived communities that could be utilised to target early 
detection initiatives. 
Chapter 3 hypothesis (a): The number of patients with oral cancer (oral 
cavity cancer and oropharyngeal cancer) a general dental practitioner in 
Scotland can expect to see will be low. 
Chapter 3 hypothesis (b): Dentists working in more deprived areas will 
expect to see a greater number of patients with oral cancer (oral cavity 
cancer and oropharyngeal cancer) compared to dentists working in relatively 
less deprived areas. 
Chapter 4 hypothesis (a) There are a number of potentially missed 
opportunities for early detection of oral cancer in dental and other healthcare 
services. 
Chapter 4 hypothesis (b) These potentially missed opportunities increase in 
frequency in the months directly prior to the start of the referral period.  
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5.2.2.1 Chapter 2 hypothesis (a): The trends of head and neck cancer are 
increasing and are projected to continue to do so.  
This hypothesis was confirmed by the results of Chapter 2 which showed that 
the incidence rates of head and neck cancer had risen between 1975 and 2012 
and were expected to continue to do so up to 2025. These findings were 
generally in agreement with the trends observed globally as well as more 
locally in the United Kingdom, and the literature review that has been 
presented in Chapter 1 has discussed some of this existing evidence in detail. 
Specifically, Louie et al. (2015) undertook a detailed cancer registry analysis 
in England and reported that the incidence rates of head and neck cancer had 
increased by 59% between 1995 and 2011, although they did not show any 
evidence of having examined the socioeconomic distribution of this burden. 
Similar trends were also observed in the current study in Scotland, although 
the increase observed over the same period (1995-2011) was lower at 
approximately 32%. 
5.2.2.2 Chapter 2 hypothesis (b): This increase in the incidence rates of 
head and neck cancer will largely be driven by an increase in the 
rates of oropharyngeal cancer. 
This hypothesis was also supported by the findings of Chapter 2. The increase 
in the incidence rates of head and neck cancer appeared to be largely driven 
by the rates of oropharyngeal cancer, which exhibited a dramatic rise 
between 1975 and 2012 (RR 3.45, 95% CI 2.66-4.48) and almost doubled 
between 2001 and 2012 (RR 1.85, 95% CI 1.53-2.25). These rates were also 
projected to continue to rise at a rapid rate up to 2025 and even surpass the 
rates of oral cavity cancer, which were expected to have only a relatively 
modest increase. 
Once again, these results were in general agreement with the previous global 
evidence discussed in the literature review in Chapter 1. More locally, similar 
results were observed in England where the increase in the incidence burden 
of head and neck cancer was largely driven by a rise in the rates of 
oropharyngeal cancer (Louie et al., 2015). The authors also predicted that the 
rates of oropharyngeal cancer would continue to increase up to 2025, and this 
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too was in agreement with the findings of the study presented in Chapter 2 of 
this thesis.  
5.2.2.3 Chapter 2 hypothesis (c): The patient profile of oropharyngeal 
cancer will differ from other subsites, particularly in relation to 
socioeconomic status. 
The current study demonstrated a gender and socioeconomic inequality in the 
incidence burden of head and neck cancer, with males and those from the 
most deprived areas of Scotland consistently exhibiting the highest rates of 
cancer, irrespective of subsite. Moreover, a dose-effect relationship was also 
seen, with the rates of cancer increasing as the level of deprivation increased.  
The risk profile of oropharyngeal cancer was very similar to this, with males 
and those from the most deprived areas consistently exhibiting the greatest 
incidence burden. The peak age of incidence of oropharyngeal cancer was 
slightly lower (5-10 years) than that of the other subsites examined in this 
thesis. These findings were in agreement with a previous retrospective 
analysis conducted in the United States (Gillison et al., 2012b) that also 
reported an increased burden of oropharyngeal cancer among males, as well 
as a brief presentation in Scotland which reported that this was the fastest 
increasing cancer (particularly in men) (Junor et al., 2010). Dahlstrom et al. 
(2015), in their study examining 356 patients that were diagnosed with 
oropharyngeal cancer at the University of Texas MD Anderson Cancer Centre, 
reported that the patients included in their study exhibited high levels of 
education, income, and overall socioeconomic status. This was in 
contradiction to the findings of this thesis which showed a socioeconomic 
inequality in the distribution of the incidence burden of oropharyngeal 
cancer, with those from the most deprived areas consistently exhibiting the 
highest incidence rates.  
Therefore, this hypothesis was rejected as, despite being slightly younger, the 
overall patient profile of oropharyngeal cancer did not differ considerably 
from the other subsites, particularly with regard to socioeconomic status. 
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5.2.2.4  Chapter 2 hypothesis (d): in relation to the socioeconomic 
distribution of head and neck cancer (oral cavity and 
oropharyngeal cancer), there will be a clear stratification of “high-
risk” areas in the more deprived communities that could be 
utilised to target early detection initiatives. 
This hypothesis was confirmed by the findings of Chapter 2 which showed that 
the most deprived areas of Scotland consistently exhibited the highest 
incidence rates of cancer, irrespective of subsite, thus representing “high-
risk” areas that could be utilised to target early detection efforts. 
Additionally, this socioeconomic inequality between the most and least 
deprived areas of Scotland exhibited a dose-effect relationship, with the rates 
of cancer rising as the levels of deprivation increased.  
These findings were in general agreement with the global evidence presented 
previously in Chapter 1. More locally, these results were corroborated by 
Conway et al. (2006), who also reported higher incidence rates of oral cancer 
in the most deprived areas of Scotland.  
5.2.2.5 Chapter 3 hypothesis (a): The number of patients with oral cancer 
(oral cavity cancer and oropharyngeal cancer) a general dental 
practitioner in Scotland can expect to see per year will be 
relatively low. 
This hypothesis was confirmed by the findings of Chapter 3 which showed that 
the number of patients with oral cancer (oral cavity and oropharyngeal 
cancer) a primary dental care practitioner in Scotland could expect to see per 
year was quite low. Upon application of published dental service registration 
and participation (attendance) rates, it was estimated that a primary dental 
care practitioner could expect to see one case of oral cancer every 8 years, 
one case of oral cavity cancer every 14 years, and one case of oropharyngeal 
cancer every 20 years. However, this study also used data linkage to calculate 
the actual proportion of patients that had contacted a general dental 
practitioner in the two years prior to diagnosis and, upon using these 
calculated attendance rates, the numbers were seen to increase to ten years 
for oral cancer, 17 years for oral cavity cancer, and 25 years for 
oropharyngeal cancer.  
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Although several studies had used this methodology previously to examine the 
distribution of childhood cancer and medical emergencies in relation to the 
location of health practitioners (Feltbower et al., 2004; Muller et al., 2008), 
there was only one other study that had focused on patients with oral cancer 
by undertaking a simple calculation of the headline distribution of the 
patients in relation to the number of dentists in England, Northern Ireland, 
and Wales (Ogden et al., 2015). The authors suggested that there would be 
one case of oral cancer for every ten dentists per year, and the current thesis 
reported similar, albeit slightly lower, numbers (using published rates), with 
one case of oral cancer for every 8 dentists per year. However, Ogden et al. 
(2015) did not provide any information on the definition of oral cancer used 
and the time period considered, and also did not take registration rates into 
consideration.  
5.2.2.6 Chapter 3 hypothesis (b): Dentists working in more deprived areas 
will expect to see a greater number of patients with oral cancer 
(oral cavity cancer and oropharyngeal cancer) compared to dentists 
working in relatively less deprived areas. 
This hypothesis was rejected as examination of the distribution of patients 
with oral cancer, oral cavity cancer, and oropharyngeal cancer in relation to 
the location of general dental practices in Scotland by deprivation showed no 
obvious patterns or relationships. This could partly be explained by the fact 
that although there are inequalities in access to NHS primary care services 
such as general medical practices in Scotland, the distribution of dental 
practices does not follow this pattern (Audit Scotland, 2012). Therefore, 
registration rates do not exhibit the typical skew of inequality, although 
participation (attendance) rates are lower in the more deprived communities 
(ISD Scotland, 2016b). As a result, this offsets the higher incidence rates of 
oral cancer in deprived areas as they are distributed among the higher number 
of dentists in these same deprived areas. 
No other studies could be identified to date that have examined the influence 
of socioeconomic status on the distribution of patients with oral cancer, oral 
cavity cancer, and oropharyngeal cancer in relation to the location of general 
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dental practices. Therefore, the findings reported in Chapter 3 were novel 
and could not be compared with any other studies.  
5.2.2.7 Chapter 4 hypothesis (a): There are a number of potentially missed 
opportunities for early detection of oral cancer in dental and other 
healthcare services. 
Chapter 4 showed that nearly all (95%) of the patients that were included in 
this study had contacted at least one of the four healthcare services examined 
(hospital outpatient, hospital inpatient/ day-case, primary dental care, and 
GP prescription) in the two years prior to the start of the referral period, 
while just under half (45%) had contacted a primary dental care service over 
the same period. This suggested that there were potential opportunities for 
early detection, but they were not all within primary dental care services. 
These results were, to a certain extent, in agreement with Ligier et al. (2016) 
who reported that 88% of the patients with head and neck cancer (n=342) 
from a high-incidence region in France included in their study had contacted a 
health professional (GP, dentist, ENT specialist, non-ENT specialist) at least 
once in the 2- to 12-month period preceding diagnosis, while the majority 
(80%) of them had not consulted a dentist over the same period.  
Chapter 4 also looked at novel contacts for early detection of oral cancer in 
hospital/secondary care settings (both hospital inpatient/ day-case and 
hospital outpatient), but found limited evidence of it. Instead, it identified 
considerable potential in other primary care settings, particularly GP and 
pharmacy, with 89% of patients with oral cancer that were included in this 
study being issued a GP prescription in the most recent year prior to the start 
of the referral period. Although a large proportion of these were likely to 
have been repeat prescription (Harris and Dajda, 1996; Petty et al., 2014), 
almost all of them would have been dispensed at the pharmacy. Therefore, 
there is a possibility that the pharmacy may have a role to play in the early 
detection of oral cancer, and this could be an interesting setting for further 
work.  
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Therefore, the findings of this study were in support of the hypothesis that 
there were numerous potentially missed opportunities for early detection of 
oral cancer in primary dental care as well as other healthcare settings. 
5.2.2.8 Chapter 4 hypothesis (b): These potentially missed opportunities 
increase in frequency in the months directly prior to the start of 
the referral period.  
This hypothesis was also confirmed by the findings of Chapter 4 which showed 
that the patients that were included in the current study had increased their 
frequency of contact with hospital outpatient, hospital inpatient/ day-case, 
primary dental care, and GP prescription services in the most recent year and, 
particularly, the most recent six months prior to the start of the referral 
period. Moreover, the proportion of patients contacting these services had 
also increased over the same time period. Lyratzopoulos et al. (2015) 
previously reported that unusual pre-referral health service contacts could be 
indicative of missed opportunities for early detection of cancer and, based on 
this logic, the increasing frequency of contacts with health services observed 
in this study could be interpreted as missed opportunities in at least some of 
the cases or as potential opportunities that can be harnessed for further early 
detection efforts.  
5.3 Interpretation of results and possible explanations 
This section discusses the interpretations of some of the major findings of this 
thesis, and uses the previous literature to draw conclusions regarding possible 
explanations. 
The descriptive epidemiological study presented in Chapter 2 of this thesis 
showed that the rates of head and neck cancer were rising in Scotland, and 
this appeared to be largely driven by a dramatic increase in the rates of 
oropharyngeal cancer between 1975 and 2012. Moreover, these rates were 
predicted to continue to rise up to 2025, with the rates of oropharyngeal 
cancer bypassing the rates of oral cavity cancer, which were expected to 
exhibit a more modest increase. These results were in keeping with Louie et 
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al. (2015) who reported that the increasing burden of head and neck cancer in 
England between 1995 and 2011 appeared to be largely driven by the 
incidence rates of oropharyngeal cancer. Moreover, they predicted that 
oropharyngeal cancer would account for one third of the projected burden of 
head and neck cancer by 2025. Human papilloma virus infections have been 
shown to play an aetiological role in oropharyngeal cancer (Gillison, 2004; 
D'Souza et al., 2009), and Hashibe and Sturgis (2013) proposed that the 
changing profile of head and neck cancer incidence could be explained by the 
controlling of a “tobacco epidemic while a human papillomavirus epidemic 
emerges”. This statement was supported by Louie et al. (2015) when they 
demonstrated that the increasing rates of oropharyngeal cancer were 
paralleled by a rise in sexually transmitted infections (used as a proxy for HPV 
infection in their study). They suggested that these results “highlighted 
changing sexual behaviours”, based on the evidence that HPV infections may 
be transmitted via oral sexual behaviours (Hemminki et al., 2000; D'Souza et 
al., 2009), and made an urgent call for primary prevention through 
administration of the HPV vaccine in males and females in England.  
Although many countries have exhibited a dramatic decrease in the rates of 
oral cavity cancer in the recent past (Chaturvedi et al., 2013), the results of 
this thesis showed an increase in incidence rates between 1975 and 2012 in 
Scotland. Similar escalating trends were also observed in the Netherlands, 
Brazil, and Denmark (Chaturvedi et al., 2013), as well as in England (Louie et 
al., 2015). However, this increase could not be attributed to smoking, based 
on the decreasing rates of lung cancer observed in England and Scotland (ISD 
Scotland, 2015; Louie et al., 2015), and the role of HPV in the aetiology of 
oral cavity cancer is still unclear (Hübbers and Akgül, 2015). Possible 
alternative explanations could be an increase in alcohol consumption, known 
to act synergistically with tobacco, in more recent birth cohorts (Franceschi 
et al., 2000; Chaturvedi et al., 2013); a greater prevalence of smokeless 
tobacco consumption among the growing South-Asian Community in Scotland 
(Herrero et al., 2003; Lambert et al., 2011; The Scottish Government, 2017a); 
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and the migration of populations from regions with high incidence of head and 
neck cancer (Warnakulasuriya et al., 1999; Mangtani et al., 2010). 
The differences in incidence rates between the sexes possibly reflected the 
greater prevalence of HPV infections and tobacco and alcohol consumption 
among men compared to women (IARC, 2007; ScotPHO, 2008; Chaturvedi et 
al., 2011; Gillison et al., 2012b; Hashibe and Sturgis, 2013). Although the 
difference in smoking rates between males and females in Scotland was quite 
low (22% in males vs 20% in females) (ScotPHO, 2015), the prevalence of 
hazardous drinking (defined by the Scottish Government as being over the 
recommended 14 units of alcohol per week) among males (36%) was more 
than double the rates observed in women (17%) (The Scottish Government, 
2015). A previous meta-analysis reported that males were more likely to 
indulge in “risky behaviours” such as smoking, drinking, and unprotected sex, 
and this gender gap in behavioural tendencies varied with age (Byrnes et al., 
1999). The authors explained these differences using three theoretical 
models. The first was the self-regulatory model proposed by Byrnes (1998) 
which suggested that the gender gap was a result of “double standards with 
respect to parenteral monitoring” that resulted in women and girls 
encountering greater restrictions while growing up, lack of knowledge 
regarding “self-correcting strategies” among men, and overconfidence among 
men and boys. The second biopsychosocial theory was proposed by Lipsitt and 
Mitnick (1991) and suggested that periodic changes in a number of factors 
such as self-perception, biological maturation, risk perceptions, personal 
values, cognitive scope, and perceptions of the social environment affected 
men and women in different ways and at different times, resulting in a gender 
gap that varied with age. The last theory was Wigfield and Eccles (1992) 
expectancy-value model which suggested that gender differences in behaviour 
were a result of variations in the expectations of men and women. However, 
Byrnes et al. (1999) clarified that they had isolated these three models to 
explain the gender differences in behavioural factors as they were the most 
relevant to the findings of their meta-analysis and, in reality, there were 
several other models that could also explain aspects of the gender gap.  
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The socioeconomic determinants of health inequalities have been a key focus 
of research over the last century. In the United Kingdom, evidence of a social 
pattern in disease distribution was first reported by Sir Douglas Black in the 
influential Black Report where he divided the British population into six social 
classes and reported that members of the lowest class exhibited mortality 
rates that were approximately double that exhibited by the highest social 
class (Black, 1982). Although this report had several limitations, it formed the 
foundation for a subsequent explosion of research in the field of 
socioeconomic determinants of health. Notably, the Whitehall study of British 
civil servants used grade of employment as a marker of socioeconomic status 
and reported a social gradient for all major causes of death (Marmot et al., 
1984). 
The WHO International Agency for Research on Cancer proposed that 
socioeconomic factors could affect inequalities in health through a number of 
pathways including access to medical care health selection, factors operating 
in early life, health-related behaviours, material factors, and psychosocial 
factors (Pearce, 1997). The epidemiological study of this thesis demonstrated 
a socioeconomic inequality in the distribution of head and neck cancer in 
Scotland, with the most deprived areas exhibiting higher rates of cancer 
compared to the least deprived areas, irrespective of the subsite considered. 
This socioeconomic gap could be explained to a certain extent by an 
inequality in the distribution of risk factors. The Whitehall study II (Marmot et 
al. 1991) demonstrated a clear link between socioeconomic position and 
several established behavioural and biological risk factors, with lower social 
classes consistently exhibiting higher prevalence of smoking, poor diet, 
obesity, and lack of physical activity. In keeping with this, the prevalence of 
smoking was seen to be much higher in the most deprived areas (36%) of 
Scotland compared to the least deprived areas (10%) in 2012 (ASH Scotland, 
2014). Moreover, the number of cigarettes smoked per day was also higher in 
the most deprived areas (15.3) compared to the least deprived areas of 
Scotland (12.6) (ASH Scotland, 2014). A similar inequality was also observed 
with regard to alcohol consumption, with the number of people (per 100,000) 
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being admitted to hospital for alcohol-related reasons being eight times 
higher in the most deprived areas compared to the least deprived areas (ISD 
Scotland, 2017l). A cross-sectional analysis examining the relationship 
between deprivation and alcohol and tobacco outlet density in Scotland 
reported that the most deprived areas had the greatest densities of both 
(Shortt et al., 2015), and this social gradient in the supply of tobacco and 
alcohol would likely be reflected in the consumption rates and, subsequently, 
the incidence rates of tobacco and alcohol related diseases. Moreover, 
previous studies have suggested that higher socioeconomic position may have 
resulted in a reinforcement of healthy behaviours such as maintenance of oral 
hygiene and regular physical exercise (Liberatos et al., 1988; Ross and Wu, 
1995), while education and higher-level occupations were often associated 
with better access to health services and reduced exposure to occupational 
risk factors of head and neck cancer (Riechelmann, 2002). With regard to HPV 
infections, a previous small clinical series conducted at the University of 
Texas MD Anderson Cancer Centre examined the socioeconomic characteristics 
of oropharyngeal cancer by HPV status and reported that patients with HPV-
positive oropharyngeal cancer usually exhibited higher levels of income and 
education (Dahlstrom et al., 2015). Moreover, within this group, non-smokers 
tended to have the highest socioeconomic status. Gillison et al. (2008), in 
their case-control analysis, reported that patients with HPV-negative head 
and neck cancer were more likely to have high school degrees and were also 
less likely to earn $50,000 or more compared to the cancer-free controls. 
However, neither of these studies considered population-level data, and 
instead focused on a very small sample of patients with oropharyngeal cancer. 
The findings of the current thesis contrasted with these studies, with the most 
deprived areas of Scotland exhibiting the highest rates of head and neck 
cancer irrespective of subsite. The dataset used did not contain information 
on HPV status and tobacco and alcohol consumption thereby preventing 
exploration of any variations in trends by risk factors in the Scottish context, 
and this could be an interesting setting for further work. 
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Another possible explanation for socioeconomic inequalities in health was the 
theory of health selection (Black, 1988), the essence of which was that health 
determined social position instead of vice versa. This selection could occur at 
different stages of life, and could be explained by one of the two following 
ideas: a) that the “sick drifted down the social hierarchy”, producing an 
accumulation of individuals at a higher risk of disease in the lower social 
groups, or b) where selection occurred at an earlier age between childhood 
and introduction to the labour market, that is, the health status in childhood 
ultimately determined the social status of an adult. Common background 
factors operating in early life may also lead to inequalities in health, and this 
was termed as ‘indirect selection’ (Wilkinson, 1986). These include genetic 
factors, early life experiences that led to biological changes, and various 
social, psychological, cultural and educational factors. Ben-Shlomo and Davey-
Smith (1991) stated that early life influences shaped the lives people led as 
adults and the social environments in which they existed, and these 
conditions, in turn, could be related to ill health. Lastly, psychosocial factors 
associated with job strain, low control, and low social support may also 
increase the risk of disease. For example, a perceived ‘lack of control over 
health’ among individuals in lower socioeconomic strata may have led to the 
adoption of health behaviours such as smoking or poor diet, which increased 
the risk of developing disease (Pearce, 1997).  
The descriptive epidemiological study (Chapter 2 of this thesis) was 
undertaken bearing secondary prevention of oral cancer in mind, with the 
focus on trends from a socioeconomic perspective aiming to identify target 
“high-risk” subgroups of the population for further early detection efforts. 
The two strategies for early detection, namely, screening and early diagnosis, 
have been discussed previously in Chapter 1. To reiterate, the goal of 
screening was to identify pre-cancerous lesions in an apparently healthy 
population, while that of early diagnosis was to detect the signs and 
symptoms of cancer in a timely manner so as to achieve diagnosis at an earlier 
stage when the prognosis was better (WHO, 2006). The overarching aim of this 
thesis was to identify opportunities for early detection of oral cancer in 
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various healthcare settings. However, the cohort for this study was identified 
based on a diagnosis of oral cancer, and this automatically biased the results 
in favour of opportunities for early diagnosis rather than screening. Given that 
the difference between the two strategies essentially lies in the clinical stage 
progression of the disease, there was a possibility that some of these 
healthcare service contacts occurred before the clinical signs and symptoms 
of oral cancer had become apparent, and further research with regard to 
OPMDs would help clarify whether these contacts could represent missed 
opportunities for opportunistic screening instead. Therefore, although 
interpretation of the opportunities identified in this thesis was not as 
straightforward as expected and screening and early diagnosis differ 
fundamentally in terms of logistics and resources (WHO, 2006), the findings 
did contribute towards identification of the subgroup of the population and 
the alternative healthcare services that could be utilised to target further 
early detection efforts. 
Dental health services are provided across a range of settings in Scotland, and 
the dental care team typically consists of dentists, dental nurses, hygienists, 
therapists, receptionists/managers, and dental technicians. The majority of 
general dental services are provided by general dental practitioners who are 
independent contractors that provide services on behalf of the various NHS 
Health Boards. Public Dental Service dentists are those that are employed by 
the NHS Health Boards, and their main function is to provide dental services 
to those with special care needs and those living in geographical areas where 
it may be difficult to access a general dental practitioner, while the Hospital 
Dental Services in Scotland accepts patient referrals from medical and dental 
practitioners and primarily provide secondary care services. Recently, the 
Scottish Government’s Oral Health Improvement Plan, published in January 
2018, set the direction for tackling oral health inequalities to reorientation of 
services from the simple oral health focus to a wider, more prevention-based 
approach (The Scottish Government, 2018). It also recommended community 
engagement and development activities, and specifically mentioned oral 
cancer risk assessment and preventive pathways. Early detection of oral 
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cancer in primary dental care services is largely dependent on patients 
consulting general dental practitioners on a regular basis, and the results of 
this thesis showed that a bulk of the patients with oral cancer in Scotland 
simply did not do so. There could be several possible explanations for this, 
some of which have been discussed previously in Chapter 1. Netuveli et al. 
(2006) in their study using data from the Health Survey for England (2001) and 
the British Household Panel Survey reported that the “inverse screening law” 
was applicable to patients with oral cancer, with those at the highest risk of 
developing cancer being the least likely to contact dental services on a 
regular basis. The authors suggested that this could be because “risk 
behaviours tend to cluster in the same individuals”, with heavy smokers and 
drinkers more likely to avoid risk-aversion behaviours such as regular dental 
attendance. Another possible explanation proposed was the role of 
psychological factors in a patient’s decision to seek help. Hackett et al. (1973) 
suggested that delay in seeking help was often a conscious and deliberate act 
on the part of the patient, and this was often fuelled by underlying 
psychosocial factors such as fear and perceptions of social accountability. 
Moreover, worry, though a complex variable, was seen to be inversely 
proportional to the duration of delay, with those worrying about a particular 
symptom often exhibiting reduced delay (Hackett et al., 1973). This was 
supported by a recent extensive review that examined the components and 
possible solutions for late stage diagnosis of oral cancer and found that factors 
such as fear, denial, worry, and perceptions of social responsibilities often 
caused patients to delay seeking medical help upon observing symptoms 
(Güneri and Epstein, 2014). Conversely, a considerably older study suggested 
that the most common determinant of delay was cancer knowledge 
(Antonovsky and Hartman, 1974), and this was corroborated by a case-series 
analysis in the Netherlands that used self-reported questionnaires to examine 
delays in seeking medical help and reported that patients were more likely to 
visit a healthcare provider sooner after self-discovery of symptoms if they had 
prior knowledge and a higher level of awareness of cancer (Tromp et al., 
2005).  
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This thesis also examined whether early detection of oral cancer in primary 
dental care services was a realistic expectation, given the relatively low 
incidence burden in Scotland. The results showed that the number of patients 
with oral cancer per dentist was very low, and a general dental practitioner in 
Scotland could expect to encounter only one patient with oral cancer every 
ten years or, in other words, only four patients over a career spanning 40 
years. Further exploration showed that this situation worsened if individual 
subsites were considered, with a general dental practitioner in Scotland 
expecting to see only one case of oral cavity cancer every 17 years and one 
case of oropharyngeal cancer every 25 years. However, these results do not 
intend to “over-burden” general dental practitioners in Scotland by creating 
an expectation for early detection of oral cavity cancer and oropharyngeal 
cancer separately. Instead, the purpose of this additional exploration by 
subsites was to highlight the need for vigilance and the importance of 
conducting extra- and intra-oral examinations during routine dental check-
ups. Moreover, awareness of certain signs and symptoms that could suggest 
involvement of a particular subsite is also necessary. For example, dysphagia 
or odynophagia lasting for more than three weeks, a persistent lump in the 
throat, and persistent pain in the throat lasting for more than three weeks 
could be indicative of oropharyngeal cancer, while ulceration or unexplained 
swellings of the oral mucosa persisting for more than three weeks and/or all 
red or mixed red and white patches of the oral mucosa persisting for more 
than three weeks could suggest oral cavity cancer (NHS Scotland, 2016b).  
Therefore, the results of Chapter 3 of this thesis suggest that the consequence 
of limiting early detection efforts for oral cancer to primary dental care 
services only was that a large section of the population would be neglected. 
However, almost all (95%) of the patients included in this thesis had contacted 
one of the four services (hospital outpatient, hospital inpatient/ day-case, 
primary dental care, and GP prescription) examined in the two years prior to 
the start of the referral period, suggesting that there were opportunities for 
early detection in alternative healthcare services. This was in agreement with 
Ligier et al. (2016) who reported that 88% of the 342 patients with head and 
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neck cancer that were included in their study had contacted a health 
professional at least once in the 2- to 12-month period preceding referral. 
Paudyal et al. (2014), in their systematic review examining patient 
acceptance of oral cancer screening in non-dental settings, reported that 
most patients preferred to contact a general medical practitioner upon 
detecting symptoms primarily because of ease of access, familiarity with the 
practitioner, local nature and relevance in case of a health-related 
intervention. “Lack of trust of a dentist” was cited as another reason why 
patients preferred general medical practitioners over dentists, and this was 
rooted in the belief that dentists were “teeth specialists” and did not have 
the same power as a general medical practitioner to write prescriptions and 
refer patients. Financial costs may also have had a role to play as, under the 
National Health Service in the United Kingdom, all contacts with general 
medical practitioners are free of charge while only check-up and examination 
contacts with general dental practitioners are free. All other treatments by a 
general dental practitioner are chargeable. Given that a large proportion of 
the patients with oral cancer that were included in this study were from the 
most deprived areas of Scotland, there was a possibility that this factor 
influenced their decision to approach alternative healthcare services upon 
self-discovery of symptoms. Lastly, difficulty in access and lack of availability 
of appropriate dental services may also have affected a patient’s decision to 
contact alternative healthcare services instead.  
Another key finding of this thesis was that the patients with oral cancer that 
were included in this study had increased their frequency of contacts with 
health care services in the one year and, specifically, the six-month period 
prior to the start of the referral period. Although not all of these contacts 
were necessarily cancer-related, these results do suggest that there may have 
been missed opportunities for earlier diagnosis and referral in at least some of 
these cases. Multiple consultations before referral are usually associated with 
delays in the diagnostic process (Lyratzopoulos et al., 2014), and factors 
contributing to patient, professional, or system delays have been discussed in 
detail in the literature review in Chapter 1. Briefly, patient factors that may 
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have contributed to multiple pre-referral appointments and delays in the 
diagnostic process include “no show” events, failure to follow up on results, 
and psychosocial factors (Lyratzopoulos et al., 2015). Professional factors that 
may have played a role include the failure of dental and medical practitioners 
to recognise malignant lesions of the oral cavity due to the non-specific 
appearance and potentially insidious nature of these lesions (Güneri and 
Epstein, 2014); vague or unspecific clinical signs (Bruun, 1976); lack of 
experience/unfamiliarity with the disease (Guggenheimer et al., 1989); low 
index of suspicion (Holland, 1975); deficient clinical examination (Robbins et 
al., 1950); and presence of co-morbidities (Allison et al., 1998). System delays 
could be caused by factors such as limited accessibility and affordability of 
healthcare services, availability of specific treatments, and difficulties in 
scheduling appointments (Güneri and Epstein, 2014). To this mix of factors, 
this thesis adds the additional issues of relatively low volume of oral cancer in 
Scotland and poor dental attendance patterns (despite universal population 
coverage) among the target population.  
5.4 Methodological strengths and limitations 
This section reviews some of the strengths and limitations of this thesis, 
particularly in relation to the nature of the data used and the methodology 
employed. The strengths and limitations of each study have been considered 
in the discussion sections of the relevant chapters, and this section mainly 
summarises those relevant to this thesis in its entirety. 
5.4.1 Routine administrative data 
Grzeskowiak et al. (2013) stated that it was almost an ethical obligation on 
the part of researchers to exploit routinely collected health data if they 
would help develop a better understanding of the disease and its risk profile. 
The main strength of this thesis lay in the use of robust, routinely collected 
administrative health data with full population coverage, and such data has 
several advantages. Firstly, this study used individual-level data that covered 
the entire population of Scotland, resulting in a relatively large sample size 
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that increased the generalisability, accuracy, and precision of the results and 
minimised the risk of several types of bias including selection bias and recall 
bias. Secondly, the data were routinely collected as part of clinical and/or 
administrative procedures and were therefore readily available, allowing 
exploration of the various research questions in a timely and cost-efficient 
manner. Thirdly, the data collection process was standardised and 
unobtrusive, and enabled examination of the various elements of a patient’s 
healthcare service contact history over several years. Fourthly, as discussed in 
detail previously, the quality of the data that was collected and maintained in 
Scotland was extremely high, which further increased the strength of the 
evidence (Brewster et al., 1994; Brewster et al., 1997; Brewster et al., 2002). 
Lastly, routinely collected administrative data had the additional advantage 
of allowing linkage of several databases. In Scotland, it was estimated that 
approximately 96.5% to 99.9% of the population had a Community Health 
Index (CHI) number, which is a register of all patients who have used the 
Scottish National Health Service, and this unique identification number 
allowed linkage of all healthcare records of a particular individual across time 
and location (Pavis and Morris, 2015). The specific advantages and 
disadvantages of the data linkage process have been discussed in further 
detail in the next section. 
Routinely collected data also has several limitations, and these are mainly 
related to their availability. Firstly, data from general practitioners were 
unavailable in Scotland and this restricted a detailed exploration of contacts 
made by the patients. Instead, this thesis considered prescriptions issued by 
GPs as a proxy for contact with a general practitioner, based on the 
assumption that all prescriptions were associated with a face-to-face contact 
with a GP hence creating an opportunity for the early detection of oral 
cancer. However, in reality, a large proportion of these were likely to have 
been repeat prescriptions, and introduction of the electronic prescription 
service in Scotland meant that many of these could have been dispensed 
online and did not require actual contact with a general practitioner (Digital 
Health, 2017). A recent cross-sectional study examining repeat prescriptions 
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issued by 29 general practices in one Primary Care Trust in England reported 
that approximately 77% of all prescriptions issued in 2011 were repeat 
prescriptions, with the mean number of repeat items per individual being 1.87 
(Petty et al., 2014). Approximately 43% of the population in the United 
Kingdom had received at least one repeat prescription in the year of study, 
and the authors stated that their results were largely “typical of the UK” as 
their study included both small and large practices that covered a wide 
socioeconomic and cultural range of population. Although the proportion of 
repeat prescriptions issued in Scotland is currently not measured, personal 
communication with the principle pharmacist at the Information Services 
Division Scotland revealed that the generally accepted assumption was that 
approximately 80% of all prescriptions issued in Scotland were repeat 
prescriptions (McTaggart, 2018). This must be taken into consideration when 
interpreting the results of this thesis as it may have led to an overestimation 
of contacts with a GP.  
Data on the severity of the disease (stage of cancer at the time of diagnosis) 
were unavailable, and this information would have allowed further 
examination of the impact of missed opportunities for early detection on 
prognosis and determination of whether pre-referral contact with a 
healthcare service could result in a shift to an earlier stage of cancer at the 
time of diagnosis. Lack of data on the HPV status of patients and behavioural 
factors such as smoking and alcohol consumption prevented exploration of the 
driving factors of the trends seen in Chapter 2, and also restricted the 
development of a clearer risk factor profile of patients. There was a potential 
for misclassification of the primary neoplasm and subsequent errors in the ICD 
code assigned. This may have influenced the results, particularly where 
additional exploration by subsite was performed. Lastly, data on the source of 
referral were also unavailable, and this information would have allowed 
accurate estimation of the proportion of patients with oral cancer that had 
consulted and been referred by alternative healthcare services.  
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5.4.2 Data linkage 
The data linkage process aims to match routinely collected health data of the 
same individual across various databases using a unique identification number 
or various personal identifiers such as name, age, and sex. Scotland currently 
has some of the best administrative health data in the world, with 
approximately 96.5% to 99.9% of the Scottish population having a Community 
Health Index number, and linkage of this data would allow researchers to 
“unleash, at scale, the power of health service and wider administrative 
data” (Pavis and Morris, 2015). The Scottish Government’s strategy for data 
linkage, “Joined up data for better decisions: A strategy for improving data 
access and analysis”, acknowledges that the advantages of this process are 
numerous and summarises them into five key benefits (The Scottish 
Government, 2012a). Firstly, it allows provision of a high-quality cross-
sectoral evidence base that can be used for policy planning and strategic 
development, which in turn speeds up the process of service improvement. 
Secondly, linking various existing, routinely collected healthcare databases 
enhances the quality and consistency of the data itself through deletion of 
duplicate records in the system and correction of data artefacts. Moreover, it 
maximises the potential of the data by allowing researchers to develop 
reliable methods of producing statistics and examine complex issues affecting 
society in a non-intrusive manner. Thirdly, it allows longitudinal research, 
both retrospective and prospective, to be executed easily and in a cost-
efficient manner. Fourthly, it increases the capacity to accurately evaluate 
public sector programs by providing the means to answer sophisticated 
research questions and reducing the cost of carrying out surveys instead. 
Lastly, feedback loops focusing on linkage activities allows monitoring of the 
quality and consistency of the data. 
As discussed previously, the quality of data linkage in Scotland is also quite 
high, and Kendrick and Clarke (1993) reported that clerical monitoring of pair-
wise linking showed that the false negative rates (the proportion of pairs 
which the system fails to link) and the false positive rates (the proportion of 
pairs which are incorrectly linked) were both approximately three percent 
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only. In this thesis, data linkage allowed examination of the patient’s past 
medical history in terms of their utilisation of health care services in a cost-
efficient, complete, and non-intrusive manner. It also lowered the risk of 
selection bias and permitted testing of various novel hypotheses. Providing 
access to the de-identified, linked research datasets through a federated 
network of “safe havens” also eliminated the need for individual patient 
consent, and instead relied on consent from the legal data controllers 
following a rigorous assessment of the research protocol (Pavis and Morris, 
2015). 
However, data linkage also has several limitations. In Scotland, this is 
achieved by using the probabilistic matching method which accounts for 
discrepancies in personal identifiers (discrepancy rate of three percent) that 
may lead to approximately 15% of true links being missed (Kendrick and 
Clarke, 1993). There is a certain level of uncertainty associated with this 
method, particularly when performing longitudinal or cross-generational 
matching of records as there may be changes in name or address, 
typographical errors, or individuals lost to follow-up because of a change in 
country or state of residence (Grzeskowiak et al., 2013). A systematic review 
examining the accuracy (the proportion of records that were truly linked) and 
specificity (proportion of truly unmatched records) of probabilistic data 
linkage found that it ranged from 74% to 98% and from 99% to 100%, 
respectively (Pinto da Silveira and Artmann, 2009). The authors also 
mentioned that these figures were largely dependent on the quality and 
number of fields available for linkage. 
Moreover, as discussed previously, Bohensky et al. (2010), in their structured 
narrative review of factors that affected the quality of data linkage, reported 
that age, sex, race, setting, health, and socioeconomic status were usually 
associated with a risk of incomplete data linkage, although the evidence on 
the association between some of these factors and the probability of 
incomplete linkage occurring was inconsistent. Additionally, they also 
suggested that this incomplete linkage could be caused by factors such as 
governance issues including the need for consent, method of linkage 
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employed, and accuracy and completeness of the original datasets used for 
linkage. Additionally, factors such as lack of a standardised definition for data 
or inconsistencies in coding practices may further complicate matters by 
introducing a certain level of systemic bias in the results of the study and, 
therefore, must be kept in mind when interpreting outcomes.  
Therefore, in relation to the data linkage research executed in this thesis 
(Chapter 3 and 4), although on one hand there were real strengths in collating 
all the data on patients that were diagnosed with oral cancer in Scotland, 
there were also some limitations in terms of missing linkages which must be 
considered when interpreting the results. However, the impact of missing 
linkages would lead to an under- rather than an over-ascertainment of 
opportunities for early detection, and hence the findings of this thesis were 
generally conservative. 
5.4.3 Measurement of socioeconomic status 
Miech and Hauser (2001) defined socioeconomic status as “a broad concept 
that refers to the placement of persons, families, households and census 
tracts or other aggregates with respect to the capacity to create or consume 
goods that are valued in our society". There are two main approaches to 
measuring socioeconomic status, namely, the compositional approach which 
takes into account the characteristics of the individual and the contextual 
approach which considers the characteristics of the individual’s environment 
(Kaplan, 1999). Both of these approaches have their own strengths and 
limitations. For example, a compositional measure such as education has 
several advantages such as ease of measurement; reasonable stability beyond 
early adulthood; increased possibility of capturing aspects of lifestyle and 
behaviour; less likely to be influenced by disease than income or occupation; 
and higher levels of education usually predict better jobs and, consequently, 
better working conditions, housing, and neighbourhood. However, it also has 
several limitations such as the fact that it has different social meaning and 
consequences in different populations and at different times; increases in 
years of education are not always accompanied by a consistent increase in 
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SES; and the economic returns of education may vary with race/ethnicity and 
gender. Similarly, occupation as an SES measure provides a structural link 
between education and income, captures the environmental and working 
conditions of an individual, and is less volatile than income. However, there is 
difficulty associated with classification of homeowners and retirees, it cannot 
always be measured precisely, it does not take into account racial or gender 
differences in the benefits that arise from employment in the same 
occupation, and occupational class usually includes a range of heterogeneous 
occupations which may vary considerably in terms of the education required 
and the associated income and prestige. Contextual measures, on the other 
hand, usually include ecologic measures that capture the social and economic 
conditions that affect all individuals living in a particular geographic area 
(Shavers, 2007). Their accuracy is influenced by factors such as the amount of 
time elapsed since the data was collected and the dynamic nature of the area 
including gentrification, variations in industry and employment rates, and 
movements in and out of the area. 
The Scottish Index of Multiple Deprivation is a composite measure of 
socioeconomic status that takes into account 38 indicators in seven domains 
which include both compositional (income, employment, health, education) 
and contextual measures (geographic access, crime, and housing) (Donnelly, 
2009). The main advantage of using such a measure is that it incorporates 
both individual-level and area-level factors which may provide additional 
insight. Moreover, it may also be useful for area-wide planning. However, the 
main limitation of such an index is that aggregation of SES may result in 
confounding brought about by a measure of area-level SES that is difficult to 
interpret (Shavers, 2007). The influence of individual measures of SES on the 
results of epidemiological studies are dependent on the research question and 
population being examined (Shavers, 2007). However, consideration of the 
effects of the individual measures included in the Scottish Index of Multiple 
Deprivation on the findings of the studies presented in Chapters 2, 3, and 4 
was considered to be beyond the scope of this thesis.  
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An essential issue to consider while interpreting the results of this thesis is the 
phenomenon of “ecological fallacy”, caused by the use of geographic area-
based measures of socioeconomic status as surrogate individual measures. 
Such deprivation indices assign individuals living within a certain area the 
same socioeconomic status, and this can result in individual-level inferences 
being made from area-level relationships (Berkman and Macintyre, 1997; 
Macintyre and Ellaway, 2000). For example, Chapter 3 of this thesis 
considered the deprivation status of the dental practices, and not that of the 
patients themselves, to calculate the number of patients per dentist. The 
linkage study, on the other hand, considered the SIMD fifth of the patient’s 
area of residence to better elucidate if deprivation had any effect on their 
likelihood of attending a dentist. This may have resulted in ecological fallacy 
as a patient who lives in a particular SIMD fifth may not necessarily attend a 
dental practice within the same SIMD fifth, just as the registration profile of a 
practice may not necessarily reflect the SIMD fifth his/her practice is located 
in.  
However, such ecological interpretation also has several advantageous in 
terms of indicating the social and physical environment or circumstances, for 
example, adequate access to health care services. Additionally, it also helps 
better understand small area diseases, plan ways to tackle them based on 
availability of health services, and monitor population level inequalities. 
Ideally, a combination of individual and area-based socioeconomic measures 
would be utilised in order to take account of individual and area effects 
5.5 Further work 
The findings of this study and the limitations imposed by data availability, 
time, and resources made it evident that additional research in the field of 
potential or missed opportunities for the early detection of oral cancer was 
necessary. This section summarises some of the further work that could be 
undertaken.  
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One of the key limitations of the current thesis was the unavailability of 
general practitioner data in Scotland, necessitating the use of prescriptions 
issued by GPs as a proxy for contact instead. However, the Scottish Primary 
Care Information Resource (SPIRE) was introduced in May 2017 and, although 
not a national database that collects data on a routine basis, this service will 
collect some information from general practitioner practice records for 
further use in research, efforts to improve care, and the planning of services 
(ISD Scotland, 2017k). Future research should utilise data from this resource 
to further explore missed opportunities and the role of general medical 
practices in the early detection of oral cancer. Moreover, as mentioned 
previously, an estimated 80% of the GP prescriptions issued to the patients 
with oral cancer that were included in this study were likely to be repeat 
prescriptions and, therefore, did not necessarily require face-to-face contact 
with a general practitioner (McTaggart, 2018). However, the majority of these 
patients would have come in contact with a pharmacist at the time of 
dispensing the prescribed medications, and future studies could explore these 
prescription-dispensing contacts in order to further clarify the role of 
pharmacies in early detection strategies for oral cancer.  
A key finding of this thesis was that the majority of the patients diagnosed 
with oral cancer were older males from the most deprived areas of Scotland 
who exhibited low levels of engagement with dental services. Moreover, 
although this data was unavailable in the current study, previous evidence 
suggests that these individuals were also likely to exhibit higher prevalence of 
risky health behaviours such as smoking and alcohol consumption. Therefore, 
future studies could focus on these individuals and attempt to understand 
their motivations for engaging in such risky health behaviours and the extent 
to which they felt supported when attempting cessation. Additionally, 
emphasis could also be laid on trying to understand ways in which to support 
these individuals in the management of risk and motivate them to engage with 
healthcare services on a more frequent basis.  
Further risk stratification of the communities in relation to the location of 
alternative healthcare services such as general practitioners and pharmacies 
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could be undertaken to allow estimation of the expected number of patients 
with oral cancer that would be seen per year by these services. This would 
inform further early detection strategies in alternative healthcare settings.  
The findings of this thesis also showed that the patients with oral cancer had 
significantly increased their frequency of contacts with the GP prescription 
services in the most recent months prior to diagnosis. However, the 
proportion of these contacts that were actually cancer-related was unknown, 
and a future study could carry out a detailed exploration of the nature of the 
prescriptions issued by the general practitioners in order to develop a better 
understanding of this. 
Another limitation of the current thesis was the utilisation of head counts of 
dentists to explore the distribution of the incidence burden of the disease in 
relation to the location of general dental practitioners in Scotland. 
Unfortunately, whole-time equivalent data for GDPs were unavailable, and 
future studies could consider utilising national workforce reports and activity 
data as a proxy measure of this to derive an even more accurate estimation of 
the number of patients a general dental practitioner could expect to see per 
year.  
Unfortunately, data on the source of referral were currently unavailable at 
the national level in Scotland, and this thesis performed a superficial 
exploration of the routes to diagnosis by considering the last service 
contacted before the start of the referral period as a proxy for the referral 
source. It would take considerable effort to collate data on the sources of 
referral from all of the local clinical IT systems, and this could be another 
area of focus for future studies as it would permit exploration of the routes to 
diagnosis of oral cancer accurately.  
The introduction of President Barack Obama’s The Precision Medicine 
Initiative in the United States, and NHS England’s Improving Outcomes 
Through Personalised Medicine strategy shifted the focus of research from the 
prevalent “one size fits all” approach, which developed strategies and made 
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recommendations bearing an “average person” in mind, to the “precision 
medicine” approach which tailored prevention strategies and treatments to 
subgroups of patients at the highest risk of developing a particular disease 
(The White House, 2015; NHS England, 2016). In Scotland, the Stratified 
Medicine Scotland Innovation Centre, introduced in 2013, aimed to accelerate 
the adoption of precision medicine by bringing together researchers, industry 
innovators, and clinicians to link together Scotland’s domain expertise, data 
assets, and delivery capability. The descriptive epidemiological study included 
in this thesis explored the trends of head and neck cancer in Scotland by 
various socio-demographic determinants, bearing early detection and the 
principles of precision medicine in mind. The broad goal of such an 
examination was to identify the subgroups of “high-risk” individuals that 
should be the focus of targeted early detection efforts. Although the findings 
of this thesis accomplished that to a certain extent, further risk stratification 
is necessary. Future studies could utilise nationally available data on HPV 
status and the stage of cancer at the time of diagnosis to examine variations 
in incidence trends. Additionally, further analyses of the existing data taking 
the Scottish Government’s Urban Rural Classification (The Scottish 
Government, 2016) into consideration can be undertaken as this will allow 
further risk stratification of patients based on their area of residence and, 
subsequently, their access to various healthcare services.  
Although the results of this thesis can be generalised to other countries with 
similar universal healthcare settings such as the NHS, caution must be taken 
when interpreting the results in the context of other countries with different 
health and population infrastructures. Gallagher et al. (2018) recently 
reported that the majority (69%) of the world’s 1.6 million dentists were 
distributed in Europe and America, leaving the majority of the global 
population in developing countries such as India with approximately 30% of 
the available workforce. Therefore, the methodology and findings of the 
current thesis can be used to guide similar analyses in such countries where 
the distribution of a considerably higher burden of cancer among a lower 
volume of dentists would likely provide a different picture of opportunities for 
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early detection. Such analyses could also take availability of resources and the 
infrastructure of alternative healthcare services in such countries into 
consideration.  
5.6 Conclusions and recommendations 
Kingdon (2011), a political scientist from the United States, suggested that in 
order to achieve any significant change in population health, it was essential 
to consider three main issues, namely, “communicate the nature of the 
problem to be solved, identify appropriate evidence based policies, and 
engage with politics to achieve the desired change”. This section discusses the 
thesis in this context by summarising the main findings to describe the nature 
of the problem identified, and then utilising these results to make policy and 
practice recommendations for the prevention of oral cancer at the community 
and healthcare service levels. 
5.6.1 Thesis conclusions 
The findings of this thesis showed that the burden of head and neck cancer 
had increased in Scotland between 1975 and 2012, and this appeared to be 
largely driven by a rapid rise in the incidence of oropharyngeal cancer in 
recent decades. Moreover, this burden of incidence was projected to continue 
to rise up to 2025, with the rates of oropharyngeal cancer surpassing the rates 
of oral cavity cancer, which were expected to exhibit only a relatively modest 
increase. Socioeconomic inequality in the distribution of head and neck 
cancer was also observed, with those from the most deprived areas of 
Scotland being at the highest risk of developing cancer. This pattern was 
consistent for all subsites, with oropharyngeal cancer being no exception, as 
had been previously suggested by Dahlstrom at al. (2015). Moreover, an 
almost dose-like effect appeared to exist, with the burden of cancer 
increasing with worsening levels of deprivation. The burden of incidence of 
cancer was higher among men than women, and among older age groups, 
although the peak age of incidence of oropharyngeal cancer (61-65 years) was 
only slightly lower than that of oral cavity cancer (71-75 years). Thus, overall 
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the sociodemographic profile of the various subsites of head and neck cancer 
appeared to be largely similar.  
The overarching aim of this thesis was to identify opportunities for the early 
detection of oral cancer, and it was anticipated that the sociodemographic 
profile of the patients would inform community-based risk stratification that 
could target efforts and initiatives to improve early detection. The World 
Health Organisation (2006) recently clarified and made distinct the two main 
strategies for early detection, namely, screening and early diagnosis of 
cancer, with the key difference between the two being the stage of clinical 
progression of the disease. While the aim of screening was to identify pre-
cancerous lesions in an apparently healthy population, the latter aimed to 
achieve a “stage shift” (to an earlier stage) through timely detection of the 
signs and symptoms of cancer and prompt referral and treatment (WHO, 
2006). This thesis primarily focussed on opportunities for early detection 
through early diagnosis, grounded in the fact that the main cohort analysed in 
Chapter 4 was based on patients who had been diagnosed with oral cancer 
(rather than including data on oral potentially malignant disorders). There 
was a possibility that some of the healthcare service contacts examined as 
opportunities for early detection could have occurred before the clinical signs 
and symptoms of oral cancer had become apparent. This should be taken into 
consideration when interpreting the results of this thesis, and further research 
with regard to OPMDs would help clarify whether these contacts could 
represent missed opportunities for opportunistic screening.  
Despite the increasing trends, the overall incidence rates of oral cancer were 
relatively low in Scotland, and this thesis was among the first to question the 
feasibility of early detection in a dental setting in the light of this low disease 
volume. Examination of the distribution of the oral cancer burden in relation 
to the location of general dental practices in Scotland showed that a dentist 
would encounter one case of oral cancer every ten years, one case of oral 
cavity cancer every 17 years approximately, and one case of oropharyngeal 
cancer every 25 years. At the outset, it was anticipated that this time frame 
would be markedly reduced in the deprived communities because of the high 
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incidence of oral cancer. However, due to the even distribution of NHS dental 
practices and practitioners, which do not exhibit an unequal or skewed 
distribution in Scotland, specific locations or practices could not be identified 
for targeting further support, training, or pathways. This was further 
complicated by the fact that the majority of patients with oral cancer that 
were included in this study had made no contact with a general dental 
practitioner in the two years preceding diagnosis, thus further limiting 
opportunities for early detection 
However, approximately 95% of the patients with oral cancer that were 
included in this study had contacted NHS hospital services (either hospital 
outpatient or hospital inpatient/day-case), clinics for GP prescriptions, or 
primary dental care services in the two years prior to the start of the referral 
period, suggesting that there were potential opportunities for early detection 
in alternative healthcare services. Although no novel settings (e.g. specific 
clinical specialities) for early detection in hospital or secondary care settings 
were identified, this thesis did recognise considerable potential in other 
primary care settings, particularly GP and pharmacy. Approximately 89% of 
the patients with oral cancer that were included in this study had been issued 
with a GP prescription in the most recent year prior to the start of the 
referral period and, although a significant proportion (possibly up to 80%) of 
these were likely to be repeat prescriptions (McTaggart, 2018), they would 
have all been dispensed in a pharmacy. This suggests that pharmacists may 
have a role to play in the early detection of oral cancer as they are in an ideal 
position to provide preventive advice on smoking and alcohol cessation, 
increase awareness about the risk factors and signs and symptoms of oral 
cancer, monitor changes in medications and attendance patterns, and refer 
patients exhibiting the warning symptoms and signs of oral cancer (e.g. 
persistent mouth lesions that have not healed with medication) in a timely 
fashion (Weinberg, 2006). 
The proportion of patients contacting each of the four services increased over 
the two -year period prior to the start of the referral period, as did the mean 
number of contacts with each of these services. However, the differences 
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between the individual years had more clinical significance than those 
between six-month periods. The frequency of primary dental care service and 
GP prescription contacts significantly increased in the most recent year prior 
to the start of the referral period compared to the previous year. Of those 
who had contacted a primary dental care service, more than half (52%) had 
made an unusual number of contacts (exceeding “routine”, that is, two 
contacts per year) in the most recent year prior to the start of the referral 
period, and 41% of these contacts were for examination and diagnostic 
purposes. When considering the most recent six-month period prior to the 
start of the referral period, 51% of the patients with oral cancer that were 
included in this study had made at least one contact and 13% had made more 
than one contact with a primary dental care service. Additionally, the 
proportion of patients making an unusual number of contacts, particularly for 
examination and diagnosis purposes, exhibited an upward trend throughout 
the period examined. Therefore, not only were more patients contacting 
these services closer to the start of the referral period, their frequency of 
contact, particularly with the dental and GP prescription services, had also 
increased. Moreover, the contacts with the primary dental care services were 
mainly associated with examination and diagnostic procedures. All of these 
contacts could represent potential or missed opportunities for early 
detection, appointments with potential oral cancer concerns, or potential 
further opportunities for earlier detection and referral.  
Lastly, a preliminary exploration of healthcare service contacts made just 
before and during the one-month referral period was also undertaken, in an 
attempt to assess the feasibility of utilising this data to examine the routes to 
diagnosis. The findings showed that the two most common services contacted 
most recently before the start of the referral period were GP prescription and 
hospital outpatient, suggesting that there was a possibility that these 
consultations were the sources of referral. However, unavailability of data on 
the referral source and time made further exploration of the routes to 
diagnosis unfeasible. The findings of this analysis also showed that almost all 
of the patients (98%) included in the current study had contacted at least one 
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of the four services during the one-month referral period, and the most 
commonly contacted services were hospital outpatient and GP prescription. In 
comparison, very few patients had consulted dental or hospital inpatient/ 
day-case services during the same period. Moreover, the hospital outpatient 
and hospital inpatient/ day-case specialties contacted most frequently within 
this period were ENT, general surgery, oral and maxillofacial surgery, and oral 
surgery, suggesting that, as suspected, these contacts were likely to be 
already associated with the symptoms and signs and referral for oral cancer. 
There was also a possibility of the hospital outpatient service being the 
referral destination for a large proportion of the patients included in this 
study.  
Therefore, this thesis identified several areas, particularly with regard to 
subgroups of the population at the highest risk of developing cancer and 
alternative healthcare services, that future early detection efforts can and 
should target.  
The findings of this thesis were used to develop recommendations in relation 
to improving early detection of oral cancer, and these have been discussed in 
the following section. 
5.6.2 Recommendations  
The 70th World Health Assembly recently adopted a draft resolution, “Cancer 
prevention and control in the context of an integrated approach” (WHO, 
2016), the broad consensus of which was that cancer was a growing global 
public health concern and required prioritization and funding. It clarified that 
a more concerted approach for the prevention and management of cancer was 
necessary in order to achieve the Sustainable Development Goals by 2030, 
particularly the target to decrease premature mortality from non-
communicable diseases (NCDs) including cancer by one third, and the target 
which endeavoured to achieve universal health coverage to improve cancer 
care and outcomes (WHO, 2016). 
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The findings of this thesis could inform development of policy and practice in 
primary and secondary prevention of oral cancer, including a focus on the 
potential role of risk stratification of communities to better target early 
detection efforts at the community and healthcare service levels. The 
recommendations made in section have been developed taking the Behaviour 
Change Wheel (BCW), proposed by Michie et al. (2011), into consideration. 
Following an extensive review and synthesis of 19 behaviour change 
frameworks from a wide range of disciplines, the BCW was formulated with 
the goal of aiding development of interventions and policies to change 
behaviour. The core of the wheel was formed by a ‘behaviour system’, which 
was composed of the three basic components of behaviour change including 
capability, opportunity, and motivation. The middle layer of the wheel 
included nine intervention functions that could be used to target any deficits 
in the core, while the outermost layer was formed by seven policy actions 
that could enable the interventions necessary for behavioural change. 
5.6.2.1 Recommendations for the primary prevention of oral cancer  
Primary prevention aims to minimise the incidence burden of a particular 
disease by decreasing the prevalence of its key risk factors in the general 
population. Sheiham and Watt (2000) suggested the utilisation of a “common 
risk factor approach” to achieve this. The basis of this approach was that 
health improvement activities targeting a small number of risk factors would, 
in the long run, affect a larger number of diseases at a lower cost and with 
greater efficiency and effectiveness, compared to measures targeting a single 
specific disease. The strategy also aimed to improve health by minimising the 
prevalence or clustering of multiple risk factors such as tobacco and alcohol, 
which are both known to play an aetiological role in a number of diseases, by 
creating supportive environments for cessation and facilitating behavioural 
changes.  
In keeping with this, the Scottish Government, in their reports titled Changing 
Scotland’s Relationship with Alcohol: A Framework for Action and Tobacco 
Control Strategy - Creating a Tobacco-Free Generation, developed and 
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recommended strategies aiming to reduce the consumption of tobacco and 
alcohol in Scotland, provide support to families and communities, create 
positive public attitudes that encourage positive choices, and improve 
treatment and support (The Scottish Government, 2009; The Scottish 
Government, 2013). Additionally, Scotland has also led the world in upstream 
policy legislation to address smoking and alcohol – including the ban on 
smoking in public spaces (The Scottish Government, 2005) and the recently 
introduced Alcohol Minimum Pricing policy (The Scottish Government, 2012b). 
Reviews of these strategies showed a reduction in the rates of consumption of 
tobacco and alcohol in Scotland, although the most deprived communities 
continued to exhibit higher prevalence of smoking and alcohol misuse 
compared to the least deprived areas (NHS scotland, 2016a; Reid et al., 
2017).  
There is also a need for midstream community or downstream clinical setting 
approaches, including, for example the, development of a more “tailored” 
approach that prioritises those from lower socioeconomic strata groups. 
General dental practitioners as well as other healthcare professionals should 
be encouraged to educate patients, particularly those from the most deprived 
areas of Scotland, on the major health risks associated with tobacco and 
alcohol consumption and the benefits of cessation, and also provide support 
by referring the patients to appropriate cessation programs. The 
establishment of community-based support groups and help-lines for the 
cessation of smoking and alcohol consumption, particularly in the most 
deprived areas, should be promoted.  
The Scottish Government (2017b), in Scotland’s Oral Health Plan, proposed 
the introduction of an Oral Health Risk Assessment (OHRA), defined as “a full 
dental examination” accompanied by “a discussion between the dentist and 
patient about the associated risk factors such as smoking, alcohol intake and 
medication”. Execution of such an assessment by general dental practitioners 
is recommended as it will permit identification of “high risk” individuals (i.e. 
males, individuals who smoke and drink, and those from lower socioeconomic 
strata). General dental practitioners should also be encouraged to follow-up 
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this subgroup of the population at the highest risk of developing oral cancer, 
and carry out opportunistic screening when possible, as identification of an 
OPMD and cessation of smoking could reverse the disease or prevent the 
manifestation of malignancy. 
The prevalence of human papilloma virus infections, a major risk factor for 
oropharyngeal cancer (Herrero, 2003), can be minimised with the help of the 
prophylactic HPV vaccines. Rowhani-Rahbar et al. (2009), in their case-control 
study nested within a randomised controlled trial of a bivalent vaccine for the 
prevention of cervical dysplasia, reported that the prevalence of oral HPV 
infections was lower in the vaccine arm of their study compared to the 
placebo arm 4 years after vaccination. Therefore, it has been hypothesized 
that vaccination could prevent the incidence of oral HPV infections and, 
subsequently, decrease the incidence of HPV-associated oropharyngeal cancer 
(Gillison, 2014). However, currently only women receive the HPV vaccine 
under the National Health Service in the United Kingdom, and vaccination of 
adolescent males is not recommended as there is still limited evidence on its 
cost-effectiveness (The Scottish Government, 2017c). Although there is 
preliminary evidence of a certain level of “herd-immunity” in Scotland 
following the introduction of the national vaccination program in 2008 
(Cameron et al., 2016), further efforts are still necessary. Moreover, there 
will continue to be unvaccinated cohorts (those who were too old for the 
relatively recently introduced school vaccination programme) for decades to 
come, and other primary (and secondary) prevention efforts will be required. 
Therefore, general dental practitioners as well as other healthcare 
professionals could be encouraged to provide preventive advice and promote 
the adoption of safer sexual practices (Massachusetts Dental Society, 2017). 
Additionally, development of community outreach programs that disseminate 
information on HPV infections, provide preventive advice, and encourage 
safer sex by distributing condoms, particularly among younger and 
disadvantaged populations, is encouraged. 
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5.6.2.2  Recommendations for the secondary prevention of oral cancer 
through early detection 
5.6.2.2.1 Recommendations at the community level 
The Scottish Government’s Oral Health Improvement Plan clarified that the 
previously proposed Oral Health Risk Assessment would now be introduced in 
general dental practices and, in time, “all adult patients would receive an 
OHRA on a regular basis with intervening reviews between assessments” (The 
Scottish Government, 2018). It is recommended that, following widespread 
implementation, this OHRA should be utilised to undertake risk stratification 
of communities and identification of subgroups of the population requiring 
additional support, so as to better target early detection efforts in the future. 
One of the key findings of this thesis was that a considerable proportion of the 
patients with oral cancer that were included in this study did not have regular 
contact with a general dental practitioner. Therefore, development of 
community-based programs that reach out to people, particularly those from 
the most deprived areas of Scotland, and encourage them to consult general 
dental practitioners on a regular basis could be developed. The Scottish 
Government recently introduced the Community Link Worker Programme, 
which aims to mitigate the effects of the social determinants of health among 
individuals living in the most deprived areas of Scotland (The Scottish 
Government, 2017d). A Community Link Worker (CLW) has been defined as a 
“generalist social practitioner based in a GP practice serving a 
socioeconomically deprived community”, and their main role is to provide 
non-clinical support to patients and encourage them to take control of their 
health by setting and accomplishing goals and overcoming barriers (The 
Scottish Government, 2017d). CLWs essentially act as links between people 
and their communities through GP practices and, therefore, may have a 
potential role in the secondary prevention of oral cancer. The possibility of 
utilising such workers to reach out to those at the highest risk of developing 
cancer should be further explored. Such efforts could include home visits by 
the CLWs to identify high-risk individuals based on whether they exhibited key 
behavioural risk factors such as smoking and alcohol consumption, and 
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delivery of preventive advice regarding the risks associated with such habits 
and the benefits of cessation, and provision of motivation to attend cessation 
programs. Additionally, the CLWs could also reach out to the section of the 
population that was not registered or exhibited poor attendance patterns with 
a general dental practice and encourage them to contact GDPs more regularly 
by providing information on the benefits of doing so. The possibility of 
carrying out superficial examinations of the oral cavity for detection of 
possible OPMDs and referral could also be examined, although it is necessary 
to take associated governance issues and training and resources necessary into 
consideration when doing so. 
The results of this thesis showed that the patients with oral cancer had 
increased their frequency of healthcare service contacts in the months 
immediately preceding diagnosis. This suggests that there were avoidable 
delays in the diagnostic process, and early detection efforts should aim to 
minimise them by targeting the patient, professional, and system levels. 
Antonovsky and Hartman (1974), in their seminal review of delays in the 
detection of cancer, first suggested that the most common determinant of 
patient delay was cancer knowledge. This was more recently reinforced by 
Tromp et al. (2005) in their case-series analysis conducted in the Netherlands 
(reviewed previously in Chapter 1) where they suggested that patients were 
more likely to minimise the delay in seeking professional help upon self-
discovery of symptoms if they had prior knowledge of the signs and symptoms 
of cancer. Therefore, early detection strategies should aim to increase 
awareness among the general population, and particularly the disadvantaged 
communities, through the dissemination of information on the signs and 
symptoms of oral cancer among communities; promotion of community-based 
educational events; provision of training on self-examination for lesions by 
health care professionals; mass media campaigns; and distribution of 
educational materials including leaflets, flyers, and videos that are easily 
understandable by the general public, thus creating awareness, empowering 
patients, and discouraging them from delaying seeking help. However, these 
programs have also been reported to have limited benefits. Austoker et al. 
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(2009), in their systematic review, reported that although such cancer 
awareness programs, when delivered to individuals, were efficient in 
increasing cancer knowledge in the short term, they showed no evidence of 
promoting early presentation of cancer. Moreover, there was also no evidence 
of public education programs reducing the stage of cancer at the time of 
diagnosis. Therefore, although efforts to minimise patient delays and increase 
cancer awareness cannot be ignored entirely, it is apparent that greater 
emphasis should be given to efforts targeting delays at the professional and 
system levels. 
5.6.2.2.2  Recommendations for healthcare services 
Although community-based measures are a key element of early detection 
efforts, even the most well-planned, structured appeals often fail, creating a 
need to adopt a wider approach. As Jackson (1985) powerfully articulated, 
“when the burden of ‘doing all the many things one should do’ falls 
differentially, behavioural change techniques require supplementation with 
environmental strategies”. Such approaches should address deficiencies and 
gaps in the existing systems, so as to avoid “victim-blaming”. This section 
uses the findings of this thesis to make recommendations for improvement of 
early detection at the healthcare service level. 
The findings of this thesis repeatedly draw attention to the fact that the 
patients with oral cancer exhibited poor dental attendance patterns, thus 
automatically limiting early detection of oral cancer. Therefore, greater 
efforts to develop and evaluate innovative strategies for dental services to 
reach out to all patients, particularly those from the deprived communities, 
and fully engage and provide additional motivation and support to increase 
regular attendance rates are necessary. Furthermore, the possibility of using a 
policy approach to incentivising engagement with this section of the 
population through the development of a system that “rewards” practitioners 
for broadening the reach of their practices and reaching out to subgroups of 
the population that require additional motivation and support should be 
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explored (Birch, 2015). These efforts may in the long run help to improve the 
early detection of oral cancer. 
It has also been suggested that failure on the part of health professionals in 
recognising malignant lesions can be attributed to several factors such as a 
low index of suspicion (Holland, 1975), lack of experience or unfamiliarity 
with the disease (Guggenheimer et al., 1989), knowledge gaps regarding risk 
factors and preventive measures (Gómez et al., 2010), and low prevalence of 
the disease and its non-specific appearance and potentially insidious nature 
(Güneri and Epstein, 2014). Mighell and Gallagher (2012) suggested that 
healthcare practitioners should be encouraged to regularly assess their levels 
of awareness and keep up-to-date with Continuing Professional Development 
topics recommended by the General Dental Council. Additionally, strategies 
to promote education (via hands-on training sessions, video demonstrations, 
or seminars) of dental practitioners on the early detection of oral cancer, 
including provision of information on the use of adjunctive techniques for 
diagnosis and proficiency in recognition of the signs and symptoms of oral 
cancer in a timely manner should be developed so as to minimise professional 
diagnostic delays.  
Scheduling or system delays can be caused by factors such as barriers in the 
health care system, availability of resources, healthcare economics, access to 
health care facilities, and the availability of appropriate treatments. Efforts 
could also be made to ensure that general dental practices are accessible to 
all individuals and are equipped with all the essential technologies and 
medications. Additionally, all members of the health care team, including 
general dental practitioners as well as dental care professionals such as dental 
nurses and dental hygienists, should receive adequate training on the signs 
and symptoms of oral cancer and should also be familiarised with the referral 
processes in place. 
Implementation of the Scottish Government’s (2017b) Oral Health Risk 
Assessment should be promoted as this would assist dental practitioners in 
identifying individuals at the highest risk of developing oral cancer (i.e. 
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smokers, drinkers, males, individuals above 60 years of age, and those 
residing in the most deprived areas). Additionally, Scotland’s Oral Health Plan 
also recognised that six-monthly check-ups were unnecessary (except among 
children or cases where a specified need had been identified), and the use of 
frequency of attendance as part of the OHRA was suggested. The findings of 
this thesis showed that patients with oral cancer increased their frequency of 
contact with healthcare services in the months preceding diagnosis, and 
implementation of the OHRA would help in identifying such individuals. GDPs 
should also be encouraged to follow-up such “high-risk” individuals on a 
regular basis, and perform opportunistic screening for oral cancer when 
possible.  
The development of a risk prediction tool, defined as one that aims to 
“predict the probability or risk of a condition or event among individuals, or 
occasionally groups, based on a combination of known or measured 
characteristics” (Usher-Smith et al., 2015), for oral cancer is recommended. 
Such a tool will allow stratification of the population by risk and, 
subsequently, identification of individuals that screening and behavioural 
change programmes should be tailored to target. This tool could also include a 
system (possibly electronic) that flags up unusual patterns of contact 
(multiple contacts over short periods of time) with healthcare services and 
monitors recall interval, as it will allow practitioners across all healthcare 
services to identify and focus greater diagnostic efforts on individuals 
exhibiting a sudden increase in their frequency of contact with healthcare 
services, thus minimising further delays.  
The findings of this thesis showed that although there were opportunities for 
early detection, they did not all lie within the dental setting. Therefore, 
efforts to engage alternative healthcare services, particularly general 
practitioners and pharmacists, in early detection efforts for oral cancer by 
providing them with adequate training, preferably by dental practitioners, on 
the recognition of the signs and symptoms of oral cancer and the appropriate 
referral practices in place are necessary. Pharmacists have a potentially vital 
role in early detection efforts through regular patient contact and the 
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opportunity to monitor any changes in the medications prescribed and the 
patient’s contact patterns. Therefore, policy efforts should aim to work with 
pharmacists and equip them with the ability to directly refer patients in case 
of suspected oral cancer. Additionally, the development of better networking 
between dental and other primary care services should be promoted.  
In conclusion, opportunities for early detection exist and need to be further 
explored and exploited, both in dental and wider primary healthcare services, 
if early diagnosis and clinical stage shifts, resulting in improved outcomes and 
survival of patients with oral cancer, are to be achieved.
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Appendices 
Appendix 1: List of ICD-10 codes requested from the 
Scottish Cancer Registry 
C00: Malignant neoplasm of lip [Excl: skin of lip (C43.0, C44.0)] 
C00.0: External upper lip (Upper lip: NOS, lipstick area, vermilion border) 
C00.1 External lower lip (lower lip: NOS, lipstick area, vermilion border) 
C00.2 External lip, unspecified (Vermilion border NOS) 
C00.3 Upper lip, inner aspect (Upper lip: buccal aspect, frenulum, mucosa, oral 
aspect) 
C00.4 Lower lip, inner aspect (Lower lip: buccal aspect, frenulum, mucosa, oral 
aspect) 
C00.5 Lip, unspecified, inner aspect (Lip, not specified whether upper or lower: 
buccal aspect, frenulum, mucosa, oral aspect) 
C00.6 Commissure of lip 
C00.8 Overlapping lesion of lip 
C00.9 Lip, unspecified 
C01: Malignant neoplasm of base of tongue (Incl.: Dorsal surface of base of 
tongue, Fixed part of tongue NOS, Posterior third of tongue) 
C02: Malignant neoplasm of other and unspecified parts of tongue 
C02.0 Dorsal surface of tongue: Anterior two-thirds of tongue, dorsal surface 
Excl.: dorsal surface of base of tongue (C01) 
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C02.1 Border of tongue: Tip of tongue 
C02.2 Ventral surface of tongue: Anterior two-thirds of tongue, ventral surface, 
Frenulum linguae 
C02.3 Anterior two-thirds of tongue, part unspecified: Middle third of tongue 
NOS, Mobile part of tongue NOS 
C02.4 Lingual tonsil Excl.: tonsil NOS (C09.9) 
C02.8 Overlapping lesion of tongue: Malignant neoplasm of tongue whose point 
of origin cannot be classified to any one of the categories C01-C02.4 
C02.9Tongue, unspecified 
C03: Malignant neoplasm of gum [(Incl.: alveolar (ridge) mucosa, gingiva; Excl.: 
malignant odontogenic neoplasms (C41.0-C41.1)] 
C03.0Upper gum 
C03.1Lower gum 
C03.9Gum, unspecified 
C04: Malignant neoplasm of floor of mouth 
C04.0 Anterior floor of mouth: Anterior to the premolar-canine junction 
C04.1 Lateral floor of mouth 
C04.8 Overlapping lesion of floor of mouth 
C04.9 Floor of mouth, unspecified 
C05: Malignant neoplasm of palate 
C05.0 Hard palate 
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C05.1 Soft palate (Excl.: nasopharyngeal surface of soft palate (C11.3) 
C05.2 Uvula 
C05.8 Overlapping lesion of palate 
C05.9 Palate, unspecified: Roof of mouth 
C06: Malignant neoplasm of other and unspecified parts of mouth 
C06.0 Cheek mucosa: Buccal mucosa NOS, Internal cheek 
C06.1 Vestibule of mouth: Buccal sulcus (upper)(lower), Labial sulcus 
(upper)(lower) 
C06.2 Retromolar area 
C06.8 Overlapping lesion of other and unspecified parts of mouth 
C06.9 Mouth, unspecified: Minor salivary gland, unspecified site, Oral cavity NOS 
C07: Malignant neoplasm of parotid gland 
C08: Malignant neoplasm of other and unspecified major salivary glands 
[Excl.:malignant neoplasms of specified minor salivary glands which are 
classified according to their anatomical location, malignant neoplasms of minor 
salivary glands NOS (C06.9), parotid gland (C07)] 
C08.0 Submandibular gland: Submaxillary gland 
C08.1 Sublingual gland 
C08.8 Overlapping lesion of major salivary glands: Malignant neoplasm of major 
salivary glands whose point of origin cannot be classified to any one of the 
categories C07-C08.1 
C08.9 Major salivary gland, unspecified: Salivary gland (major) NOS 
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C09: Malignant neoplasm of tonsil [Excl.: lingual tonsil (C02.4), pharyngeal 
tonsil (C11.1)] 
C09.0 Tonsillar fossa 
C09.1 Tonsillar pillar (anterior)(posterior) 
C09.8 Overlapping lesion of tonsil 
C09.9 Tonsil, unspecified- Tonsil:NOS, faucial, palatine 
C10 Malignant neoplasm of oropharynx [Excl.: tonsil (C09.-)] 
C10.0 Vallecula 
C10.1 Anterior surface of epiglottis: Epiglottis, free border [margin], 
Glossoepiglottic fold(s) Excl.:epiglottis (suprahyoid portion) NOS (C32.1) 
C10.2 Lateral wall of oropharynx 
C10.3 Posterior wall of oropharynx 
C10.4 Branchial cleft: Branchial cyst [site of neoplasm] 
C10.8 Overlapping lesion of oropharynx: Junctional region of oropharynx 
C10.9 Oropharynx, unspecified 
C11: Malignant neoplasm of nasopharynx 
C11.0 Superior wall of nasopharynx: Roof of nasopharynx 
C11.1 Posterior wall of nasopharynx: Adenoid, Pharyngeal tonsil 
C11.2 Lateral wall of nasopharynx: Fossa of Rosenmüller, Opening of auditory 
tube, Pharyngeal recess 
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C11.3 Anterior wall of nasopharynx: Floor of nasopharynx, Nasopharyngeal 
(anterior)(posterior) surface of soft palate, Posterior margin of nasal (choana, 
septum) 
C11.8 Overlapping lesion of nasopharynx 
C11.9 Nasopharynx, unspecified: Nasopharyngeal wall NOS 
C12: Malignant neoplasm of piriform sinus (Incl.:Piriform fossa) 
C13: Malignant neoplasm of hypopharynx [Excl.:piriform sinus (C12)] 
C13.0 Postcricoid region 
C13.1 Aryepiglottic fold, hypopharyngeal aspect- Aryepiglottic fold:NOS, 
marginal zone 
[Excl.:aryepiglottic fold, laryngeal aspect (C32.1)] 
C13.2 Posterior wall of hypopharynx 
C13.8 Overlapping lesion of hypopharynx 
C13.9 Hypopharynx, unspecified: Hypopharyngeal wall NOS 
C14: Malignant neoplasm of other and ill-defined sites in the lip, oral cavity 
and pharynx [Excl.:oral cavity NOS (C06.9)] 
C14.0 Pharynx, unspecified 
C14.2 Waldeyer ring 
C14.8 Overlapping lesion of lip, oral cavity and pharynx: Malignant neoplasm of 
lip, oral cavity and pharynx whose point of origin cannot be classified to any one 
of the categories C00-C14.2 
C32: Malignant neoplasm of larynx 
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C32.0 Glottis: Intrinsic larynx, Vocal cord (true) NOS 
C32.1 Supraglottis: Aryepiglottic fold, laryngeal aspect, Epiglottis (suprahyoid 
portion) NOS, Extrinsic larynx, False vocal cord, Posterior (laryngeal) surface of 
epiglottis, Ventricular bands 
Excl.: anterior surface of epiglottis (C10.1); aryepiglottic fold:NOS (C13.1); 
hypopharyngeal aspect (C13.1); marginal zone (C13.1) 
C32.2 Subglottis 
C32.3 Laryngeal cartilage 
C32.8 Overlapping lesion of larynx 
C32.9 Larynx, unspecified 
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Appendix 2: List of MIDAS treatment codes included 
within each grouping 
There are approximately 500 treatment fee codes (Items of Service) included in 
the Statement of Dental Remuneration (SDR), which is the primary dental care 
contract for NHS Scotland (PSD, 2017). For the purpose of this thesis, these 
codes were divided into three groups, namely, Exam and Diagnosis, Emergency, 
and Treatment. The list of individual treatment codes was too extensive to 
include in this Appendix, and the descriptions of the main items of service 
provided on the ISD website have been used to define the groups below instead 
(ISD Scotland 2017m). Please refer to the Statement of Dental Remuneration for 
the individual codes (PSD, 2017). 
Exam and Diagnosis 
1) Examinations: This includes three types of examination 
(a) Simple examination: This is the most common and can be claimed every 6 months 
for an adult patient.  
(b) Extensive examination: This can be claimed every 24 months for an adult patient. 
(c) Full case assessments: This can be claimed every 24 months for an adult patient. 
2) Radiographs (x-rays) 
 
Emergency 
1) Recalled attendance: happens when a dentist is required to return to his/her 
surgery out-with normal working hours to treat a patient who has a dental 
emergency. 
2) Treatment Urgently Required for Acute Conditions 
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3) Occasional Treatment: assessment and advice 
Treatment 
1) Simple periodontal: Treatment of the gums and supporting tissues of the 
teeth. Simple treatment includes scaling and polishing of the teeth and oral 
hygiene instruction. 
2) Complex periodontal: Complex periodontal treatment includes scaling of the 
teeth over a prolonged period with removal of overhanging ledges and oral 
hygiene instruction. 
3) Fillings: The most common method of treating caries is to provide a filling, 
also known as a restoration. The table shows data on fillings made from all 
materials available to dentists practising under the NHS General Dental Service 
regulations. The most common material used is silver amalgam. 
4) Root treatments: Root canal therapy is provided when infection reaches the 
pulp chamber (the nerve) within the hollow centre of the tooth. It involves 
removal of the inflamed or diseased tissue, shaping and sterilisation of the root 
canal and sealing of the canal with an inert, sterile sealant material. High 
incidence of claims for this item of treatment may indicate: poor dietary habits 
leading to decay; social deprivation; or dental treatment being sought only after 
pain occurs. 
5) Veneers: A thin layer of tooth coloured material to restore the appearance of 
a natural tooth surface if it is damaged or discoloured. 
6) Inlays: A gold restoration cast to fit a prepared tooth cavity when there is 
insufficient tooth tissue remaining to retain a filling. 
7) Crowns: Crowns are provided where there is insufficient sound tooth tissue 
remaining to restore the tooth by means of a filling. A crown is an artificial cap 
made of porcelain, porcelain and metal, metal or plastic material. It is shaped 
to represent the natural tooth surface which it replaces and is fitted over the 
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stump of the remaining natural tooth or over a metal post inserted into the root 
canal of a tooth which has previously undergone root canal treatment. 
8) Bridges: A bridge is a fixed dental appliance replacing a missing tooth or 
teeth. This appliance is fixed to natural teeth adjacent to the space created by 
the missing tooth or teeth. The pontic is the part of the bridge filling the space 
created by each missing tooth. 
9) Dentures: Dentures are removable appliances containing artificial teeth which 
replace natural teeth. The artificial teeth are held on a plate covering a greater 
area of the oral tissue than the space created by the missing tooth/teeth. A full 
denture is a plate containing artificial teeth replacing all natural teeth in the 
upper and/or lower jaw. A partial denture is a plate replacing one or more but 
not all natural teeth in the upper or lower jaw. 
10) Orthodontic treatment: Orthodontic appliance therapy is the treatment of 
crowded or misaligned teeth using removable and/or fixed appliances. 
11) Domiciliary visits: Domiciliary visits made by a dentist to provide dental 
treatment for a patient confined, because of their physical or mental condition, 
to their current place of residence. 
12) Extractions: Teeth are extracted when they are beyond repair, by patient 
treatment choice or electively for treatments such as orthodontics. 
13) Surgical treatments: A surgical extraction is an extraction which requires the 
lifting of a flap of gum and possibly the removal of a portion of bone to allow 
access to a tooth or root before it can be extracted.
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Appendix 3: Ethical approval letter from the West of 
Scotland Research Ethics Service  
 
 
 
 
 
 
 
 
 
 
 
WoSRES  
West of Scotland Research Ethics Service 
 
Dr Mitana Purkayastha 
 
 
West of Scotland Research Ethics Service 
 Ground Floor – The Tennent Institute 
 Western Infirmary  
 38 Church Street  
 Glasgow G11 6NT  
 Date 5th June 2014 
 Our Ref WoS ASD 958 
 Direct line 0141 211 2126 
 Fax 0141 211 1847 
 E-mail 
Judith.Godden@ggc.sc
ot.nhs.uk 
 
 
 
Dear Dr Purkayastha 
 
Full title of project: Burden of Oral Cancer in Scotland and the UK 
 
You have sought advice from the West of Scotland Research Ethics Service Office 
on the above project. This has been considered by the Scientific Officer and you 
are advised that based on the submitted documentation (email correspondence 
2nd April 2014) it does not need NHS ethical review under the terms of the 
Governance Arrangements for Research Ethics Committees (A Harmonised 
Edition). This advice is based on the following. 
 
• The project is a surveillance study using data only obtained as part of usual care. 
The data will be supplied as fully anonymous data sets and will be dealt with 
according to the governance arrangements already in place for each of these 
datasets. 
 
Note that this advice is issued on behalf of the West of Scotland Research Ethics 
Service and does not constitute a favourable opinion from a REC. It is intended to 
satisfy journal editors and conference organisers and others who may require 
evidence of consideration of the need for ethical review prior to publication or 
presentation of your results. 
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However, if you, your sponsor/funder or any NHS organisation feels that the 
project should be managed as research and/or that ethical review by a NHS REC 
is essential, please write setting out your reasons and we will be pleased to 
consider further. 
 
Where NHS organisations have clarified that a project is not to be managed as 
research, the Research Governance Framework states that it should not be 
presented as research within the NHS. 
 
Kind regards  
 
 
 
 
 
Dr Judith Godden, WoSRES Scientific Officer/Manager 
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Appendix 4: Ethical approval letter for Study 1 (Chapter 
2) from the University of Glasgow College of Medicine, 
Veterinary and Life Sciences Research Ethics Committee  
 
 
 
 
5th December 2014 
Dear Mitana Purkayastha, Dr David Conway, Dr Alex McMahon, Dr John Gibson 
 
 
MVLS College Ethics Committee 
 
 
Project Title: UK Trends in Head and Neck Cancer 
Project No:  200140024 
 
 
The College Ethics Committee has reviewed your application and has agreed that there 
is no objection on ethical grounds to the proposed study. They are happy therefore to 
approve the project, subject to the following conditions 
• Project end date: September 2017 
 
• The research should be carried out only on the sites, and/or with the groups 
defined in the application. 
 
• Any proposed changes in the protocol should be submitted for reassessment, 
except when it is necessary to change the protocol to eliminate hazard to the 
subjects or where the change involves only the administrative aspects of the 
project. The Ethics Committee should be informed of any such changes. 
 
• You should submit a short end of study report to the Ethics Committee within 3 
months of completion. 
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• Data Storage: the GU Code of Good Practice in Research states: “The University 
requires data to be securely held for a period of ten years after the completion of 
a research project.” 
 
 
 
Yours sincerely 
 
Prof. Andrew C. Rankin 
Deputy Chair, College Ethics Committee 
 
 Andrew C. Rankin 
Professor of Medical Cardiology 
BHF Glasgow Cardiovascular Research Centre 
College of Medical, Veterinary & Life Sciences 
 University of Glasgow, G12 8TA  
Tel: 0141 211 4833 
Email: andrew.rankin@glasgow.ac.uk 
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Appendix 5: Ethical approval letter for Study 2 and 3 
(Chapters 3 and 4) from the University of Glasgow College 
of Medicine, Veterinary and Life Sciences Research Ethics 
Committee  
 
 
 
17th December 2015 
Dear Mitana Purkayastha, Prof David Conway, Dr Alex McMahon, Prof John Gibson 
 
 
MVLS College Ethics Committee 
 
 
Project Title:  Opportunities for opportunistic oral cancer screening 
 
Project No:  200150057 
 
The College Ethics Committee has reviewed your application and has agreed that there 
is no objection on ethical grounds to the proposed study. It is happy therefore to 
approve the project, subject to the following conditions: 
• Project end date: March 2018 
 
• The data should be held securely for a period of ten years after the completion of the 
research project, or for longer if specified by the research funder or sponsor, in 
accordance with the University’s Code of Good Practice in Research: 
(http://www.gla.ac.uk/media/media_227599_en.pdf)  
 
• The research should be carried out only on the sites, and/or with the groups defined in 
the application. 
 
• Any proposed changes in the protocol should be submitted for reassessment, except when 
it is necessary to change the protocol to eliminate hazard to the subjects or where the 
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change involves only the administrative aspects of the project. The Ethics Committee 
should be informed of any such changes. 
 
• You should submit a short end of study report to the Ethics Committee within 3 months 
of completion. 
 
 
 
 
Yours sincerely 
 
Prof. Andrew C. Rankin 
 Deputy Chair, College Ethics Committee   
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Andrew C. Rankin 
Professor of Medical Cardiology 
BHF Glasgow Cardiovascular Research Centre 
College of Medical, Veterinary & Life Sciences 
 University of Glasgow, G12 8TA  
Tel: 0141 211 4833 
Email: andrew.rankin@glasgow.ac.uk 
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Appendix 6: ISD data confidentiality form 
 
 
Confidential Data Release Form 
 for users of NHS personal data 
 
 
1 User Details 
 
Name: Mitana Purkayastha 
Job title: Student 
Organisation: University of 
Glasgow Dental School 
Address: 378, Sauchiehall Street,
  
    City centre.  
    G2 3JZ      
    United Kingdom  
  
Tel No:07586408109 
 
Data Protection Reg No: 
Z6723578. 
 
2 Sponsor Details  
See Rule 6 for appropriate sponsor 
Name: Dr David Conway   
Job title: Clinical Senior Lecturer
  
Organisation: University of 
Glasgow Dental School  
Address: R1012 Level 10 
Glasgow Dental Hospital & School 
378 Sauchiehall Street 
Glasgow G2 3JZ 
   
 
Tel No: 01412119750 
 
3 Name(s) of all co-user(s):  
Only the user and people listed here will have access to the data. This should include only those for whom 
access is essential to the work. Please see rule 3 
 
Dr Alex McMahon 
 
Mitana Purkayastha 
  
4 Nature of data requested, including a list of variables required: 
Only data essential to the proposed work should be requested. 
 
See Appendix 1  
 
5 All purposes for which data will be used, including publications:  
No data which carries the risk of identification of an individual will be put into the public domain. Please 
refer to the Information Services Division’s (ISD) Statistical Disclosure Control Protocol and/or discuss with 
the ISD Head of Statistics where disclosure is a concern. Please see Rule 5 
 
 
-Research epidemiological analyses,  
-PhD thesis, 
-Publication in peer reviewed journal, 
-Dissemination at scientific meetings/conferences 
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6 Proposed method of transfer of data: 
The final decision will be taken in consultation with the NSS analyst and should comply with NSS policy 
 
nhs.net to alexander.mcmahon@nhs.net 
 
7 Measures in place to protect and use the data securely and confidentially:  
Describe the physical and electronic systems for data storage and access  
 
See Appendix 2 
 
8 Intended duration of use of data:  
All users and co-users must agree to destroy the data after an agreed date using a certificated electronic 
destruction process. Paper data must also be destroyed  
 
10 years 
 
9 Date data to be destroyed:  
Staff from NSS may contact to confirm destruction  
April 2024  
 
User’s Declaration 
I declare that I understand and undertake to abide by the Rules for 
confidentiality, security and release of data received from NSS as specified in 
paragraphs 1-5 listed below. 
 
Signature:   Date: 16/06/2014 
 
Sponsor’s Declaration 
I declare that _Mitana Purkayastha and Alex McMahon___ (name above as the 
user of the data requested), is a bona fide worker engaged in a reputable 
project and that the data requested can be entrusted to him/her in the 
knowledge that (s)he will conscientiously discharge his/her obligations in regard 
to confidentiality of the data, as stated in paragraphs 1-5 listed below. I am 
happy for him/her to receive these data. 
Signature: ___ ____________ Date: 
 ____18/6/14_____________________ 
 
Professional registration no.: eg GMC/GDC   71938 
 
 
For NSS only 
Caldicott Guardian, NHS National Services Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh, 
EH12 9EB  
Information request number ____________________________________________________ 
 
Release authorised by 
 ___________________________________Date_____________ Senior manager (HOG or HOP) 
 
 ___________________________________Date_____________ Caldicott Guardian or deputy 
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RULES ON CONFIDENTIALITY, SECURITY AND RELEASE OF INFORMATION 
FOR USERS OF NHS PERSONAL DATA 
 
1. Personal data held by NSS have been notified under the Data Protection Act 1998 
for the purposes of: 
Staff Administration Licensing and Registration  
Advertising, Marketing and 
Public Relations 
Research 
Accounts and Records Crime Prevention and 
Prosecution of Offenders 
Consultancy and Advisory 
Services 
Administration of Justice 
Health Administration and 
Services 
Trading/sharing in Personal 
Information 
Information and Databank 
Administration 
Blood Transfusion (Blood, 
Tissue and Stem Cells) Services 
Legal Services Lending and Hire Services, 
Library Services  
Public and Environmental 
Health Surveillance and 
Analysis 
Transfer of Primary Medical 
Records by Practitioner Services 
Education  National Fraud Initiative – Data 
Matching  
It cannot be used for any other purposes. 
 
2. If the data received from NSS are to be held on computer, the signatory of this 
request, or the organisation they represent, should have an appropriate 
notification with the Office of the Information Commissioner. Details of the 
registration number should be entered on page 1 of this document. Whether 
stored on computer or otherwise, the signatory should be aware that the Data 
Protection Act 1998 requires that all personal data is processed fairly and lawfully 
and in accordance with the Data Protection Principals. 
 
3. Data received from NSS should not be divulged to any person whose name is not 
specified as a ‘co-user of data’ nor used for any purpose other than that declared 
on page 1 (Intended use of data) of this document. All users and co-users must 
understand their responsibilities in protecting data provided. 
 
4. Proper safeguards should be applied in keeping the data secure and destroying it 
on completion of the work/project declared on page 1 to prevent any breach of 
confidentiality. Any misuse or loss of these data should be notified immediately 
to the NSS Data Protection Officer nss.dataprotection@nhs.net  
 
5. Statistics or results of research based on data received from NSS should not be 
made available in a form which: 
a) directly identifies individual data subjects or creates a risk of indirect 
identification. The risk should be assessed using ISD’s Statistical Disclosure 
Control Protocol and may be discussed with the ISD Head of Statistics if disclosure 
is a concern; 
b) is not covered by the ‘intended use of data’ clause specified on page 1. 
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6. Sponsor Details on form:  
• For release to NHS operational units of data relating to their own treated 
patients the sponsor should be the unit’s Medical Director. For releases of 
data relating to patients in a specific directorate, the relevant Clinical 
Director may sign the statement. 
• For release to NHS Boards of data relating to their resident population the 
sponsor should be Director of Public Health. 
• For release to CHPs of data relating to their resident population or of people 
treated in their units, the sponsor should be the Clinical Director of the CHP  
• For release of data to General Practice regarding their registered patients, 
the sponsor should be a GP principal in that practice. 
• For releases to researchers of data which have not required PAC authorisation, 
the sponsor will be the registered health professional responsible for ensuring 
the confidentiality of the data. 
• For release of data to an organisation holding a contract with an NHS Board 
or with the Scottish Government: for the purpose of fulfilling that contract 
the sponsor will be the NHS Board Director of Public Health or a registered 
health professional in the Scottish Government. 
• For release of workforce data, the sponsor should be a senior manager in the 
organisation to which data will be released 
 
7. The information provided to you is derived from systems used in the NHS for 
the administration of health services or from the registrations held by the 
General Register Office for Scotland. Although there are quality assurance 
processes in place, the data may contain undetected inaccuracies about an 
individual patient, member of staff or department. Therefore the data are 
not collected for the purpose of informing direct clinical decisions about 
individual patients, or judging the performance of individual staff and should 
be verified if to be used for either of these purposes.  
 
8. A signed paper copy of the confidentiality statement should be sent to the analyst 
by mail or by fax to the following fax no. 0131 275 7606 
 NSS would welcome copies of any publications based on data supplied.
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Appendix 7: Information Governance training from the 
Medical Research Council 
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Appendix 8: University of Glasgow Data Security Protocol 
 
 
 
 
Community Oral Health Section, School of Medicine, College of Medicine, 
Veterinary and Life Sciences, Glasgow Dental Hospital and School. 
 
CONFIDENTIAL DATA SECURITY PROTOCOL [v. 27 May 2014] 
 
Named responsible individual: David Conway 
 
Data security is, however, everyone’s responsibility.  
.  
• Via the consent process, we have been trusted with confidential information 
(defined in Appendix 1). It is our duty to ensure that the privacy and 
confidentiality of the data are respected. 
• Data security includes recording, storage, access, transfer, uses, and retention of 
data records. 
• Data security is relevant for both paper and electronic records and for both 
quantitative and qualitative data. 
 
All new members of staff at the Community Oral Health Section will require 
clearance through Disclosure Scotland prior to taking up post.  
 
Both permanent Unit staff (employed by Glasgow University or NHS Scotland) 
and temporary staff employed by the Community Oral Health Section through 
Glasgow University’s approved recruitment agency (Blue Arrow) will be required 
to sign the Unit’s research data security and confidentiality agreement. 
 
Recording / Entering data: 
• Data must be accurate / authenticate / credible / and verifiable. 
• The data need to be accurately entered. 
• Data validation and check procedures must be followed. 
• Validation includes randomly checking 10% of records.  
• Missing data should be logged and followed up. 
 
Mobile devices:  
• Data should only be collected on encrypted laptops.  
• Confidential data should not be saved onto key sticks, CDs, external hard-drives 
or smart phones. 
 
Storage of data: 
• Offices must be locked when unoccupied.  
• Paper records must be stored in locked cabinets. 
• Computer files and databases must be password protected. 
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• Computers must be locked when away from desk [Ctrl, Alt, Del → Lock 
Workstation]. 
• Databases and audio recordings need to be backed up and saved in the 
appropriate folder on the MVLPublic (J:) drive at: 
o J:\MED\DentalSchool\DPHU 
o Access to each folder should be on a ‘need to use’ basis and is controlled 
centrally by IT Services 
o Local management of the DPHU folder is undertaken by Research Secretary – Mr 
John McHugh 
• Duplicate copies of databases and audio recordings should be avoided. 
• All audio-recordings should be deleted from recording devices once uploaded to 
the J Drive. 
 
Access to data( J:\MED\DentalSchool\DPHU): 
o Access to confidential Childsmile data should be accessed by authorised 
individuals only (please see Appendix 2). 
• No unauthorised access is permitted.  
• Passwords (both computer log-in and those associated with individual data files) 
must be changed following staff changes. 
• All team members with access to data will have to sign a confidentiality form. 
• Access to confidential data from individual research studies, undertaken as part 
of the evaluation of Childsmile, will be allocated on a strict ‘need to access’ 
policy.  
 
Transfer of data: 
• Data-base creation, data extraction and data transfer should be kept to a 
minimum. 
• All transfers of confidential data, including those between named data users 
within the Community Oral Health Section (listed above), need to be approved 
by David Conway.  
• Confidential data should only be transferred outwith the Community Oral Health 
Section following approval of David Conway. 
• Electronic data containing personal identifiers must only be sent from and to 
nhs.net email addresses or by using a secure enhanced file sharing service such 
as Globalscape. 
• Databases need to be password protected. 
• Passwords must be sent in a separate e-mail. 
 
Uses: 
• Analyses of confidential data should be done on the University J Drive only. 
• For evaluation and research purposes all data will be analysed anonymously, i.e., 
confidential information, name, date of birth, postcode and CHI will be 
removed. 
• Transfer procedures (above) need to be followed prior to release for analysis.  
• No publication will appear in any form in which an individual may be identified 
unless the written permission of that individual has been obtained.  
 
Retention: 
• In keeping with the Data Protection Act (1998) records will not be retained for 
longer than necessary.  
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• Records required for current business: paper records should be stored in locked 
cabinets in the Community Oral Health Section and electronic records on the 
University servers.  
• Following completion of a study and of all analyses, confidential data will no 
longer be stored at the Community Oral Health Section.  
• Records no longer required for current business use will be transferred to the 
University Records Centre for archiving.  
• In the case of Childsmile, confidential records will be transferred to NHS NSS ISD 
for storage in the dental data warehouse.  
 
Audit: 
Information stored on the University J drive will be subject to internal review on 
a quarterly basis and all unnecessary files (e.g.., duplicate databases or 
database extractions no longer required) deleted. University of Glasgow Records 
and Information Management Service will audit our protocols. 
  
SHIP Safe Haven 
 
Members of staff at the Community Oral Health may be authorised to access the 
Scottish Health Informatics Programme (SHIP) system. Access to the SHIP system 
is for approved only and unauthorised users must not access the system.  
 
• Appropriate approvals (e.g.. PAC, CHIAG, Cladicott Forum) must be granted. 
• Users are required to have ‘SHIP-approved researcher status’ which includes 
attendance at an appropriate training session.  
• No data or tables should be removed from the SHIP system without approval from 
a Research Coordinator (RC). The RC will run a disclosure control on tables to be 
released to ensure data confidentiality. 
 
The Community Oral Health Section may also be asked to provide data to be 
used in the SHIP system.  
• Data should only be provided to an approved member of the eDRIS team after 
appropriate data approvals have been granted.  
• Data must not be provided directly to the researcher accessing the data within 
SHIP. 
• A secure enhanced file sharing service such as Globalscape must be used to 
transfer data between the Community Oral Health Section and eDRIS.  
• To access the file sharing service, eDRIS will supply a username by email and a 
the corresponding password by phone. 
 
For further guidelines and assistance, please contact eDRIS at nss.edris@nhs or 
0131 275 7333. 
 
 
 
 
What is confidential information?  
 
The term “Confidential Information” applies to: 
• data relating to identifiable individual patients, donors, NHS 
Scotland staff or practitioners: 
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o in hand-written, typewritten, printed or machine readable form 
o on a document, microfiche, CD, magnetic medium (disk, tape, video, etc.) or computer 
screen 
• some business data, including that relating to financial 
information, details of projects, trade secrets, programming code  
copyright. 
 
Individuals may be identified by: 
• name 
• unique reference number (e.g.., CHI number, hospital case reference number/patient 
identifier, NHS number, GMC number, etc.) 
• address 
• postcode 
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Appendix 9: Approval letter from the Public Benefit and 
Privacy Panel for Health and Social Care 
 
 
 
Public Benefit and Privacy Panel for Health and Social Care 
nss.PBPP@nhs.net  
www.informationgovernance.scot.nhs.uk 
 
 
Ms Mitana Purkayastha  
University of Glasgow Dental School  
Community Oral Health  
378 Sauchiehall Street  
City Centre  
Glasgow  
G2 3JZ 
 
Date: 21st April 
2016  
Your Ref:  
Our Ref: 1516-
0378  
 
 
Dear Ms Purkayastha 
 
 
Re: Application 1516-0378/Purkayastha: Opportunities for opportunistic oral cancer 
screening 
 
Thank you for your application for consideration by the Public Benefit and Privacy Panel for 
Health and Social Care. 
Your application has undergone proportionate governance review and has been approved. 
 
The Panel have made the following comment 
 
• Should, following this proposal, a recommendation be made to develop an oral screening 
programme this phase will require completion of a Privacy Impact Assessment and should also 
include an appropriate public engagement exercise 
 
This approval is given to process data as specified in the approved application form, and is limited 
to this. Approval is valid for the period specified in your application. You are required to notify 
the Panel Manager of any proposed change to any aspect of your proposal, including purpose or 
method of processing, data or data variables being processed, study cohorts, individuals accessing 
and processing data, timescales, technology/infrastructure, or any other relevant change. 
 
I would take this opportunity to remind you of the declaration you have made in your application 
form committing you to undertakings in respect of information governance, confidentiality and 
data protection. In particular you should be aware that once personal data (irrespective of de-
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identification or other controls applied) has been extracted from NHSS Board(s) and transferred to 
you, that you will then become the Data Controller as defined by the Data Protection Act (1998). 
 
Please note that summary information about your application and its approval, including the title 
and nature of your proposal, will be published on the panel website 
(www.informationgovernance.scot.nhs.uk). 
 
I hope that your proposal progresses well, 
 
Yours Sincerely 
 
Ashley Gray 
Panel Manager 
NHS Scotland Public Benefit and Privacy Panel for Health and Social Care 
Email: nss.PBPP@nhs.net 
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Appendix 10: eDRIS User Agreement 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
National Services Scotland (NSS)  
eDRIS User Agreement 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NSS is the commonly known name of the Common Services Agency (CSA) 
© NHS National Services Scotland 2013. All rights reserved 
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1. INTRODUCTION  
This document is the Agreement that Users of eDRIS enter into prior to 
accessing data. It also contains information on the current legal framework 
and the penalties that may apply should you breach this Agreement. 
 
1.1 The Parties 
 
Parties to this Agreement are:- 
 
I. You being an individual User (as hereinafter defined); and 
II. The Common Services Agency (more commonly known as National 
Services Scotland), a statutory body constituted pursuant to the 
National Health Service (Scotland) Act 1978 (as amended) and having 
its headquarters at Gyle Square, 1 South Gyle Crescent, Edinburgh, 
EH12 9EB, acting through eDRIS (“NSS”); and 
 
III. The Sponsoring or Employing Organisation1 (as hereinafter defined) 
 
1.2 The Context 
 
1.2.1 The Farr Institute @ Scotland2 is a research collaboration bringing 
together the Universities of Aberdeen, Dundee, Edinburgh, Glasgow, St 
Andrews and Strathclyde with NSS. The Farr Institute is a collaboration to 
harness health data for patient and public benefit and to ensure the safe and 
secure use of electronic patient records and other population-based datasets 
for research purposes. The Farr Institute follows the Guiding Principles for 
Data Linkage. 
 
1.2.2 Electronic Data Research and Innovation Service (eDRIS) is a service 
designed to provide a single point of contact and to assist researchers in study 
design, approvals and data access via a secure analytical environment. eDRIS 
is designed to assist researchers to uphold the Guiding Principles for Data 
Linkage and is a NSS service. 
 
1.3 NSS eDRIS User (‘User’ and also referred to herein as “you”) 
 
To be given NSS eDRIS User status and provided with appropriate access to 
study datasets you must comply with the following:- 
 
1.3.1 You must demonstrate that you have satisfactorily completed a 
mandatory NSS approved training course which ensures you are fully aware 
of the policies and procedures governing individual privacy, data protection 
and freedom of information. 
 
1.3.2 You must be aware of the sanctions which may apply should you 
breach this Agreement or compromise the security, availability or 
confidentiality of the data. 
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1.3.3 You will re-attend training within 2 weeks of the expiry of your 
training certificate if this occurs within the time period of your study. 
 
 
1.3.4 The study you are working on must have evidence of approval from 
the relevant authorising bodies, for example, Privacy Advisory Committee 
(“PAC”),  
CHI Advisory Group (CHIAG), ethics where appropriate. 
 
 
1.3.5 You have read the NHS Confidentiality Code of Practice  
 
1.3.6 You are affiliated with an Approved Organisation. 
 
1.3.7 You sign, date and complete the declaration agreeing to be bound 
by the requirements of this document and return it prior to being given 
access to your data. The declaration must also be signed by an authorised 
signatory from your Authorising organisation. 
 
1.3.8 You confirm to be bound by this Agreement at every login to eDRIS. 
 
  
 
1 Hereafter referred to as Authorising Organisation.  
2 The Farr Institute @ Scotland replaced the ScottisH Informatics 
Programme (SHIP). 
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2 RESPONSIBILITIES 
 
 
2.1 User Responsibilities 
 
2.1.1 As a User you are required to familiarise yourself with the contents of 
this Agreement and the Data Protection Principles (see Appendix A hereto). 
You are obliged to be guided by the Guiding Principles for Data Linkage and 
uphold the security and confidentiality of the data and IT resources made 
available to you as a User. 
 
2.1.2 As a User you are responsible for ensuring that the data you are working 
on is not read, viewed or handled by anyone not named in the relevant 
approvals for that study. If it appears that anyone is deliberately attempting 
to view, read or handle data not within their authorised duties, the facts 
must be reported by you immediately to the Research Coordinator. 
 
2.1.3 As a User if you are responsible for, or aware of the occurrence of an 
unintentional disclosure of information, you must report this without delay 
to the Research Coordinator. 
 
2.1.4 As a User you must not login, or attempt to login to the national safe 
haven from an environment not meeting the national safe haven 
requirements notified to you by NSS from time to time. Some Users will be 
allowed remote access to the national safe haven but they must ensure that 
the data can not be viewed by anyone not identified in the relevant approvals 
for this study. 
 
2.1.5 As a User you should not discuss information which could breach an 
individual’s privacy in public places; in this context a public place may be 
taken to be anywhere where people not directly involved with the study may 
be present. 
 
2.1.6 As a User you must only access the national safe haven from 
workstations managed by your Authorising Organisation or from a recognised 
safe setting (safe access point). 
 
2.1.7 ‘Revolution R Enterprise’ analytical tool is provided for ‘Academic Use’ 
only for bona-fide academic, non commercial purposes by academics. 
‘Academic Use’ means any teaching and/or non-government funded research 
as conducted by or under the direction of a professor or other academic 
professional within an academic environment and excludes any and all 
commercial use. 
 
2.1.7.1 Academic Users will not be allowed to use data or data outputs 
generated through use of the data, regardless of their origin for any 
commercial exploitation. 
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Examples of commercial use of data (and therefore forbidden use) include: 
2.1.7.2 Using the data for “commercial” research where the research is 
undertaken for the private purposes of an organisation and / or where the 
primary objective is to generate income. This objective is distinct from non-
commercial research where the primary objective is to put material in the 
public domain for the public benefit. 
 
2.1.7.3 Acting as paid ‘agents’ of businesses for whom the research study was 
not designed nor funded. 
 
2.2 Authorising Organisation3 
 
2.2.1 Approved Organisations for direct access to individual level data via 
eDRIS are restricted to public sector organisations (e.g.. Universities, NHS, 
Local Authorities and Scottish Government). Researchers/Users from the 
Scottish Government and Local Authorities will have access to data via a safe 
setting only. 
 
2.2.2 The Authorising Organisation agrees to abide by the terms of this 
Agreement and takes responsibility for ensuring that the User(s) comply with 
the provisions of this Agreement. 
 
2.2.3 The Authorising Organisation needs to be aware that any breach of 
this Agreement may lead to the withdrawal of access to eDRIS for the 
Organisation and its staff, and that NSS may report serious legal or 
regulatory breaches to the appropriate authorities (such as the Information 
Commissioner and professional regulatory bodies). 
 
2.2.4 Licences for MS Office 2010 (e.g.. word, excel etc) must be provided 
entirely at its own expense by the Authorising Organisation for Users 
accessing eDRIS remotely. 
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3 ACCESS TO DATA 
 
 
3.1 Requirements for accessing data in the national safe haven both via 
remote access and via a safe setting. 
 
3.1.1 Prior to being given access to the data, you must have read and signed 
this Agreement. If you have any questions about the contents of this 
Agreement you should raise them with your Research Coordinator. 
 
3.1.2 At the start of the study you will be allocated a user name and 
password which will provide you with access to the study data folder. 
 
3.1.3 At each login to the study you will be required to re-affirm your 
undertaking to uphold data confidentiality and security in terms of 
this Agreement. 
 
3.1.4 Telephone conversations should not be held while accessing the 
national safe haven. The only exception being to contact the Research 
Coordinator or a member of the research team for the relevant study. 
 
3.1.5 You must not leave your workstation unattended for any reason 
unless you ensure that you either log out or activate the screen saver. 
 
3.1.6 All output(s) must be cleared with the Research Coordinator to ensure 
that they do not breach an individual’s privacy. Under no circumstances will 
uncleared output(s) be released (see Section 5 below). 
3.2 The national safe setting is located at Nine BioQuarter, Little France Road, 
Edinburgh. 
 
3.2.1 Your visit to the safe setting must be pre arranged and take place within 
normal working hours (08.30 - 16.30 Monday to Thursday, 08.30 – 15:30 Friday). Your 
visit is at NSS convenience and may be cancelled or rescheduled at any point. 
 
3.2.2 On arrival at Nine BioQuarter you will come up to the 2nd floor. Please ask at 
the main building reception for the location of the lifts or stairs. Access to the Farr 
Institute office is via the buzzer at our main office door. 
 
3.2.3 You will be met by the Research Coordinator or another member of the eDRIS 
team. They will ask to see your Photo ID and you will be asked to sign the Visitors 
book. You will be issued with a visitor’s pass. 
 
3.2.4 Whilst at Nine BioQuarter you will abide by all local policies pertaining to 
visitors to the site e.g.. car parking, smoking, health and safety, fire evacuation, 
etc. These will be explained to you by your eDRIS Research Coordinator or team 
member. 
 
3.2.5 The use of landlines / mobile phones or any other mobile device within the 
national safe haven room / booth located at Nine BioQuarter is not allowed. Phones 
and other devices must be switched off and stored in a locker along with any bags. 
Only paper, pen and reference books are allowed in the room or booth. 
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3.2.6 If you need to make or receive a call please do so in the kitchen area. 
Having telephone conversations in the safe setting room / booth where data 
access is provided is not allowed. 
 
3.2.7 CCTV is in operation in each safe setting room / booth recording behaviour. 
No audio is recorded. Images are retained for 30 days before being overwritten. 
CCTV is not optional. 
 
3.2.8 At the end of your visit you will be escorted back to reception where you 
must sign out from the visitors’ book and return your visitor’s pass. 
 
3.2.9 Procedures to be followed at other safe settings may differ. 
 
 
Authorising Organisation is defined in Appendix B - Glossary. 
  
5 
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4 DATA SECURITY 
 
4.1 Handling of data  
4.1.1 All Users are required to maintain the security and confidentiality of their 
study datasets in accordance with this Agreement and  
 will not reuse data for purposes outside the scope of each approved study  
 will not share data with anyone who is not a named user on the approvals granted 
for that study  
 will not attempt to link the study data to any other data without explicit 
permission  
 will not attempt to identify any individual within the study data  
 will not attempt to reuse the data for commercial purposes beyond those stated in 
the approvals granted prior to the study commencing  
 will not share their login details with any other person  
 will remotely access eDRIS only in suitable locations where work cannot be read by 
anyone not named on the approval request. 
 will not discuss information which could breach an individual’s privacy in a 
public place, in this context a public place may be taken to be anywhere 
where people not directly involved with this study may be present.
 
 
4.1.2 The eDRIS Service will securely archive the data, analysis syntax, and output 
associated with the study when the study is complete. 
 
4.2 Storage and copying of Data 
 
4.2.1 The storage of or copying of data outwith the eDRIS technical environment is 
strictly forbidden. 
 
4.2.2 Under no circumstances should data be written from the workstation screen 
or attempts made to save screen shots or photograph the screen. 
 
4.2.3 Under no circumstances should attempts be made to use removable data 
storage devices (e.g.. USB storage devices, memory pens/sticks, personal digital 
assistants (PDAs), etc). The eDRIS technical environment includes software to 
monitor system use. 
 
5 RELEASE OF OUTPUT 
 
5.1 Release of Statistical Output  
5.1.1 All output will be reviewed by the Research Coordinator and will only be 
released in line with the Data Controllers’ disclosure control requirements. At the 
end of your session you must request your outputs to be disclosure cleared by your 
assigned Research Coordinator. The Research Coordinator will review your outputs, 
and thereafter if cleared for release will send them to you via email. 
 
5.2 Output Clearance 
 
5.2.1 The User agrees to meet the requirements of safe, non disclosive outputs. 
 
5.2.2 Only outputs which have been approved as non disclosive can be used as part 
of presentations, publications, papers and analysis. If the approval granted 
stipulated a requirement that you share all analysis/papers etc. with the Data 
Controller it is your responsibility to ensure that you comply. 
 
5.2.3 In the event that eDRIS, taking advice from NSS, decides not to release the 
requested output, the User will have an opportunity to demonstrate to eDRIS and, 
where appropriate, the study Data Controllers, that the outputs are anonymised and 
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safe for publication or release. However, the final decision to release any output 
remains with eDRIS and not the User. 
 
5.2.4 On request from the eDRIS Research Coordinator the User must provide a 
description of variables used, new variables/measures/indices created, 
documentation of datasets and programs used in producing analytical output(s) to 
ensure that the Research Coordinator has the information needed to make a decision 
on the request for output release. 
 
5.2.5 The User shall ensure that all publications in any format should acknowledge 
NSS. Depending on the content of the data it may also be courteous to acknowledge 
the Data Controller(s) associated with the study. Abstracts/papers intended for 
journal publication may be required to be reviewed for clearance by your Research 
Coordinator. If it is intended to present any unpublished data at a 
conference/seminar an abstract may be required for clearance. These obligations 
are at the discretion of the Data Controller(s) and should be agreed between all 
parties prior to the study commencing. 
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6. GENERAL PROVISIONS 
 
6.1 Interpretation 
 
If you require an explanation concerning the interpretation or the relevance of this 
Agreement you should discuss the matter with your Research Coordinator. 
 
6.2 Non-Compliance  
Any breach of this Agreement may result in the User and his/her organisation 
being subjected to investigation in accordance with eDRIS Sanctions (see Section 7 
below). 
 
6.3 Amendments  
This Agreement will be amended as required to reflect the development of policy 
and procedures, and the changing needs in security and confidentiality. 
 
 
7. OFFENCES AND PENALTIES 
 
7.1 Offences  
7.1.1 Signing this Agreement demonstrates that the prospective User understands 
the seriousness of the undertaking and that they and their authorising organisation 
understand the penalties that may be imposed hereunder for breaches of security 
or confidentiality. 
 
7.1.2 It is essential that Users understand the nature of, and reason for, penalties 
for breaches which either constitutes non-compliance with this Agreement and other 
standards, or more serious incidents which could lead to the disclosure of personal 
information. Therefore, Users are only able to access study datasets if they have 
signed this Agreement and successfully completed mandatory training approved by 
NSS from time to time and also fulfilled the criteria stated in Section 1.3 above. 
 
7.1.3 NSS reserves the right to suspend access to the national safe haven if they 
believe that any User is perpetrating or attempting to perpetrate any of the 
breaches listed in Table 1. 
 
7.1.4 NSS has discretionary powers over the application of penalties for self-
reported breaches. 
 
7.1.5 Application of the penalties for intentional breaches of this Agreement is non-
discretionary. The penalties for such breaches (set out in Table 1 below) are fixed 
tariffs. 
 
7.1.6 Self-reported unintentional breaches will be penalised with discretion; if a 
penalty is to be applied the relevant tariff (set out in Table 1 below) will be 
considered a maximum only. Users who take full and prompt action to report an 
unintentional breach will not normally be penalised but may be asked to repeat 
training. Penalties for repeated self-reported but unintentional breaches will 
increase at NSS’s discretion with each breach committed. 
 
7.1.7 All breaches and the penalties and tariffs applied will be reported in full by 
the Research Coordinator to the NSS Executive Team and other interested parties. 
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7.2 Legal / Statutory Penalties 
 
7.2.1 NSS believe that penalties will only be an effective deterrent if they 
are fully understood, and it should also be clear that we are much more 
concerned about prevention than punishment. 
 
7.2.2 The Statistics and Registration Services Act (SRSA) 2007 Act states, in 
section 39(9) that a person who contravenes subsection (1) “is guilty of an 
offence and liable —  
(a) on conviction on indictment, to imprisonment for a term not exceeding 
two years, or to a fine, or both; (b) on summary conviction, to imprisonment 
for a term not exceeding twelve months, or to a fine not exceeding the 
statutory maximum, or both.” 
 
7.2.3 However, this subsection of the Act does not apply when the person 
making the disclosure “reasonably believes” that either Personal Information 
is not specified in the information which is disclosed, or that that a person's 
identity can not be deduced from the information, or that a person's identity 
can not be deduced from the information taken together with any other 
published information. 
 
7.2.4 Nevertheless, the removal of Personal Information from the secure 
confines of a Safe Haven remains a breach of this Agreement, regardless of 
whether a User had ‘reasonable belief’. Users are advised through this 
Agreement that they should regard only the statistical outputs which they 
have received from the Research Coordinator or NSS member of staff, to be 
non-disclosive, and that receiving such an output from the Research 
Coordinator or NSS member of staff is the basis for their ‘reasonable belief’. 
 
7.2.5 Users are made aware through this Agreement that NSS will always seek 
prosecution for any breach of the SRSA 2007. Under the SRSA 2007 legislation, 
the only exceptions are where the disclosure was unintentional and self-
reported, or the ‘reasonable belief’ defence is unambiguously relevant. 
However, the reasonable belief defence is effectively removed through 
notification in this Agreement (see Section 7.3 below). 
 
7.2.6 Section 55 of the Data Protection Act 1998 states that the knowing or 
reckless obtaining or disclosure of personal data without the consent of the 
data controller is a criminal offence. NSS will inform the appropriate 
authorities if they believe a section 55 offence has been committed by a 
User. 
 
 
7.3. Non-compliance 
 
7.3.1 A series of penalties for breaches will come into force when this 
Agreement and Declaration are signed. The majority of these breaches can 
be dealt with by NSS with no additional input from the relevant Data 
Controller(s) for the specific study. The result of any public breaches as per 
sections 10 through 13 inclusive in Table 1 below would be a very high loss of 
trust in eDRIS, and cause considerable political damage to Farr Institute @ 
Scotland and NSS. 
 
318 
 
 
7.3.2 NSS is capable of carrying out any individual User or institutional ban. 
 
7.4 Use of data for personal or commercial gain 
 
7.4.1 Unless stated in the approvals granted prior to the study commencing 
the selling on, and any other commercial exploitation, of data or outputs 
created through the use of the national safe haven for any personal financial 
or commercial exploitation or gain, and such use of eDRIS by Users acting as 
paid ‘agents' of businesses, are strictly forbidden. 
 
7.5. Right of appeal 
 
7.5.1 The right to an internal appeal is allowed. Thus all appeals should be 
to the stakeholder with the highest level of involvement with the offence. 
 
7.5.2 If a User considers a penalty following a self-reported unintentional 
breach is unfair, the right of appeal is to the organisation(s) with the primary 
responsibility for enforcement (as detailed in the Table 1 below). 
 
7.6. Offences and Penalties 
 
7.6.1 The penalties listed in Table 1 below, for intentional discovered 
breaches, are non-discretionary. The penalties for such breaches are fixed 
tariffs. 
 
7.6.2 Penalties may be imposed at the discretion of NSS for other offences 
not listed in Table 1 below that are considered by NSS to breach the terms 
and conditions of the use of eDRIS. 
 
7.6.3 Under this Agreement, and if an obligation agreed by all parties hereto 
prior to the study commencing (see section 5.2.5 above) the User agrees to 
inform the Research Coordinator of any publications (external conferences, 
journal articles, reports) using outputs from eDRIS and also of any errors 
found in the data, outputs or publications. Whilst there is no formal penalty 
hereunder for not informing NSS, the User may be contacted by the Research 
Coordinator to provide such information. If the User does not provide such 
information, NSS reserves the right to take appropriate action. 
 
7.6.4 It should be noted that whilst data subjects are not the owners of the 
data for the purposes of this document, they have the right to take 
independent civil action against any offender who damages them by release 
of their Personal Information. 
 
0 
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Table 1 
 
Offence Expected Penalty Notes/Example Type 
1. Using the service 
and/or data for 
commercial purposes 
beyond those stated in 
the relevant approvals 
prior to the study 
commencing 
First offence 6 months access 
suspension 
Second offence 1 year access 
suspension 
Third offence permanent suspension 
See Sections 2.1, 4.1.1 and 7.4 of 
this Agreement 
NSS eDRIS User 
Agreement 
  
2. Infringing safe haven 
requirements 
First offence 6 months access 
suspension 
Second offence 1 year suspension 
Third offence permanent suspension 
 NSS eDRIS User 
Agreement 
 
   
3. Attempting to 
infringe data security 
requirements 
First offence 2 years access suspension 
Second offence permanent suspension 
See 10 below ‘infringing data 
security requirements’ 
NSS eDRIS User 
Agreement 
   
4. Transferring log in 
details to any other 
user 
First offence 1 year access suspension 
Second offence permanent suspension 
This includes sharing login details 
(whether user name, password or 
both) with someone else, even 
someone working on the same 
project or a supervisor. 
NSS eDRIS User 
Agreement 
 
5. Providing false 
information on the NSS 
eDRIS User 
Agreement or 
Declaration 
Permanent suspension  NSS eDRIS User 
Agreement 
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Table 1 
 
Offence Expected Penalty Notes/Example Type 
6. Attempt to access 
datasets to which not 
authorised 
Permanent suspension  NSS eDRIS User 
Agreement 
7. Attempt to use data 
for purpose not 
specified in the 
Application 
Permanent suspension An example includes using data 
obtained under a study for a new 
research study that has not been 
approved. 
NSS eDRIS User 
Agreement 
 
8. Attempt to use data 
or Output other than 
for 
statistical research 
Permanent suspension An example includes selling 
eDRIS 
data or eDRIS Outputs for 
personal 
or corporate financial gain. 
NSS eDRIS User 
Agreement 
9. Sharing any data 
which have not been 
disclosure cleared. 
Permanent suspension 
NB sharing data outputs which prove to be disclosive 
will 
be subject to more severe penalties. 
This includes, for example, data 
transcribed, written or 
photographed from the screen 
NSS eDRIS User 
Agreement 
   
10. Infringing data 
security requirements 
a) Permanent suspension (individual); 
AND 
b) 1 year suspension (authorising organisation) 
See Section 4 (Data Security). NSS eDRIS User 
Agreement 
Violation of Statutory 
Law (Criminal Offence) 
 
11. Failure to report a 
Disclosure 
First offence 1 year access suspension (individual) 
Second offence permanent suspension (individual); 
AND 
b) First offence 6 months suspension (authorising 
organisation) 
Second offence 1 years suspension 
(authorising organisation) 
An example includes where there 
has been an unintentional 
disclosure and the User has 
become aware and has chosen 
not 
to inform the Research 
Coordinator 
NSS eDRIS User 
Agreement 
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Offence Expected Penalty Notes/Example Type 
12. Attempt to 
identify 
individuals 
a) Permanent suspension from all eDRIS data 
services 
(individual); 
AND 
b) 1 year suspension from all eDRIS data services 
(authorising organisation/institution) 
Section 55 of the Data Protection Act 1998 states 
that the 
knowing or reckless obtaining or disclosure of 
personal 
data without the consent of the data controller is a 
criminal 
offence. 
This is where a User attempts to 
identify an individual, household 
or 
business in the data. 
NSS eDRIS User 
Agreement 
Violation of Statutory 
Law (Criminal 
Offence) 
13. Deliberately 
making disclosive 
data 
available to others 
a) Permanent suspension from (individual); 
AND 
b) 1 year suspension from eDRIS (authorising 
organisation/institution) AND 
Making disclosive data available to others is a 
criminal 
offence and breaches may be subject to 
prosecution. 
Identifying a relevant individual and providing that 
information to another party for personal gain is a 
serious 
criminal offence in terms of the Statistics and 
Registration 
Service Act, with potentially a 2 year jail term, a 
£2000fine, and a criminal record.  Section 55 of the 
Data Protection Act 1998 states that the knowing or 
reckless obtaining or disclosure of personal data 
without consent of the data controller is a criminal 
offence 
 NSS eDRIS User 
Agreement 
Violation of Statutory 
Law (Criminal 
Offence) 
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8. REVIEW 
 
This Agreement will be reviewed by NSS every two years or more frequently 
if appropriate, to take into account changes to legislation that may occur, 
and/or guidance from the Scottish Government, NSS and Farr Institute @ 
Scotland. 
 
9. DECLARATIONS AND AGREEMENT 
 
The parties hereto hereby declare and agree to comply with all the provisions 
of this Agreement as follows:- 
 
9.1 Study Number 
 
 
 
Please ensure that sections 9.2 and 9.3 are completed before returning this 
form to eDRIS. 
Where relevant section 9.4 should also be completed. 
 
9.2 NSS eDRIS User (You) 
 
By signing and dating below you confirm that you have read, understood and 
agree to comply with all the provisions of this Agreement. Any breach by you 
of this Agreement will result in your access being restricted and may be 
subject to eDRIS sanctions. NSS has a duty, and is entitled hereunder, to 
report legal or regulatory breaches to the appropriate authorities (such as 
the Information Commissioner and professional regulatory bodies). 
  
 
 
 
9.3 Your Authorising Organisation  
(Note: Must be signed by a Head of Department, Information Custodian, or 
equivalent.) 
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“We declare that the above named User is a bona fide researcher engaged in 
a reputable study for which all relevant required permissions have been 
granted, and that the data requested can be entrusted to this person in the 
knowledge that they will conscientiously discharge their obligations in regard 
to the confidentiality of the data. This Organisation agrees to abide by all the 
terms of this Agreement and shall ensure that the above named User complies 
with all the provisions of this Agreement. 
 
 
 
We declare that we understand that any breach of this Agreement by us or 
by the above-named User may lead to the withdrawal of access for this 
Organisation and its staff, and that NSS has a duty, and is entitled hereunder, 
to report legal or regulatory breaches to the appropriate authorities (such as 
the Information Commissioner and professional regulatory bodies).” 
  
9.4 Student Supervisor  
(Note: Where the User is a student, the following Declaration must be signed 
by the student’s supervisor.) 
 
By signing and dating below you confirm that you will ensure that the above 
named User has read, understood and will comply with all the provisions of 
this Agreement. 
 
9.5 The Common Services Agency (commonly known as National Services 
Scotland) 
(Note: This section must be completed by the eDRIS Team for all User 
Agreements.) 
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Name: ____________________________________________________ 
 
Position: ____________________________________________________ 
 
Signature: ___________________________________________________ 
 
Date signed: ___________________________________________________ 
 
For and On behalf of 
______________________________________________ The Common 
Services Agency  
 
 
Appendix A – The Data Protection Principles 
 
1 “Personal data shall be processed fairly and lawfully and, in particular, 
shall not be processed unless-(a) at least one of the conditions in Schedule 2 
is met, and (b) in the case of sensitive personal data, at least one of the 
conditions in Schedule 3 is also met”. 
 
2 “Personal data shall be obtained only for one or more specified and lawful 
purposes, and shall not be further processed in any manner incompatible with 
that purpose or those purposes”. 
 
3 “Personal data shall be adequate, relevant and not excessive in relation to 
the purpose or purposes for which they are processed”. 
 
4 “Personal data shall be accurate and, where necessary, kept up to date”. 
 
5 “Personal data processed for any purpose or purposes shall not be kept for 
longer than is necessary for that purpose or those purposes”. 
 
6 “Personal data shall be processed in accordance with the rights of data 
subjects under this Act”. 
 
7 “Appropriate technical and organisational measures shall be taken against 
unauthorised or unlawful processing of personal data and against accidental 
loss or destruction of, or damage to, personal data”. 
 
8 “Personal data shall not be transferred to a country or territory outside the 
European Economic Area unless that country or territory ensures an adequate 
level of protection for the rights and freedoms of data subjects in relation to 
the processing of personal data”. 
 
Appendix B – Glossary 
 
Academic Use - any teaching and/or non-government funded research as 
conducted by or under the direction of a professor or other academic 
professional within an academic environment and excludes any and all 
commercial use. 
 
Appropriate access - the access a User will be given to appropriate areas of 
eDRIS.  
This access may be across network links that are fixed or virtual. 
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Approved Organisations - for direct access to individual level data held on 
eDRIS are restricted to public sector organisations (e.g.. Universities, NHS, 
Local Authorities and Scottish Government). Researchers/Users from the 
Scottish Government and Local Authorities will have direct access to data via 
the physical national safe haven only. 
 
Approved Researcher - is a researcher who has demonstrated they have 
satisfactorily completed the mandatory NSS approved training which ensures 
that they are fully aware of the policies and procedures governing individual 
privacy, data protection and freedom of information. In addition to ensure 
awareness and understanding of obligations specific to health data, Approved 
Researchers must also read the NHS Confidentiality Code of Practice. See 
further criteria for ‘eDRIS User’ 
 
 
Anonymised information – information from which no individual can be 
identified. 
 
Authorising Organisation - is the employing or sponsoring organisation 
signing the NSS eDRIS User Agreement in support of the User. The Authorising 
Organisation shall ensure that the User complies with the provisions of this 
Agreement. 
 
Commercial use of information – sharing Information (data or outputs) for 
corporate gain. 
 
Data Controller – a person who (either alone or jointly or in common with 
other persons) determines the purposes for which and the manner in which 
any personal data are, or are to be, processed. 
 
Data custodian – is responsible for the security of the database and may need 
to set up both physical and network security systems. If the data custodian 
finds evidence of unauthorized access, the data custodian is responsible for 
reporting the security breach to the Data Controllers, as well as fixing 
existing security weaknesses so future breaches do not occur. 
 
Data processor – any person (other than an employee of the Data Controller) 
who processes the data on behalf of the Data Controller. 
 
Data Protection Act 1998 (DPA) – the main UK legislation which governs the 
handling and protection of information relating to living people. 
 
Data sharing – the disclosure of data from one or more organisations to a 
third party organisation or organisations, or the sharing of data between 
different parts of an organisation. Data Sharing can take the form of 
systematic, routine data sharing where the same data sets are shared 
between the same organisations for an established purpose; and exceptional, 
one off decisions to share data for any of a range of purposes. 
18  
Disclosure controlled/cleared outputs - is used to describe an output which 
is considered not to contain information which could be used, in conjunction 
with other data, to identify a person. 
 
eDRIS User or User – is a researcher, employed by a eDRIS Approved 
Organisation to whom the National Services Scotland (NSS), under the 
Statistics and Registration Services Act (SRSA) 2007 and Data Protection Act 
1998, has granted access to study datasets for the purposes of statistical 
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research. The User will have approvals from the relevant authorising bodies 
and will have completed NSS approved training, read the NHS Confidentiality 
Code of Practice ensuring awareness of policy and procedures governing 
individual privacy, data protection and freedom of information and has signed 
this Agreement (see 1.3). Note an Approved Researcher refers to an individual 
who has satisfactorily completed the NSS Approved Training and read the NHS 
Confidentiality Code of Practice only. 
 
Information - includes both data and outputs where data are the raw details 
used to create outputs resulting from an analytical operation producing 
analysis; graphs; tables etc. The output can be in any format e.g.. paper, 
electronic etc. 
 
NSS Approved Training – Courses approved by NSS as suitable for researcher 
training in preparation for access to study datasets are listed in the frequently 
asked questions section of the eDRIS website. 
 
Outputs – the results of an analytical operation producing analysis; graphs; 
tables etc. The output can be in any format e.g.. paper, electronic etc. 
 
Personal data (or Personal information) – data which relate to a living 
individual who can be identified— 
 
a from those data, or  
b from those data and other information which is in the possession of, or is 
likely to come into the possession of, the Data Controller, and includes any 
expression of opinion about the individual and any indication of the intentions 
of the Data Controller or any other person in respect of the individual. 
 
Processing of data – in relation to information or data, means obtaining, 
recording or holding the information or data or carrying out any operation or 
set of operations on the information or data, including— 
 
a organisation, adaptation or alteration of the information or data, 
 
b retrieval, consultation or use of the information or data, 
 
c disclosure of the information or data by transmission, dissemination or 
otherwise making available, or 
 
d alignment, combination, blocking, erasure or destruction of the 
information or data. 
 
Research Coordinator – in the context of this Agreement is the eDRIS 
Research Coordinator employed by NSS who ensures that Users have 
completed the approved mandatory training, the Agreement is signed by the 
User, the declaration is signed by the User and the authorising organisation, 
and are aware of the penalties if they breach this Agreement. The Research 
Coordinator is also responsible for ensuring the User complies with the terms 
of this Agreement and approves outputs before release to the User. 
 
Safe Haven – is a national or local environment operating to procedures 
designed to uphold the Guiding Principles for Data Linkage and providing 
secure access to data whilst maintaining the utmost confidentiality. Local 
safe havens may have virtual or fixed lines to access eDRIS. NSS operates the 
Safe Haven for Scotland. 
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Safe Haven Requirements – the following list the criteria for remote Safe 
Haven workstations accessing eDRIS.  
 the safe haven should be located in a secure location e.g.. segregated area, 
windows and doors can be locked  
 the physical safe haven setting must ensure that data can not be viewed or 
read by anyone not identified in the relevant approvals for this study.  
 workstations must have screen savers installed and activated while left 
unattended  
 telephone conversations should not be held while accessing the data  
 data should not be written from the screen, or attempts made to 
photograph the screen  
 no attempt should be made to save screen shots  
 no attempt should be made to store or copy data  
 no attempt should be made to use removable data storage devises  
 MS Office 2010 Licence (e.g.. word, excel etc) must be provided by the 
Authorising Organisation. 
 
Stakeholder - in the context of this Agreement could be NSS, NSS & Other(s) 
or Other(s). 
 
Statistics and Registration Services Act - The Statistics and Registration Services Act 
(SRSA) 2007 Act states that a person who discloses Personal Information “is guilty of 
an offence and liable — (a) on conviction on indictment, to imprisonment for a term 
not exceeding two years, or to a fine, or both; (b) on summary conviction, to 
imprisonment for a term not exceeding twelve months, or to a fine not exceeding 
the statutory maximum, or both.” 
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Appendix 11: Search Strategy 
Databases searched: Pubmed, EmBase, Medline, Google Scholar. Additionally, 
the reference lists of key papers were scanned for relevant literature, and the 
publication lists of notable authors in the field were checked for any recent 
publications. 
Search terms used (adapted to individual databases): 
1. "head and neck neoplasms"/ or facial neoplasms/ or mouth neoplasms/ or 
otorhinolaryngologic neoplasms/ 
2. (head or neck) adj3 (cancer* or neoplasm* or carcinoma* or tumo?r* or 
adenocarcinoma* or oncolog* or malignan* or lymphoma* or melanoma* or 
squamous)).ti. 
3. exp Mouth Neoplasms/ 
4. ((oral or intra-oral or intraoral or mouth or lip* or tongue or cheek* or cheek 
lin* or gingiv* or gum* or palat* or "roof of mouth" or odontogenic or teeth or 
tooth or buccal or buccal mucosa or face or facial or maxilla*) adj3 (cancer* or 
neoplasm* or carcinoma* or tumo?r* or adenocarcinoma* or oncolog* or 
malignan* or lymphoma* or melanoma* or 
squamous)).ti. 
5. exp Lip Neoplasms/ 
6. exp Gingival Neoplasms/ 
7. exp Palatal Neoplasms/ 
8. exp Tongue Neoplasms/ 
9. exp Tonsillar Neoplasms/ 
10. exp Mandibular Neoplasms/ 
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11. exp Maxillary Neoplasms/ 
12. exp Odontogenic Tumors/ 
13. exp Oropharyngeal Neoplasms/ 
14. ((oropharyn* or tonsil* or retromolar*) adj3 (cancer* or neoplasm* or 
carcinoma* or tumo?r* or adenocarcinoma* or oncolog* or malignan* or 
lymphoma* or melanoma* or squamous)).tw. 
15. exp Pharyngeal Neoplasms/ 
16. ((pharyn* or throat) adj3 (cancer* or neoplasm* or carcinoma* or tumo?r* or 
adenocarcinoma* or oncolog* or malignan* 
17. Incidence or burden  
18. early detection or early diagnosis or screening or opportunistic screening 
19. “missed opportunities” or “ delays in diagnosis” or (diagnostic delays*) or 
(system delay*) or (patient delay*) or (professional delay*) 
 
 
